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A b st r a c t
S-palmitoylation is the reversible post-translational attachment o f the 16-carbon saturated fatty 
acid palmitate to the sulphydryl group o f cysteine residues through a thioester linkage. The 
primary function of palmitoylation has often been regarded as simply a means to increase the 
hydrophobicity and membrane affinity o f modified proteins, allowing them to become stably 
membrane-associated. However, recent evidence has demonstrated additional roles for 
palmitoylation in regulating protein trafficking, the membrane micro-localisation o f proteins, 
protein stability, and protein-protein interactions. A family o f twenty-three mammalian proteins 
containing a conserved DHHC cysteine-rich domain have recently been identified, and several 
o f these proteins have been shown to palmitoylate specific substrate proteins. The DHHC 
family of palmitoyl transferases are polytopic membrane proteins containing 4-6 membrane- 
spanning domains that are localised to distinct intracellular membranes, including the 
endoplasmic reticulum, Golgi apparatus, endosomes, and the plasma membrane. Since 
palmitoyl transferases are integral membrane proteins, substrate proteins must contain 
additional membrane targeting signals that mediate membrane association prior to palmitate 
transfer. For many proteins, the mechanism that mediates initial membrane binding prior to 
palmitoylation is clear; for example, initial membrane binding can be mediated by 
transmembrane domains or other lipid modifications such as prenyl or myristoyl groups, which 
are added to proteins in the cytosol. However, a number of palmitoylated proteins lack any 
obvious membrane targeting motifs and it is unclear how this class of proteins associate with 
membranes to allow palmitoylation to occur. The vesicle-associated, exocytotic chaperone 
Cysteine String Protein (CSP) is an example o f such a protein. CSP is extensively 
palmitoylated on a “string’ o f fourteen cysteine residues present within its signature cysteine 
string domain. Palmitoylation of CSP is essential for its intracellular sorting and function, and 
thus it is important to understand how this essential modification of CSP is regulated. In this 
study, a detailed mutagenesis approach has been employed to elucidate the mechanisms 
governing the initial membrane targeting of CSP, and the enzymes that palmitoylate CSP have 
been identified. As well as providing important information on CSP palmitoylation and 
membrane interactions, it is hoped that this analysis will also serve as a paradigm to understand 
the mechanisms by which other proteins become palmitoylated.
As a first step to characterising CSP membrane interactions, a hydrophobic 31 amino acid 
domain o f CSP was identified as the minimal membrane binding domain present within the 
protein. This domain includes the cysteine string domain, and indeed cysteine residues within 
this domain are proposed to play an essential role in membrane interaction prior to
palmitoylation. Membrane association o f the minimal membrane binding domain is not 
sufficient to trigger palmitoylation, which requires additional residues downstream o f the 
cysteine string domain. Intriguingly one role o f these downstream residues in CSP appears to 
be to weaken membrane affinity and indeed, in contrast to the minimal membrane binding 
domain, full-length CSP was cytosolic in the absence o f palmitoylation. The family of 23 
DHHC proteins were screened for activity against CSP, showing that palmitoylation is 
specifically enhanced by co-expression of the Golgi-localised palmitoyl transferases DHHC3, 
DHHC7, DHHC15 or DHHC17; co-expression of these enzymes is sufficient to promote the 
stable membrane attachment of CSP. CSP mutants with an increased membrane affinity were 
localised to the ER, and thus physically separated from the Golgi-localised partner DHHC 
proteins of CSP, offering an explanation of why these mutants are not palmitoylated. 
Interestingly, palmitoylation of an ER-localised mutant could be rescued by Brefeldin A (BFA) 
treatment, which promotes the mixing of ER and Golgi membranes, supporting the view that 
mutants with an increased membrane affinity are not palmitoylated because they associate with 
‘inappropriate’ membranes. In addition, the palmitoylated mutant remained at the ER following 
BFA washout and did not traffic to more distal membrane compartments, suggesting that 
palmitoylation of CSP may have a specific requirement to take place at Golgi membranes to 
facilitate subsequent intracellular sorting.
A model is proposed whereby CSP utilises a weak membrane affinity to “sample” intracellular 
membranes for DHHC protein content. As partner DHHC proteins of CSP are restricted to the 
Golgi, palmitoylation and stable membrane attachment only occurs at this intracellular 
compartment. Mutations that enhance initial membrane affinity prevent sampling and lead to 
accumulation of CSP on abundant cellular membranes such as the ER. As a palmitoylated CSP 
mutant did not traffic from the ER, the coupling of CSP palmitoylation to Golgi membranes 
may therefore be an important requirement for subsequent sorting. These findings suggest that 
membrane “sampling” through specialised protein domains might be a common mechanism 
employed by substrate proteins to locate their specific DHHC partner proteins.
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C h a p t e r  O n e : In t r o d u c t io n
t  I IA I’THR ONI:
1.1 In t r o d u c t io n
Eukaryotic cells are compartmentalised into discrete membrane-bounded organelles, each 
possessing specialised functions that are fundamental to cellular viability. To maintain their 
specificity and function, the identity of each organelle is defined by a unique composition of 
proteins and lipids. During membrane trafficking, membrane constituents and cargo are 
transported from one compartment to another, reaching their correct subcellular localisation 
without compromising this membrane integrity. In order to achieve this, proteins and lipids 
must be faithfully targeted to their specific resident subcellular membranes, or else cells risk the 
scrambling of membrane compartments and subsequent loss of organelle and cellular identity.
Membrane proteins potentially face a myriad of lipid bilayer-enclosed intracellular 
compartments with which to associate; therefore, mechanisms that regulate the trafficking of 
these proteins, from their synthesis until the deposition at their correct final destination, must 
exist. The mechanisms that target a membrane protein to its correct intracellular compartment 
are thus fundamental to cellular organisation and function.
1.2 M e m b r a n e  p r o t e in s
A classic example of a membrane-associated protein is one that transverses the lipid bilayer 
through one (bitopic) or more (polytopic) hydrophobic membrane-spanning domains. During 
synthesis, many integral (also called intrinsic) membrane proteins are co-translationally inserted 
into the endoplasmic reticulum (ER) membrane, where they are transported through the 
secretory pathway (See Chapter 1.7) until they reach their resident organelle membrane. 
Transmembrane proteins interact extensively with the hydrocarbon chains of membrane lipids 
through hydrophobic interactions and can only be released from membranes through the action 
of detergents, which disrupt the hydrophobic core of the phospholipid bilayer. Bitopic 
membrane proteins can be categorised as Type I-IV according to the way that they are inserted 
into the membrane and the resultant topology (Blobel, 1980; von Heijne and Gavel, 1988). 
Type I membrane proteins have an amino terminal (N-terminal) cleavable signal peptide and an 
apolar stop-transfer sequence resulting in a luminal N-terminus and a cytoplasmic carboxyl (C-) 
terminus. Type II membrane proteins have the reverse topology to Type I membrane proteins, 
due to the presence of an uncleaved signal peptide either internally or at the N-terminus. Type 
III membrane proteins are topologically identical to Type I membrane proteins, but possesses an 
N-terminal stop transfer sequence (von Heijne and Gavel, 1988). Another class of intrinsic 
membrane proteins, C-tail anchored proteins (or Type IV membrane proteins), are topologically
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similar to Type II membrane proteins, yet do not encode a signal sequence and hence become 
membrane inserted post-translationally (Kutay et al., 1993). C-tail anchored proteins possess a 
hydrophobic segment near to their C-terminus, which is inserted into the lipid bilayer, leaving 
the N-terminus orientated cytosolically (Kutay et al., 1993; Kutay et al., 1995). Polytopic 
membrane proteins may have their N- and C-termini on the same or opposite sides of the lipid 
bilayer.
In contrast to intrinsic membrane proteins, peripherally associated membrane proteins are 
traditionally viewed as ones that are synthesised on free ribosomes and interact relatively 
weakly with membranes. Peripheral membrane proteins are able to associate with membranes 
either directly, through electrostatic interactions involving charged amino acids and 
phospholipid headgroups, and/or indirectly via interactions with integral membrane proteins. 
Due to their weak ionic membrane interactions, peripheral membrane proteins are able to be 
solubilised in solutions of high ionic strength {e.g. 1M NaCl) or high pH {e.g. 0.1M Na2C 03, pH 
11), and are classically distinguished from integral membrane proteins based on this difference 
in membrane release. However, some membrane proteins share elements with both integral and 
peripheral membrane proteins. These membrane proteins are synthesised as soluble proteins but 
become modified by the attachment of hydrophobic lipid groups, allowing them to interact 
extensively with the hydrophobic core of the bilayer, and requiring detergent for solubilisation. 
The post-translational attachment of lipid groups is not specific to soluble proteins but also 
occurs with some integral membrane proteins. Examples of the different types of membrane- 
associated protein are illustrated in Figure 1.1.
1.3 L ipid  m o d if ic a t io n  o f  p r o t e in s
Proteins may be modified by the covalent attachment of lipid groups containing long (C,4-C2o) 
hydrocarbon chains, which, due to their hydrophobic nature, are able to embed in the 
phospholipid bilayer of intracellular membranes. Lipid anchors often enable otherwise soluble 
proteins to become membrane-associated; however, since both soluble and integral membrane 
proteins can be modified in this way, and more than one type of lipid modification may be 
present on an individual protein, the attachment of lipid anchors are likely to serve functions 
other than simply membrane-tethering. Indeed, recent studies have highlighted roles for lipid 
anchors in targeting proteins to specific subcellular membranes or specific microdomains 
present within the same membrane (El-Husseini et al., 2001; Goodwin et al., 2005; Rocks et al., 
2005; Roy et al., 2005). Lipid-modified proteins can be divided into four subgroups based on
-3-
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C. Lipid-anchored proteins
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Figure 1.1 C la sse s  of m em brane proteins. A. Transmembrane (TM) proteins interact 
extensively with the hydrocarbon core of the phospholipid bilayer, through one or more 
membrane-spanning domains. Proteins containing a single-pass membrane-spanning domain 
are known as bitopic proteins (i), whereas proteins that have more than one membrane- 
spanning domain are termed polytopic membrane proteins (ii). The N- and C-termini may be 
present on either or both sides of the bilayer. B. Peripheral membrane proteins (purple) interact 
with the surface of membranes. This interaction is either indirect through binding to another 
membrane protein (i; light blue) or direct through electrostatic interactions involving charged 
amino acids (dark blue) and the phospholipid headgroups on the inner leaflet of the membrane. 
C. Soluble proteins can become membrane-associated by the addition of one or more lipid- 
anchor(s) (i). Peripherally associated membrane proteins and TM proteins containing one 
(shown) or more membrane-spanning domains may also be post-translationally modified with 
lipid anchor(s) (ii-iii).
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the nature of the attached lipid: fatty acylated, prenylated, glypiated and cholesteroylated 
(Figure 1.2).
In eukaryotic cells, two types of membrane anchor, prenyl and acyl groups, allow proteins to 
associate with the cytosolic face of intracellular membranes. In contrast to prenylation and 
acylation, glypiation and cholesteroylation serve to tether proteins to the extracellular leaflet of 
the plasma membrane: both of these processes occur post-translationally and luminally 
(Englund, 1993; Mann and Beachy, 2004).
Glypiation is one of the most-studied lipid modifications, involving the modification of 
numerous functionally diverse proteins with a glycosylphosphatidyl inositol (GPI) anchor 
(Englund, 1993). The GPI anchor consists of a phosphatidyl inositol group embedded in the 
outer leaflet of the plasma membrane, connected by glycerophosphate to a complex 
oligosaccharide linker, which in turn is connected to the C-terminus of the protein through 
phosphoethanolamine (Englund, 1993).
Cholesteroylation refers to the modifcation of proteins with cholesterol, and is exemplified by 
the secreted tissue patterning factor Hedgehog (Mann and Beachy, 2004; Porter et al., 1996b). 
The addition of cholesterol to Hedgehog is essential for its normal cellular location, thereby 
preventing inappropriate signaling activity (Porter et al., 1996a).
1.3.1 P r e n y l a t io n
The covalent attachment of isoprenyl groups, such as famesyl (C,5) or geranylgeranyl (C20), 
occurs via a stable thioether linkage to one or more cysteine residues at or near the C-terminus 
of proteins. The donors for famesylation and geranylgeranylation are farnesyl pyrophosphate 
and geranylgeranyl pyrophosphate, respectively, and the enzymes responsible have been 
identified and characterised at the molecular level (Casey and Seabra, 1996). The three 
isoprenyltransferases, famesyltransferase (FTase), geranylgeranyltransferase I (GGTase I), and 
geranylgeranyl transferase II (GGTase II) can be divided into two groups depending on the 
consensus sequence they recognise (Zhang and Casey, 1996). Candidate proteins for FTase and 
GGTase I are those with cysteine residues at a C-terminal CaaX motif, where the cysteine 
residue (C) is followed by two aliphatic amino acids (a), and X is the carboxyl-terminal residue 
(Clarke, 1992; Zhang and Casey, 1996). Conversely, GGTase II specifically acts on Rab 
proteins that have two cysteine residues at or near the C-terminus (Farnsworth et al., 1994; 
Seabra et al., 1992). Following protein isoprenylation, the terminal three amino acids are
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(i) S-Palmitoylation
(ii) A/-Palmitoylation
(iii) /V-Myristoylation
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C Glypiation
\ /
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Gl cN
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Figure 1.2 H ydrophob ic lipid m o d ifica tio n s.
Figure 1.2 Hydrophobic lipid m odifications. The structures of lipid anchors that are 
covalently attached to eukaryotic proteins via post-translational modifications are shown. A.  
Fatty acylated proteins may be S-palmitoylated (i) through the attachment of a 16-carbon 
saturated fatty acid, palmitate, via a labile thioester bond to the thiol group of cysteine residues. 
Alternatively, proteins may be A/-palmitoylated (ii) via a stable amide bond to an N-terminal 
glycine. Occasionally, A/-palmitoylation occurs as the result of a spontaneous bond 
rearrangement following the addition of palmitate to an N-terminal cysteine (red side-chain). 
Proteins modified by the addition of a 14-carbon saturated fatty acid, myristate, to an N-terminal 
glycine residue via a stable amide linkage are known to be A/-myristoylated (iii). 8 . Prenylation 
involves the addition of branched unsaturated prenyl groups, such as farnesyl (C:15; i) or 
geranylgeranyl (C:20; ii), to one or more cysteines at or near the C-terminus via a stable 
thioether linkage. The addition of glycophosphitidylinositol (GPI; C) and cholesterol (D) occurs 
in the ER and results in the deposition of proteins on the exoplasmic face of the PM. A 
simplified structure of a GPI anchor is shown; proteins are linked at their C-terminus through a 
phosphodiester linkage to a phosphoethanolamine unit of GPI. The phosphoethanolamine unit 
is linked to trimannosyl-non-acetylated glucosamine (Man3-GlcN) core, with the reducing end of 
GlcN linked to phosphatidylinositol (PI). The covalent bond generated as a result of the 
modification are shaded: thioester, yellow; amide, grey; thioether, green. A blue sphere 
represents the modified protein. Chemical structures were generated using ChemBioDraw® 
Ultra 11.0 software (CambridgeSoft®, Cambridge, Massachusetts, U.S.A.).
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proteolytically cleaved, and the new terminal carboxylate group is methyl esterified, creating a 
C-terminal S-isoprenyl cysteine a-methyl ester (Clarke et al., 1988; Gutierrez et al., 1989). The 
majority of Ras and Rho small GTPase family proteins terminate with a CaaX motif and 
undergo sequential isoprenylation by FTase or GGTase I, proteolysis and carboxyl methylation 
(Pechlivanis and Kuhlmann, 2006). Farnesylation of H- (Harvey-), K- (Kirsten-) and N- 
(Neuroblastoma-) Ras is essential for membrane association and Ras signalling (Magee and 
Marshall, 1999). The Rab family of GTPases are geranylgeranylated on one or both cysteines 
by GGTase II, at C-terminal CC, CXC or CCX(XX) motifs (Farnsworth et al., 1994; Zhang and 
Casey, 1996). Rab family proteins modified by GGTase II require a helper protein, Rab escort 
protein (REP), to be efficiently prenylated (Pereira-Leal et al., 2001).
1.3.2 F a t t y  a c y l a t io n
Fatty acylation refers to the covalent attachment of fatty acids to proteins. Three classes of fatty 
acylation in eukaryotes have been described: A-myristoylation, A-palmitoylation and S- 
palmitoylation.
/V-myristoylation is the irreversible addition of the 14-carbon saturated fatty acid myristate to 
the N-terminal glycine of proteins by an amide bond. Proteins that become myristoylated 
usually begin with the sequence Met-Gly, and often contain a serine or threonine at position 6. 
A-myristoylation usually occurs co-translationally, whereby the initiating methionine is cleaved 
by cellular methionylaminopeptidases, followed by the addition of myristate to the N-terminal 
glycine by the enzyme A-myristoyl transferase (NMT) using myristoyl CoA as its substrate 
(Farazi et al., 2001; Towler et al., 1987). Less frequently a protein may be TV-myristoylated 
post-translationally, for example following proteolytic cleavage which reveals an otherwise 
hidden myristoylation motif (Zha et al., 2000). Of all eukaryotic proteins, approximately 0.5% 
are N-myristoylated (Resh, 2006), including many signalling proteins, such as members of the 
Src family of non-receptor tyrosine kinases, guanine nucleotide binding (G-) protein a  subunits 
of heterotrimeric G proteins, and proteins involved in membrane fusion events, for example Arf 
proteins (Resh, 1999). In addition to the role myrisoylation plays in membrane binding, X-Ray 
crystallography has revealed how myristoylation contributes towards the structural stability of 
proteins, such as the catalytic subunit of protein kinase A (PKA) (Zheng et al., 1993), and the 
protein shell of poliovirus (Chow etal., 1987).
Some myristoylated proteins are able adopt two conformations: one in which the myristate is 
available for bilayer interactions, and one in which it is sequestered inside a hydrophobic pocket
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within the protein. The transition between these two conformations is known as a ‘myristoyl 
switch’ (McLaughlin and Aderem, 1995) and often allows membrane binding to be dynamically 
regulated. The triggers for the switch include ligand binding, electrostatic interactions and 
proteolysis (Resh, 1999). For example, guanine nucleotide exchange from the guanine 
diphosphate (GDP-) bound form of Arf to the guanine triphosphate (GTP-) bound generates a 
conformational change in Arf that exposes its myristoylated N-terminus allowing for membrane 
binding (Goldberg, 1998).
In addition to protein acylation with myristoyl groups, many proteins are modified by 
attachment of the fatty acid palmitate. This occurs by distinct mechanisms to A-myristoylation, 
and will be discussed in detail in Chapter 1.4.
1.3.3 M e m b r a n e  a f f in it y  o f  l ip id  a n c h o r s
The effects that various lipid anchors exert on the affinity of proteins for intracellular 
membranes can be estimated by measuring the rate of association/dissociation of model 
acylated and prenylated peptides for artificial phospholipid vesicles (Peitzsch and McLaughlin, 
1993; Shahinian and Silvius, 1995; Silvius and l'Heureux, 1994). Such studies have 
consistently implied that neither farnesylation nor myrisoylation alone provide sufficient 
hydrophobicity to stably anchor modified proteins to intracellular membranes. Accordingly, a 
peptide modified by a single farnesyl group dissociates from liposomes within 1-2 minutes 
(Silvius and l'Heureux, 1994). Analysis of myristoylated peptide binding to phospholipids 
bilayers revealed a of approximately KT* M: this dissociation constant provides barely 
enough energy to incorporate into the plasma membrane (Peitzsch and McLaughlin, 1993). 
Fatty acids with longer hydrocarbon chains, and therefore greater hydrophobicity, confer 
stronger membrane association than fatty acids with shorter and less hydrophobic chains, and 
the strength of membrane binding of acylated peptides has been shown to be directly 
proportional to the number of carbon atoms in the hydrocarbon chain (Peitzsch and 
McLaughlin, 1993). Thus, a C 16 palmitoyl group has a higher membrane affinity than a C14 
myristoyl group, but nevertheless a single palmitate still does not allow stable membrane 
binding of peptides (Peitzsch and McLaughlin, 1993).
The stable membrane binding of both farnesylated and myristoylated proteins requires 
additional signals to enhance membrane affinity, which can include hydrophobic residues or a 
polybasic domain, which interacts electrostatically with acidic phospholipids. For example, the 
prenylated protein K-ras has six lysines at its C-terminus, which act synergistically with an
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adjacent famesyl group to enhance stable plasma membrane binding (Hancock et al., 1990). 
Similarly, the myrisoylated N-terminal domain of Src contains basic amino acids, which 
enhance membrane binding through electrostatic interactions with acidic phospholipid 
headgroups (Sigal et a l., 1994). Alternatively, a second lipid anchor, such as palmitate can 
promote stable membrane binding of both famesylated and myristoylated proteins. Indeed, 
tandem lipid modifications have been shown to be sufficient at promoting high affinity 
interactions with lipid bilayers (Peitzsch and McLaughlin, 1993; Shahinian and Silvius, 1995).
1.4 PALMITOYLATION
Palmitoylation refers to the post-translational addition of the 16-carbon saturated fatty acid 
palmitate to proteins in one of two ways: by a cleavable thioester linkage to the sulphydryl 
group of cysteine residues (known as S-palmitoylation), or, less frequently, by an amide linkage 
(known as A-palmitoylation).
The amide bond in A-palmitoylation (palmitoylamide) is non-cleavable, and has only been 
described for a few proteins, the first being the secreted signalling protein sonic hedgehog 
(Pepinsky et al., 1998), where palmitate is attached to a N-terminal cysteine. In this case, 
palmitate is thought to initially attach to the cysteine residue through a thioester bond, after 
which spontaneous bond rearrangement generates the amide linkage. Palmitate has also been 
shown to be attached to an N-terminal glycine residue by an amide bond, as is the case for the 
subunit of heterotrimeric G proteins (Kleuss and Krause, 2003).
Nearly all palmitoylated proteins are S-palmitoylated. It is important to note that labelling a 
protein as being ‘palmitoylated’ is historically based on the observed incorporation of [3H] 
palmitic acid into proteins. However, when the lipid profile of palmitoylated proteins has been 
examined using techniques such as mass spectrometry, it is clear that other medium- and long- 
chain fatty acids are also attached to proteins through thioester linkages, such as the saturated 
fatty acids myristate and stearate (Liang et al., 2002; Nadler et al., 1994), and the unsaturated 
fatty acids oleate or arachidonate (Hallak et al., 1994). Therefore, the term S-acylation is more 
appropriate; however, since the majority of S-acylated proteins incorporate palmitate, the term 
palmitoylation is generally used, and will be used synonymously with acylation hereafter.
A key difference between palmitoylation and m yristoylation/farnesylation is that S- 
palmitoylation is a reversible modification, and thus the membrane binding of palmitoylated 
proteins can be under regulation. Indeed, the membrane localisation and activity of Ras
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proteins are regulated by cycles of palmitoylation and depalmitoylation (See Chapter 1.4.2) 
(Rocks et al., 2005).
1.4.1 P r o t e in  f e a t u r e s  a sso c ia t e d  w it h  p a l m it o y l a t io n
In contrast to other forms of lipid modification, such as prenylation or myristoylation, which 
have well-defined consensus sequences for modification (See Chapters 1.3.1-2), there is no 
general consensus that specifies whether a protein becomes palmitoylated or not. In fact, the 
only sequence requirement for palmitoylated proteins appears to be the presence of a cysteine 
residue. Palmitoylated cysteine residues are, however, frequently located close to the regions 
within a protein that are primarily associated with membrane binding: for example, cysteines 
adjacent to membrane-spanning, hydrophobic or polybasic domains, or close to the site of a 
different lipid anchor, such as a prenyl or myristoyl group. The synaptic vesicle protein 
synaptotagmin I is palmitoylated on a cluster of five cysteine residues adjacent to the 
transmembrane anchor (Chapman et al., 1996); it is predicted that one of the cysteines is located 
in the cytoplasmic tail region, while the remaining four are in the transmembrane region 
(H eindel et al., 2003). Indeed, for most palmitoylated transmembrane proteins, the 
palmitoylated cysteines are located within the ten amino acids flanking the transmembrane 
domain/cytoplasmic domain boundary (Bijlmakers and Marsh, 2003). Ras proteins are dually 
modified by prenylation and palmitoylation in their C-terminus, and the site modified by 
palmitate is only 4-5 amino acids upstream of the famesyl anchor (Hancock et al., 1989; 
Hancock et al., 1990). Similarly, in nearly all proteins having dual palmitate and myristate 
modifications at their N-terminal, the palmitoylated cysteine is localised immediately after the 
myristoylated glycine (Resh, 1999). However, since some otherwise cytosolic proteins (i.e. 
those not in possession of membrane-spanning domains or additional lipid anchors) have 
cysteine residues that may become palmitoylated, the factors that determine whether a cysteine 
in a protein gets palmitoylated are more complex than simply just being close to a membrane- 
binding domain.
1.4.2 F u n c t io n s  o f  p a l m it o y l a t io n
Protein palmitoylation has a primary function in allowing otherwise soluble proteins, including 
both exclusively palmitoylated and dually lipidated proteins, to become stably membrane-bound 
by increasing the affinity of the modified protein for the lipid bilayer through the insertion of 
the hydrophobic C16 lipid anchor. However, despite the important role that palmitoylation plays 
in membrane binding, it is becoming clear that palmitoylation does not always function as a
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simple membrane anchor. This point is emphasised by the demonstrated palmitoylation of a 
number of transmembrane proteins, which clearly do not require palmitoylation for membrane 
anchoring. Furthermore, palmitoylation of extracellular proteins has also been documented 
(Pepinsky et al., 1998). Indeed, palmitoylation has now been shown to play diverse roles in 
addition to membrane tethering: in the targeting of both soluble and transmembrane proteins to 
distinct membrane compartments and membrane microdomains (El-Husseini et al., 2001; Roy 
et al., 2005); in the trafficking of proteins between various intracellular membranes (Goodwin et 
al., 2005; Kang et al., 2004; Kinlough et al., 2006; Rocks et al., 2005); in promoting protein 
stability, for example by regulating protein degradation or ensuring correct protein folding (Lam 
et al., 2006; Valdez-Taubas and Pelham, 2005); and in regulating protein-protein interaction 
(Hayashi et al., 2005). Examples of just a few of the multiple functions that palmitoylation 
plays are given below.
Palmitoylation is required for efficient biosynthetic delivery of some polytopic membrane 
proteins to the plasma membrane, such as members of the G-protein coupled receptor (GPCR) 
family. This is the case for the human 5 opiod receptor (Petaja-Repo et al., 2006) and the 
canine histamine H2 receptor (Fukushima et al., 2001). Furthermore, palmitoylation has been 
shown to influence the localisation of proteins within plasma membrane microdomains. H-ras 
is dually palmitoylated at cysl81 and cysl84, and monopalmitoylation of H-ras at each of these 
cysteines alters the lateral segregation of H-ras between plasma membrane cholesterol- 
dependent and cholesterol-independent microdomains (Roy et al., 2005). Palmitoylation- 
dependent effects on protein microlocalisation within membranes have also been highlighted for 
growth associated protein (GAP-) 43 and postsynaptic density (PSD-) 95 (El-Husseini et al., 
2001).
The trafficking of many transmembrane proteins between the plasma membrane and various 
intracellular membranes can also be regulated by palmitoylation.
Palmitoylation-dependent trafficking between the plasma membrane and the Golgi is 
exemplified by the postsynaptic receptor trafficking of AMPA (a-amino-3-hydroxy-5-methyl-4- 
isoxazole propionic acid) receptors. AMPA receptors have four subunits, GluRl-GluR4, which 
are palmitoylated at two sites: site one is at the end of transmembrane domain two, and site two 
is within the C-terminal domain. The stable cell surface expression of AMPA receptors depends 
on its interaction with protein 4 .IN, since disrupting this interaction leads to a decrease in cell 
surface expression (Shen et al., 2000). Palmitoylation at the C-terminal site inhibits the 
interaction with protein 4 .IN, resulting in the agonist-induced regulated endocytosis of the
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AMPA receptor (Hayashi et al., 2005). In contrast, palmitoylation at site one appears to be 
more important in regulating the biosynthetic delivery of AMPA receptors to the plasma 
membrane, as palmitoylation of this site by the Golgi-localised PAT DHHC3/GODZ suppresses 
the sorting of the receptor from the Golgi (Hayashi et al., 2005; Uemura et al., 2002). 
Furtherm ore, the activation of AMPA receptors by glutamate addition promotes 
depalmitoylation (Hayashi et al., 2005).
MUC1 is a mucin-like transmembrane protein normally expressed on the apical membrane of 
epithelial cells, where it has a protective function. Palmitoylation of MUC1 has been shown to 
regulate its trafficking between the plasma membrane and endosomes. MUC1 is dually 
palmitoylated on cysteines located at the boundary of the transmembrane domain and the C- 
terminal tail. Blocking palmitoylation by mutating these cysteine residues inhibits the recycling 
of MUC1 from endosomes back to the cell surface, resulting in the accumulation of MUC1 in 
endosomal compartments (Kinlough etal., 2006).
Palmitoylation is also involved in the sorting of synaptotagmin 1 from the plasma membrane to 
an intracellular vesicle pool. Synaptotagmin 1 is palmitoyated on five cysteine residues in the 
boundary between the transmembrane and cytoplasmic region (Heindel et al., 2003). Mutating 
these cysteine residues prevents palmitoylation of synaptotagmin 1, leading to an increase in 
cell surface expression in both PC 12 cells and primary hippocampal neurons. Palmitoylation is 
thus required for internalisation and sorting of synaptotagmin 1 to the presynaptic vesicle pool 
(Kang et al., 2004).
The role of palmitoylation in the trafficking of otherwise cystosolic proteins is best illustrated 
by the small GTPase Ras. A dynamic palmitoylation-depalmitoylation cycle drives the 
distribution of Ras between the plasma membrane and Golgi membranes. Palmitoylation of 
farnesylated Ras at the Golgi leads to stable membrane-binding and onward transport to the 
plasma membrane, where it is able to participate in signalling events. Depalmitoylation of Ras 
at the plasma membrane releases Ras into the cytosol where it transiently interacts with 
membranes by virtue of a farnesyl anchor until it becomes palmitoylated, and hence stably 
membrane-associated, once again, at the Golgi (Goodwin et al., 2005; Rocks et al., 2005).
Finally, the functions of palmitoylation are not just restricted to membrane targeting or 
membrane trafficking: palmitoylation presents more diverse roles, as exemplified by two yeast 
proteins, the yeast chitin synthase Chs3p, and the yeast homologue of syntaxin 6, T lglp. In 
these cases although palmitoylation still influences protein trafficking it also has effects on
-13-
I  H A H  I K O N h
protein aggregation and protein stability. Chs3p is a transmembrane protein containing 6-8 
predicted membrane-spanning domains and is involved in cell wall growth. Preventing Chs3p 
palmitoylation leads to its aggregation and blocks the trafficking of Chs3p out of the ER (Lam 
et al., 2006). This suggests that palmitoylation of Chs3 may be required, and serves as a 
marker, for the proper folding of the protein. T lglp  mediates fusion between endosomes and 
the trans Golgi network, and is palmitoylated by Swflp on two cysteine residues neighbouring 
the transmembrane domain (Valdez-Taubas and Pelham, 2005). Palmitoylation prevents the 
ubiquitination of T lg lp  by the E3 ubiquitin ligase, Tulip, which would result in T lglp  being 
targeted to the vacuole for degradation (Valdez-Taubas and Pelham, 2005). Here, 
palmitoylation protects T lg lp  from degradation and ensures that it is retained in its correct 
subcellular localisation. Interestingly, interplay between protein palm itoylation and 
unbiquitination has also been observed for mammalian proteins. The co-receptor for Wnt, 
LRP6 (lipoprotein receptor-related protein 6), is palmitoylated on two cysteines adjacent to its 
transmembrane domain: mutating these cysteines leads to the ubiquitination of LRP6 and its 
retention in the endoplasmic reticulum (Abrami et al., 2008).
1.4.3 M e c h a n ism  o f  p a l m it o y l a t io n
Whether palmitoylation in vivo is a spontaneous occurrence or enzyme-mediated has been much 
debated in recent years. The lack of readily identifiable palmitoylation consensus motifs, the 
difficulty in purifying putative active palmitoylation enzymes, and the high reactivity of acyl- 
coenzyme A donors with substrate protein thiols in vitro, which permits in vitro palmitoylation 
in the absence of a catalyst, all contributed to the belief that palmitoylation may not be a 
catalytic event in vivo (Dietrich and Ungermann, 2004). For spontaneous palmitoylation to 
occur, the sulphydryl group on the cysteine residue would require deprotonation to form a 
thiolate. Thiolate is a reactive nucleophile, and so nucleophilic attack of the highly reactive a- 
carbon of the thioester bond between the coenzyme A and the palmitoyl group could occur. The 
pKa of cysteine ionisation to form a thiolate is ~8.5 and so thiolate formation in the cell cytosol 
(pH 7.3-7.4) would be predicted to be a rare event (Dietrich and Ungermann, 2004). However, 
the amino acids that surround a cysteine could promote thiolate formation in vivo, perhaps 
allowing spontaneous palmitoylation to occur. The pKa of cysteine-containing peptide 
sequences was decreased following the addition of charged (lysine/arginine) or aromatic amino 
acids to the peptide sequence (Bizzozero et al., 2001), suggesting that by lowering the pKa 
these residues could increase the ionisation of the neighbouring cysteine and thus promote 
thiolate formation.
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1.4.3.1 S p o n t a n e o u s  p a l m it o y l a t io n
In agreement with palmitoylation being a spontaneous event, many proteins and peptides have 
been shown to be palmitoylated on cysteine residues in vitro in the absence of a specific 
acyltransferase, using palmitoyl-coenzyme A as the acyl donor. Furthermore, several 
similarities between in vitro palmitoylation, and cellular palmitoylation have been observed. 
Such similarities include palmitoylation on specific cysteine residues, the requirement for prior 
TV-myristoylation, and the need for other proteins or cofactors.
Peptide fragments derived from in vivo palmitoylated proteins were palmitoylated in vitro, 
while other cysteine-containing peptides were not (Bharadwaj and Bizzozero, 1995), suggesting 
that spontaneous palmitoylation can be a specific event, as would be expected for a process that 
needs to be regulated in vivo. This non-enzymic reaction is not just restricted to peptides: the 
Ga subunit of heterotrimeric G proteins became autopalmitoylated in vitro on the same cysteine 
residue that is palmitoylated in vivo (Duncan and Gilman, 1996). In addition, palmitoylation 
only occured after Ga had first been myristoylated on an N-terminal glycine. Furthermore, 
palmitoylation of Ga in vitro was greatly enhanced by inclusion of GPy subunits in the 
palmitoylation reaction (Duncan and Gilman, 1996). Similarly, the SNARE (soluble N- 
ethylmaleimide-sensitive factor attachment protein receptor) SNAP25 (25 kDa synaptosome- 
associated protein) was also palmitoylated in vitro, and this was shown to be dramatically 
enhanced by the presence of its binding partner, the SNARE syntaxin 1A (Veit, 2000).
Finally, the conditions used for palmitoylation of peptides in vitro, specifically the dependence 
on time, pH, temperature and the concentration of the substrate, suggests that the reaction could 
occur spontaneously in vivo (Bano et al., 1998). If palmitoylation were to occur spontaneously 
in vivo, then this process would need to be regulated. Such regulation may be accomplished by 
protein palmitoyl thioesterases, which deacylate palmitoylated proteins (see Chapter 1.6), and/or 
by specific binding partners of the palmitoylation substrate.
Despite the ability of some proteins and peptides to undergo palmitoylation on specific 
cysteines and in the absence of an enzyme in vitro, several factors argue against spontaneous 
palmitoylation occurring in vivo.
First, non-selective palmitoylation of proteins also occurs in vitro. For example, the 
cytoskeletal protein actin has five cysteine residues that are not palmitoylated in vivo, however, 
conditions that favour palmitoylation of peptide fragments in vitro also non-specifically 
palmitoylate actin (Bano et al., 1998). Conversely, not all palmitoylated proteins could be
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palmitoylated in vitro (e.g. Fyn kinase) or palmitoylation was inefficient (e.g. for GAP-43, 
SNAP25 and some Ga subunits) (Duncan and Gilman, 1996).
Second, palmitoylation in cells is dependent on the sequence surrounding the palmitoylation 
site, which would be difficult to regulate if cysteine residues were able to undergo spontaneous 
palmitoylation in vivo. Mutation of residues surrounding the palmitoylated cysteine residue in 
the tyrosine kinase Fyn abolishes its palmitoylation in vivo but the mutant protein is still able to 
undergo spontaneous palmitoylation in vitro (Resh, 1999). However, a caveat to these points, 
as discussed in Chapter 1.4.3, is that thiolate formation in vivo may be critically dependent upon 
surrounding amino acids: this requirement could be bypassed in vitro, for example, through 
manipulation of the pH and salt concentration.
It is also noteworthy to mention that most of the free cytosolic fatty acyl-coenzyme A within a 
cell is thought to be sequestered by acyl-coenzyme A binding proteins (ACBPs), ubiquitously 
expressed cytosolic proteins of ~ 10 kDa, which bind medium- and long-chain acyl-coenzyme 
A esters with very high affinities (Faergeman et al., 1996; Faergeman and Knudsen, 1997; 
Frolov and Schroeder, 1998; Rosendal et al., 1993). In this way, physiological concentrations 
of acyl-coenzyme A are predicted to be much lower than the concentrations required for 
spontaneous palmitoylation in vitro, although, the actual free cytosolic concentration of long- 
chain acyl-coenzyme A esters is not known (Faergeman and Knudsen, 1997). Indeed, the 
addition of physiological concentrations of ACBPs to in vitro palmitoylation reaction mixtures 
results in a concentration-dependent inhibition of the otherwise spontaneous palmitoylation of 
both proteins and peptides (Dunphy et al., 2000; Leventis et al., 1997). By taking into 
consideration the existence of cytosolic ACBPs, it is predicted that in the absence of a catalyst 
the rate of palmitoylation of membrane-associated proteins in cells would be extremely slow 
(days) (Leventis et al., 1997), and therefore not physiologically relevant, given the short 
palmitoylation half lives of some proteins in vivo. For example, the half-life of palmitate 
turnover on N-Ras was predicted to be around twenty minutes (Magee et al., 1987), and indeed 
more recent experiments have suggested a far more rapid rate of turnover (Goodwin et al., 
2005; Rocks et al., 2005).
Finally, even in the absence of ACBPs, the rates at which in vitro palmitoylation reactions 
proceed vary greatly, and in most cases have been relatively slow. Given that many 
palmitoylated proteins are subject to dynamic cycles of acylation and deacylation in vivo, the 
spontaneous acylation of proteins in cells seems unlikely to be a widespread event.
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1.4.3.2 P r o t e i n  a c y l t r a n s f e r a s e s
The enzymes that catalyse the thioesterification of cysteines in substrate proteins with palmitate 
have only relatively recently been reported. The identification of protein acyltranferases (PATs) 
was previously hindered in part by the difficulties in preserving enzyme activity of putative 
PATs following purification or membrane solubilisation. Furthermore, previous attempts to 
purify PAT activity have been misleading; for example, one PAT that was purified to apparent 
homogeneity and shown to have activity towards Ras proteins was later identified as thiolase A, 
a peroxisomal enzyme (Liu et al., 1996).
The first enzyme possessing PAT activity towards cytosolic proteins was identified and isolated 
from Saccharomyces cerevisiae in 2002 (Lobo et al., 2002). Ras proteins and their post- 
translational processing are conserved from yeast to man. Wild-type mature Ras is localised 
primarily to the cytoplasmic face of the plasma membrane (Magee and Marshall, 1999). Plasma 
membrane targeting of most Ras proteins is dependent on a series of post-translational 
modifications, specifically famesylation of a C-terminal CaaX  box cysteine, -aaX  proteolysis 
and methyl esterification of the newly exposed cysteinyl a-carboxyl, prior to palmitoylation of 
one or more neighbouring cysteines (Hancock et al., 1990). To identify the genes responsible 
for palmitoylation of yeast Ras2, a previously characterised prenylation-deficient Ras2 mutant 
protein was exploited. Replacing the C-terminal CaaX box of yeast Ras2 (CCIIS) with a basic 
extension sequence (CSIIKLIKRK) generated a mutant Ras2 protein, which could be 
palmitoylated on the equivalent cysteine to wild-type protein and targeted correctly, while 
bypassing the requirement for famesylation (Mitchell et al., 1994). A genetic screen of a Ras2 
palmitoylation-dependent yeast strain was employed to identify mutations that diminished Ras2 
palmitoylation, as determined by loss of viability. Two legitimate complementation groups that 
disrupted modified Ras2 palmitoylation were identified; one was designated ERF2 (for effector 
o f Ras function), and the other was recognized as ERF4 (also called SHR5; suppressor o f  
hyperactive Ras) (Bartels et al., 1999). An in vitro palmitoylation assay was used to confirm 
that the Erf2p/Erf4p complex directly catalysed ^-palmitoylation of yeast Ras. By incubating 
partially purified Erf2p/Erf4p with prenylated Ras in the presence of tritiated palmitoyl 
coenzyme A as the palmitate donor, the rate of Ras2 palmitoylation was 160-fold greater than 
the rate in the absence of the Erf2p/Erf4p complex (Lobo et al., 2002). The catalytic activity of 
the yeast Ras PAT requires a heterodimeric complex of both Erf2p and Erf4p, since neither 
protein is capable of carrying out palmitoylation reactions individually (Lobo et al., 2002). 
Concurrent with the discovery of the Erf2p/Erf4p complex as a palmitoyl transferase, a second 
yeast protein, A krlp  (Ankyryn repeat-containing protein), was shown to catalyse the S- 
palmitoylation of the yeast type I casein kinase Yck2p in vitro (Roth et al., 2002). Unlike the
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PAT for the yeast Ras2, A krlp does not require to be part of a complex for catalytic activity, as 
it is able to work independently without accessory subunits (Roth et al., 2002). Sequence 
analysis of Erf2p, Erf4p and A krlp reveals that there is a single region of sequence homology 
between Efr2p and Akrlp: both Efr2p and A krlp share a conserved 51-residue-long zinc-finger 
like domain, known as a DHHC (aspartate-histidine-histidine-cysteine) cysteine-rich domain 
(CRD), which is not present in Erf4p.
In addition to the DHHC-CRD family of PATs, a second class of palmitoylating enzymes has 
been identified. These PATs modify N-terminal cysteines on proteins that are located 
exclusively in the lumen of organelles. These PATs were first identified in Drosophila 
melanogaster and were shown to palmitoylate N-terminal cysteines of the secreted morphogens 
Hedgehog and Wnt (Chamoun et al., 2001; Zhai et al., 2004). The A-pal mi toy 1 transferase 
Skinny hedgehog {Ski\ also known as Rasp, Central missing, and Sightless), was first shown to 
be required for the palmitoylation of Hedgehog (Chamoun et al., 2001) and subsequendy, Spitz 
(M iura et al., 2006). Wnt requires a different A-palmitoyltransferase, Porcupine {Pore), for 
palmitoylation (Zhai et al., 2004). Skinny hedgehog and Porcupine do not possess the 
conserved DHHC domain as seen for the yeast PATs, but share limited sequence homology 
with certain O-acyltransferases that add acyl groups onto hydroxyl groups of membrane- 
anchored substrates (Hofmann, 2000).
1.5 THE D H H C  FAMILY OF PALMITOYL ACYLTRANSFERASES
The finding that the two PATs in yeast, Erf2p and A krlp, share a conserved DHHC domain, 
and that mutations within this domain abolish catalytic activity (Lobo et al., 2002; Roth et al., 
2002), suggested that the DHHC domain may be a palmitoyl transferase motif. Similarly, it was 
proposed that proteins containing the DHHC-CRD may represent a family of PATs (Roth et al., 
2002). Subsequent analysis of the yeast and mammalian genomes has identified a family of 
seven proteins in yeast; Akrlp, Akr2p, Erf2p, Pfa3p, Pfa4p, Pfa5p and Swflp; and twenty-three 
in mammals; DHHC1-DHHC23 (Fukata et al., 2004), all containing a conserved DHHC-CRD 
(Figure 1.3). Genetic and biochemical analyses have demonstrated the palmitoyl transferase 
activity of several of these DHHC-CRD containing proteins, and accordingly, many substrates 
have been identified.
Five yeast DHHC-containing proteins have been shown to catalyse 5-palmitoylation so far and 
several enzyme-substrate pairs have been identified. As mentioned above, in vitro and in vivo 
palmitoylation assays have shown that Erf2p palmitoylates Ras (Lobo et al., 2002), and A krlp
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Figure 1.3 The DHHC family of palmitoyl acyltransferases. A. Members of the DHHC 
family of palmitoyl transferases are polytopic integral membrane proteins encoding 4-6 
predicted membrane-spanning domains with the DHHC Cysteine Rich Domain and both N- and 
C-termini oriented cytosolically. B. Alignment of the twenty-three mouse DHHC proteins; 
conserved residues are shaded in grey.
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palmitoylates Yck2p (Roth et al., 2002). In addition to Yck2p, A krlp also palmitoylates the 
sphingoid long-chain base kinase, Lcb4 (Kihara et al., 2005). Swflp is likely to be the enzyme 
responsible for palmitoylation of the yeast SNAREs Snclp, T lg lp  and Syn8p (Valdez-Taubas 
and Pelham, 2005). Pfa3p (Protein fatty acyltransferase 3) has been shown to palmitoylate 
Vac8p, a protein involved in yeast vacuolar inheritance, in vitro and in vivo (Hou et al., 2005; 
Smotrys et al., 2005), while palmitoylation of the yeast chitin synthase, Chs3p, is dependent on 
Pfa4p (Lam et al., 2006). Substrates for the remaining two yeast DHHC-CRD proteins, Akr2p 
and Pfa5p, have yet to be determined.
Palmitoyl transferase activity has been reported for nine of the twenty-three mammalian 
DHHC-CRD proteins to date and, for the majority of these PATs, palmitate can be incorporated 
into multiple substrates. The first mammalian DHHC-CRD protein shown to have PAT activity 
was DHHC3, also known as GODZ (Keller et al., 2004; Uemura et al., 2002). The y2 subunit 
of the GABAa (y-aminobutyric acid) receptor is essential for postsynaptic clustering of GABAa 
receptor subtypes (Essrich et al., 1998), and palmitoylation of the y2 subunit in a non-neuronal 
cell line was dependent on co-expression of DHHC3 (Keller et al., 2004). Subsequently, Fukata 
et al screened all twenty-three mammalian DHHC-CRD proteins for their ability to increase 
radiolabelled palmitate incorporation into the neuronal scaffolding protein, PSD-95, in non­
neuronal cells (Fukata et al., 2004). Palmitoylation of PSD-95 was increased after co­
expression of DHHCs -2, -3, -7 and -15 in COS7 cells, however, DHHC15 produced the 
greatest incorporation of palmitate (Fukata et al., 2004). To date, PAT activity has been 
confirmed for DHHCs -2, -3, -7, -8, -9, -15, -17, -18 and -21 (Femandez-Hemando et al., 2006; 
Fukata et al., 2004; Hayashi et al., 2005; Huang et al., 2004; Keller et al., 2004; Ohyama et al., 
2007; Swarthout et al., 2005). Substrate proteins ascribed to these DHHC proteins are listed in 
Table 1.
The finding that some proteins are palmitoylated by multiple PATs implies a certain level of 
redundancy for enzyme substrates. However, not all PATs were able to palmitoylate every 
protein tested, and thus PATs do display a certain level of substrate specificity. Finally, not 
every DHHC-CRD protein has been shown to possess palmitoylation activity. This may be 
because their substrate proteins have yet to be determined, or because some of the DHHC 
proteins require accessory proteins. For example, the DHHC proteins that palmitoylate yeast 
and mammalian Ras, Erf2p and DHHC9, require Er4p and GCP16, respectively, for stable 
expression and transferase activity (Lobo et al., 2002; Swarthout et al., 2005). Finally, it may 
be that not all DHHC-CRD containing proteins harbour palmitoyl transferase activity.
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T a b le  1: DHHC p r o t e in  s u b s t r a t e s  id e n t i f i e d
DHHC Substrates
DHHC2 eNOS (Femandez-Hemando et al., 2006) 
PSD-95 (Fukata et al., 2004)
DHHC3 AMPA receptor subunits (Hayashi et al., 2005) 
Gas(Fukata et al., 2004)
GABAa receptor subunits (Keller et al., 2004) 
PSD-95 (Fukata et al., 2004)
SNAP-25 (Fukata et al., 2004)
DHHC7 eNOS (Femandez-Hemando et al., 2006) 
G^ (Fukata et al., 2004)
GAP-43 (Fukata et al., 2004)
PSD-95 (Fukata et al., 2004)
SNAP-25 (Fukata et al., 2004)
DHHC8 eNOS (Femandez-Hemando etal., 2006)
DHHC9 H-/N-Ras (Swarthout et al., 2005)
DHHC15 GAP-43 (Fukata et al., 2004) 
PSD-95 (Fukata et al., 2004)
DHHC17 CSP (Ohyama et al., 2007)
GAD-65 (Huang et al., 2004) 
htt (Huang et al., 2004)
Lck (Fukata et al., 2004)
PSD-95 (Fukata et al., 2004; Huang et al., 2004) 
SNAP25 (Fukata et al., 2004; Huang et al., 2004) 
Synaptotagmin 1 (Huang et al., 2004)
DHHC18 Lck (Fukata et al., 2004)
DHHC21 eNOS (Femandez-Hemando et al., 2006)
A b b r e v i a t i o n s :  AM PA, a-amino-3-hydroxy-5-methyl-4-
isoxazole propionic acid; CSP, cysteine string protein; eNOS, 
endothelial n itric  oxide synthase; GAD, G lutam ate 
decarboxylase 65; GAP-43, Growth-associated protein 43; htt, 
huntingtin; PSD-95, Post-synaptic density protein of 96 kDa; 
SNAP25, synaptosomal-associated protein of 25 kDa.
Recently, an acyl biotin exhange method was employed that identified thirty-five novel 
palmitoylated proteins in yeast, including eight SNARE proteins (Drisdel and Green, 2004; 
Roth et al., 2006). Yeast strains deficient in multiple DHHC-CRD-containing proteins revealed 
several potential enzyme-substrate pairs and demonstrated that the DHHC-CRD family of 
proteins account for the majority of cellular palmitoylation reactions in yeast (Roth et al., 2006).
1.5.1 T h e  DHHC d o m a in  a n d  c a t a l y t i c  a c t i v i t y
The DHHC-CRD was first reported when a unique clone was isolated from a human pancreatic 
cDNA library (Putilina et al., 1999). Sequence analysis revealed a cysteine-rich domain which
-21-
includes a Q H 2 zinc finger-like region upstream of a complex Cys-His region (Putilina et al.,
1999). Accordingly, the approximately 50-residue long DHHC-CRD is classed as a variant of 
the C2H2 zinc finger motif (Bohm et al., 1997), and is defined by the core asp-his-his-cys 
tetrapeptide sequence (Figure 1.3).
The first clue that the conserved DHHC-CRD domain was linked to PAT activity was 
established when a yeast genetic screen of palmitoylation-dead mutants revealed point 
mutations within the ERF2 DHHC-CRD (Bartels et al., 1999). Subsequently, site-directed 
mutations introduced into the DHHC signature motif of the yeast PATs, Erf2p (H201A and 
C203S) and A krlp  (D543A, H544A and C546A), abolished the in vivo labelling of their 
substrate proteins, confirming the requirement of the DHHC motif for catalytic activity (Lobo et 
al., 2002; Roth et al., 2002). Furthermore, a similar loss of palmitoylating activity has been 
reported whenever cysteine mutations have been introduced into the DHHC domain of any of 
the DHHC-CRD family of proteins studied (Ducker et al., 2004; Femandez-Hemando et al., 
2006; Fukata et al., 2004; Hayashi et al., 2005; Huang et al., 2004; Lam et al., 2006; Lobo et 
al., 2002; Roth et al., 2002; Smotrys et al., 2005; Swarthout et al., 2005; Valdez-Taubas and 
Pelham, 2005). Mutational analysis revealed that Erf2p and A krlp  form an acyl-enzyme 
intermediate when incubated with palmitoyl-coenzyme A, likely becoming palmitoylated on the 
conserved cysteine within the DHHC motif (Lobo et al., 2002; Roth et al., 2002). Similar 
autopalmitoylation has been observed for all of the DHHCs in which analysis has been carried 
out (Ducker et al., 2004; Fukata et al., 2004; Hayashi et al., 2005; Keller et al., 2004; Lobo et 
al., 2002; Roth et al., 2002; Smotrys et al., 2005; Swarthout et al., 2005). These observations 
have led to suggestions that palmitate transfer from enzyme to substrate may be required for 
palmitoylation, however the exact mechanism has not yet been determined. Interestingly, 
mutation of the conserved histidine residue in the DHHC m otif of Erf2p preserved 
autopalmitoylation of Erf2p, but led to a loss of PAT activity, suggesting that the histidine may 
be involved somehow in palmitate transfer from enzyme to substrate (Lobo et al., 2002).
1.5.2 M e m b r a n e  t o p o l o g y  a n d  s u b c e l l u l a r  l o c a l i s a t i o n  o f  DHHC-CRD
PROTEINS
The DHHC-family of PATs are a family of polytopic integral membrane proteins that share 
little or no homology out-with their DHHC-CRD (Figure 1.3). DHHC proteins and/or PAT 
activities have been identified on diverse intracellular membranes; examples include the Golgi, 
ER, plasma membrane, endosomes/vesicular compartments and the yeast vacuole (Dunphy et 
al., 1996; Fukata et al., 2004; Huang et al., 2004; Keller et al., 2004; Roth et al., 2002;
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Schroeder et al., 1996; Singaraja et al., 2002; Swarthout et al., 2005; Uemura et al., 2002; 
Valdez-Taubas and Pelham, 2005; Veit et al., 2001).
The transmembrane topology of A krlp  has been investigated experimentally by constructing 
several A krlp  mutants with the coding sequence for the yeast secretory protein invertase 
introduced into each of the putative hydrophilic loop domains (as revealed by hydropathy 
analysis) (Politis et al., 2005). In S. cerevisiae, invertase is glycosylated at 10 sites, and since 
glycosyltransferase activity is present only in the lumen of intracellular organelles, the 
transmembrane topology and orientation can be determined biochemically. This analysis 
revealed that A krlp has 6 membrane-spanning domains, with both the N- and C-termini and the 
DHHC-CRD located cytoplasmically. The DHHC-CRD is present on an intracellular loop 
between the fourth and fifth membrane-spanning domains (Politis et al., 2005). Hydropathy 
sequence analysis predicts that a similar topology holds for all of the DHHC-CRD containing 
proteins, having between four and six transmembrane domains, with the DHHC-CRD located 
on the second or third cytoplasmic loop and with both the N-and C-terminal domains 
cytosolically exposed (Figure 1.3) (Mitchell eta l., 2006).
1.6 P r o t e in  t h io e st e r a se s
The dynamic palmitoylation of some proteins, for example H-and N-Ras (Rocks et al., 2005), 
suggests that mechanisms must exist to remove palmitate groups from proteins in a regulated 
manner. Such regulation is achieved by the action of palmitoyl thioesterases, enzymes that 
selectively cleave the thioester linkage of palmitoylated proteins (Figure 1.4).
Three such palmitoyl thioesterases have been identified and characterized: the lysosomal 
hydrolase, protein palmitoyl thioesterase 1 (PPT1) and its homologue PPT2, and the 
cytoplasmic enzyme, acyl-protein thioesterase (APT1) (B ellizzi et al., 2000; Camp and 
Hofmann, 1993; Devedjiev et al., 2000; Duncan and Gilman, 1998; Soyombo and Hofmann, 
1997).
PPT1 was originally purified from bovine brain cytosol, and the palmitoyl thioesterase activity 
of PPT1 was demonstrated by its ability to remove radiolabelled palmitate from H-ras and Ga 
subunits (Camp and Hofmann, 1993). Subsequent cloning of the rat and bovine cDNA 
identified PPT1 as a classical lysosomal hydrolase, which is targeted to the lumen of lysosomes 
by mannose-6-phosphate modification of A-linked oligosaccharides (C am p et al., 1994; 
H ellsten et al., 1996; Sleat et al., 1996; Verkruyse and Hofmann, 1996). The lysosomal
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Palm itoyl transferase
HS-CoA Pal-CoA
p a lm i to y la t io n
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Thioesterase
Figure 1.4 Regulation of palm itoylation. Palmitoyl transferases catalyse the addition of 
palmitate moieties from palmitoyl-coenzyme A (Pal-CoA) to the sulphydryl group of cysteine 
residues through a thioester linkage (yellow). The thioester bond is cleavable and so allows 
protein palmitoylation to be a reversible modification, and proteins may be depalmitoylated in 
vivo through the action of thioesterases. A blue sphere represents the modified protein. The 
chemical structure was generated using ChemBioDraw® Ultra 11.0 software (CambridgeSoft®).
localisation of PPTl argues against a role in the regulated depalmitoylation of substrates, and 
instead points towards a role for PPTl in the degradation of palmitoylated proteins.
Later studies isolated palmitoyl protein thioesterase activity from rat liver cytosol, which was 
termed APT l (Duncan and Gilman, 1998). Subsequent sequence analysis revealed that APT I 
had been previously described as a lysophospholipase (Sug im oto  et al., 1996; Wang et al.,
1997a; Wang et al., 1997b). APTl is a cytosolic protein showing substrate preference for 
acylated proteins over other lipidated substrates, and cleaves thioesters in both acyl-coenzyme A 
and acylated proteins (Duncan and Gilman, 1998). APT I has been demonstrated to have 
thioestarase activity towards Ras proteins, G(I subunits, eNOS and viral glycoproteins (Duncan 
and Gilman, 1998; Duncan and Gilman, 2002; Veit and Schmidt, 2001; Yeh et al., 1999). The 
expression of APT1 increases the rate of palmitate turnover on Gu subunits (Duncan and 
Gilman, 1998), and disruption of the A PT I gene in S. cerevisiae leads to a significant reduction 
in acyl protein thioesterase activity and prevents the depalmitoylation of the yeast G(1 subunit 
homologue, G p a lp  (D uncan and Gilm an, 2002). S im ilarly , APT! regulates the 
depalmitoylation of eNOS since overexpression of APT1 and eNOS in a heterologous cell line 
leads to an increased turnover of 3H palmitic acid on eNOS (Yeh et al., 1999). A second 
lysophospholipase sharing sequence homology to APT1 has been identified (Toyoda et al.,
1999), though thioesterase activity and substrate specificity have not been determined. It is
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suspected that many protein palmitoyl thioesterases exist, each having substrate specificity to 
regulate depalmitoylation cycles in vivo. However, many proteins are stably palmitoylated, for 
example SNAP25 and synaptotagmin I (Heindel et al., 2003; Kang et al., 2004), therefore an 
interesting possibility is that sensitivity to APT1 or similar enzymes dictates whether or not a 
protein undergoes dynamic palmitoylation.
1.7 The secretory pathway
The concept of a secretory pathway was introduced with the advent of electron microscopy in 
the 1960s and 1970s and by biochemical experiments, which showed that proteins to be secreted 
are synthesised in the endoplasmic reticulum and move to and through the Golgi complex, from 
where they are packaged into secretory vesicles (Palade, 1975). Movement of proteins through 
the compartments of the secretory pathway is mediated by transport vesicles, which bud from 
donor membranes and are targeted to specific acceptor compartments. Fusion of the vesicles 
with the acceptor membrane then transfers lipid and protein to that compartment. Membrane 
fusion is a fundamental event in a wide variety of cellular processes including cell growth and 
division, vesicular traffic along the secretory pathway, organelle inheritance, and 
neurotransmitter and hormone release. Most research has supported the general belief that all 
types of cells, from yeast to man, share a universal core membrane fusion mechanism with 
specialised features in different pathways. Furthermore, these underlying mechanisms appear to 
be conserved among all eukaryotic cells and also between constitutive and regulated secretory 
pathways (Katagiri etal., 1995).
1.7.1 CONSTITUTIVE AND REGULATED SECRETION
Exocytosis is the fusion of intracellular vesicles with the plasma membrane and takes place 
through two separate pathways: constitutive and regulated. The former occurs in all eukaryotic 
cells and functions in the continual maintenance of plasma membrane lipids and proteins and 
the extracellular environment. Regulated exocytosis is a more specialised pathway limited to 
cells carrying out specific functions, and where secretion occurs only in response to particular 
stimuli. In most cases an increase in intracellular calcium ion concentration is the major trigger 
for regulated exocytosis (Lin and Scheller, 2000). Regulated exocytosis underlies diverse 
processes such as enzyme and cytokine release, neurotransmitter release and endocrine hormone 
secretion. Regulated exocytosis therefore forms the basis of co-ordinated responses such as 
movement and behaviour (Knight, 1999). It is also crucial in controlling the levels of different 
lipids, receptors, and transporters in the plasma membrane, so altering the cell’s limiting
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membrane. For example, the insertion of Glut4 glucose transporters into the plasma membrane 
of fat and muscle cells in response to insulin stimulation occurs via regulated exocytosis (Rea 
and James, 1997).
Regulated secretory vesicles undergo a series of maturation steps before they become fusion 
competent; these maturation steps include vesicle tethering prior to docking at the plasma 
membrane, followed by vesicle priming (Klenchin and Martin, 2000; Sudhof, 2004). Following 
vesicle priming, the vesicle is able to respond to the increase in intracellular calcium 
concentration and undergo fusion with the plasma membrane in a regulated manner. 
Biochemical and genetic studies have identified a vast array of proteins involved in the 
intracellular transport of secretory vesicles and their subsequent fusion with the plasma 
membrane. At least three protein families appear to be universally involved in all intracellular 
fusion reactions: the SNAREs (SNAP receptors) and associated proteins (A-ethylmaleimide- 
sensitive factor [NSF] and soluble NSF attachment proteins [SNAPs]), the Secl/M uncl8  
homologs (SM proteins), and small GTPases known as Rabs and their effector proteins (Jahn et 
al., 2003). It is thought that the function of SNARE proteins is to mediate vesicle docking and 
lipid bilayer fusion (Weber et al., 1998), while the Seel and Rab/Rab effector proteins assist by 
regulating SNARE complex association and vesicle targeting (Grosshans et al., 2006; Jahn,
2000). Following fusion, the SNAREs are disassembled in a process dependent on the ATPase 
NSF, releasing them for another round of membrane fusion (Littleton et al., 2001). This basic 
fusion machinery appears to be conserved between different transport steps and amongst all 
eukaryotes (Bonifacino and Glick, 2004).
1.8 The SNARE proteins
At the heart of intracellular trafficking lie the SNARE proteins, a conserved family of small and 
integral membrane proteins that play a crucial role in mediating intracellular fusion in 
eukaryotic cells of numerous organisms (Bruns and Jahn, 2002; Jahn and Sudhof, 1999; Jahn et 
al., 2003). SNARE proteins were originally discovered in independent studies of yeast and 
mammalian cells (Bennett and Scheller, 1993), and on the basis of their localisation and overall 
structure, SNAREs were divided into two categories: v-(vesicle) SNAREs and t-(target 
membrane) SNAREs. In neuronal synaptic vesicle exocytosis, the v-SNAREs are VAMP1/2 
(also known as synaptobrevin), and the t-SNAREs are syntaxin 1A/B and SNAP25A/B (Jahn et 
al., 2003). The v-SNAREs are located on the membrane of the trafficking vesicle, and the t- 
SNAREs are present on target membranes. However, since this classification is not appropriate 
for all membrane fusion events, for example, in homotypic membrane fusion where the two
-26-
membranes are functionally and structurally equivalent, SNARE proteins have been re­
classified as Q- and R-SNAREs (see Chapter 1.8.1) (Fasshauer et al., 1998b). Two different 
biochemical approaches, immunoprecipitation and sucrose-gradient centrifugation, yielded 
evidence of complex formation between the SNAREs and two proteins previously discovered as 
essential for secretion in yeast and intra-Golgi transport in mammalian cells: a-SNAP (Secl7p) 
and NSF (Secl8p) (Sollner et al., 1993b). The fundamental importance of the SNARE proteins 
in neurosecretion is highlighted by the ability of tetanus and botulinum neurotoxins, which 
specifically cleave these proteins, to abolish neurotransmission (Schiavo et al., 1992a; Schiavo 
et al., 1993a). The defining feature of all SNAREs is a homologous domain of ~60 amino acids 
referred to as the SNARE motif (Weimbs et al., 1997).
1.8.1 SNARE PROTEINS AND MEMBRANE FUSION
SNARE proteins on opposing membranes interact to form a highly stable trimeric SNARE (or 
core) complex (Sollner et al., 1993a; Sollner et al., 1993b). The intrinsic stability of the 
SNARE complex is supported by data showing that it resists denaturation by the ionic detergent 
sodium dodecyl sulphate (SDS) (Hayashi et al 1994), has a melting temperature of more than 90 
°C (Fasshauer et al., 1998a; Yang et al., 1999), and that SNAREs assembled into a complex can 
resist proteolysis by the botulinum and tetanus toxins (Hayashi et al 1994).
Formation of the SNARE core complex is tightly coupled to membrane fusion as it brings the 
two opposing membranes into close proximity (Hayashi et al., 1994). During SNARE complex 
assembly, the individual coiled-coil (helical) SNARE motifs present in the SNARE proteins 
interact to form a parallel four-helix bundle (Poirier et al., 1998). X-ray crystallography of the 
core complex involved in neuronal exocytosis revealed that one helix is provided by VAMP, 
one by syntaxin 1 A, and the other two by SNAP25 (Sutton et al., 1998). There are several layers 
of hydrophobic interactions between the different helices (designated as -7 through to +8), with 
a central (or ‘zero’ layer) ionic interaction formed between three glutamines and one arginine 
residue (Sutton et al., 1998). Shortly after the structure of the neuronal SNARE complex was 
presented, it was noted that essentially all SNARE proteins contained either a conserved 
arginine (R) or glutamine (Q) residue that would contribute to zero layer interactions (Fasshauer 
et al., 1998b). In light of this, it was proposed that SNAREs be reclassified as R- or Q-SNAREs 
(Fasshauer et al., 1998b). R-SNAREs comprise the VAMPs, Qa-SNAREs include the syntaxins, 
and Qb- and Qc-SNAREs are the homologues of the N- and C-terminal SNARE motif, 
respectively, of SNAP25 (Bock et al., 2001; Fasshauer et al., 1998b). All functional cellular
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SNARE complexes appear to contain one copy of R-, Qa-, Qb-, and Qc-SNARE motifs (Jahn et 
al., 2003).
It is generally (though not universally) believed that formation of a trans-SNARE complex is 
sufficient to pull the opposing membranes together, overcoming the energy barrier opposing 
fusion of the two lipid bilayers. Indeed, the introduction of cognate SNAREs into different 
populations of liposomes generated SNARE interactions that facilitated a slow rate of liposome 
fusion (Weber et al., 1998). The fusion of these proteoliposomes has been demonstrated with 
specific combinations of the cognate Q-and R-SNAREs only (McNew et al., 2000; Parlati et al.,
2000), suggesting that complementary SNAREs on opposing membranes are necessary and 
sufficient to determine their compatibility for fusion. Although SNAREs are sufficient to 
catalyse fusion in vitro, this occurs at a slow rate and it is likely that other factors facilitate 
fusion in vivo. Indeed, the addition of SM proteins into SNARE reconstituted liposomes has 
been shown to stimulate in vitro fusion activity by several-fold (Shen et al., 2007), and factors 
that regulate the formation of a 1:1 stoichiometric syntaxin/SNAP25 acceptor complex have 
also been proposed to greatly enhance fusion efficiency (Pobbati et al., 2006; Weninger et al., 
2008). Consistent with the ability of SNAREs to enhance fusion in vitro, studies using the 
botulinum and tetanus toxins in the squid giant axon have shown that SNARE action occurs 
downstream of vesicle docking, with toxin cleavage of SNAREs preventing vesicular fusion but 
leaving docking unaffected (Hunt et al., 1994; O'Connor et al., 1997). More recent work, 
however, has suggested an important role for syntaxin in the docking of secretory granules in 
neuroendocrine cells (Gulyas-Kovacs et al., 2007).
After membrane fusion, the crs-SNARE complex is dissociated through the action of a-SN A P 
and the ATPase NSF (Littleton et al., 2001; Sollner et al., 1993a). a-SNAP binds to the core 
complex, in turn recruiting NSF and simultaneously enhancing and harnessing its ATPase 
activity for complex disassembly (Barnard et al., 1997), allowing the free SNAREs to be 
released for subsequent rounds of fusion.
At least 35 SNARE proteins have been identified in mammals, with the majority specifically 
localised to distinct membrane compartments; the creation of particular SNARE complexes may 
contribute to the specificity of membrane fusion fundamental to membrane compartment 
organisation (Bock et al., 2001).
Despite the general agreement that the SNARE complex plays an important role in synaptic 
membrane fusion, evidence from other systems has indicated that core complex assembly does
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not coincide with fusion pore opening. The SNARE complexes mediating sea urchin egg 
cortical vesicle fusion are disrupted prior to membrane fusion in the presence of free Ca2+ 
concentrations that trigger maximal membrane fusion (Tahara et al., 1998). Similarly, in this 
same system, fusion is unaffected by proteolytic removal of membrane proteins, including the 
SNAREs (Szule et al., 2003). In yeast vacuolar fusion, blocking SNAREs with anti-SNARE 
antibodies after complex dissociation by NSF prevents complex reformation but vesicular 
fusion remains uninhibited (Ungermann et al., 1998). Furthermore, it has been proposed that 
the V0 subunits of the vacuolar protein pump form trans-complexes across otherwise opposing 
vacuolar membranes that may create a proteolipid-lined channel spanning both membranes. The 
suggestion is that the trans-SNARE pairing on opposing membranes serves to assemble the V0 
subunits into these trans-complexes (Peters et al., 2001). Following this, the trans-SNARE 
pairs may go on to help stabilise the opposing membranes, or may simply become dispensable. 
However, mutations in the V0 subunit only delay fusion, whereas mutations in SNAREs can 
block fusion. Thus SNARE-mediated fusion remains to be the most popular model.
1.8.2 S y n t a x in
Syntaxin was originally described as an antigen for a monoclonal antibody, HPC-1, that labels ~ 
35 kDa proteins localised to the plasma membrane in neurons, and subsequently, as a protein 
that interacts with the synaptic vesicle membrane protein, synaptotagmin, and N-type Ca2+- 
channels (Barnstable et al., 1985; Bennett et al., 1992; Inoue et al., 1992; Yoshida et al., 1992). 
There are 15 members of the syntaxin family in the human genome, each localised to various 
intracellular organelles and essential for multiple distinct intracellular fusion events (Teng et al.,
2001). The specific syntaxin isoforms each mediate specific membrane fusion events: syntaxin 
1A is almost exclusively found in neuronal and neuroendocrine cells and functions in regulated 
exocytosis at the plasma membrane. The importance of this protein in exocytosis was 
demonstrated in PC 12 cells, where microinjection of anti-syntaxin 1A antibodies inhibited 
calcium-dependant secretion (Bennett et al., 1993). Syntaxin 1A forms complexes with 
SNAP25 (Pevsner et al., 1994a), VAMP (Calakos et al., 1994; Pevsner et al., 1994a), and 
synaptotagmin (Bennett et al., 1992; Sollner et al., 1993a), and binds to at least 10 other 
neuronal proteins, including M uncl8 (Hata et al., 1993; Pevsner et al., 1994a; Pevsner et al., 
1994b), complexins (M cM ahon et al., 1995), a-SN A P, rsec6/rsec8 (H su  et al., 1996), 
CIRL/latrophilin (Krasnoperov et al., 1997), tomosyn (Fujita et al., 1998), M uncl3 (Betz et al., 
1997) and cysteine string protein (Evans et al., 2001; Nie et al., 1999). Syntaxin 1A also 
directly interacts with and functionally regulates Ca2+ channels (Bezprozvanny et al., 1995;
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Sheng eta l., 1994; Sutton et al., 1999; Wiser et al., 1996), cystic fibrosis Cl channels (Naren et 
al., 1997), K+ channels (Fili et al., 2001) and epithelial Na+ channels (Qi et al., 1999).
Syntaxin is a C-tailed membrane-anchored protein: it is membrane-associated by virtue of a 
single stretch of hydrophobic amino acids close to its C-terminus. Nuclear magnetic resonance 
(NMR) spectroscopy has revealed that the N-terminus of syntaxin 1A consists of a short 
unstructured N-terminal sequence followed by an autonomous Habc regulatory domain 
consisting of three alpha helices (Fernandez et al., 1998). A linker domain separates the Habc 
domain and the SNARE motif. Syntaxin exists in at least two conformations: one being an 
open conformation, in which the SNARE motif is exposed and thus available for core complex 
formation, and another being a closed conformation, where the Habc domain folds back onto the 
SNARE motif, preventing syntaxin assembly into the SNARE complex (Dulubova et al., 1999). 
As these conformational states of syntaxin differ in their ability to promote core complex 
formation, it appears likely that circumstances controlling membrane fusion will regulate 
transformations between these two conformations.
1.8.3 SNAP25
SNAP25 is a plasma membrane-attached SNARE that binds to synaptobrevin/VAMP and 
syntaxin. SNAP25 was first isolated as a 25 kDa neuronal protein localised exclusively to 
presynaptic terminals (Oyler et al., 1989). Subsequently, two highly homologous isoforms, 
SNAP25A and SNAP25B, were isolated and found to differ by only nine amino acids (Bark and 
Wilson, 1994). The expression of SNAP25A/B exclusively in neuronal and neuroendocrine 
cells relates to their requirement for fast regulated exocytosis pathways, for example, in synaptic 
vesicle exocytosis. SNAP23 is another member of the SNAP25 protein family, sharing ~60% 
amino acid identity with SNAP25 (Ravichandran et al., 1996; Wang et al., 1997c). SNAP23 is 
ubiquitously expressed and functions in both constitutive and regulated exocytosis in non­
neuronal cells (Leung etal., 1998; Rea etal., 1998).
In the core complex, syntaxin binds to SNAP25, inducing a conformational change in SNAP25 
necessary for the formation of the core SNARE complex (Fasshauer et al., 1997). SNAP25 
contributes two of its a-helices to the core SNARE complex, one SNARE motif from its N- 
terminal domain and the other from its C-terminal domain (Sutton et al., 1998). The essential 
role of SNAP25 in exocytosis is demonstrated by the action of botulinum neurotoxins (BoNTs) 
of serotypes ‘A ’ and ‘E’, which selectively cleave SNAP25 near the C terminus resulting in the 
inhibition of exocytosis (Blasi etal., 1993; Schiavo etal., 1993a; Schiavo etal., 1993b).
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1.8.3.1 SNAP25 AND MEMBRANE BINDING
SNAP25 is synthesised as a soluble protein, yet it is bound to the cytoplasmic face of the 
plasma membrane. Membrane association of SNAP25 is dependent on palmitoylation of up to 
four cysteine residues present within a cysteine-rich linker domain located between the two 
SNARE motifs: deletion of a twelve amino acid region containing the four cysteines, or 
mutation of the cysteines within the cysteine-rich domain of SNAP25, both render the protein 
cytosolic (G onelle-G ispert et al., 2000; Lane and Liu, 1997; V eit et al., 1996). Since 
palmitoylation of proteins occurs on membranes, mechanisms that target SNAP25 to its site of 
palmitoylation must exist. The minimum membrane-binding domain of SNAP25 has been 
mapped to amino acids 85-120: this domain includes the palmitoylated cysteine-rich domain 
plus the twenty-eight amino acids immediately downstream of this region (Gonzalo et al., 
1999). Interestingly, SNAP25 remains membrane-bound even after chemical depalmitoylation, 
suggesting that in the absence of palmitoylation, other factors exist to allow continued 
association of SNAP25 with the plasma membrane (Gonzalo et al., 1999). The SNARE protein 
syntaxin 1 has been implicated in the trafficking of SNAP25 to the plasma membrane, by acting 
as a chaperone protein for SNAP25 (Vogel et al., 2000; Washboume et al., 2001); by analogy, 
the interaction of syntaxin with SNAP25 at the plasma membrane may persist in the absence of 
SNAP25 palmitoylation, thus allowing SNAP25 to remain membrane-bound following de­
palmitoylation. Several data have supported these hypotheses in both neuronal and non­
neuronal cells. Removal of the C-terminus of SNAP25 by BoNT/E in chromaffin cells disrupts 
the interaction of SNAP25 with syntaxin, leading to the partial redistribution of SNAP25 into 
the cytosol (Rickman et al., 2004). In non-neuronal cells, newly synthesised exogenously 
expressed SNAP25 is effectively localised to the cytosolic fraction: on co-expression of 
syntaxin, there was a dramatic increase in the proportion of SNAP25 localised to the membrane 
fraction (Vogel et al., 2000). Furthermore, co-expression of a mutant syntaxin that is lacking its 
transmembrane domain resulted in both syntaxin and SNAP25 remaining in the cytosolic 
fraction (Vogel et al., 2000). Finally, a mutant SNAP25 that is missing its cysteine-rich domain 
was efficiently targeted to membranes when co-expressed with syntaxin (Gonelle-Gispert eta l., 
2000; Vogel et al., 2000).
Despite these findings, several lines of evidence have argued against a role for syntaxin in the 
trafficking and stable membrane binding of SNAP25, at least in neuroendocrine cells. In PC12 
cells, the majority of SNAP25 is not found in a complex with syntaxin (Xiao et al., 2004). 
Additionally, the minimum membrane binding domain of SNAP25, amino acids 85-120, traffics 
to the plasma membrane in PC 12 cells, despite lacking the binding site for syntaxin (Gonzalo et 
al., 1999). Similarly, a mutation generated within the N-terminal domain of SNAP25 (glycine
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43 to aspartate) that abolishes its interactions with syntaxin does not perturb the correct plasma 
membrane targeting and palmitoylation of SNAP25 in PC 12 cells (Loranger and Linder, 2002). 
Finally, in neuroendocrine cells, downregulation of the SM protein M uncl8 prevents plasma 
membrane delivery of syntaxin, however the trafficking of SNAP25 is unaffected (Arunachalam 
et al., 2007). Thus, it appears that initial membrane targeting and palmitoylation of SNAP25 
may occur independently of syntaxin in neuronal/neuroendocrine cells. The inefficient 
membrane binding of SNAP25 in non-neuronal cells, however, suggests that these cell types 
may lack a specific factor required for SNAP25 membrane targeting and palmitoylation.
Recently three DHHC proteins, DHHC-3, -7 and -17 were shown to increase incorporation of 
radiolabelled palmitate into SNAP25 (Fukata et al., 2004).
1.8.4 VAMP
The final member of the neuronal ternary SNARE complex is the vesicle-associated membrane 
protein (VAMP; also called synaptobrevin) family of small conserved C-tail anchored proteins, 
first identified as a neuronal specific protein isolated from a cDNA expression library of 
Torpedo californica electromotor nucleus mRNA (Sudhof e ta l., 1989; Trimble et al., 1988). 
Sequence homology has identified several different VAMP isoforms, each localised to distinct 
subcellular compartments where they function as R-SNAREs in membrane fusion events 
(Advani et al., 1998; Galli et al., 1998; Wong et al., 1998; Zeng et al., 1998). VAMP1 and 
VAMP2 are the two isoforms involved in Ca2+-dependent regulated exocytosis in neuronal and 
neuroendocrine cells (Baumert et al., 1989; Trimble et al., 1988), whereas cellubrevin is a 
ubiquitously expressed VAMP isoform involved in constitutive exocytosis pathways in non­
neuronal cells (M cM ahon  et al., 1993). VAMPs contain four functional domains: a 
transmembrane domain flanked by a variable C-terminal intravesicular tail and a conserved 
coil-coil region containing a SNARE motif, and an N-terminal proline-rich region (Elferink et 
al., 1989; Sudhof et al., 1989; Trimble et al., 1988). The VAMPs contribute directly to 
membrane fusion by providing one helix to the core complex (Sutton et al., 1998), and mice 
lacking the gene for VAMP2 have dramatically reduced Ca2+-dependent exocytosis (Schoch et 
al., 2001). VAMPs are essential for membrane fusion events and are susceptible to cleavage by 
TeNT and BoNT serotypes ‘B ’, ‘D’, ‘F ’ and ‘G’ (Schiavo et al., 1992a; Schiavo et al., 1992b; 
Schiavo et al., 1993a; Schiavo et al., 1993c; Schiavo et al., 1994; Yamasaki et al., 1994a; 
Yamasaki e ta l., 1994b). VAMP2 has also been shown to be required for synaptic vesicle 
endocytosis (Deak et al., 2004).
-32-
I  HA!  I h R  O N I :
1.9 SNARE REGULATORS
The finding that membrane fusion can be recreated in vitro by reconstituting SNARE proteins 
into lipid bilayer vesicles suggests that the SNARE proteins comprise the minimal machinery 
required for membrane fusion reactions (W eber et al., 1998). However, this in vitro fusion 
process is very slow compared to the extremely rapid membrane fusion reactions that can take 
place in vivo (for example, synaptic vesicle fusion can occur in less than one millisecond 
following a rise in intracellular Ca2+ concentration (Sabatini and Regehr, 1996)). This 
discrepancy may reflect suboptimal conditions used in the in vitro fusion reactions, for example, 
aggregation of SNARE proteins (Liu et al., 2005); alternatively, it is possible that other factors 
may assist in the membrane fusion reaction in vivo. Indeed, membrane fusion must be tightly 
regulated, both temporally and spatially, ensuring that non-specific and inappropriate fusion 
reactions are prevented, and that (in the case of regulated exocytosis) membrane fusion is 
closely coupled to the stimulus. Such regulation is carried out by SNARE regulators, which 
include (but are not limited to) the SM proteins, the Rab proteins, members of the 
synaptotagmin family and many other membrane-associated proteins, such as cysteine string 
protein.
1.9.1 T h e  m a m m a lia n  u n c  h o m o lo g u e s
A group of Caenorhabditis elegans mutants that exhibit an uncoordinated (unc) phenotype, and 
which are wholly or partially paralysed were identified (Brenner, 1974). A subset of these unc 
mutants exhibited characteristics suggestive of defects in presynaptic neurotransmitter release 
(Hosono et al., 1987), and several genes in this unc subgroup were identified. Mammalian 
homologues of two of these C. elegans unc genes include M unc-13  (Brose et al., 1995; 
Varoqueaux et al., 2002) and Munc-18 (Hata et al., 1993; Pevsner et al., 1994b).
1.9.1.1 MUNC13
The mammalian homologues of the C. elegans unc-13 were cloned and named M uncl3-1, 13-2, 
and 13-3 (Brose et al., 1995). Munc 13-1 and 13-3 are specific to neurons and neuroendocrine 
cells, while M uncl3-2 is expressed only in brain. These proteins have a molecular weight of 
~200 kDa and contain a C-terminal C l domain that binds diacylglycerol and phorbol ester, and 
two or three C2 domains that serve as Ca2+/phospholipid-binding or protein interaction domains. 
Munc-13 is known to interact with at least 7 exocytotic proteins; RIM1, syntaxin, calmodulin, 
D O C 2a (double C2 protein, a  isoform), m sec7-l, a brain-specific spectrin, and Munc-18 
(B ro se  et al., 2000). M uncl3  is essential for regulated exocytosis, since evoked
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neurotransmitter release is blocked in neurons lacking M uncl3, the consequence of a dramatic 
decrease in the number of mature (fusion competent) vesicles (A ugustin  et al., 1999; 
Varoqueaux et al., 2002). Furthermore, overexpression of M uncl3 in neuroendocrine cells has 
no apparent effect on the number of vesicles docked at the plasma membrane yet still leads to a 
threefold increase in Ca2+-dependent exocytosis (Ashery et al., 2000). Both of these findings 
point to a role for M uncl3 in promoting the priming step of vesicle maturation in regulated 
exocytosis, which is likely to involve SNARE complex formation. The C-terminal domain of 
M uncl3 binds directly to the autoinhibitory N-terminal domain of syntaxin, and M uncl3 
mutants that are unable to bind syntaxin are unable to promote vesicle priming in 
neuroendocrine cells, as assessed by rescue experiments in a null background (Stevens et al., 
2005). Furthermore, loss of secretion in C. elegans uncl3  mutants was partially restored on 
overexpression of a constitutively “open” form of syntaxin (Richmond et al., 2001). Thus, a 
current model for the function of Muncl3 in regulated exocytosis is based on the hypothesis that 
M uncl3 promotes vesicle priming by regulating the conformational state of syntaxin, through 
stabilising or promoting its open conformation thus making it available for SNARE complex 
formation (Richmond et al., 2001).
1.9.1.2 MUNC18
Muncl8-1 was first characterised in brain as a protein that binds to syntaxin with high affinity 
(Hata and Sudhof, 1995), and was later cloned by homology screening based on its similarity to 
D rosophila  Rop (Ras opposite) and C. elegans Unc 18 (Halachmi and Lev, 1996). Three 
isoforms of M uncl8 have been described (M uncl8-1, M uncl8-2 and M uncl8-3) all of which 
are involved in exocytosis at the plasma membrane. Muncl8-1 is the predominantly expressed 
isoform in neuronal and neuroendocrine cells, whereas M uncl8-2 and -3  are ubiquitously 
expressed (Hata et al., 1993; Hata and Sudhof, 1995; Katagiri et al., 1995; Pevsner et al., 
1994b; Tellam et al., 1995). All SNARE-mediated intracellular membrane fusion processes 
studied to date involve a M uncl8 homologue (Dulubova et al., 1999), highlighting its central 
role in these fusion pathways. M uncl8 is a soluble hydrophilic protein and its membrane 
localisation is largely dependent on its interaction with the SNARE syntaxin (Rickman et al., 
2007).
Muncl8 proteins are required for exocytosis: secretion is blocked in S. cerevisae Seclp mutants 
and in Drosophila Rop null mutants, and synaptic transmission is inhibited in murine Muncl8-1 
null mutants (Harrison et al., 1994; Novick et al., 1980; Verhage et al., 2000). The finding that 
overexpression of Drosophila Rop led to a decrease in neurotransmitter release (Schulze et al.,
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1994), suggested a negative role for M uncl8 in secretion; however, no inhibitory role was 
observed on overexpression of Muncl8-1 in neuroendocrine cells (Graham et al., 1997). The 
inhibitory effect caused by Rop overexpression most likely reflects a perturbation in the balance 
of exocytotic protein expression, rather than highlighting an inhibitory role of M uncl8 in 
membrane fusion. The roles M uncl8 has in secretion are likely exerted through its interaction 
with syntaxin, and indeed syntaxin 1A becomes unstable in the absence of M uncl8-1 
expression (Voets et al., 2001). Furthermore, there is evidence that plasma membrane delivery 
of syntaxin requires M uncl8, as syntaxin is unable to exit from the ER/Golgi in the absence of 
M uncl8  in non-neuronal cells (M edine et al., 2007; Rowe et al., 2001) and after 
downregulation of M uncl8 in PC12 cells (Arunachalam et al., 2007). These findings suggest 
that M uncl8 chaperones newly synthesised syntaxin to the plasma membrane.
1.9.1.3 MUNC18 a n d  s y n t a x in  1A b in d in g
SNARE complex formation is regulated in part by the conformational status of syntaxin. In the 
open conformation, the SNARE motif is exposed and thus available for core complex 
formation, whereas in the closed conformation, the Habc domain folds back onto the SNARE 
motif, preventing SNARE complex assembly (Dulubova et al., 1999). Interestingly, M uncl8 
has recently been shown to bind the N-terminus of syntaxin in both the open and closed 
conformations (Khvotchev et al., 2007; Rickman et al., 2007). In the early secretory pathway, 
M uncl8 is exclusively bound to the closed conformation of syntaxin, thus preventing SNARE 
complex formation prior to plasma membrane delivery (Medine et al., 2007; Rickman et al., 
2007). At the plasma membrane, a conformational change allows syntaxin to adopt the open 
conformation, and participates in SNARE complex assembly (Medine et al., 2007; Rickman et 
al., 2007). It will be interesting to identify factors that regulate the conversion of syntaxin from 
a closed to an open form; one interesting candidate in this regard is M uncl3, however 
membrane lipid composition may also have a role (Darios and Davletov, 2006).
1.9.2 The Rab GTPases
The Rab proteins are members of the Ras superfamily of small, monomeric GTPases, whose 
primary function is in marking the site of attachment between donor and acceptor membranes, 
thereby providing spatial specificity to fusion reactions (Grosshans et al., 2006). Rab proteins 
function in vesicular trafficking throughout the secretory and endocytic pathways, with each 
Rab protein regulating a distinct transport step (Collins, 2003).
-35-
HAIM 1 R ( ) \ h
The Rabs were first identified in genetic screens in yeast as proteins essential for vesicular 
trafficking (Salminen and Novick, 1987; Segev et al., 1988). Subsequently, eleven yeast Rab 
proteins have since been identified, and more than sixty have been discovered in mammals, 
each localised to specific membrane compartments where they regulate multiple and discrete 
intracellular trafficking events, including vesicle budding, motility, docking and fusion (Novick 
and Zerial, 1997; Pereira-Leal and Seabra, 2000; Pereira-Leal and Seabra, 2001; Pfeffer, 2001). 
Rab proteins do not contain a transmembrane domain, but are instead tethered to membranes via 
a dual C-terminal geranylgeranyl anchor, which contributes to the reversible membrane binding 
of Rab that is fundamental to its function.
The function of the Rab proteins lies in their ability to act as molecular switches, cycling 
between an inactive GDP-bound form in the cytosol, and an active GTP-bound form that is 
membrane-bound (Grosshans et al., 2006). At steady-state, most Rab proteins are in their active 
GTP-bound form, in which they are thought to initiate membrane attachment by interacting with 
specific effector proteins on the target membrane, thus tethering the two membranes together 
(Pfeffer, 2001). Following membrane fusion, a GTPase activating protein (GAP) inactivates 
Rab by triggering the hydrolysis of Rab-GTP to Rab-GDP (Grosshans et al., 2006). GDI (GDP 
dissociation inhibitor) recognises GDP-bound Rab, binding it tightly and removing it from the 
membrane by enveloping the hydrophobic geranylgeranyl anchors (Araki et al., 1990; Wu et al., 
1996). Specific membrane-bound GEFs (guanine nucleotide exchange factors) recognise GDP- 
Rab and catalyze the exchange of GDP and GDI for GTP, thereby allowing Rab to rebind to its 
specific intracellular membrane in order to participate in another round of fusion (Grosshans et 
al., 2006).
Rab3 is the most highly expressed member of the Rab family in brain and endocrine tissues 
(Fischer von Mollard et al., 1991). Rab3 has four isoforms, Rab3A, Rab3B, Rab3C and Rab3D, 
which are all functionally redundant (Schluter et al., 2004; Touchot et al., 1987). Although the 
Rab3 proteins are expressed at highest levels in neuronal and neuroendocrine cells, they have 
also been found in exocrine glands and adipocytes (Baldini et al., 1995; Schluter et al., 2002). 
All isoforms of Rab3 appear to be localised to exocytotic vesicles, from which they dissociate 
following exocytosis (Fischer von Mollard et al., 1991; Fischer von Mollard et al., 1994). Rab3 
has been implicated in various steps of the exocytotic pathway, including vesicle docking, 
fusion and biogenesis (Darchen and Goud, 2000), however the precise function remains unclear.
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1.9.3 T h e  s y n a p t o t a g m in s
The final stages of neurotransmitter release depend upon a rise in intracellular free Ca2+ 
concentration, triggering the opening of a ‘fusion pore’, with the subsequent release of vesicular 
contents. Much work has therefore focussed on the idea of a Ca2+ ‘sensor’, which functions to 
detect and respond to this localised rise in intracellular Ca2+, resulting in neurotransmitter 
release. In 1981, a 65-kDa antigen (then called p65) was found to be present on the surface of 
synaptic vesicles and large dense-core vesicles (LDCVs) (Matthew et al., 1981). The cDNA 
encoding this protein was cloned and its sequence determined and subsequently renamed 
synaptotagmin 1 (Perin et al., 1990). The synaptotagmins are type I transmembrane proteins 
with a single membrane-spanning domain. The intra-lum inal N-terminal domain is 
glycosylated, and the C-terminal domain is composed of tandem Ca2+-binding motifs called C2 
domains, which are homologous to the Ca2+-binding domain of protein kinase C (PKC) (Perin et 
al., 1990; Perin et al., 1991). In addition to being glycosylated, synaptotagmin is palmitoylated 
on cysteines adjacent to its transmembrane domain; both these modifications are required for 
the correct vesicle targeting of synaptotagmin (Chapman et al., 1996; Haigh et al., 1989; Kang 
et al., 2004; Kanno and Fukuda, 2007). Since synaptotagmin was originally cloned, twelve 
additional isoforms have been discovered (Craxton, 2001), each characterised by an N-terminal 
transmembrane domain, a variable linker, and two tandem C-terminal C2-domains (C2A- and 
C2B-domains) (Perin et al., 1991).
The balance of evidence suggests that the synaptotagmins function as key Ca2+ sensors for 
exocytotic vesicle fusion (Chapman, 2002; Fernandez-Chacon et al., 2001; Geppert et al., 1994; 
R hee et al., 2005; Sudhof, 2004). As would be expected for a putative Ca2+ sensor, 
synaptotagmin binds three and two calcium ions via its C2A- and C2B-domains, respectively 
(Fernandez et al., 2001; Ubach et al., 1998), which facilitates the interaction of these domains 
with membranes (Davletov and Sudhof, 1993). In addition to calcium binding, synaptotagmin 
has been shown to interact with several neuronal proteins, including the SNAREs syntaxin and 
SNAP25, and the exocytotic chaperone protein cysteine string protein (CSP) (Bennett et al., 
1992; Evans and Morgan, 2002; Schiavo et al., 1997; Shao et al., 1997). Through the C2A- 
domain, synaptotagmin binds to syntaxin and phospholipids in a calcium-dependent manner 
(Bennett et al., 1992; Davletov and Sudhof, 1993; Shao et al., 1997), and through the C2B- 
domain it interacts with SNAP25 (Schiavo et al., 1997). Evidence that synaptotagmin functions 
as a Ca2+-sensor for neurotransmitter release was obtained when expression of a synaptotagmin 
mutant, with reduced affinity for Ca2+, in a null background, led to a decrease in the Ca2+- 
sensitivity of neurotransmitter release (Fernandez-Chacon et al., 2001). Mutations created in 
SNAP25 that reduced its affinity for synaptotagmin diminished exocytosis in PC 12 cells (Zhang
-37-
I  I I AI ' I  r.K O N h
et al., 2002b), and inhibitors preventing synaptotagmin from binding to syntaxin or SNAP25 
abruptly blocked release from cracked PC 12 cells (Earles et al., 2001), suggesting that 
synaptotagmin binding to SNAREs is necessary for fusion to proceed. It has been proposed that 
synaptotagmin simultaneously binds both the SNARE complex and membranes (Davis et al., 
1999); this would place it in an ideal position to regulate SNARE function. Recently, it has been 
demonstrated that following calcium binding, synaptotagmin induces membrane curvature 
through insertion of its C2A- and C2B-domains into the phospholipid bilayer of the plasma 
membrane, which effectively “pulls” the plasma membrane towards the vesicle membrane and 
reduces the energy barrier between the opposing membranes, thus promoting vesicle fusion 
(Martens et al., 2007; Shahin et al., 2008).
1.10 Cy st e in e  s t r in g  pr o t e in
Cysteine string proteins (CSPs) are predominantly vesicle-associated proteins that are essential 
for regulated exocytosis in neuronal and neuroendocrine cells (Chamberlain and Burgoyne, 
1998a; Chamberlain and Burgoyne, 1998b; Graham and Burgoyne, 2000; Umbach et al., 1994). 
The importance of CSP for viability is demonstrated in Drosophila csp null mutants and CSP 
knockout mice, with both exhibiting progressive uncoordinated motor behaviour prior to 
premature death (Fernandez-Chacon et al., 2004; Zinsmaier et al., 1994). Drosophila csp null 
mutant larvae have a decreased number of nerve terminals (Bronk et al., 2005; Dawson-Scully 
et al., 2007). Furthermore, these mutant larvae show a decrease in synchronous transmitter 
release and an increase in both asynchronous release and paired-pulse facilitation, suggesting 
that CSP helps to couple Ca2+-influx to exocytosis (Heckmann et al., 1997). Finally, CSP 
knockout mice have a decrease in synaptic transmission and enhanced synaptic depression, 
suggesting that CSP has a neuroprotective function (Fernandez-Chacon et al., 2004).
1.10.1 D isc o v e r y  o f  CSP
In 1990, a hybridoma library screening of antigens against the Drosophila nervous system was 
used to identify novel synaptic proteins. Immunohistochemical staining of Drosophila heads by 
one of the monoclonal antibodies was localised exclusively to synaptic nerve terminals, and the 
resultant cDNAs were recovered and sequenced. Two novel proteins, generated by alternative 
splicing, were found to contain a continuous string of eleven cysteine residues, and as a result, 
were named the cysteine string proteins (Zinsmaier et al., 1990). The localisation of CSP to 
synaptic nerve terminals suggested an involvement for CSP in synaptic transmission, however 
its role was yet to be determined.
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1.10.2 CSP ISOFORMS
Since the discovery of CSP in Drosophila (Gundersen and Umbach, 1992; Zinsmaier et al., 
1990; Zinsmaier et al., 1994), CSP has been identified in Torpedo (Gundersen and Umbach, 
1992), Xenopus laevis (Mastrogiacomo et al., 1998b), C. elegans (GenBank Accession Number 
AAK39254) and several mammalian species, including rat (Mastrogiacomo and Gundersen,
1995), mouse (GenBank Accession Number AF032115), bovine (Chamberlain and Burgoyne,
1996) and human (Coppola and Gundersen, 1996). There is no CSP homologue in yeast. 
Sequence analysis of the mammalian CSPs reveals high homology, with 98-100% identity at the 
amino acid level. Homology between mammalian CSPs and CSPs from other classes vary: 
Torpedo and Xenopus CSP share 85-86% homology to mammalian CSPs, Drosophila is 50- 
60% identical, while the C. elegans CSP is the most divergent, with only 37-38% sequence 
similarity.
In addition to the two isoforms of CSP originally identified in Drosophila (CSP1 and 3) 
(Zinsmaier et al., 1990), a third isoform (CSP2) has been identified (Zinsmaier et al., 1994). 
The three Drosophila  isoforms are encoded by the same gene localised on chromosome 3 at 
position 79E1-2 and are generated by alternative splicing (Zinsmaier et al., 1994). A fourth 
Drosophila splice variant has been postulated (Arnold et al., 2004). Two mammalian isoforms, 
CSP1 and CSP2, have since been identified in rat (Mastrogiacomo and Gundersen, 1995), 
bovine (Chamberlain and Burgoyne, 1996) and human (Coppola and Gundersen, 1996) tissue. 
CSP1 is the mammalian homologue to Torpedo CSP (Gundersen and Umbach, 1992), while 
CSP2 is identical to CSP1 with the exception of the C-terminus. CSP2 is generated by the 
retention of a seventy-two nucleotide exon insert which introduces premature stop codons, 
resulting in a C-terminally truncated CSP isoform (Chamberlain and Burgoyne, 1996; Coppola 
and Gundersen, 1996). Finally, the mRNA sequences of two further mammalian isoforms, 
CSPp and y, have been described: the full mRNA sequence of the CSP|3 isoform has been 
isolated from human testis and a mouse testis cDNA library, while only a partial mRNA 
sequence of the human CSPy, and predicted coding sequences of the human CSPy and mouse 
CSPy isoforms, have been obtained (Evans et al., 2003). A summary of the various mammalian 
CSP isoforms can be found in Table 2.
1.10.3 T is s u e  d i s t r ib u t io n  a n d  s u b c e l l u l a r  l o c a l i s a t i o n  o f  CSP
Despite having been first identified in brain, CSP is expressed in a wide range of non-neuronal 
tissues, including the adrenal medulla of the adrenal gland (Chamberlain and Burgoyne, 1996; 
Kohan et al., 1995), pancreas (Braun and Scheller, 1995; Chamberlain and Burgoyne, 1996),
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T a b le  2: T h e  m a m m a lia n  CSP i s o f o r m s
Isoform Tissue
Distribution
Subcellular
localisation
Comments
CSP1/a Adrenal gland; 
Brain; Kidney; 
Lung; Liver; 
Muscle; Pancreas; 
Retina; Spleen; 
Testis.
Secretory vesicles; 
Secretory granules; 
Plasma membrane.
198 amino acids; 
Highly enriched in 
brain; multiply 
palmitoylated.
CSP2 Kidney, Spleen. Unknown. A C-terminally 
truncated isoform 
encoding amino 
acids 1-167 of 
CSP1
cspp Testis. Trans-Go\gi Network. 199 amino acids; 
Non-palmitoylated
CSPy Testis. Unknown. 189 amino acids.
References: Boal et al., 2007; Braun and Scheller, 1995; Brown et al., 1998; 
Chamberlain and Burgoyne, 1996; Chamberlain et al., 2001; Fernandez- 
Chacon et al., 2004; Pupier et al., 1997; Redecker et al., 1998; Schmitz et al.,
2006; Zhang et al., 1998.
kidney, liver, spleen, lung and testis (Chamberlain and Burgoyne, 1996). CSP mRNA was 
detected in all human tissues examined (Coppola and Gundersen, 1996).
Consistent with its widespread expression, CSP is not restricted to synaptic vesicles, but has 
been found associated with secretory vesicles in several non-neuronal cells, including 
chromaffin granules of the adrenal medulla (Chamberlain et al., 1996), pancreatic zymogen 
granules (Braun and Scheller, 1995), insulin-containing granules (Brown et al., 1998; Zhang et 
al., 1998), secretory granules of neurosecretory neurons in the neurohypophysis (Pupier et al.,
1997), cortical granules of Xenopus oocytes (Gundersen et al., 2001), and synaptic-like 
microvesicles of pinealocytes (Redecker et al., 1998). Furthermore, CSP has been shown to be 
localised to the plasma membrane in adipocytes (Chamberlain et al., 2001) and in Calu-3 lung 
epithelial cells (Zhang et al., 2002a). Finally, CSP has also been localised at the ER in Calu-3 
cells (Zhang et al., 2002a).
1.10.4 CSP DOMAINS
Analysis of the amino acid sequence reveals that CSP has five domains; an N-terminal domain, 
a J-domain, a linker domain, a hydrophobic cysteine string domain and a C-terminal domain: 
the relative location of these domains is outlined in Figure 1.5.
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Figure 1.5 Domain stru c tu re  of C ysteine String Protein CSP has five domains: an N- 
terminal domain, a J domain, a linker domain, the signature cysteine string domain (shaded), 
and a variable C-terminal domain. The relative positioning of these domains are illustrated, and 
residues lying at the boundaries of the domains in bovine CSP are numbered above. The 
cysteine string domain contains fourteen cysteine residues (numbered 1-14), and the majority of 
these cysteines are believed to palmitoylated in vivo.
Between all species, the J-domain, the linker domain and the cysteine string domain are all 
highly conserved, whereas the extreme N-terminal and the C-terminal domains are variable. 
The N-terminal domain of CSP is phosphorylated by protein kinase A on a serine at position 10 
(Evans et al., 2001; Evans and Morgan, 2005), and this phosphorylation reduces the affinity of 
CSP for syntaxin l A (Evans et al., 2001) and synaptotagmin l (Evans and Morgan, 2002). The 
J-domain is a conserved region of approximately seventy amino acids that is homologous to the 
bacterial DnaJ proteins, and is the defining domain of the DnaJ/Hsp40 (Heat shock protein of 40 
kDa) family of molecular chaperones. Through its J domain, CSP functions as a molecular 
chaperone by binding to and activating the ATPase activity of the ubiquitous chaperone Hsc70 
(Braun et al., 1996; Chamberlain and Burgoyne, 1997a; Chamberlain and Burgoyne. 1997b). 
The conserved linker domain, flanked by the J domain and the cysteine string domain, has been 
proposed to have a functional role in regulated exocytosis (Zhang et al., 1999). However, the 
putative functional role of the linker domain of CSP is based upon a single mutation (E93V) 
within the linker region, which reversed the inhibitory effects of CSP2 (but not CSP) 
overexpression on exocytosis (Zhang et al., 1999). Thus, it is not easy to assess exactly what 
role the linker domain plays in exocytosis. In addition, both the J domain and (to a lesser 
extent) the linker domain have been shown to be involved in maintaining normal intracellular 
Ca2+ levels prior to neurotransmitter release (B ronk  et al., 2005). Furthermore, the linker 
domain, together with the cysteine string domain, has been shown to be important for CSP self­
association (Boal et al., 2004; Swayne et al., 2003). The cysteine string domain is the defining 
domain of CSP and contains fourteen cysteines within twenty-four amino acids (in vertebrates), 
the majority of which are palmitoylated (Gundersen et al., 1994). The intrinsic hydrophobicity
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of the cysteine string domain, and the ability of its many cysteines to become palmitoylated, 
suggests that this domain is fundamentally important for CSP membrane binding.
1.10.5 M e m b r a n e  a s s o c i a t i o n  a n d  p a l m i t o y l a t i o n  o f  CSP
In 1994, an antiserum was raised against CSP from the marine ray Torpedo. This CSP 
antiserum labelled Torpedo cholinergic synaptic vesicles and revealed that endogenous Torpedo 
CSP is a predominantly membrane-associated protein of approximately 34 kDa (Mastrogiacomo 
et al., 1994a). Unexpectedly, immunoblot analysis using the CSP antiserum revealed that the 
molecular weight of CSP in Torpedo was 6-7 kDa greater than the product of in vitro translated 
CSP, leading to the proposal that CSP is post-translationally modified in vivo (Mastrogiacomo 
et al., 1994a). Furthermore, the differential solubility of in vitro translated CSP and endogenous 
CSP in detergents demonstrated that the increase in molecular mass of native CSP correlated to 
an increase in its hydrophobicity (Mastrogiacomo et al., 1994a).
Several complementary approaches were used to demonstrate for the first time that CSP is 
palmitoylated (Gundersen et al., 1994). First, following microinjection into Xenopus oocytes, 
the molecular mass of a pool of in-vitro translated CSP is increased by 7 kDa, and this higher 
molecular weight form was labelled with 3H palmitic acid. Second, both endogenous CSP and 
the higher molecular mass variant of exogenously expressed CSP recovered from Torpedo  
electric organ were sensitive to treatm ent with methanolic potassium hydroxide and 
hydroxylamine, reagents that selectively cleave the fatty acyl thioesters of proteins. 
Interestingly, while the 34 kDa form of CSP recovered from the micro-injected oocytes was 
membrane-associated, the 27 kDa fraction of CSP was only recovered in the cytosolic pool. 
Finally, gas chromatography-mass spectrometry was used to determine that the predominant 
fatty acid attached to CSP is palmitic acid, though a small amount of stearic acid was also 
detected. In Torpedo CSP, as many as eleven of the thirteen cysteine residues were found to be 
fatty acylated, though the number of cysteines palmitoylated in CSPs from other species has yet 
to be determined (Gundersen et al., 1994). CSP is stably palmitoylated, and palmitoylation of 
CSP is thought to take place fairly quickly following its synthesis, since very little of the lower 
molecular weight (hence unpalmitoylated) form of CSP is detected in tissues (Gundersen et al.,
1996). Antibodies specific for the N- and C-terminal domains of CSP were both able to 
precipitate CSP from intact synaptic vesicles in Torpedo (Mastrogiacomo et al., 1994b). Since 
CSP is fatty acylated, it was suggested that CSP is tethered to the cytoplasmic surface of 
vesicles by a palmitoylated cysteine string domain, with both the N-and C-termini located 
cytoplasmically (Mastrogiacomo et al., 1994b).
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Several studies have demonstrated that chemical depalmitoylation of CSP does not disrupt CSP 
membrane association (Chamberlain and Burgoyne, 1998a; Mastrogiacomo et al., 1998a; van 
de Goor and Kelly, 1996); furthermore, chemically-depalmitoylated CSP can only be released 
from membranes by treating with detergent (Mastrogiacomo et al., 1998a). These results 
indicate that the membrane association of depalmitoylated CSP is mediated by the ability of 
hydrophobic amino acids within the cysteine string domain to interact with the lipid bilayer: 
following deacylation, the cysteines within the cysteine string domain remain in a hydrophobic 
environment (Mastrogiacomo et al., 1998a). Interestingly, when a CSP mutant in which the 7 
central cysteine amino acids were mutated to the less hydrophobic amino acid serine (7CS) and 
was expressed in PC 12 and HeLa cells, it was found to be cytosolic and unpalmitoylated 
(Chamberlain and Burgoyne, 1998a).
Finally, the importance of an intact palmitoylated cysteine string domain for the function of 
CSP, in addition to membrane binding, was demonstrated when cysteine deletions were 
introduced into the cysteine string domain of Drosophila. Deletion of some of the cysteine 
residues in the cysteine string domain resulted in a protein that was correctly targeted to 
membranes, but was not able to rescue the null mutant phenotype (Arnold et al., 2004).
1.10.6 L e t h a l i t y  o f  CSP i n a c t i v a t i o n  in  D r o s o p h il a
The functional importance of CSP for D rosophila  viability was determined soon after its 
discovery, through analysis of the phenotype of null (cspRI) and partial (cspxl) csp  gene 
deletions (Zinsmaier et al., 1994). Ninety-six percent of flies that lacked the entire csp gene died 
embryonically, and those that hatched died prematurely in a temperature-sensitive manner: flies 
lived for only 4-5 days at 22 °C, while at 25 °C death occurred rapidly (hours). Preceding 
death, the flies displayed progressively uncoordinated motor behaviour finally leading to 
paralysis. These tem perature-sensitive phenotypes prompted investigations into the 
physiological defects resulting from csp deletions. Electroretinography performed on adult 
survivors suffering from a partial loss of the csp gene (cspxl) identified a loss of “on” and “o ff ’ 
transients at higher tem peratures, correlating to a tem perature-sensitive loss of 
neurotransmission (Zinsmaier et al., 1994).
To determine the cellular basis for the temperature-sensitive loss of neurotransmission in 
Drosophila cspRI and cspxl gene deletions, electrophysiological recordings at the neuromuscular 
junction of Drosophila cspxl mutant larvae were measured. The recordings revealed that a 
partial loss of the csp gene results in nerve impulses that are unable to trigger neurotransmitter
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release at non-permissive temperatures: there was a reduction by 50% of depolarization- 
secretion coupling at 22 °C, and a complete loss at 30 °C, which was overcome by restoring the 
temperature back to 22 °C (Umbach et al., 1994). These were the first results to implicate CSP 
in regulated exocytosis; no temperature-sensitive effect on spontaneous release was observed 
(Um bach et ah, 1994). The effects of loss of the csp gene in Drosophila  were strongly 
reminiscent of dnaJ  deletion mutants observed in Escherichia coli: growth of E. coli was 
blocked at high temperatures, but permitted at lower temperatures (O hki et al., 1992), 
suggesting that CSP may have a chaperone-like activity. These early observations provided the 
foundation of a working hypothesis for CSP function: that CSP may act as an exocytotic 
chaperone, by helping to stabilise components of the neurotransmitter release machinery.
1.10.7 CSP AND REGULATED EXOCYTOSIS
Following the observed effects in transmitter release in Drosophila csp  null mutants, much 
work has focussed on identifying the role of CSP in regulated exocytosis, and in particular, the 
precise steps during vesicle fusion at which CSP functions. Shortly after the cloning of 
Drosophila CSP, a putative functional role for CSP was proposed following attempts to identify 
potential subunits of presynaptic calcium channels in vertebrates (Gundersen and Umbach, 
1992). Injection of Torpedo electric lobe mRNAs into Xenopus oocytes resulted in the ectopic 
expression of functional voltage-sensitive N-type calcium channels, and the activity of these 
calcium channels was abolished by the co-expression of specific antisense RNA transcripts 
(Gundersen and Umbach, 1992). Consequently, the resultant cDNA isolated from the Torpedo 
inhibitory antisense RNA was found to encode CSP, and thus CSP was proposed to be a 
potential calcium channel subunit or modulator (Gundersen and Umbach, 1992). The proposal 
that CSP was an essential component of calcium channels was only briefly held however, since 
CSP was subsequently shown to be localised not to the plasma membrane (where N-type 
calcium channels reside), but to synaptic vesicles in Torpedo electric organ (Mastrogiacomo et 
al., 1994b). CSP has since been found localised to many types of secretory vesicles (see Chapter 
1.10.3). It was subsequently proposed that CSP, present on docked vesicles, might be able to 
activate nearby calcium channels, thus forming an important link between synaptic vesicles and 
calcium channels. This hypothesis was attractive as it implied that calcium entry would be 
greatest through channels that were physically linked to synaptic vesicles. In support of this 
model, in vitro translated CSP has been shown to specifically bind a recombinant fusion protein 
containing a domain that encodes a cytoplasmic loop of the a ,A  subunit of P/Q-type calcium 
channels (Leveque et al., 1998).
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Later studies suggested that the temperature-sensitive loss of neurotransmission in csp mutants 
at the Drosophila neuromuscular junction involved either a defect in Ca2+ entry or in the ability 
of Ca2+ to trigger exocytosis (Umbach and Gundersen, 1997; Umbach et al., 1998). First, the 
temperature-sensitive loss of neurotransmission could be overcome by stimulating mutant 
neuromuscular junctions with secretagogues that bypass presynaptic Ca2+ channel opening, such 
as a-latro toxin  and ionomycin, at non-permissive temperatures (32 °C) (Umbach and 
Gundersen, 1997). Second, Ca2+ crimson fluorescence was used to measure cytosolic calcium 
influx into mutant nerve terminals following stimulation. At 22 °C, there was an increase in the 
fluorescence intensity after stimulation, indicating normal Ca2+ entry. However, when the 
temperature was raised to 32 °C, no increase in the fluorescent intensity was observed, 
suggesting that at elevated temperatures Ca2+ entry is inhibited in csp mutants (Umbach et al.,
1998). Collectively, these results implied that CSP acts upstream of, or within, the calcium 
signalling cascade mediating evoked exocytosis.
Despite the data supporting a role for CSP in Ca2+ channel regulation, several studies are 
inconsistent with this notion. In particular, subsequent studies revealed that calcium entry was 
not impaired in Drosophila csp mutants (Dawson-Scully et al., 2000; Morales et al., 1999). 
Work utilising the fluorescent calcium indicator fura-2 AM revealed that, despite having a huge 
reduction in neurotransmitter release, Drosophila csp null mutant nerve terminals retain a robust 
increase in presynaptic Ca2+ signals at elevated temperatures, but indeed exhibit an increased 
rate of Ca2+ clearance (Dawson-Scully et al., 2000). Furthermore, it was shown that the 
reduction in neurotransmitter release in Drosophila csp null mutant nerve terminals could be 
restored at non-permissive temperatures by raising the extracellular Ca2+ concentration. These 
findings suggest that Drosophila csp null mutants have a decreased efficiency in the ability of 
Ca2+ to trigger neurotransmitter release, and are indicative of a direct function for CSP in 
exocytosis, downstream of Ca2+ entry. In addition to these analyses of Ca2+ channel activity in 
csp null mutants, many studies have failed to demonstrate the binding of CSP to native Ca2+ 
channels (Leveque et al., 1998; Martin-Moutot et al., 1996; Pupier et al., 1997). Furthermore, 
calcium channel activity is not detectably modified by either overexpression of CSP in PC 12 
and insulinoma cells or by deletion of csp in Drosophila (Brown et al., 1998; Chamberlain and 
Burgoyne, 1998b; Dawson-Scully et al., 2000).
The cloning of the mammalian CSPs enabled further analysis of the effects CSP had on 
regulated exocytosis. There have been contradictory reports of the effects on regulated 
exocytosis following the overexpression of CSP in neuroendocrine cells. PC 12 cells stably 
overexpressing CSP showed a ~50% increase in dopamine release, suggesting that CSP exerts a
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positive function on exocytosis (Chamberlain and Burgoyne, 1998b). However, in contrast, 
transient overexpression of CSP in pancreatic |3-cell lines or chromaffin cells significantly 
reduced secretion (Boal et al., 2004; Brown et al., 1998; Graham and Burgoyne, 2000; Zhang et 
al., 1998). This inhibitory effect of CSP transient overexpression likely reflects perturbation of 
the exocytotic machinery caused by excess CSP titrating other essential components. Indeed, 
CSP knockdown in pancreatic (3 cells reduced insulin secretion (Zhang et al., 1998), supporting 
the notion that CSP has a positive role in exocytosis. These combined studies highlight an 
important role for CSP in regulated exocytosis in non-neuronal cells in addition to neurons. 
Furthermore, the effects of CSP overexpression or knockdown in exocytosis in these cells were 
preserved in permeabilised cells; exocytosis from permeabilised cells is independent of calcium 
channel activity, further demonstrating that CSP has calcium channel-independent functions in 
exocytosis. Interestingly, more thorough investigation of CSP function in exocytosis using 
carbon fibre amperometry found that the overexpression of CSP in adrenal chromaffin cells 
resulted in a 82% decrease in the number of fusion events, and the release events that did occur 
were much slower (Graham and Burgoyne, 2000). This implicated CSP in the control of either 
fusion pore formation or opening. Other proteins that exhibit effects on fusion kinetics are 
those that modulate exocytosis through interaction with the SNARE complex or its components, 
for example the putative calcium sensor synaptotagmin (Wang et al., 2001), complexin (Archer 
et al., 2002) and M uncl8 (Barclay et al., 2003; Fisher et al., 2001). Thus, the functions of CSP 
in regulated exocytosis may be through the interactions of CSP with members of the SNARE 
complex or SNARE regulators; interestingly, mice lacking the CSP gene have a decrease in 
SNARE complex formation (Chandra et al., 2005). Consistent with this theory, CSP and 
VAMP have been found in a complex following immunoprecipitation of rat brain homogenate 
(Leveque et al., 1998) and a direct interaction between CSP and VAMP2 has been reported 
(Boal et al., 2004). The t-SNARE syntaxin has been shown to bind CSP in vitro in Drosophila, 
and the defect in neurotransmission caused by overexpression of syntaxin is overcome by 
overexpressing CSP (Nie et al., 1999). Similarly in neuroendocrine cells, syntaxin forms a 
complex with CSP in vitro, which is dependent on the phosphorylation state of CSP (Evans et 
al., 2001). Finally, synaptotagmin has been shown to bind CSP both in vitro and in vivo and, as 
in the interaction of CSP with syntaxin, has a reduced affinity for CSP when phosphorylated 
(Evans and Morgan, 2002); this interaction may explain how CSP affects the Ca2+-sensitivity of 
exocytosis (see previous section). When an unphosphorylatable mutant of CSP was 
overexpressed in chromaffin cells, the inhibition of exocytosis was still observed (as in the 
overexpression of wild-type CSP), but the release kinetics and the total vesicle content that was 
released per fusion event were no different to those in control cells (Evans et al., 2001). Since 
the only difference in these experiments was the phosphorylation state of CSP, it was suggested
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that the phosphorylation of CSP plays a role at a late stage of exocytosis. Finally, it has been 
hypothesized that phophorylated CSP may act through an unidentified protein to slow the 
kinetics of release, while unphosphorylated CSP may chaperone the interaction of syntaxin 
and/or VAMP for faster release (Evans et al., 2003).
1.10.8 P r o p o s e d  f u n c t i o n  o f  CSP a s  a n  e x o c y t o t i c  c h a p e r o n e  p r o t e in
The molecular cloning of CSP and the deduced amino acid sequence revealed that CSP contains 
a J domain, a 70 amino acid domain present within a number of eukaryotic Hsp40 proteins, 
which is homologous to a region of the bacterial protein DnaJ and other unrelated eukaryotic 
proteins. DnaJ interacts with the chaperone protein DnaK, and, as part of a complex with the 
nucleotide exchange factor, GrpE, stimulates the ATPase activity of DnaK, allowing it to 
function in many cellular processes, such as protein folding and replication of bacteriophage 
lambda (Liberek et al., 1988; Liberek et al., 1991; Yochem et al., 1978). The eukaryotic 
homologue of the bacterial DnaK proteins is the Hsp70 (Heat shock protein of 70 kDa) protein 
family, an abundant and ubiquitous family of chaperone proteins involved in many protein 
folding reactions, such as the folding of newly-synthesised proteins, the refolding of misfolded 
and aggregated proteins, and providing protein stability during translation and translocation 
(Mayer and Bukau, 2005). Hsc70 (Heat shock cognate protein of 70 kDa) is constitutively 
expressed, whereas Hsp70 expression can be regulated by heat-shock. The functions of Hsp70 
depend on its ability to selectively bind short hydrophobic stretches of substrate polypeptides, a 
process that is regulated by a cycle of ATP binding, hydrolysis and nucleotide exchange 
(M inami et al., 1996). The ATP-regulated association of Hsp70 with substrate proteins is 
brought about by a conformational change in the C-terminal peptide binding domain of Hsp70 
upon ATP binding, in which the substrate binding pocket is in an open conformation and Hsp70 
has a low affinity for substrates and fast association and dissociation rates (Bukau and Horwich,
1998). Following ATP hydrolysis, the substrate binding pocket of Hsp70 adopts a closed 
conformation, which has a high affinity for substrates and slow exchange rates (Bukau and 
Horwich, 1998).
The interactions of CSP with Hsp70 proteins are likely central to its function. Recombinant 
CSP can interact with both recombinant and purified Hsc70, and this interaction is ATP- 
dependent (Chamberlain and Burgoyne, 1997b). Furthermore, this binding of CSP to 
Hsp70/Hsc70 increases the ATPase activity of these proteins by as much as 14-fold (Braun et 
al., 1996; Chamberlain and Burgoyne, 1997b). Importantly, there is also genetic evidence for 
the interaction of Csp and hsc70-4 in Drosophila (Bronk et al., 2001). The J domain of CSP is
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necessary and sufficient to stimulate ATPase activity: a truncation mutant containing the J 
domain alone was able to stimulate the ATPase activity of Hsc70 (Braun et al., 1996); 
conversely, a truncation mutant lacking the J domain was not (Chamberlain and Burgoyne, 
1997b). The functional importance of the ability of CSP to stimulate the ATPase activity of 
Hsc70 was shown when CSP, in a complex with Hsc70, prevented the aggregation of a model 
unfolded substrate (Braun et al., 1996; Chamberlain and Burgoyne, 1997a). This observation 
suggests that CSP/Hsc70 might regulate the folding of specific exocytotic proteins.
The J domain of DnaJ/Hsp40 proteins consists of four alpha helices containing a highly 
conserved tripeptide histidine-proline-aspartic acid (HPD) motif located within a loop region 
between helices II and III (Qian et al., 1996). The HPD motif is required for ATPase 
stimulation, as mutations within the HPD motif (H43Q or D45A) of CSP abolished binding to 
Hsc70 and thus prevented the stimulation of its ATPase activity (Chamberlain and Burgoyne, 
1997a).
The anticipated function of CSP as a chaperone is thus proposed to centre on its ability to 
interact with and stimulate the ATPase activity of Hsc70. CSP has been shown to interact with 
the SNARE proteins syntaxin and VAMP, and synaptotagmin, and it is possible that the 
exocytotic chaperone activity of CSP may be exerted during these interactions (Boal et al., 
2004; Evans et al., 2001; Evans and Morgan, 2002; Leveque et al., 1998; Nie et al., 1999). It 
would be interesting to determine whether CSP regulates the folding of these proteins, or is 
involved in the assembly/disassembly of protein complexes associated with the exocytotic 
fusion machinery. In support of this theory is the observation that CSP null mice have a 
decrease in SNARE complex formation (Chandra et al., 2005); this perhaps reflects a chaperone 
role of CSP in promoting SNARE complex assembly. Consistent with the hypothesis that CSP 
acts as an exocytotic chaperone, CSP has been found on synaptic vesicles in a complex with 
Hsc70 and several vesicular proteins. For example, as part of a complex with Hsc70, CSP has 
been im plicated in vesicle filling, through interactions with the enzyme glutamate 
decarboxylase (GAD) (Hsu et al., 2000). GABA is the major inhibitory neurotransmitter in 
brain (Roberts and Kuriyama, 1968), and is synthesised by GAD: the activity of GAD is 
dependent on phosphorylation by a kinase located on the synaptic vesicle membrane (Hsu et al.,
1999). Hsc70 and CSP binding to GAD are thought to aid GAD targeting to synaptic vesicle 
membranes, thereby facilitating GABA synthesis (Hsu et al., 2000). In addition, CSP has been 
found as part of a chaperone complex containing aG D I, Hsp90 and Hsc70 (Sakisaka et al., 
2002). As outlined in Chapter 1.9.2, Rab3A is the major Rab GTPase in neurons, and Rab 
cycling depends on its dissociation from vesicles through the action of aG D I (Luan et al.,
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1999). Following vesicle fusion, the CSP-Hsp90-Hsc70 chaperone complex is thought to target 
aG D I to vesicle membranes, thereby indirectly functioning in vesicle trafficking by promoting 
Rab3A recycling (Sakisaka et al., 2002).
CSP has also been implicated as a regulator of G protein signalling at the plasma membrane 
(Natochin et al., 2005). Heterotrimeric G proteins are composed of a ,  (3 and y subunits, which, 
when activated, dissociate into Ga and GPy subunits that interact with downstream effectors. 
Activation of G proteins involves the exchange of GDP bound to Ga for GTP, catalysed by a 
guanine nucleotide exchange factor (GEF). CSP has been shown to interact with G ^ and act as 
a GEF, by promoting GDP/GTP exchange. Furthermore, the interaction of CSP with Hsc70 and 
SGT (small glutamine-rich tetratricopeptide) was found to regulate the GEF activity of CSP 
(Natochin et al., 2005).
In addition to functions related to secretory vesicle dynamics, CSP may also have a chaperone 
function at early compartments in the secretory pathway. For example, CSP has been proposed 
to function in the maturation, biogenesis and trafficking of the cystic fibrosis transmembrane 
conductance regulator (CFTR), a cAMP-regulated chloride channel located on the apical 
membrane of epithelial cells that functions in salt secretion and absorption (Zhang et al., 2002a; 
Zhang et al., 2006). CFTR exists in two forms, an immature, core glycosylated form, and a 
mature, fully glycosylated form; CSP interacts predominantly with the immature form (Zhang et 
al., 2002a). Overexpression of CSP in HEK293 cells blocks the formation of mature CFTR, 
leading to the accumulation of the immature form in the ER, and hence preventing CFTR 
trafficking to the plasma membrane (Zhang et al., 2002a). The regulation of CFTR trafficking 
is dependent on CSP possessing a functional J domain, since overexpression of the CSP(H43Q) 
mutant, which is unable to bind to Hsc70 or stimulate its ATPase activity (Chamberlain and 
Burgoyne, 1997a), restored the maturation and export of CFTR (Zhang et al., 2006). Although 
these results are of significant interest, one possibility is that CSP overexpression has effects on 
the folding of newly synthesised proteins such as CFTR by sequestering Hsc70. A similar 
caveat also applies to other studies utilising CSP overexpression.
1.11 M e m b r a n e  t a r g e t in g  a n d  t r a f f ic k in g  o f  pa l m it o y l a t e d  p r o t e in s
As the enzymes that transfer palmitate onto substrate proteins are membrane-associated, 
substrate proteins require being membrane proximal in order to be palmitoylated. Thus, it is 
essential that palmitoylated proteins have a mechanism to target them to the specific membrane 
compartment that houses their partner PAT. The mechanisms that govern the initial membrane
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targeting and subsequent trafficking of palmitoylated proteins are dependent on the type of 
membrane protein involved and its final subcellular localisation.
For the majority of palmitoylated transmembrane proteins (with the exception of Type IV 
membrane proteins: see Chapter 1.2, and below), the route of primary membrane interaction is 
obvious: these proteins are co-translationally inserted into the ER membrane by a signal- 
peptide-mediated process. From the ER these proteins can traffic through the secretory pathway 
until they reach the compartment where their partner PAT is localised; if this is prior to reaching 
their resident membrane, the protein is subsequently sorted to its target membrane. This is true 
for the palmitoylated vesicle membrane protein synaptotagmin, a palmitoylated Type I 
membrane protein that associates with vesicle membranes through an N-term inal 
transmembrane domain. Synaptotagmin traffics through the secretory pathway to the plasma 
membrane; the internalisation and subsequent sorting of synaptotagmin to the intracellular 
vesicle pool is dependent on both glycosylation at an N-terminal intralumenal domain and 
palmitoylation of cysteines adjacent to the transmembrane domain (Han et al., 2004; Kang et 
a l,  2004).
C-terminal anchor proteins (Type IV membrane proteins) are post-translationally inserted into 
the ER and subsequently sorted into budding vesicles for transport through the secretory 
pathway until they reach their resident membrane (Kutay et al., 1995). The vesicle-associated 
SNARE protein VAMP2 is a Type IV membrane protein that can be palmitoylated in vitro (Veit 
et al., 2000). The two yeast VAMP2 homologues, Snc-lp and Snc-2p (Suppressor of the null 
allele of CAP), are palmitoylated on a single cysteine in vivo. Whilst this palmitoylation is not 
essential for the exocytotic function of these proteins, it was suggested to be involved in protein 
stability (Couve et al., 1995). Insertion of VAMP2 into the ER membrane requires ATP and is 
dependent upon a tail of 15-22 hydrophobic amino acids (Kutay et al., 1995; Whitley et al., 
1996); in fact, a stretch of 12 hydrophobic amino acids is sufficient to integrate VAMP2 into 
microsomal membranes (Whitley et al., 1996). Targeting of VAMP2 to ER membranes 
requires 4 positively charged amino acids within an amphipathic helix, located to the N- 
terminus of the insertion sequence (Kim et al., 1999). Sorting determinants for the trafficking 
of C-tail anchored proteins out of the ER include the length of the tail anchor, though other 
factors are likely to exist. For example, the trafficking of VAMP2 to synaptic vesicle 
membranes following membrane insertion in the ER requires co-expression of another protein, 
synaptophysin 1 (Honsho et al., 1998; Pennuto et al., 2003), and specific amino acids within the 
SNARE domain (Grote et al., 1995; Hao et al., 1997).
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How are palmitoylated proteins that lack membrane-spanning domains targeted to their 
membrane-associated partner PAT? These proteins are synthesised on free ribosomes yet must 
be targeted to membranes in order to be palmitoylated. Many soluble proteins undergo 
modification with different lipids prior to palmitoylation. For example the Ras- and Rho- 
GTPases, which have tandem isoprenyl and palmitoyl anchors, are synthesised on free 
ribosomes and become farnesylated in the cytoplasm by a farnesyltransferase prior to 
palmitoylation (Adamson et al., 1992; Hancock et al., 1989). Similarly, members of the Src 
family of tyrosine kinases, certain Ga subunits, and eNOS, all have tandem myristoyl and 
palmitoyl anchors, and myrisoylation is a prerequisite for subsequent palmitoylation (Koegl et 
al., 1994; Morales et al., 1998; Robinson et al., 1995). Thus, for these proteins, a different lipid 
modification attached to the proteins in the cytoplasm serves as their primary membrane- 
targeting signal. The finding that these dual-modified proteins require modification with either 
a prenyl or a myristoyl group prior to palmitoylation, and that long-lived membrane association 
of these proteins depends on palmitoylation (See Chapter 1.3.3), both contributed to the kinetic 
membrane trapping model (Shahinian and Silvius, 1995). In this model, proteins that are 
modified with a single myristoyl or famesyl anchor (and thus have weak membrane affinity) 
will cycle on and off membranes, thereby “sampling” the different intracellular membranes, 
until they eventually encounter a membrane housing their partner PAT. Palmitoylation by the 
membrane-resident PAT yields a dually-lipidated protein that has a stronger membrane affinity, 
resulting in a much longer-lived association with the membrane; hence the protein becomes 
membrane “trapped”. This stronger membrane affinity might now ensure that the protein does 
not dissociate from the membrane during vesicle budding and trafficking, resulting in efficient 
intracellular sorting. In this way, the primary lipid modification serves to target the protein to 
membranes in order for it to be palmitoylated; once palmitoylated, the protein can be sorted to 
its correct final destination. Release of the palmitoylated protein from the membrane can also 
be regulated through depalmitoylation by a protein acylthioesterase (e.g H/N-Ras; see Chapter
1.4.2 and (Rocks et al., 2005). The kinetic trapping model is exemplified by the Ras proteins; 
furthermore, it is supported by biophysical studies that have measured the varied membrane 
affinities of lipidated peptides for model membranes, and fluorescence bleaching techniques 
applied to dually lipidated proteins in live cells (Goodwin et al., 2005; Peitzsch and 
McLaughlin, 1993; Rocks et al., 2005; Shahinian and Silvius, 1995; Silvius and l'Heureux, 
1994).
Finally, some palmitoylated soluble proteins lack consensus sites for modification with prenyl 
or myristoyl anchors, yet are still able to become stably associated with membranes via 
palmitoylated cysteines. These proteins, which include the secretory vesicle proteins CSP and
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GAD-65, and the plasma membrane SNARE SNAP25, must possess mechanisms that allow 
initial membrane targeting prior to palmitoylation. The exact mechanism that underlies the 
initial membrane targeting, palmitoylation, and subsequent trafficking of such proteins to their 
target membranes is limited. Perhaps the best characterised example is for GAD-65, which is 
synthesised as a soluble hydrophilic protein, yet is stably associated with vesicle membranes 
through the palmitoylation of two cysteines within the N-terminus (Christgau et al., 1991; 
C hristgau  et al., 1992). The extreme N-terminus of GAD-65 is required for GAD-65 
association with Golgi membranes, and this region is sufficient to target other soluble proteins 
to Golgi membranes (Solimena et al., 1993; Solimena et al., 1994). Furthermore, only once 
GAD-65 is palmitoylated on cysteines at positions 30 and 45, is it able to be moved out of the 
Golgi and sorted into the desired carrier vesicle (Huang et al., 2004; Kanaani et al., 2002). 
However, the molecular mechanisms that govern initial membrane interactions of other non- 
myristoylated/prenylated proteins remain unknown. In particular, it is not clear whether these 
proteins utilise a similar mechanism for initial membrane targeting or whether more protein- 
specific mechanisms are employed. An additional area of interest is the role that palmitoylation 
plays in specifying the sorting of these proteins to defined intracellular locations such as the 
plasma membrane or secretory vesicles.
1.12 A im s  a n d  h y p o t h e sis
The mechanisms that govern initial membrane targeting, palmitoylation, and subsequent 
trafficking of solely palmitoylated proteins to their target membranes are ambiguous. Following 
synthesis, these proteins somehow need to be presented to their membrane-resident partner PAT 
for palmitate transfer to take place. In most cases, palmitoylation is a prerequisite for the 
subcellular trafficking of these proteins to their resident membrane compartment. Thus, the 
initial membrane targeting of these proteins is thereby essential for their localisation, and hence 
their function. It is possible that a common mechanism governs the initial membrane targeting 
of these proteins. One hypothesis is an extension of the kinetic membrane-trapping model 
proposed for dual-lipidated proteins, outlined in Chapter 1.11 (Shahinian and Silvius, 1995). 
This hypothesis states that in the absence of a primary lipid anchor, other mechanisms that 
provide initial affinity for membranes, and hence target the protein to its resident PATs, could 
substitute. Examples of such membrane affinity could include clusters of basic amino acids or 
hydrophobic domains. Palmitoylation would then regulate the subsequent sorting of these 
proteins to their correct subcellular membrane. This model would explain how some proteins, 
in particular palmitoylated proteins that have no obvious membrane-targeting motifs, are 
presented to their membrane-resident partner PAT in order for palmitate transfer to occur.
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Following palmitoylation, the protein is now stably membrane-bound, and can be sorted to its 
final subcellular membrane. The exocytotic chaperone protein, CSP, is an excellent model 
protein with which to test this hypothesis. CSP is synthesised as a soluble protein, yet is stably 
and permanently associated with vesicle membranes through a palmitoylated cysteine string 
domain. Furthermore, the recent cloning of 23 mammalian palmitoyl transferases allows for the 
cellular site of CSP palmitoylation to be examined in vivo. The aims of this study are to 
determine the mechanisms that govern the initial membrane binding of CSP, its palmitoylation 
and subsequent trafficking routes to vesicle membranes. The above hypothesis will be tested, 
and a model for the initial membrane binding, palmitoylation and subsequent trafficking of this 
class of otherwise soluble, yet palmitoylated membrane proteins, will be proposed.
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2.1 M a t e r ia l s  a n d  su p p l ie r s
2.1.1 C h e m ic a l s
All chemicals were supplied by the Sigma-Aldrich Company Ltd (Dorset, U.K.), except where 
otherwise stated, and were of the highest grade available.
2.1.2 M o l e c u l a r  b io l o g y  r e a g e n t s
Oligonucleotide primers were synthesised by Sigma™-Proligo® (Dorset, U.K.). DNA 
polymerases and dNTPs were obtained from Promega Corporation U.K (Southampton, 
Hampshire, U.K.). XLl-Blue Supercompetent Cells (strain recAl endAl gyrA96 thi-1 hsdR17 
supE44 relA l lac [FproAB lacIqZDM15 TnlO (Tetr)]) were purchased from Stratagene (La 
Jolla, U.S.A). One Shot® TOPIO Competent Cells (Strain F- mcrA (mrr-hsdRMS-mcrBC) 
80/acZM15 lacXIA recA l ara \39  (ara-leu)1691 galU galK  rpsL  (StrR) endA \ nupG) were 
obtained from Invitrogen Ltd (Paisley, U.K.). QIAfilter® Plasmid Maxi Kit, QIAprep® Spin 
Miniprep Kit and QLAquick® Gel Extraction Kit were acquired from Qiagen Ltd (Crawley, 
West Sussex, U.K.). DNA ladders (100 bp and 1 kB) were purchased from New England 
Biolabs (U.K.) Ltd (Hitchin, Hertfordshire, U.K.).
2.1.3 C e l l  c u l t u r e  m e d ia  a n d  p l a st ic s
All cell culture plastics were purchased from Coming B.V, (Schiphol-Rijk, The Netherlands) 
unless otherwise specified. Thirteen millimetre coverslips and 24-well plates, pre-coated with 
poly-D-lysine, were purchased from Biotrace International (Bridgend, U.K.). RPMI Media 
1640, Dulbecco's Modified Eagle Medium (D-MEM), OPTI-MEM, Horse Serum, Foetal Calf 
Serum, F-10 Nutrient Mixture (Ham), L-Glutamine, Trypsin-EDTA and Lipofectamine™ 2000 
Reagent were all purchased from Invitrogen Ltd. Six-well plates were coated with 1 ml Poly-D- 
Lysine (100 ng/ml, in sterile distilled (d) H20 )  for 1 hour at room temperature, then washed 
twice with RPMI 1640 and stored at 4°C until required.
2.1.4 A n t ib o d ie s
2.1.4.1 P r im a r y  a n t ib o d ie s
The anti-calreticulin antibody was from Abeam pic (Cambridge, U.K.). Recombinant human 
calreticulin was produced in the Baculovirus insect cell system and raised in rabbit polyclonal
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whole antiserum  IgG. D ilutions were 1:1000 for im m unoblotting and 1:200 for 
immunofluorescence.
The anti-Cysteine string protein polyclonal antibody was purchased from  StressGen 
Biotechnologies Corporation (Victoria, B.C., Canada). This immunoaffinity purified rabbit 
antibody was raised against a synthetic peptide corresponding to the extreme C-terminus of rat 
cysteine string protein (residues 182-198) conjugated to KLH and raised in rabbit. Dilutions 
were 1:10000 for immunoblotting and 1:100 for immunofluorescence.
Clontech laboratories, Inc (Mountain View, CA, U.S.A) supplied the Living Colors® A.v. anti- 
GFP (JL-8) affinity purified monoclonal IgG2a antibody. This antibody was produced by 
hybridoma cells against full-length Aequoria victoria green fluorescent protein and was used at 
a dilution of 1:5000 for immunoblotting.
The sheep anti-Grasp55 antibody was a gift from Dr Francis Barr (Shorter et al., 1999) and was 
used at a dilution of 1:50 for immunofluorescence.
The anti-HA and Rhodamine-conjugated anti-HA antibodies were from Roche (Welwyn Garden 
City, Hertfordshire, U.K.). Both antibodies are specifically raised to the peptide epitope 
YPYDVPDYA, derived from the human influenza haemagglutinin (HA) protein. The 
monoclonal rat anti-HA (clone 3F10) was used at a dilution of 1:1000 for immunoblotting. The 
Rhodamine-conjugated mouse monoclonal antibody (clone 12CA5) was used at 1:100 for 
immunofluorescence. A fluorescein isothiocyanate-conjugated (FITC) anti-HA mouse 
monoclonal IgG2a was supplied by Santa Cruz Biotechnology Inc (Heidelberg, Germany) and 
used for immunofluorescence at a dilution of 1:50.
A mouse monoclonal a-SNAP antibody (Clone 77.1) was purchased from Synaptic Systems 
(Gottingen, Germany). The antibody was raised against recombinant full length rat aSNAP and 
was used at a dilution of 1:5000 for immunoblotting.
An anti-m uncl8 antibody was supplied by Becton Dickinson (Oxford, UK). Purified 
monoclonal mouse IgGl antibody was raised against the C-terminus of rat Munc-18-1 and was 
used at a dilution of 1:250 for immunoblotting.
A mouse anti-transferrin receptor monoclonal antibody (clone H68.4) was purchased from 
Zymed Laboratories Inc (Cambridge, UK). Affinity purified mouse IgGl antibody was raised
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against the N-terminus of recombinant human transferrin receptor. A dilution of 1:1000 was 
used for immunoblotting.
2.1.4.2 S e c o n d a r y  a n t ib o d ie s
Alexa Fluor® 594 goat anti-rabbit, Alexa Fluor® 488 goat anti-rabbit, Alexa Fluor® 568 donkey 
anti-sheep affinity purified antibodies were from Invitrogen Ltd and used at a dilution of 1:400 
for immunofluorescence.
Horse-radish peroxidase (HRP)-conjugated donkey anti-rabbit, goat anti-rat and sheep anti­
mouse antibodies were from GE Healthcare UK Ltd (Little Chalfont, Buckinghamshire, U.K.) 
and used for immunoblotting at a dilution of 1:2000. An ImmunoPure HRP-conjugated rabbit 
anti-sheep antibody was supplied by Pierce Biotechnology (Rockford, IL, U.S.A) and used for 
immunoblotting at a dilution of 1:2000.
2.1.5 R a d io a c t iv e  m a t e r ia l s
l9,10(n)-3H]Palmitic acid was obtained from PerkinElmer (Beaconsfield, Buckinghamshire, 
U.K.). Pro-mix L-|35S] in vitro cell labelling mix was purchased from Amersham pic (Little 
Chalfont, Buckinghamshire, U.K.).
2.1.6 P l a sm id s
Living Colors® pEGFP-C2 and dsRed2-ER fluorescent vectors were purchased from Clontech 
laboratories, Inc. A pCR2.1-TOPO vector was purchased from Invitrogen Ltd. To generate the 
EGFP-CSP plasmid, full-length bovine CSP (lacking the initiating methionine) was PCR 
amplified and inserted in frame into pEGFP-C2 as a HindlU/BamHl fragment containing a 
linker sequence as part of the multiple cloning site encoding the following amino acids: 
SGRTQISSSSL. This plasmid was constructed by Dr. Luke Chamberlain (Zhang et al., 1998) 
and was used as a template for generating all of the CSP mutants used in this study. The 
following CSP mutants were constructed by Dr. Luke Chamberlain: CSP(C1-3S), CSP(C4-7S), 
CSP(C8-10S), CSP(C11-14S), CSPM36 and CSPn3_198. A plasmid containing human SNAP25B 
fused to an N-terminal GFP tag was provided by Dr. Maureen Linder (Gonzalo et al., 1999). 
pEFBOS-HA vectors containing each of the twenty-three mouse DHHC-containing palmitoyl 
transferases were gifts from Professor Masaki Fukata (Fukata et al., 2004). DHHC3(C157S), 
DHHC7(C160S) and DHHC17(C457S) site-directed mutants were constructed by Dr. Christine
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Salaiin (INSERM U845, Faculte de Medecine Paris Descartes, Paris, France). The DHHC17- 
EGFP plasmid was provided by Dr Alaa El-Husseini (Huang et al., 2004).
2.2 St a n d a r d  m o l e c u l a r  b io l o g y  p r o t o c o l s
E.coli were cultured in sterile 2 x YT culture media (16 g/1 bacto-tryptone, 10 g/1 yeast extract, 
5 g/1 NaCl; pH 7.0) containing 100 pg/ml ampicillin or 30 pg/ml kanamycin according to 
standard protocols (Sambrook et al., 1989). 2 x YT agar plates were prepared by supplementing 
2 x YT culture media with 1.5% (w/v) bacto-agar (Melford Laboratories Ltd) prior to 
autoclaving. On cooling to approximately 60 °C, the appropriate concentration of antibiotic 
was added and, following gentle mixing, approximately 25 ml was poured into 10 cm2 diameter 
Petri dishes. Plates were allowed to set at room temperature before storage at 4 °C for up to 
four weeks.
For diethyl pyrocarbonate (DEPC) -treated water, 500 pi DEPC was added to 1 1 of 0.22 pm- 
sterile-filtered distilled water for 16 hours, then autoclaved and left to cool.
2.2.1 A m p l i f i c a t io n  o f  DNA b y  PCR
The polymerase chain reaction (PCR) was used to amplify and introduce mutations into 
segments of DNA of a known sequence. Standard PCR (Chapter 2.2.1.1) was used to amplify 
fragments of DNA used for subcloning, and site-directed mutagenesis (Chapter 2.2.1.2) was 
used to introduce nucleotide substitutions into double-stranded plasmid DNA.
2.2.1.1 S t a n d a r d  PCR
Two oligonucleotide primers were designed, each having different sequences which were 
complementary to opposite strands of a known section of template DNA. A reaction mix 
consisting of 50 ng of template DNA, 5 pi of 10 x reaction buffer, 125 ng of each sense and
Jt
antisense oligonucleotide primer, 1 pi of a 10 mM dNTP mix (10 mM of each dATP, dCTP, 
dGTP and dTTP in DEPC-treated dH20) and 0.75 pi of Pfu DNA polymerase, made to a final 
volume of 50 pi with DEPC-treated dH20 was constructed. Initially, template DNA was heat- 
denatured by heating the reaction mixture to 95 °C for 1 minute prior to thermal cycling 
reactions. Typically, template DNA was heat-denatured at 95 °C for 30 seconds, primers were 
allowed to anneal for 30 seconds at 55 °C and DNA synthesis was promoted for 1 minute at 72
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°C for a total of 30 cycles. A final incubation at 72 °C for 7 minutes terminated DNA synthesis. 
PCR products were stored at 4  °C until required.
2.2.1.2 S it e -d ir e c t e d  m u t a g e n e sis
Two complementary primers were designed to anneal to the same sequence on opposite strands 
of the plasmid with the desired mutation flanked with 15-20 nucleotides. Where possible, 
primers were designed to have a melting temperature (Tm) of at least 78 °C, to contain a 
minimum GC content of 40%, and to terminate with one or more C or G bases. The Tm of 
primers was calculated using the following formula: Tm = 81.5 + 0.41 (%GC) - (675/A) - % 
mismatch, where N  = primer length in bases, and the % GC and % mismatch are whole 
numbers. A reaction mixture was assembled, containing 50 ng of template DNA, 5 pi of 10 x 
reaction buffer, 125 ng of each sense and antisense primer, 1 pi of a 10 mM dNTP mix, 1 pi of 
Pfu polymerase and made to a final volume of 50 pi with DEPC-treated dH20. DNA was heat 
denatured at 95 °C for one minute. Thermal cycling parameters were as followed; DNA was 
heat denatured at 95 °C for 30 seconds, primer annealing took place at 55 °C for 30 seconds, 
and DNA synthesis proceeded at 68 °C: the time allowed for DNA synthesis varied depending 
on the template used - generally, an extension time of one minute for every kb of plasmid length 
was sufficient. The number of cycles depended on the number of nucleotide substitutions 
created; generally twelve cycles were required for a single nucleotide substitution, sixteen 
cycles for up to three nucleotide substitutions, and eighteen cycles for more than three 
nucleotide substitutions. To select for mutation-containing synthesised DNA, 1 pi of Dpn I was 
added to the PCR reaction and incubated at 37 °C for 1 h. Dpn I cleaves dam methylated DNA 
isolated from E. coli, and hence specifically digests the non-mutated parental plasmid (i.e. 
template cDNA). Ten percent (v/v) of the Dpn I-treated PCR reaction was subjected to agarose 
gel electrophoresis (Chapter 2.2.2) to verify amplification of mutated DNA. Two microlitres of 
the PCR product was used to transform XLl-Blue supercompetent cells (Stratagene; Chapter 
2.2.7), and, typically, plasmid DNA from three separate colonies was isolated (Chapter 2.2.9). 
Sequencing of both strands of the plasmid DNA was used to verify the desired mutations were 
incorporated and to ensure any additional unwanted mutations were absent (Chapter 2.2.13).
2.2.2 A g a r o se  g e l  e l e c t r o p h o r e sis
DNA fragments generated by PCR (Chapter 2.2.1) and restriction endonuclease digestion 
(Chapter 2.2.5) were resolved electrophoretically through agarose gels (1% (w/v)) in tris-acetate 
(TAE) buffer (40 mM Tris-acetate, 1 mM EDTA) supplemented with 2.5 p,g/ml ethidium
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bromide (Severn Biotech Ltd, Kidderminster, Worcestershire, U.K.). Typically, 10% (v/v) of a 
PCR or restriction digest product, or 1 pg plasmid DNA, was added to a 6 x stock of DNA 
Loading Buffer (10% (w/v) Ficoll 400 (Pharmacia Biotech, Uppsala, Sweden), 0.25% (w/v) 
Bromophenol Blue, in dH20) and made up to a final volume of 12 pi in DEPC-treated dH20, 
prior to loading. Samples were subjected to a potential difference of 120 V for approximately 30 
minutes prior to visualisation by UV irradiation. To estimate the concentration and size of the 
DNA to be analysed, samples were routinely electrophoresed against 5 pi of a 100 bp or 1 kB 
DNA ladder (New England Biolabs).
2.2.3  P u r if ic a t io n  o f  D N A  f r o m  a g a r o se  g e l s
DNA fragments generated by PCR (Chapter 2.2.1) and restriction endonuclease digestion 
(Chapter 2.2.5) and subjected to agarose gel electrophoresis (Chapter 2.2.2) were purified using 
the QIAquick® extraction kit (Qiagen Ltd) according to the manufacturer’s protocol. A band 
corresponding to the DNA fragment required was visualised by UV irradiation and excised. 
Three volumes of Buffer QG were added to the gel slice and the mixture was heated to 50 °C 
for 10 minutes with occasional mixing to solubilise the agarose. One gel volume of isopropanol 
was added to the mix, and after briefly mixing, the contents were decanted into a QIAquick® 
spin column and centrifuged at 17 500 x g for 1 minute, and the flow-through was discarded. 
The column was washed once with 500 pi Buffer QG to remove any residual agarose, followed 
by a further wash with 750 pi of Buffer PE. After discarding the flow-through the column was 
centrifuged for a further minute at 17 500 x g to eliminate any residual buffer in the column. 
Finally, 30 pi of DEPC-treated dH20 was added to the column, and after a minute, the column 
was centrifuged at 17 500 x g for 1 minute, and the eluted DNA was collected into a sterile 1.5 
ml tube. Successful recovery of DNA was determined by subjecting 10% (v/v) of the sample to 
agarose gel electrophoresis (See Chapter 2.2.2).
2.2.4 TA  CLONING
DNA fragments generated by standard PCR (Chapter 2.2.1.1) were cloned into a pCR2.1-TOPO 
vector (Invitrogen Ltd). pCR2.1-TOPO vectors are supplied linearized containing single 
overhanging 3’-deoxythymidine (T) residues. Tag-amplified PCR products contain a single 
deoxyadenosine (A) overhang at the 3’ end, allowing Topoisomerase I from Vaccinia virus to 
ligate the PCR product directly into the TOPO vector. For this purpose, P/w-amplified PCR 
products were Tag-treated prior to TA cloning. A cocktail containing 20 pi of gel-purified PCR 
product (Chapter 2.2.5), 2 pi of 10 x Mg2+-free buffer, 1.2 pi of 25 mM Mg2+, 0.4 pi of alO mM
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dNTP mix and 0.4 pi of Tag polymerase was incubated at 72 °C for 20 minutes. To ligate the 
Tag-treated PCR product to the TOPO vector, two microlitres of the Tag-treated PCR product 
were added to 0.5 pi of pCR2.1 TOPO vector and incubated at room temperature for 5 minutes. 
Half a microlitre of salt solution (1.2 M NaCl, 0.06 M MgCl2) was added prior to the 
transformation of TOP10 competent cells (Promega Corporation U.K.; Chapter 2.2.7).
2.2.5 R e s t r i c t i o n  e n d o n u c le a s e  d i g e s t i o n  o f  DNA
Most plasmid vectors contain polycloning sites that consist of recognition sequences for various 
restriction enzymes. Digestion of DNA with the appropriate restriction endonucleases was 
performed in order to generate compatible ends for sub-cloning and to confirm successful 
ligation of a construct. Directional cloning was achieved by using two restriction enzymes 
lacking complementarity between the two protruding ends to ensure that re-circularisation of the 
vector was inefficient. If both of the restriction enzymes work well in the same buffer, the 
digestion was carried out simultaneously; otherwise, sequential reactions were performed, with 
the enzyme that works best in the buffer containing the lowest ionic strength being used first, 
followed by the second enzyme. In most cases, 1-5 pg of vector DNA were digested in a 20 pi 
reaction mixture containing 1 pi of the restriction enzyme and 2 pi of 10 x enzyme buffer by 
incubating at 37 °C for approximately 1 hour. The restriction digestions were terminated by 
incubation at 70 °C for 10 minutes and confirmation of successful digestion was sought by 
subjecting the DNA to agarose gel electrophoresis (Chapter 2.2.2).
2.2.6 L ig a t io n  o f  p la s m id  v e c t o r  a n d  i n s e r t  DNA
Ligation of a fragment of foreign DNA to a linearised plasmid vector involves the formation of 
phosphodiester bonds between adjacent 5 ’-phosphate and 3’-hydroxy residues at the termini of 
double-stranded DNA. This reaction can be catalysed in vitro by using bacteriophage T4 DNA 
ligase (Promega Corporation U.K.). The efficiency of producing monomeric circular 
recombinant genomes is affected by the relative concentrations of the termini of both the 
plasmid and the foreign DNA. Concentrations of vector and insert DNA were estimated by 
agarose gel electrophoresis (Chapter 2.2.2) and comparison with DNA molecular weight 
markers of known concentration. Various vectoninsert ratios were tested to find the optimum 
ratio for each particular vector and insert. In most cases, a molar mass ratio of 1:1 or 1:3 
vector:insert was found to work well. The molar mass ratio for DNA molecules was estimated 
using the following formula: [ng vector x insert size (kb) / vector size (kb)] x molar ratio of 
insert = ng of insert required. Individual ligation reactions were set up using the appropriate
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vector:insert ratios, 1 pi of T4 DNA ligase, and 2 pi of 10 x enzyme buffer in a final volume of 
10 pi. The ligation reactions were incubated at 16 °C overnight, and terminated by incubation at 
70 °C for 10 minutes.
2.2.7 T r a n s f o r m a t io n  o f  c o m p e t e n t  c e l l s
Commercially available XLl-Blue supercompetent cells (Stratagene) and TOPIO competent 
cells (Promega Corporation U.K.) were used as bacterial host to amplify cloned plasmid DNA; 
the method used is described by Hanahan (Hanahan, 1983) and was the same for each 
competent cell type. XLl-Blue supercompetent cells were specifically used for plasmid DNA 
synthesised by site-directed mutagenesis (Chapter 2.2.1.2), while TOPIO competent cells were 
used for routine transformations. Cells stored at -80 °C were allowed to thaw on ice, and a 50 
pi aliquot of bacterial suspension was gently transferred to a thin-walled tube. One microgram 
of DNA (or 2 pi of the PCR product from a site-directed mutagenesis reaction) was added to the 
competent cells, mixed gently and incubated on ice for 30 minutes. Competent cells were heat- 
shocked at 42 °C for 45 seconds to encourage DNA uptake, and allowed to recover by 
incubating on ice for 2 minutes. Two hundred microlitres of 2 x YT culture media was added to 
the cells before incubation at 37 °C for one hour with shaking (~150 rpm). The transformation 
reactions were plated onto sterile 2 x YT agar plates (Chapter 2.2) pre-warmed to 37 °C and 
supplemented with the appropriate antibiotic (100 pg/ml ampicillin or 30 pg/ml kanamycin). 
Plates were inverted and incubated at 37 °C for approximately 16 hours.
2.2.8 S m a l l -sc a l e  p l a sm id  p r e p a r a t io n : “m in ip r e p s ”
Transformants were analysed by purifying plasmid DNA from individual clones and identifying 
the insert in the recombinant plasmid by restriction enzyme digest and agarose gel 
electrophoresis. The “miniprep” protocol used in this study was a modified alkaline lysis 
method of Bimboim and Doly (Birnboim and Doly, 1979) using a QIAprep® Miniprep Kit 
(Qiagen Ltd) according to manufacturer’s guidelines, with modification. Briefly, individual 
bacterial colonies were picked from the agar plates and used to inoculate 3.5 ml 2 x YT culture 
media containing the appropriate antibiotic. Bacterial colonies were grown up for 
approximately 16 hours at 37°C with vigorous shaking (~150 rpm). One-and-a-half millilitres 
of the culture was transferred to 1.5 ml microfuge tubes and centrifuged at 17 500 x g for 1 
minute to pellet bacterial cells, the supernatant was discarded. Cells were resuspended in 250 pi 
Buffer P i (50 mM Tris-Cl, pH 8.0; 10 mM EDTA, 100 pg/ml Rnase A) by vortexing. To lyse, 
an equal volume of Buffer P2 (200 mM NaOH, 1% (w/v) SDS) was added to the cells followed
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by gentle mixing. Three hundred and fifty microlitres of buffer N3 was added to neutralise the 
alkaline solutions, the contents gently mixed, followed by centrifugation at 17 500 x g for 10 
minutes to pellet cell debris. The supernatant containing plasmid DNA was transferred to a 
QLAprep® Spin Column, which consists of a silica matrix that selectively adsorbs plasmid DNA 
when present in a high salt buffer. The column was centrifuged at 17 500 x g for one minute, 
washed once with 500 p.1 of Buffer PB and once with 750 pi Buffer PE followed by a final 
centrifugation at 17 500 x g for 1 minute. Purified plasmid DNA was eluted from the column 
into a sterile 1.5 ml tube by adding 50 pi Buffer EB (10 mM Tris-Hcl, pH 8.5), and after 1 
minute, centrifuging for 1 minute at 17 500 x g. The restriction enzyme(s) used to prepare the 
vector and insert DNA for ligation were used to digest the purified plasmid DNA (as before; 
Chapter 2.2.5). Where this was not possible (for example, if digestion had resulted in 
obliteration of the restriction site), restriction enzymes that cleave flanking polycloning 
sequences were used. Identification of DNA “inserts” was achieved by electrophoresing 10% 
(v/v) of the digested plasmid alongside 10% (v/v) of the undigested plasmid “miniprep” on a 
1% (v/v) agarose gel (Chapter 2.2.2).
2.2.9 L a r g e - s c a l e  p r e p a r a t io n  o f  p la s m id  DNA: “m a x ip r e p s”
Purified plasmid DNA was isolated from bacterial cultures following a modified alkaline lysis 
system (Birnboim and Doly, 1979) using a QIAGEN® Plasmid Maxi Kit (Qiagen Ltd) according 
to manufacturer’s guidelines, with modification. Briefly, single colonies picked from agar 
plates were cultured in 100 ml of 2 x YT culture media containing the appropriate antibiotic 
overnight at 37 °C, with vigorous shaking (~150 rpm). Bacterial cells were harvested by 
centrifugation at 4 300 x g for 20 minutes at 4 °C and resuspended in 10 mis of cold Buffer PI 
(50 mM Tris-Cl, pH 8.0; 10 mM EDTA, 100 pig/ml Rnase A). Lysis of bacterial cells was 
achieved by the addition of 10 mis of Buffer P2 (200 mM NaOH, 1% (w/v) SDS) with gentle 
mixing followed by an incubation period of 5 minutes. Following this, the alkaline solution was 
neutralised and cellular components precipitated using 10 mis of chilled potassium acetate 
solution (3.0 M; pH 5.5), with gentle mixing. Immediately, the lysate was transferred to a 
QIAfilter® Cartridge and incubated at room temperature. After 10 minutes, the cleared lysate 
was filtered into a QIAGEN-tip column that had been previously equilibriated with 10 mis of 
Buffer QBT (750 mM NaCl, 50 mM MOPS, pH 7.0; 15% (v/v) isopropanol). After the cleared 
lysate had passed through the resin, the QIAGEN-tip was washed twice with 30 mis Buffer QC 
(1.0 M NaCl, 50 mM MOPS, pH 7.0; 15% (v/v) isopropanol) to remove RNA, proteins and 
other impurities. The plasmid DNA was eluted into a 50 ml centrifuge tube by adding 15 mis 
of Buffer QF (1.25 M NaCl, 50 mM Tris-Cl, pH 8.5; 15% (v/v) isopropanol) to the QIAGEN-
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tip. Eluted DNA was concentrated, desalted and precipitated by mixing with 10.5 mis of 
isopropanol and centrifuging at 4 300 x g for 1 hour at 4 °C. Further purification was achieved 
by washing the pellet with 5 mis of 70% (v/v) ethanol. Following centrifugation at 4 300 x g 
for 15 minutes at 4 °C, the supernatant was decanted and the pellet was allowed to air dry for 10 
minutes. Finally, the purified plasmid DNA was dissolved in 200-500 pi DEPC-treated H20 and 
the concentration determined spectrophotometrically (Chapter 2.2.11). Plasmid DNA was 
stored at -20  °C.
2.2.10  G l y c e r o l  st o c k s
For long-term storage of plasmids, stocks containing a bacterial broth suspended in 40% (v/v; 
final concentration) sterile glycerol were prepared for storage at -  80 °C. Five hundred 
microlitres of overnight culture was added to 500 pi sterile 80% (v/v) glycerol in a sterile 1.5 ml 
tube. The sample was vortexed to promote mixing and frozen at -  80 °C. When a new stock of 
plasmid DNA was required, a small amount of the glycerol stock was transferred on a sterile tip 
to 100 ml of fresh 2 x YT culture media for overnight growth and large-scale plasmid isolation 
(Chapter 2.2.9).
2.2.11  Q u a n t it a t io n  o f  D N A
To measure the amount of nucleic acid in a relatively pure preparation, spectrophotomeric 
measurement of the amount of ultraviolet irradiation absorbed by the DNA bases was used. 
Double-stranded DNA was diluted 1:200 in DEPC-treated H20 and the absorbance was 
measured at 260 nm. The concentration of nucleic acid in the sample can now be calculated, 
since an absorbance of one at 260 nm corresponds to approximately 50 pg/ml for double­
stranded DNA. A ratio between readings at 260 nm and 280 nm (A260/A280) provides an 
estimate of the relative purity of the nucleic acid: pure DNA has an A260/A280 value of 1.8, 
and this value is lower if there is contamination with protein or phenol (Sambrook et al., 1989).
2.2.12  N u c l e ic  a c id  p r e c ip it a t io n
Nucleic acid precipitation with ethanol was used for concentrating nucleic acids. Sodium 
acetate (3M, pH 5.2) was added to the nucleic acid solution to a final concentration of 300 mM. 
To this, 2.5 volumes of absolute ethanol (stored at -20  °C) was added, and the solution was 
chilled at -20  °C for approximately 20 minutes. The precipitate of nucleic acid was then
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recovered by centrifugation at 17 500 x g for 30 minutes, the supernatant aspirated and the 
purified DNA pellet resuspended in DEPC-treated H20 at the desired concentration.
2.2.13 D N A  SEQUENCING
To verify the mutants generated, sequencing of all constructs on both strands was performed by 
The Sequencing Service, University of Dundee, Dundee, U.K.
2.3  G e n e r a t io n  o f  m u t a n t  c o n st r u c t s
For generating the CSP N-terminal truncation mutants, oligonucleotide primers incorporating 
restriction sites flanking the cDNA region of interest were designed (Appendix one; mutated 
nucleotides are underlined and in bold). CSP cDNA was amplified using standard PCR 
practices (Chapter 2.2.1.1) and the resultant amplified product was ligated into a pCR2.1-TOPO 
vector (Invitrogen Ltd; Chapter 2.2.6). These constructs were Hindlll/BamHl digested and 
ligated in frame into a Living Colors® pEGFP-C2 vector (Invitrogen Ltd).
For CSP C-terminal truncations, a premature stop codon was introduced into the EGFP-CSP 
template by site-directed mutagenesis (Chapter 2.2.1.2) using primers described in Appendix 
two; mutated nucleotides are underlined and in bold.
Amino acid substitution(s) introduced into EGFP-CSP and HA-DHHC15 were performed by 
site-directed mutagenesis (Chapter 2.2.1.2) and the oligonucleotide primers used are listed in 
Appendices three and four; mutated nucleotides are underlined and in bold.
2.4  M a m m a l ia n  c e l l  c u l t u r e
Rat pheochromocytoma-12 (PC 12) cells were cultured in suspension in 150 cm2 flasks in 
Complete Media (RPMI-1640 supplemented with 10% (v/v) horse serum, 5% (v/v) Foetal Calf 
Serum (FCS) and 1% (v/v) penicillin-streptomycin (all Invitrogen Ltd). Human Embryonic 
Kidney (HEK) -293 cells, HeLa cells and COS 1 cells were all cultured in 75 cm2 flasks in 
DMEM (Invitrogen Ltd) supplemented with 10% (v/v) FCS and 1% (v/v) penicillin- 
streptomycin. Chinese Hamster Ovary (CHO) cells were cultured in 75 cm2 flasks in F-10 
Nutrient Mixture (Ham) (Invitrogen Ltd) supplemented with 10% (v/v) FCS, 1 % L-Glutamine 
(Invtrogen) and 1% (v/v) penicillin-streptomycin. All cells were cultured at 37 °C in a
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humidified atmosphere containing 95% (v/v) air and 5% (v/v) C 0 2, according to standard 
procedures (Doyle et al., 1994).
To passage, PC 12 cells were harvested by centrifugation at 500 x g for 3 minutes, the 
supernatant discarded, and the cell pellet resuspended in 10 ml Trypsin-EDTA (0.05% Trypsin, 
0.53 mM EDTA#4Na; Invitrogen Ltd) and incubated for 5 minutes at 37 °C. Following 
collection of cell pellets by centrifugation at 500 x g for 3 minutes, the cells were washed once 
in Complete Media and reseeded into flasks at a ratio of 1:5 or onto 6 or 24 well plates for 
microscopic or assay purposes. All other cell lines were harvested by applying 5 ml/75 cm2 
Trypsin-EDTA to the cell layer with incubation times ranging from 1 minute to 5 minutes 
depending on the cell type. The cells were washed off the flask surface with the appropriate 
medium and resuspended, before being reseeded into flasks, typically by a dilution factor of 
1:10. For microscopic or assay purposes, cells were resuspended in the appropriate medium at 
a density of approximately 106 cells/ml before being seeded onto 6- or 24-well plates.
2.4.1 S t o r a g e  a n d  r e s u s c i t a t i o n  o f  m a m m a lia n  c e l l s
For long-term storage, 1 ml aliquots of approximately 106 cells suspended in media 
supplemented with 10% (v/v) dimethylsulfoxide (DMSO) were transferred to sterile cryotubes 
and stored in an insulated polystyrene box at -70  °C overnight. The tubes were then transferred 
to a liquid nitrogen storage facility indefinitely. To resuscitate the cells, cryotubes were thawed 
at room temperature before transferring the contents to 10 ml of the cell-type specific media, 
pre-warmed to 37 °C. The cells were resuspended in media by gentle pipetting prior to seeding 
in a 25cm2 flask and incubating overnight at 37 °C in a humidified atmosphere containing 95% 
(v/v) air and 5% (v/v) C 0 2. Cell media was replaced to remove traces of DMSO and the cells 
cultured as normal.
2.4.2 T r a n s ie n t  t r a n s f e c t i o n  o f  p la s m id  DNA i n t o  m a m m a lia n  c e l l s
To introduce exogenous cDNA into mammalian cells, the cationic lipid Lipofectamine™ 2000 
reagent (Invitrogen Ltd) was used. Lipofectamine™ 2000 reagent utilises liposomes (which are 
able to fuse with phospholipids bilayers) that associate with the negatively charged nucleic 
acids, resulting in a net positively charged or neutral lipid/nucleic acid complex, thereby 
allowing exogenous cDNA to be introduced into a cell. Approximately 106 cells/ml of media 
were seeded onto 6-well or 24-well lysine-coated plates, or into flasks, 24 hours prior to 
transfection. Plasmid cDNA of known concentration was mixed with 50 pi of OPTIMEM in a
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sterile 1.5 ml tube. Lipofectamine™ 2000 reagent, at a ratio of 2 pi of reagent for every pg of 
plasmid to be transfected, was mixed with 50 pi of OPTIMEM in a sterile 1.5 ml tube and left 
to incubate at room temperature for 5 minutes. Following the incubation period, the contents of 
the two tubes were mixed, and incubation was allowed to proceed for 20-30 minutes at room 
temperature. The cDNA:Lipofectamine™ 2000 reagent complex was transferred directly onto 
the media maintaining the cells, before returning the cells to the incubator for up to 48 h prior to 
harvesting.
2.5 P r o t e in  b io c h e m ist r y
2.5.1 SDS-PAGE
Proteins were resolved electrophoretically in vertical discontinuous sodium dodecyl sulphate 
polyacrylamide gels according to the Laemmli method (Laemmli, 1970) using two systems; the 
Bio-Rad mini-PROTEAN® 3 electrophoresis system (Bio-Rad) using 1 mm spacers for hand- 
cast gels, or the Invitrogen Ltd NuPAGE® Novex® Bis-Tris mini gel system employing pre-cast 
gels. Prior to loading, protein samples were denatured for 5 min at 100 °C in SDS sample buffer 
(50 mM Tris-Hcl, pH 6.8; 10% (v/v) glycerol, 2% (w/v) SDS, 0.1% (w/v) Bromophenol Blue) 
supplemented with 25 mM DTT. Typically, between five and twenty microlitres of the protein 
samples were loaded into each well of the gel for analysis by SDS-PAGE.
2.5.1.1 B io -R a d  m in i-PROTEAN® 3 e l e c t r o p h o r e sis  sy st e m
For hand-cast gels, clean glass plates were assembled into the casting stand according to the 
manufacturer’s guidelines. A gel cassette sandwich was constructed, which comprised of a 
resolving gel monomer (8-15% acrylamide-bisacrylamide in Resolving Buffer; 0.75 M Tris- 
HC1, pH 8.8; 0.2% (w/v) SDS) overlaid with a stacking gel monomer (5% acrylamide- 
bisacrylamide in Stacking Buffer; 0.25M Tris-HCl, pH 6.8; 0.2% (w/v) SDS). A 30% stock 
acrylamide-bisacrylamide (37.5:1) (Anachem Ltd, Luton, Bedfordshire, U.K.) was used and its 
polymerization was accelerated using 0.1% (v/v) N,N,N',N'-tetramethyl-ethane- 1,2-diamine 
(TEMED), with ammonium persulphate as the catalyst. The electrode assembly holding the gel 
cassette sandwich was held in place with a clamping frame to form an inner chamber, and was 
submerged in a Mini Tank containing tris-glycine electrophoresis buffer (25 mM Tris-Hcl, 250 
mM glycine, 0.1% (w/v) SDS). Denatured proteins were concentrated in the stacking gel by 
applying a constant current of 80 V for approximately 20 minutes, prior to being resolved at a 
constant potential of 150 V for approximately 90 minutes.
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2.5.1.2 I n v i t r o g e n  L t d  NuPAGE® N o vex®  B is -T r is  M in i G e l  S y s te m
Ten percent and 4-12% Novex® Bis-tris pre-cast NuPAGE gradient gels (Invitrogen Ltd) were 
assembled into an Xcell SureLock Mini-Cell (Invitrogen Ltd) according to the manufacturer’s 
instructions. The inner and outer chambers were filled with 1 x MES (50 mM MES, 50 mM 
Tris-Base, 1 mM EDTA, 0.1% (w/v) SDS; pH 7.3) or 1 x MOPS (50 mM MOPS, 50 mM Tris- 
Base, 1 mM EDTA, 0.1% (w/v) SDS; pH 7.7) running buffer. Electrophoresis was performed 
at a constant potential of 180 V for approximately 1 h.
2.5.2 IMMUNOBLOTTING
Following electrophoresis, separated proteins in polyacrylamide gels were transferred onto 
nitrocellulose membranes (Protran® nitrocellulose membrane, 0.45 um pore size; Whatman pic, 
Brentford, Middlesex, U.K.) in order to make them accessible to antibody detection. 
Polyacrylamide gels, overlaid with nitrocellulose membranes, were sandwiched between 2 
pieces of Whatman 3mm blotting paper (Whatman Pic), all pre-soaked in Transfer Buffer (48 
mM Tris-Base, 39 mM Glycine, 0.037% (w/v) SDS, 20% (v/v) methanol) and placed gel side 
towards the cathode into the transfer cassette of a Bio-Rad Trans-Blot Cell. To transfer 
proteins, a constant current of 90 mA was applied overnight. Successful transfer was confirmed 
by incubating membranes in a solution of Ponceau S (0.1% (w/v) Ponceau S, 3% (v/v) 
trichloroacetic acid) for one minute, followed by washing in dH20 to remove excess stain. To 
block non-specific interactions between antibody and nitrocellulose, membranes were incubated 
in 5% (w/v) non-fat dried milk (Marvel, Premier Foods, St Albans, U.K.) in PBS-T (Phosphate- 
Buffered saline (137 mM NaCl, 10 mM Phosphate, 2.7 mM KC1, pH 7.4) containing 0.02% 
(v/v) Tween® 20) for 45 minutes at room temperature with agitation. Membranes were probed 
with appropriate primary antibody concentration (Chapter 2.1.41) in PBS-T for between 1 hour 
at room temperature to 4 °C overnight (depending on the antibody used), with shaking. 
Unbound antibody was removed from membranes by washing 5 x 5  minutes in PBS-T. To 
detect sites bound by primary antibody, the membrane was exposed to appropriate horseradish- 
peroxidase conjugated secondary antibody concentration (Chapter 2.1.4.2) raised against the 
species used for the primary antibody in PBS-T supplemented with 1% (w/v) non-fat dried milk 
(Marvel) for 45 minutes with gentle agitation at room temperature. Membranes were washed for 
a further 5 x 5  minutes in PBS-T to eliminate unbound secondary antibody, followed by a final 
wash in PBS. Protein bands were visualised using enhanced chemiluminescence (ECL) 
detection methods (GE Healthcare UK Ltd) according to m anufacturer’s protocol. The 
membrane was exposed to light sensitive film (Kodak) in an X-ray cassette for between 1 
second and 20 minutes and the film developed using an automatic X-ray developer (X-OMAT).
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The film was scanned using Adobe Photoshop 7.0 (Adobe Systems, CA, U.S.A.) software on an 
Apple Macintosh.
2.5.3  F ix in g  a n d  d r y in g  o f  po l y a c r y l a m id e  g e l s
Proteins separated by SDS-PAGE were fixed by incubating the gel in fixing solution (25% (v/v) 
isopropanol, 65% (v/v) dH20, 10% (v/v) acetic acid) for 30 minutes at room temperature with 
gentle agitation. The gel was washed briefly in dH20 before being sandwiched between two 
sheets of cellulose, pre-soaked in dH20, and clamped into a frame. Gels were dried at room 
temperature for between 24 and 48 hours.
2.5.4  P r e p a r a t io n  o f  c e l l  l y sa t e s
For detection of proteins expressed in cell populations, approximately 106 transfected PC 12 
cells growing on poly-D-lysine coated 24-well plates were washed once in ice-cold PBS and 
incubated in 150 pi of ice-cold lysis buffer (1% (v/v) Nonidet P-40, 1% (v/v) n-Octyl-(3-D- 
glucopyranoside, 1% (v/v) Thesit, 0.5% (w/v) saponin in PBS, containing a protease inhibitor 
cocktail; cOmplete, Mini, Roche) for 30 minutes on ice. Lysed cells were transferred to 1.5 ml 
tubes, vortexed briefly and centrifuged at 17 500 x g for 15 minutes at 4 °C to pellet cellular 
debris. The supernatant containing the cell lysate was decanted into a separate tube containing 
50 pi of 4 x SDS sample buffer (containing 100 mM DTT; 25 mM final concentration) and 
incubated at 100 °C for 5 minutes. Cellular proteins were detected by subjecting the samples to 
SDS-PAGE and immunoblotting (Chapters 2.5.1-2).
2.5.5  P r e p a r a t io n  o f  p o st n u c l e a r  su p e r n a t a n t s
Transiently transfected cells were harvested and centrifuged at 900 x g for 5 minutes at 4 °C, 
and the supernatant discarded. The cells were washed twice in 10 ml of ice-cold PBS by 
resuspension and centrifugation at 900 x g for 5 minutes at 4 °C. Next, the cells were 
resuspended in 500 pi HES homogenisation buffer (0.32 M sucrose, 20 mM HEPES, 1 mM 
EDTA, pH 7.4, plus protease inhibitors) and homogenised with 20 strokes of a Dounce 
homogeniser. The homogenised cells were centrifuged at 500 x g for 5 minutes at 4 °C and 
supernatant containing the postnuclear supernatant (PNS) was recovered.
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2.5.6 SUBCELLULAR FRACTIONATION
Cells were separated into cytosolic and membrane fractions using a ProteoExtract® Subcellular 
Proteome Extraction Kit (Calbiochem). This approach was easier and more efficient than 
standard fractionation techniques, which often require extensive centrifugation steps. The 
ProteoExtract® Subcellular Proteome Extraction Kit relies on the differential solubility of 
specific subcellular compartments (and hence their associated proteins) in the reagent mixtures 
provided (composition not specified).
For PC 12 cell fractionations, approximately 3 x 106 cells were seeded onto each well of a 6-well 
plate, pre-coated with poly-D-Lysine, and transfected with 1-3 pg plasmid DNA. Forty-eight 
hours post-transfection, adherent cells were separated into cytosolic and membrane fractions 
following the manufacturer’s protocol, with modifications. All steps were carried out at 4  °C, 
and a protease inhibitor cocktail was included in all buffers. Briefly, cells were washed twice for 
5 minutes with 800 pi Wash Buffer followed by incubation in 400 pi Extraction Buffer I, with 
gentle agitation. After 10 minutes, the buffer was harvested, centrifuged at 500 x g for 10 
minutes to remove whole cell contaminants, and the supernatant containing the cytosolic protein 
fraction was transferred to fresh tubes. The cells were then washed for 5 minutes at 4 °C with 
Wash Buffer to remove any residual cytosolic proteins. Finally, the cells were incubated with 
400 pi Extraction Buffer II for 30 minutes, and the buffer containing membrane-bound proteins 
was removed, centrifuged at 17 500 x g for 10 minutes each, and the supernatants containing 
membrane-bound proteins isolated. To each recovered cell fraction, 167 pi of 4x SDS sample 
buffer with 25 mM DTT (final concentration) was added. For detection of proteins in each 
fraction, equal volumes of the samples were subjected to SDS-PAGE and immunoblotting 
(Chapter 2.5.1-2).
For fractionation of all other cells types, approximately 106 cells/ml of media were seeded onto 
poly-D-lysine-coated 24-well plates. Cells were transiently transfected with 0.8-3 pg plasmid 
DNA and incubated for 24-48 hours. Separation of cellular proteins into cytosolic and 
membrane fractions was performed as described above with the following modifications to the 
buffer volumes: in each case cells were washed with 400 pi Wash Buffer and fractionation was 
accomplished with 150 pi of each Extraction Buffer I and II. To each recovered cell fraction, 50 
pi of 4 x SDS sample buffer with 25 mM DTT (final concentration) was added and the samples 
were processed as before.
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2.5.7 C h e m ic a l  d e p a l m it o y l a t io n  o f  c e l l  m e m b r a n e s
Cell membranes were isolated by centrifuging postnuclear supernatants at 196 000 x g for 30 
minutes at 4 °C in a Beckman TLX ultracentrifuge (Beckman Coulter Ltd, High Wycombe, 
Buckinghamshire, U.K.), using a TLA 100.4 rotor (Beckman Coulter Ltd). The pellet 
containing the membrane fraction was resuspended in 500 pi of 1 M hydroxylamine (pH 7; 
containing protease inhibitors) or 1 M Tris (pH 7; containing protease inhibitors) and incubated 
for up to 20 hours at room temperature. The treated membranes were recovered by 
centrifugation at 196 000 x g for 30 minutes and resuspended in 500 pi SDS sample buffer 
containing 25 mM DTT. For detection of proteins in each fraction, equal volumes of the 
samples were subjected to SDS-PAGE and immunoblotting (Chapter 2.5.1-2).
2.5.8 Im m u n o p r e c ip it  a t io n
GFP and myc-tagged proteins were isolated from protein populations using a pMACS™ 
Epitiope Tag Protein Isolation Kit (Miltenyi Biotec Ltd, Bisley, Surrey, U.K.). This technique 
employs a colloidal suspension of small (50 nm in diameter) super-paramagnetic MicroBeads 
conjugated to anti-GFP or anti-myc antibodies, which specifically bind the tagged proteins. The 
magnetically labelled proteins are retained on a column in a magnetic field where non-specific 
interacting molecules can be washed away, allowing the isolation of highly purified target 
molecules. Isolated cytosolic and membrane fractions or cell lysates, from transiently 
transfected cells (Chapter 2.5.6) containing epitope-tagged target proteins, were magnetically 
labelled by incubating with 20 pi of Anti-Tag MicroBeads (raised against the epitope tag) for 30 
minutes on ice. A p Column, placed in the magnetic field of the pMACS Seperator, was 
prepared by applying 200 pi of Lysis Buffer (150 mM NaCl, 1% (v/v) Triton® X-100, 50 mM 
Tris-Hcl, pH 8.0; containing protease inhibitor cocktail). Magnetically labelled cell constituents 
were applied to the column, and unlabelled proteins were allowed to run through. The column 
was rinsed with 4 x 200 pi Lysis Buffer and 1 x 100 pi Wash Buffer 2 (20 mM Tris-Hcl, pH 
7.5; plus protease inhibitor cocktail). Twenty microlitres of SDS sample buffer (containing 25 
mM DTT), preheated to 95 °C, was added to the column and allowed to incubate for 5 minutes. 
Finally, 50 pi of hot (95 °C) SDS sample buffer (containing 25 mM DTT) was added to the 
column and the eluate containing isolated GFP or myc-tagged proteins was collected. The 
immunoprecipitate was analysed by SDS-PAGE and immunoblotting and/or autoradiography.
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2.5.9  [3H ] P a l m it ic  a c id  l a b e l l in g
Transfected PC12 cells (~ 3xl06) were cultured for 48 hours and then incubated in serum-free 
RPMI1640 medium containing lOmg/ml BSA for 30 minutes at 37 °C. Following this, the cells 
were incubated in RPMI1640/BSA containing 37 MBq/ml [3H] palmitic acid for 4 hours at 37 
°C. Radiolabelled cells were separated into cytosolic and membrane fractions using a 
ProteoExtract® Subcellular Proteome Extraction Kit (Chapter 2.5.6). Following fractionation, 
GFP-tagged constructs were isolated using a pMACS™ Epitope Tag Protein Isolation Kit 
(Chapter 2.5.8). Immunoprecipitated samples were separated by SDS-PAGE (Chapter 2.5.1) 
and transferred to duplicate nitrocellulose membranes (Chapter 2.5.2). One membrane was 
processed for immunoblotting analysis using a monoclonal GFP antibody (Chapter 2.5.2). The 
duplicate membrane was allowed to air-dry, and was sprayed three times with KODAK™ 
EN3HANCE™ Spray Surface Autoradiography Enhancer (PerkinElmer) according to the 
manufacturer’s instructions to enhance detection of radiolabel incorporation. Nitrocellulose 
membranes were exposed to light-sensitive film for 10-14 days at -80 °C.
2.5.10  [35S] METABOLIC LABELLING
Approximately 3 x 106 cells were seeded onto each well of a 6-well plate, pre-coated with poly- 
D-Lysine, and were transfected with 1-3 pg plasmid DNA. Forty-eight hours post-transfection, 
adherent cells were incubated in serum-free RPMI1640 (without cysteine/methionine) medium 
containing 10% (v/v) dialysed FBS for 45 minutes at 37 °C. Following this, the cells were 
incubated in R PM I1640(-cys/m et)/d ialysed FBS containing 4-11 M Bq/ml [35S] 
cysteine/methionine (Pro-mix L-[35S] in vitro cell labeling mix; Amersham pic) for 15 minutes 
at 37 °C. The labelled cells were ‘chased’ by incubating in normal cell culture media for 
various time points (ranging from 0 minutes to 4 hours) at 37 °C and separated into cytosolic 
and membrane fractions as before (Chapter 2.5.6). GFP-tagged constructs were isolated using 
magnetic separation following incubation of cytosolic and membrane fractions with magnetic 
microbeads coupled to GFP antibody (Miltenyi Biotec; Chapter 2.5.8). Immunoprecipitated 
samples were separated by SDS-PAGE in duplicate. Proteins on one polyacrylamide gel were 
transferred to nitrocellulose membrane and processed for immunoblotting analysis (Chapter 
2.5.2) using a monoclonal GFP antibody, whereas proteins on the duplicate polyacrylamide gel 
were fixed in fixing solution (Chapter 2.5.3). To enhance detection of radiolabel incorporation, 
the polyacrylamide gel was incubated in Amplify™ Fluorographic Reagent (Amersham pic) for 
30 minutes at room temperature with gentle agitation prior to drying (Chapter 2.5.3). Dried gels 
were exposed to light-sensitive film for 1-10 days at -80  °C.
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2.5.11 A n a l y sis  o f  p r o t e in -m e m b r a n e  in t e r a c t io n s
Approximately 10 x 106 PC12 cells were transiently transfected with 10 pg cDNA. Forty-eight 
hours post-transfection, the cells were washed in PBS and resuspended in HES buffer 
(containing protease inhibitor cocktail). The cells were homogenised with twenty stokes of a 
Dounce homogeniser and membranes recovered by centrifugation at 196 000 x g for 30 
minutes. The recovered membranes were incubated in 500 pi of HES buffer, 1 M NaCl (in 
PBS), 0.1 M sodium carbonate (pH 11.5), or 1% (v/v) Triton® X-100 (in PBS; all containing 
protease inhibitor cocktail) for 30 minutes at 4 °C, followed by centrifugation at 196 000 x g for 
30 minutes. The supernatant containing proteins released from membranes was recovered, and 
the membrane pellet was resuspended in 500 pi of HES buffer. To each sample, 167 pi of 4 x 
SDS sample buffer containing 25 mM DTT (final concentration) was added. For detection of 
proteins in each sample, equal volumes of the samples were subjected to SDS-PAGE and 
immunoblotting (Chapter 2.5.1-2).
2.6 In d ir e c t  im m u n o f l u o r e sc e n c e
Transfected PC 12 and HEK293 cells growing on poly-D-Lysine coated coverslips in 6-well 
plates were washed three times with 2 ml of PBS and fixed in 2 mis of PBS containing 4% 
formaldehyde for 30 minutes at room temperature. The cells were washed twice in PBS and 
incubated for 5 minutes in PBTA (0.3% (w/v) BSA, 0.1% (v/v) Triton® X-100 in PBS) to 
permeabilise the plasma membrane; BSA was included to block non-specific binding sites. 
Primary antibody binding was achieved by inverting the coverslips, cell-side down, on parafilm 
spotted with 50 pi of the appropriate concentration of primary antibody (Chapter 2.1.4.1) in 
PBS containing 0.3% (w/v) BSA and incubating for 1-2 hours at room temperature. Coverslips 
were returned to a 6-well plate, cell side up, and unbound antibody was removed by washing the 
cells three times in 2 ml of PBS containing 0.3% (w/v) BSA. Following this, coverslips were 
incubated cell-side down on 50 pi of the appropriate concentration of Alexa Fluor® conjugated 
secondary antibody (Chapter 2.1.4.2) raised against the species used for the primary antibody in 
PBS containing 0.3% (w/v) BSA spotted onto parafilm, for 1 hour at room temperature in 
darkness. The cells were then returned cell-side up to a 6-well plate and washed three times in 2 
ml of PBS containing 0.3% (w/v) BSA and once in 2ml of PBS. Coverslips were mounted onto 
slides, cell-side down, using Mowiol® 4-88 Reagent (Calbiochem) and allowed to dry in 
darkness at room temperature for 24 hours. Slides were stored in darkness at room temperature 
until required.
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For analysis of the CSP(C4-7L) mutant (See chapter four), cells were washed and incubated in 
PBS containing 20 pM  digitonin for 20 minutes at room temperature prior to fixing. The 
permeabilised cells were then washed three times in 2 ml of PBS prior to fixation and 
processing as described above.
2.7 CONFOCAL MICROSCOPY
Image acquisition was obtained using a Zeiss LSM 5 Pascal laser scanning confocal microscope 
(Carl Zeiss, Oberkochen, Germany) with a PlanApochromat 63x/1.4 Oil DIC objective. 
Fluorophores were scanned with an excitation double dichroic beam splitter (488 FITC/568 
TRITC). Emission wavelengths corresponding to 488 nm excitation were collected through a 
reflection short pass (RSP) filter at 580 nm followed by a Band Pass 525/50 nm filter. Emission 
wavelengths at 568 nm were collected through a Long Pass 590 nm filter. The pinhole was set 
to 1 Airy Unit and scan speed to maximum. Images were acquired at 8 bit per pixel depth and 
sequentially tracked for each channel with a minimum average of 8 passes to reduce noise.
2.8 Q u a n t it a t iv e  d e n s it o m e t r y
Quantitative densitometry values were derived using a ScanAnalysis program (Biosoft, 
Cambridge, U.K.), and were corrected for background.
2.9 D a t a  a n a l y s is
Values measured by densitometry (Chapter 2.8) were described as the mean ± standard error of 
the mean. The standard error was calculated by dividing the standard deviation by the square 
root of n-1, where n is the number of individual experiments. Statistical significance was 
determined using a two-sample unequal variance Student’s r-test using M icrosoft Excel 
software. Graphs were generated using Microsoft Excel software.
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3.1 In t r o d u c t io n
Protein palmitoylation not only provides stable membrane binding to certain substrate proteins, 
it can also regulate the intracellular localisation of proteins and target them to distinct 
membrane microdomains (El-Husseini et al., 2001; Goodwin et al., 2005; Hayashi et al., 2005; 
Kang et al., 2004; Kinlough et al., 2006; Rocks et al., 2005; Roy et al., 2005; Uemura et al., 
2002). The enzymes that catalyse the addition of palmitic acid onto cysteine(s) of mammalian 
proteins have recently been identified (Fukata et al., 2004), and are characterised by the 
presence of a signature DHHC-containing cysteine-rich domain (Roth et al., 2002). These 
DHHC-CRD palmitoyl transferases (PATs) are polytopic integral membrane proteins (Politis et 
al., 2005), which are associated with various intracellular membranes throughout the cell, 
including the Golgi apparatus, ER, the plasma membrane, endosomal and vesicular 
compartments, and the yeast vacuole (Dunphy et al., 1996; Huang et al., 2004; Keller et al., 
2004; Roth et al., 2002; Schroeder et al., 1996; Singaraja et al., 2002; Swarthout et al., 2005; 
Uemura et al., 2002; Valdez-Taubas and Pelham, 2005; Veit et al., 2001).
Since palmitoylating enzymes are membrane-anchored, substrate proteins must have a 
mechanism to associate with the specific subcellular membrane at which their partner PAT 
resides, prior to palmitate transfer. For many palmitoylated proteins, the mechanism(s) that 
govern their initial membrane binding prior to palmitoylation are obvious. Palmitoylated 
polytopic membrane proteins, such as members of the GPCR family, including the human 5 
opiod receptor (Petaja-Repo et a l ,  2006) and the canine histamine H2 receptor (Fukushima et 
al., 2001), integrate into membranes during synthesis. Other palmitoylated proteins, in 
particular those that lack membrane-spanning domains, often become modified by a different 
lipid anchor, such as a prenyl or a myristoyl group, which facilitates membrane association prior 
to palmitoylation. This is the case for the Ras- and Rho-GTPases, whose primary membrane 
targeting signal is a farnesyl anchor (Adamson et al., 1992; Hancock et al., 1989), and members 
of the Src family of tyrosine kinases, Ga subunits and eNOS, for which myristoylation serves as 
the primary membrane targeting signal (Koegl et al., 1994; Morales et al., 1998; Robinson et 
al., 1995). However, for a subset of palmitoylated proteins that are synthesised as soluble 
proteins and do not undergo lipid modification prior to palmitoylation, the primary membrane 
targeting mechanism is poorly understood. This group of proteins include molecules such as 
PSD-95 (Craven et al., 1999), an essential scaffolding protein of the post-synaptic density; the 
enzyme GAD-65, which catalyses the decarboxylation of glutamate to the inhibitory 
neurotransmitter GABA (Solimena et al., 1993; Solimena et al., 1994); SNAP25, an important 
regulator of exocytotic membrane fusion (Fane and Fiu, 1997); and cysteine string protein
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(CSP), a molecular chaperone of the Hsp40 protein family that has a range of cellular functions 
(Gundersen etal., 1994).
In neuronal and neuroendocrine cells, CSP is found predominantly localised to the membrane of 
secretory vesicles, and has also been shown to localise to the plasma membrane and ER in some 
cells types (Braun and Scheller, 1995; Chamberlain e ta l., 1996; Chamberlain et al., 2001; 
Gundersen et al., 2001; Pupier et al., 1997; Redecker et al., 1998; Zhang et al., 1998; Zhang et 
al., 2002). The stable membrane association of CSP is due to the palmitoylation of a “string” of 
cysteine amino acids present within its signature cysteine string domain (Gundersen et al., 1994; 
Gundersen et al., 1996; Mastrogiacomo et al., 1994). CSP is synthesised as a soluble protein 
and does not undergo any other known lipid modification prior to being palmitoylated. Thus, 
the primary mechanisms that target CSP to intracellular membranes are unknown. In this 
chapter, detailed mutagenesis has been used to identify the domains and amino acids required 
for the membrane targeting and palmitoylation of CSP.
3.2  M e m b r a n e  b in d in g , p a l m i t o y l a t i o n  a n d  l o c a l i s a t i o n  o f  f l u o r e s c e n t l y -  
TAGGED CSP
CSP is extensively palmitoylated within its cysteine string domain, a twenty-four amino acid 
region containing fourteen cysteines, the majority of which are thought to be palmitoylated in 
vivo (Gundersen et al., 1994). Rat phaeochromocytoma-12 cells (PC12 cells) are a tumour cell 
derivative of neuroendocrine adrenal medullary chromaffin cells that have been extensively 
used as a neuronal cell model (Morgan and Burgoyne, 1997). PC12 cells express CSP 
endogenously, where it is localised to large dense core secretory granules (Chamberlain and 
Burgoyne, 1998b). Hydroxylamine cleaves the thioester linkage between palmitate groups and 
cysteines, and has been used extensively as a tool to study protein palmitoylation (Chamberlain 
and Burgoyne, 1998a; Gundersen et al., 1994; M astrogiacomo and Gundersen, 1995; 
Mastrogiacomo et al., 1998; van de Goor and Kelly, 1996). Treatment of PC12 cell membranes 
with 1M hydroxylamine to induce the depalmitoylation of CSP results in a large (~8 kDa) shift 
in CSP mobility by SDS-PAGE (Chamberlain and Burgoyne, 1998a; Gundersen et al., 1994; 
Mastrogiacomo and Gundersen, 1995; Mastrogiacomo et al., 1998; van de Goor and Kelly, 
1996). To gauge the extent to which individual CSP molecules are palmitoylated in PC 12 cells, 
a time-course of CSP depalmitoylation was carried out by treating isolated membranes with 1 M 
hydroxylamine, pH 7.0 (or 1 M Tris, pH 7.0, as a control) for a range of times. A similar 
approach has previously been used to estimate the level of acylation of Torpedo  CSP 
(Gundersen et al., 1994). After recovery by centrifugation, proteins present within the cell
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membranes were resolved by SDS-PAGE and transferred to nitrocellulose membranes, and 
endogenous CSP was detected by immunoblotting using a polyclonal anti-CSP antibody. 
Figure 3.1 A reveals that following chemical depalmitoylation, several immunoreactive bands 
corresponding to endogenous CSP are present, and the speed that CSP migrates by SDS-PAGE 
increases with the incubation period with hydroxylamine. These results suggest that 
hydroxylamine treatment promotes the depalmitoylation of CSP in a time-dependent manner, in 
agreement with previous results obtained for Torpedo CSP (Gundersen et ah, 1994). The 
presence of several immunoreactive bands and the large decrease in mass of CSP following 
depalmitoylation are consistent with the notion that endogenous CSP is multiply palmitoylated 
in PC 12 cells.
The fusion of enhanced green fluorescent protein (EGFP) cDNA, a variant of the 
autoflourescent green fluorescent protein isolated from the jellyfish Aequoria victoria, to cDNA 
encoding a protein of interest, has long been a valuable tool for studying the localisation and 
trafficking of proteins in vivo (Chalfie et al., 1994; Cubitt et al., 1995). An EGFP tag was thus 
fused to the N-terminus of CSP (EGFP-CSP) by PCR amplification of full-length bovine CSP 
(lacking the initiating methionine; (Zhang et al., 1998) followed by in-frame insertion into a 
pEGFP-C2 vector as a HindlU/BamHl fragment by Dr. Luke Chamberlain; the N-terminal 
EGFP fusion of CSP is still functional (Zhang et al., 1998). To ensure that EGFP-CSP is 
efficiently palm itoylated, PC 12 cells transfected with EGFP-CSP for 48 hours were 
metabolically labelled with 3H palmitic acid for 4 hours, followed by immunoprecipitation of 
EGFP-CSP, SDS-PAGE and analysis by immunoblotting and fluorography. The left panel of 
Figure 3.15 shows that immunoprecipitated EGFP-CSP from transfected PC 12 cell lysates is 
present in two distinct forms, a lower molecular weight band (indicated by an arrowhead) and 
an upper band (indicated by an asterisk). Fluorography (right panel) reveals that the higher 
molecular weight form of CSP strongly incorporates radiolabel (indicated by an asterisk), 
whereas the lower molecular weight band of CSP is unlabelled. These results demonstrate that
; EGFP-CSP is palmitoylated when expressed in PC 12 cells, and confirms that the differences in
|
j  migration of CSP on SDS gels can be used as a measure of CSP palmitoylation.
| To investigate the relationship between membrane binding and palmitoylation of CSP, PC 12
cells transfected with EGFP-CSP for 48 hours were either fractionated into cytosolic (C) and 
membrane (M) fractions, or the cell membranes were isolated and membrane proteins were
i
j chemically depalmitoylated by incubation in 1 M hydroxylamine, pH 7.0 (HA) for 20 hours at
room temperature (1 M Tris, pH 7.0 (T) was used as a control). Immunoblotting using an anti- 
GFP monoclonal antibody revealed that the majority of EGFP-CSP expressed in PC12 cells is
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Figure 3.1 CSP is multiply palmitoylated. A. Isolated PC12 cell membranes were incubated 
in 1M Tris, pH 7.0, for 20 hours (0) or 1M hydroxylamine, pH 7.0, for various time points (30 
minutes, 1 hour, 2 hours, 4 hours or 24 hours) at room temperature. The treated membranes 
were recovered by centrifugation at 196 000 x g  for 30 minutes and depalmitoylation of 
endogenous CSP was analysed following SDS-PAGE and transfer to nitrocellulose membranes 
by immunoblotting using an anti-CSP polyclonal antibody. B. PC12 cells were transfected with 
EGFP-CSP for 48 h followed by incubation in 3H palmitate for 4 hours. EGFP-CSP was 
immunoprecipitated from cell lysates and subjected to SDS-PAGE and transfer to nitrocellulose 
membranes, in duplicate. One membrane was analysed by probing with a monoclonal anti- 
GFP antibody {left p a n e l ; "GFP”), the other was processed for fluorographic detection of 
incorporated radiolabel {right panel] “3H-palm”). C. PC12 cells transfected with EGFP-CSP for 
48 h were fractionated into cytosolic (C) and membrane (M) fractions. An aliquot of membranes 
was incubated in 1 M Tris, pH 7.0 (T) or 1 M hydroxylamine, pH 7.0 (HA) for 20 hours. Samples 
were separated by SDS-PAGE, transferred to nitrocellulose and probed using a monoclonal 
anti-GFP antibody. The position of molecular weight standards (in kDa) is shown on the left 
side of all panels; asterisks  identify palmitoylated CSP and arrowheads  indicate unpalmitoylated 
CSP. Representative blots are shown (n = 3). D. Untransfected PC12 cells and PC12 cells 
transfected with EGFP-CSP for 48 h growing on glass coverslips were fixed in 4% (v/v) 
formaldehyde. Untransfected PC12 cells were permeabilised and probed with a polyclonal anti- 
CSP antibody to label endogenous CSP. CSP labelling was detected by probing with a 
rhodamine-conjugated anti-rabbit IgG (red). Localisation of the labelled proteins was 
determined by confocal microscopy. Images are representative of a single 0.13 nm thick 
confocal section. Scale bar = 10 nm.
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present in the membrane fraction, with only a small percentage of the total EGFP-CSP present 
in the cytosolic fraction (Figure 3.1C). Furthermore, EGFP-CSP recovered from the membrane 
fraction of PC 12 cells migrates at the same size as palmitoylated EGFP-CSP (as indicated by an 
asterisk), whereas EGFP-CSP present in the cytosolic fraction migrates at the same size as 
hydroxylamine treated EGFP-CSP (as indicated by an arrowhead). These results are consistent 
with the concept that, in vivo, the majority of EGFP-CSP overexpressed in PC 12 cells is both 
membrane-bound and fully palmitoylated. The small percentage of cytosolic EGFP-CSP 
isolated from PC12 cells most likely represents an unpalmitoylated pool of CSP.
The results presented in Figure 3.1 A, B and C reveals that there is a large difference in migration 
of CSP by SDS-PAGE depending on the palmitoylation status: fully palmitoylated CSP 
migrates approximately 8 kDa slower than unpalmitoylated CSP. This band-shift of CSP 
allows fully palmitoylated, partially palmitoylated and unpalmitoylated variants of CSP to be 
distinguished from each other based on their migration by SDS-PAGE alone. This assay has 
distinct advantages over metabolically labelling cells with 3H palmitic acid: it allows for the 
direct analysis of the percentage of CSP molecules that are palmitoylated and the level o f 
palmitoylation of CSP, as partially palmitoylated CSP variants can be detected as intermediate 
bands between fully palmitoylated (higher molecular weight) and unpalmitoylated (lower 
molecular weight) bands (See Figure 3.1 A).
To examine the intracellular localisation of EGFP-CSP, transfected PC 12 cells were fixed and 
the localisation of EGFP-CSP was compared to the localisation of endogenous CSP by confocal 
microscopy. The left panel of Figure 3. ID illustrates that, in PC12 cells, endogenous CSP 
primarily has a punctate (vesicular) distribution, with some enrichment at the plasma 
membrane, consistent with previous findings that CSP is localised to secretory vesicles in PC12 
cells and several other non-neuronal cell types (Braun and Scheller, 1995; Brown et al., 1998; 
Chamberlain etal., 1996; Chamberlain and Burgoyne, 1998b; Gundersen eta l., 2001; Pupier et 
al., 1997; Redecker et al., 1998; Zhang et al., 1998). EGFP-CSP expressed in PC12 cells 
(Figure 3 .ID; Right panel) is also localised to punctate intracellular structures but with greater 
enrichment at the plasma membrane. It has previously been shown that CSP overexpressed in 
PC 12 cells displays a more prominent plasma membrane localisation than endogenous CSP 
(Chamberlain and Burgoyne, 1998b). This is not a consequence of the EGFP tag, and is also 
seen for untagged CSP (Chamberlain and Burgoyne, 1998b).
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CSP can be divided into five domains: an N-terminal domain, a J-domain, a linker domain, a 
hydrophobic cysteine string domain and a C-terminal domain (See Figure 1.5). It is not known 
which of these domains are required for the initial membrane binding of CSP, prior to 
palmitoylation. To identify which domains of CSP are required for its membrane association, a 
series of N- and C-terminal truncation mutants fused to EGFP were constructed. PC12 cells 
were transfected with either full-length EGFP-CSP, a C-terminal truncation mutant lacking the 
cysteine string and C-terminal domains (EGFP-CSP,.,12), a C-terminal mutant including the 
cysteine string domain but lacking the C-terminal domain (EGFP-CSP,.136), or a truncation 
mutant encoding the cysteine string domain alone (EGFP-CSP,,3_,36). Forty-eight hours post­
transfection, cells were separated into cytosolic and membrane fractions to measure the extent 
of membrane association of the transfected constructs. Equal volumes of the isolated cytosolic 
and membrane fractions were subjected to SDS-PAGE, transfer to nitrocellulose and 
immunoblotting using a monoclonal antibody against GFP. The upper panel of Figure 3.2 
illustrates that, whereas full-length EGFP-CSP and the mutant lacking the C-terminal domain 
(EGFP-CSP,.,36) are enriched in the membrane fraction, the CSP mutant lacking both the 
cysteine string and the C-terminal domains (EGFP-CSP,.,,2), and the CSP mutant encoding the 
cysteine string domain alone (EGFP-CSPn3.136), are not able to target EGFP efficiently to 
membranes. These results demonstrate that the cysteine string domain alone is not sufficient for 
membrane binding, and since EGFP-CSP,.,36 is correctly targeted to membranes, indicates that 
amino acids upstream of the cysteine string domain are required for membrane targeting. As a 
control for the fractionation procedure, duplicate nitrocellulose membranes were also probed 
using antibodies against membrane-associated and cytosolic proteins (Figure 3.2; Middle and 
Lower panels, respectively). The transferrin receptor is an integral membrane protein, whereas 
protein kinase B (PKB) is predominantly a cytosolic protein in PC12 cells (Salaun et al., 2005).
To further analyse the membrane targeting of CSP, a mutant that was lacking the J domain and 
N-terminal region of CSP (EGFP-CSP(84_,36)) was constructed (See Figure 1.5). This mutant was 
expressed in PC 12 cells for 48 hours, and it’s partitioning into cytosolic and membrane fractions 
was determined. EGFP-CSPg4_,36 was found highly enriched in the membrane fraction (Figure 
3.3A), demonstrating that amino acids 1-83 (the extreme N-terminus and the J-domain) are not 
required for membrane association of CSP (in agreement with Boal et al., 2004).
To determine the minimum  region of CSP required for membrane targeting, further N-terminal 
deletions were made. CSP truncation mutants containing amino acids 93-136 and 103-136 of 
CSP and expressed in PC 12 cells were also recovered in the membrane fraction (Figure 3.3A)
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Figure 3.2 The cysteine string domain of CSP is not sufficient for membrane association
in  v iv o .  PC12 cells were transfected with wild-type EGFP-CSP, EGFP-CSP(1.112), EGFP-CSP(1. 
136) or EGFP-CSP(113-136). Forty-eight hours post-transfection, the cells were fractionated into 
cytosolic (C) and membrane (M) fractions and analysed following SDS-PAGE and transfer to 
nitrocellulose membranes by immunoblotting using an anti-GFP monoclonal antibody (U pper  
panel) .  To confirm the faithful partition of proteins into cytosolic and membrane fractions, 
duplicate nitrocellulose membranes were probed to analyse the distribution of the transferrin 
receptor (TfR, membrane protein; Middle panef) and protein kinase B (PKB, cytosolic protein; 
Lower panel). The position of molecular weight standards (in kDa) is shown on the left side of 
the panel. Representative blots are shown (n = 3).
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Figure 3.3 A n alysis of the minimal m em brane-binding domain of CSP. PC12 cells 
transfected with wild-type EGFP-CSP or EGFP-CSP truncation mutants for 48 h were 
fractionated into cytosolic (C) and membrane (M) fractions and analysed following SDS-PAGE 
and transfer to nitrocellulose membranes by immunoblotting using an anti-GFP monoclonal 
antibody. A. Distribution of CSP truncation mutants encoding the linker domain and cysteine 
string domain only (EGFP-CSP(84-136)), EGFP-CSP(93_136), EGFP-CSP(103-136), or the cysteine 
string domain alone (EGFP-CSP(113_136)). B. Distribution of CSP truncation mutants encoding 
EGFP-CSP(103-136)> EGFP-CSP(1o6-i36)i EGFP-CSP(io9-i36)> and EGFP-CSP(H2-136)- C ■ 
Distribution of CSP truncation mutants encoding EGFP-CSP(106-136), EGFP-CSP(107-136), EGFP- 
CSP(io8- i36)i and EGFP-CSP(109-136)- The position of molecular weight standards (in kDa) is 
shown on the left side of panels A , B and C and the results shown in panels A, B and C are 
representative blots. D. The percentage CSP membrane association +/- SEM was determined 
by quantification of immunoblots by densitometry (n=4 from 3 separate experiments). Statistical 
significance was determined by a Student’s Mest, whereby * represents a p value of < 0.0016 
and ** represents a p value equal to 0.0005 compared to EGFP-CSP(106-136)- E. Alignment of 
the amino acid sequence of the minimum membrane-binding domain of CSP (amino acids 106- 
136) from various species. Conserved amino acids are shaded; cysteines are shown in bold. 
Numbering of amino acids is shown; the cysteine string domain encompasses amino acids 113- 
136.
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revealing that the entire linker domain is not required for membrane targeting. Further N- 
terminal deletions in the linker domain between amino acids 103 and 113 were constructed and, 
as shown in Figure 3.315, whereas a mutant containing amino acids 106-136 was recovered in 
the membrane fraction of PC 12 cells, a mutant having amino acids 109-136 was entirely 
cytosolic. Further mutational analysis showed that the shortest truncation that consistently 
supported robust membrane association included amino acids 106-136 of CSP (Figure 3.3C and 
D).
Alignment of this minimum membrane-binding region of CSP from different species reveals 
many conserved amino acids (Figure 3.3E). Most importantly, this region of CSP is 
predominantly hydrophobic, a property that may be required for membrane binding.
3.4 CSP MUTANTS LACKING THE C-TERMINAL DOMAIN ARE UNPALMITOYLATED AND 
MISLOCALISED
To investigate whether the membrane-associated truncated mutants of CSP are correctly 
palmitoylated, membranes prepared from PC 12 cells expressing EGFP-CSP(M36) and EGFP- 
CSP(io6-i36) f°r 48 hours were treated with 1 M Hydroxylamine, pH 7.0 (or 1 M Tris, pH 7.0 as a 
control) for 20 hours at room temperature. Previous results have shown that the chemical 
depalmitoylation of PC 12 cell membranes results in a dramatic molecular mass shift between 
palmitoylated (Figure 3.1C; asterisk) and unpalmitoylated (Figure 3.1C; arrowhead) forms of 
CSP. Although both EGFP-CSP(1.I36) and EGFP-CSP(106-i36) are localised to the membrane 
fraction (Figures 3.2 (Upper panel) and 3.3C, respectively), there was no detectable molecular 
mass shift between Tris- and hydroxylamine-treated samples (Figure 3.4A \ arrowhead). These 
results suggest that, in contrast to full-length EGFP-CSP, EGFP-CSP(M36) and EGFP-CSP(106-i36) 
are either unpalmitoylated or their level of palmitoylation is dramatically reduced. To examine 
the extent of palmitoylation of these membrane-associated CSP mutants further, cells 
expressing full length EGFP-CSP or EGFP-CSP(1_136) were metabolically labelled with 3H 
palmitic acid for 4 hours, followed by immunoprecipitation of EGFP-tagged proteins, SDS- 
PAGE and analysis by immunoblotting and fluorography. As shown previously (Figure 3.115), 
full-length EGFP-CSP immunoprecipitated from PC12 cell lysates migrates by SDS-PAGE as 
two bands, with the higher molecular weight band incorporating 3H palmitate (Figure 3.45; 
asterisk). In contrast to full length EGFP-CSP, EGFP-CSP(1.136) immunoprecipitated from PC12 
cell lysates migrates as a single species by SDS-PAGE (Figure 3.45; arrowhead) and does not 
incorporate detectable 3H palmitate (Figure 3.45), demonstrating that palmitoylation of EGFP- 
CSP(1136) is greatly decreased relative to full-length protein, despite being membrane-associated.
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Figure 3.4 CSP C-terminal truncation mutants are unpalmitoylated and m islocalised
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Figure 3.4 CSP C-terminal truncation mutants are unpalmitoyiated and m islocalised . A .
PC 12 cells were transfected with EGFP-CSP(1.136) or EGFP-CSP(io6-i3 6) for 48 h and isolated cell 
membranes were incubated in 1M Tris, pH 7.0 (T) or 1M hydroxylamine, pH 7.0 (HA) for 20 
hours at room temperature. The treated membranes were recovered by centrifugation at 196 
000 x g  for 30 minutes and analysed following SDS-PAGE and transfer to nitrocellulose 
membranes by immunoblotting using an anti-GFP monoclonal antibody. B. PC12 cells were 
transfected with EGFP-CSP or EGFP-CSPd-1 3 6) for 48 h followed by incubation in 3H palmitate 
for 4 hours. EGFP-CSP and EGFP-CSP(1.1 3 6) were immunoprecipitated from cell lysates and 
subjected to SDS-PAGE and transfer to nitrocellulose membranes, in duplicate. One 
membrane was analysed by probing with a monoclonal anti-GFP antibody (left; “GFP”), the 
other was processed for fluorographic detection of incorporated radiolabel (right; “3H-palm”). 
The position of molecular weight standards (in kDa) is shown on the left side of panels A  and B; 
a s te r i s k s  identify palmitoylated CSP and a r r o w h e a d s  indicate unpalmitoyiated CSP. The results 
shown in panels A  and B  are representative of a single experiment from three separate 
experiments. C. PC12 cells growing on glass coverslips and transfected with EGFP-CSP(1.i36) 
or EGFP-CSP(io6-i3 6) for 48 h were fixed in 4% (v/v) formaldehyde, permeabilised and probed 
with a polyclonal anti-CSP antibody to label endogenous CSP. CSP labelling was detected by 
incubating with a rhodamine-conjugated anti-rabbit IgG (red) and compared with the GFP signal 
(green). Localisation of the labelled proteins was determined by confocal microscopy and 
images are representative of a single 0.13 jxm thick confocal section. Scale bar = 10 urn.
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Since EGFP-CSP(1136) and EGFP-CSP(106_136) are membrane-bound but not efficiently 
palmitoylated in vivo, the subcellular membrane localisation of these mutants was determined to 
investigate whether they target EGFP to the same membranes as endogenous CSP. As 
protocols for subcellular fractionation of PC 12 cells do not adequately separate internal 
membranes (Gonzalo and Linder, 1998), protein distribution was examined by transfecting 
PC 12 cells with EGFP-CSP(1_136) or EGFP-CSP(106-]36) for 48 hours, fixing and permabilising the 
cells, and comparing the localisation of EGFP-CSP(1_136) or EGFP-CSP(106-i36) to that of 
endogenous CSP by confocal microscopy. To label endogenous CSP distribution, transfected 
cells were probed using an antibody that recognises the extreme C-terminus of CSP, thus 
preventing the cross-recognition of the ectopically expressed EGFP-tagged C-terminally 
truncated CSP mutants. Detection of antibody-labelled endogenous CSP was determined by 
probing cells with a rhodamine-conjugated anti-rabbit IgG antibody prior to visualisation by 
confocal microscopy. Figure 3.4C illustrates that, whereas endogenous CSP in PC I2 cells has a 
punctuate distribution with partial enrichment at the plasma membrane (red), EGFP-CSP(,_136) 
(Figure 3.4C; Upper panel, green) and EGFP-CSP(I06-i36) (Figure ?>AC\ Lower panel’, green) 
have a clearly distinct localisation to endogenous CSP. Similarly, the distribution of these 
mutants is distinct from full-length EGFP-CSP (Figure 3. ID; Right panel), implying that these 
unpalmitoyiated mutants are incorrectly sorted in PC 12 cells.
The distribution of EGFP-CSP(1_136) and EGFP-CSP(106_i36) was reminiscent of an ER localisation 
(Rocks et al., 2005; Swarthout et a l ,  2005). Thus, to determine the membrane compartment 
that the unpalmitoyiated CSP C-terminal truncation mutants associate with, PC 12 cells were 
transfected with full-length EGFP-CSP, EGFP-CSP(1_136) or EGFP-CSP(106-i36) f° r 48 hours, the 
cells were fixed, permabilised and incubated with a polyclonal antibody recognising the ER 
resident protein calreticulin. Detection of antibody labelled calreticulin was determined by 
probing cells with a rhodamine-conjugated anti-rabbit IgG antibody prior to visualisation by 
confocal microscopy. As shown in Figure 3.54, full-length EGFP-CSP (Upper panel) showed 
little overlap with the calreticulin staining. In contrast, EGFP-CSP(1136) and EGFP-CSP(106-]36) 
were both found to share significant overlap with calreticulin (Figure 3.54; middle and lower 
panels). The presence of EGFP-CSP(1.136) and EGFP-CSP(106-i36) at the ER was further confirmed 
by co-transfecting EGFP-CSP, EGFP-CSP(1_136) and EGFP-CSP(106.i36) with DsRed2-ER, a red 
fluorescent protein fused to an ER targeting sequence (Figure 3.5B). Consistent with results 
presented in Figure 3.54, EGFP-CSP(I136) and EGFP-CSP(106-i36) both showed marked overlap 
with DsRed-ER (Figure 3.5#, m iddle  and lower panels), whereas transfected EGFP-CSP 
showed little overlap with the ER marker (Figure 3.5#; Upper panel). The results presented in 
this section show that although EGFP-CSP(M36) and EGFP-CSP(106-i36) are predominantly
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Figure 3.5 L ocalisation of CSP C-terminal truncation mutants in PC12 ce lls. A. PC12 
cells growing on glass coverslips and transfected with EGFP-CSP, EGFP-CSP(1_136) or EGFP- 
CSP(106-136) for 48 hw ere fixed, permeabilised and probed with a polyclonal anti-calreticulin 
antibody. Calreticulin labelling was detected by probing with a rhodamine-conjugated anti-rabbit 
IgG (red) and compared with the GFP signal (green). B. PC12 cells growing on glass 
coverslips were cotransfected with dsRED-ER and EGFP-CSP, EGFP-CSP(1_136) or EGFP- 
CSP(106-i36). Forty-eight hours post-transfection, the cells were fixed in 4% (v/v) formaldehyde 
and the localisation of the transfected proteins, dsRED-ER (red) and EGFP-CSP, EGFP-CSP (1. 
136) or EGFP-CSP(106-136) (green) was determined by confocal microscopy. Images are 
representative of a single 0.13 ^.m thick confocal section through PC12 cells. Scale bar = 10 
p.m.
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associated with membranes, these mutant proteins are not palmitoylated and are mislocalised, 
showing noticeable overlap with ER marker proteins.
3.5 H y d r o p h o b ic  i n t e r a c t i o n s  m e d ia t e  m e m b r a n e  b in d in g  o f  n o n - p a l m i t o y l a t e d  
CSP
Peripheral membrane proteins interact weakly with membranes through ionic interactions, and 
so they can be solubilised in solutions of high ionic strength or high pH, such as 1 M sodium 
chloride or 0.1 M sodium carbonate, pH 11.5, respectively. In contrast, integral membrane 
proteins that are embedded in the phospholipid bilayer, such as transmembrane proteins, interact 
strongly with membranes through hydrophobic interactions and can only be solubilised from 
membranes in solutions containing detergent, for example the non-ionic detergent Triton® X- 
100. Based on this difference in solubility, it is possible to determine whether a protein is a 
peripheral or integral membrane protein by incubating membranes in solutions containing 1 M 
sodium chloride, 0.1 M sodium carbonate, pH 11.5, or 1% (v/v) Triton® X-100 and measuring 
the extent of the release of proteins from the membranes. To examine the type of interactions 
that mediate EGFP-CSP(I_,36) membrane association, membranes isolated from PC 12 cells 
expressing EGFP-CSP and EGFP-CSP(I_136) were incubated in HES buffer (as a control), 1 M 
sodium chloride (NaCl), 0.1 M sodium carbonate, pH 11.5 (Na2C 0 3), or HES buffer containing 
1% (v/v) Triton® X-100 for 30 minutes. Treated membranes were then centrifuged, and the 
extent of protein release from membranes under the various incubation conditions was 
determined by immunoblotting the recovered pellet (P) and supernatant (S) fractions. Figure
3.6 shows that the peripheral membrane proteins m uncl8-l and aSN A P were released to 
different extents from membranes treated with sodium chloride or sodium carbonate. In 
contrast, full-length EGFP-CSP and EGFP-CSP(1136) are both tightly associated with 
membranes, since their release into the supernatant only occurred following treatment with 
Triton X-100®. This result is consistent with the idea that the initial membrane association of 
CSP (prior to palmitoylation) is mediated by hydrophobic interactions between the cysteine 
string domain and the membrane, and reveals that non-palmitoylated mutants of CSP can 
associate tightly with membranes in the absence of palmitoylation.
3.6 A m in o  a c id s  d o w n s t r e a m  o f  t h e  c y s t e in e  s t r in g  d o m a in  a r e  r e q u ir e d  fo r
THE PALMITOYLATION AND CORRECT SORTING OF CSP
The major pool of the C-terminally truncated CSP mutant, EGFP-CSP(M36), is membrane-bound 
but not palmitoylated (Figure 3.2 and 3.4A and B). To investigate whether regions downstream
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Figure 3.6 A nalysis of membrane binding of EGFP-CSP and EGFP-CSP{1.1 36). PC12 cells 
were transfected with EGFP-CSP (A) or EGFP-CSP(1_136) (S) for 48 h and isolated cell 
membranes were incubated in HES Buffer, 1M NaCI, 0.1 M Na2C 0 3, pH 11.5, or HES Buffer 
supplemented with 1% (v/v) Triton® X-100 for 30 minutes at 4 °C. Supernatant (S) and pelleted 
membrane (P) fractions were recovered by centrifugation at 196 000 x g  for 30 minutes and 
analysed following SDS-PAGE and transfer to nitrocellulose membranes by immunoblotting 
using an anti-GFP monoclonal antibody (Upper panels). To examine the partition of peripheral 
membrane proteins into supernatant and pelleted membrane fractions, nitrocellulose 
membranes were also probed using mouse monoclonal antibodies against Munc 18 (Middle 
p a n e ls )  and a-SNAP (Lower panels). The position of molecular weight standards (in kDa) is 
shown on the left side of panels A and B, and the results shown are representative blots from 
the same experiment.
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from the cysteine string domain are required for palmitoylation of CSP, several additional C- 
terminal CSP truncation mutants were constructed. PC 12 cells were transfected with full-length 
EGFP-CSP, EGFP-CSP(m36), EGFP-CSP(1_146), EGFP-CSP(M56), or EGFP-CSP(1_]66) for 48 hours. 
Cells were then fractionated into membrane and cytosolic fractions, and the protein distribution 
was determined by SDS-PAGE and immunoblotting. Efficient palmitoylation of the mutant 
proteins was indicated by a change in mobility (as shown in Figure 3.1). By this criterion 
EGFP-CSP(1_146), EGFP-CSP(1_156), and EFP-CSP(1.166) were all found to be efficiently 
palmitoylated due to the presence of a higher molecular weight band present in the membrane 
fraction, compared to the cytosolic fraction (Figure 3.74; upper panel). These results are in 
contrast to EGFP-CSP(1.136) which migrates at the same position in both the cytosolic and 
membrane fractions (Figure 3.1 A; upper panel). To confirm the faithful partition of proteins into 
cytosolic and membrane fractions, duplicate nitrocellulose membranes were probed to analyse 
the distribution of the transferrin receptor (TfR; Figure 3.74, Middle panel) and protein kinase 
B (PKB; Figure 3.74, Lower panel). Figure 3.IB  shows that the palmitoylation of EGFP-CSP()_ 
]46), but not EGFP-CSP(1_136), was efficient in PC12 cells, and not statistically different from full- 
length EGFP-CSP. Interestingly, despite being efficiently palmitoylated, EGFP-CSP(1_146), 
EGFP-CSP(1.]56), and EFP-CSP(M66) displayed a modest reduction in membrane binding 
(significant only for EGFP-CSP(M56), and EFP-CSP(1_166)) Thus, residues between amino acids 
136-146 of CSP are clearly required for efficient palmitoylation of the cysteine string domain.
To identify the exact sequence of amino acids downstream from the cysteine string domain that 
are required for palmitoylation of CSP, EGFP-CSP(1.137), EGFP-CSP(1.138), EGFP-CSP(1139), 
EGFP-CSP(i_140), EGFP-CSP(m41), EGFP-CSP(M42), EGFP-CSP(1_I43), EGFP-CSP(1_]44), and EGFP- 
CSP(1_I45) truncation mutants were constructed and transfected into PC12 cells for 48 hours. 
Transfected cells were separated into membrane and cytosolic fractions, and protein distribution 
was determined by SDS-PAGE and immunoblotting using a monoclonal anti-GFP antibody. 
Efficient palmitoylation of the mutant proteins was determined by the band-shift assay as 
outlined in Chapter 3.2.1. An immunoblot showing the profile of these mutant proteins in 
cytosol and membrane fractions prepared from PC 12 cells is shown in Figure 3.84 (Upper 
panels). To confirm the faithful partition of proteins into cytosolic and membrane fractions, 
duplicate nitrocellulose membranes were probed to analyse the distribution of the transferrin 
receptor (TfR; Figure 3.84, Middle panel) and protein kinase B (PKB; Figure 3.84, Low er  
panel). The immunoblot reveals that there is a gradual increase in the level of palmitoylation 
(iasterisk) as the number of residues downstream from the cysteine string domain is increased, 
with the membrane-bound fraction of CSP showing an almost complete shift to a slower 
migrating, fully-palm itoylated band in the EGFP-CSP(1.145) mutant. The percentage
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Figure 3.7 Amino acids downstream  from the cy ste in e  string domain are required for 
palmitoylation of CSP. A. PC12 cells transfected with wild-type EGFP-CSP, EGFP-CSP(1.136), 
EGFP-CSP(-M46), EGFP-CSP(1.156), or EGFP-CSP(1.166), for 48 h were fractionated into cytosolic 
(C) and membrane (M) fractions and analysed following SDS-PAGE and transfer to 
nitrocellulose membranes by immunoblotting using an anti-GFP monoclonal antibody (U pper  
panel) . To confirm the faithful partition of proteins into cytosolic and membrane fractions, 
duplicate nitrocellulose membranes were probed to analyse the distribution the transferrin 
receptor (TfR, membrane protein; Middle panel) and protein kinase B (PKB, cytosolic protein; 
Lower panel). The position of molecular weight standards (in kDa) is shown on the left side of 
the panel. Representative blots are shown. B. The percentage CSP palmitoylation +/- SEM 
was determined by quantification of immunoblots by densitometry as a percentage of the total 
membrane-associated pool (n = 5 from 4 separate experiments). C. The percentage CSP 
membrane association +/- SEM was determined by quantification of immunoblots by 
densitometry (n = 5 from 4 separate experiments). Statistical significance was determined by a 
Student’s Mest, whereby * represents a p value of < 0.05 and ** represents a p value of < 
0.003, compared to wild-type EGFP-CSP.
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Figure 3.8 Amino acids downstream  from the cy ste in e  string domain are required for 
efficient palmitoylation and correct intracellular sorting of CSP ( c o n t in u e d  o v e r le a f ) .
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Figure 3.8 ( c o n t i n u e d )  Amino acid s downstream  from the cystein e string domain are 
required for efficient palmitoylation and correct intracellular sorting of CSP A. PC12 
cells transfected with the indicated EGFP-CSP C-terminal truncation mutants for 48 h were 
fractionated into cytosolic (C) and membrane (M) fractions and analysed following SDS-PAGE 
and transfer to nitrocellulose membranes by immunoblotting using an anti-GFP monoclonal 
antibody (Upper panel). To confirm the faithful partition of proteins into cytosolic and membrane 
fractions, nitrocellulose membranes were probed to analyse the distribution of control proteins in 
the fractions, the transferrin receptor (TfR, membrane protein; Middle panel) and protein kinase 
B (PKB, cytosolic protein; Lower panel). The position of molecular weight standards (in kDa) is 
shown on the left side of the panel; a ster isks  identify palmitoylated CSP and arro w h ea d s  
indicate unpalmitoyiated CSP. Representative blots are shown. B. The percentage CSP 
palmitoylation +/- SEM was determined by quantification of immunoblots by densitometry as a 
percentage of the total membrane-associated pool (n = 4 from 2 separate experiments). 
Statistical significance was determined by a Student’s f-test, whereby * represents a p value of 
< 5 x 103, ** represents a p value of < 2 x 10"4 and *** represents a p value of < 4 x 10"5 
compared to EGFP-CSP(1.136). C. The percentage CSP membrane association +/- SEM was 
determined by quantification of immunoblots by densitometry (n = 4 from 2 separate 
experiments). Statistical significance was determined by a Student’s f-test, whereby * 
represents a p value of < 0.05, ** represents a p value of < 6 x 10'3 and *** represents a p value 
of < 10'3 compared to EGFP-CSP(1_i36). D. The percentage palmitoylation of membrane- 
associated CSP +/- SEM plotted against the percentage of CSP recovered from the soluble 
fraction +/- SEM of the indicated EGFP-CSP C-terminal truncation mutants. E. PC12 cells 
growing on glass coverslips and transfected with EGFP-CSP(1.146) for 48 h were fixed in 4% (v/v) 
formaldehyde, permeabilised and probed with a polyclonal anti-calreticulin antibody. 
Calreticulin labelling was detected by probing with a rhodamine-conjugated anti-rabbit IgG (red) 
and compared with the GFP signal (green). Images are representative of a single 0.13 [im thick 
confocal section through PC12 cells. Scale bar = 10 ^m.
Soluble
Palmitoylated
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palmitoylation of the truncation mutants was significantly increased after the addition of three 
amino acids downstream from the cysteine string domain (K137A, P138A, K139A) compared 
to EGFP-CSP(].136) (Figure 3.SB). In addition to enhancing palmitoylation of CSP, the addition 
of extra amino acids to the C-terminus of the cysteine string domain also appeared to increase 
the soluble pool of the protein (Figure 3.8A, Upper panel, “C”), and became significant after the 
addition of two extra amino acids following the cysteine string domain (Figure 3.8C). Thus, 
amino acids immediately downstream from the cysteine string domain are required for the 
efficient palmitoylation of CSP.
Interestingly, and as mentioned above, there is an increase in solubility (decrease in membrane 
association) of the C-terminal truncation mutants as the number of amino acids downstream 
from the cysteine string domain increases (See Figure 3.8A and#). To explore the possibility 
that the decrease in membrane affinity of the C-terminal truncation mutants is associated with 
the increase in their palmitoylation status, the percentage of protein recovered from the soluble 
fraction of PC 12 cells expressing the C-terminal truncation mutants was plotted against the 
percentage palmitoylation of the membrane-associated pool. As can be seen from Figure 3.8D, 
there is a direct correlation between the differential solubility of the C-terminal truncation 
mutants and their ability to become palmitoylated. The correlation between CSP membrane 
affinity and the palmitoylation status of CSP indicates that the strength of membrane binding of 
CSP may be regulating the ability of CSP to get palmitoylated. However, other experiments 
will be needed to determine whether these effects are merely correlative or causal.
To explore the possibility that efficient palmitoylation of CSP corresponds to a change in 
intracellular localisation, the distribution of EGFP-CSP(1.146) in PC12 cells was examined by 
confocal imaging; cells were transfected with EGFP-CSP(1.146) for 48 hours, fixed, permabilised 
and incubated with a polyclonal anti-calreticulin antibody to label the ER. Detection of antibody 
labelled calreticulin was determined by probing cells with a rhodamine-conjugated anti-rabbit 
IgG antibody prior to visualisation by confocal microscopy. As shown in Figure 3.8D, EGFP- 
CSP(1_146) has a subcellular distribution similar to that of full-length EGFP-CSP (See Figure 
3.54; Upper panel) and does not show the same ER overlap as EGFP-CSP(1_136) (Figure 3.5/4: 
Middle panel). Thus, these results point to a model whereby efficient palmitoylation of the CSP 
C-terminal truncation mutants correlates with their correct intracellular sorting.
To investigate the mechanism whereby addition of downstream residues facilitates 
palmitoylation of the cysteine string domain, a series of point mutations were created in the 
amino acids directly downstream from the cysteine string domain, in full-length  EGFP-CSP;
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K137A, P138A, K139A, A140L, P141A, E142A and G143A. This analysis is particularly 
important in order to test whether residues downstream of the cysteine string domain, which 
regulate the palmitoylation of CSP truncation mutants, also regulate the palmitoylation of full- 
length CSP. PC 12 cells were transfected with these mutant constructs for 48 hours. Expressed 
proteins were separated into membrane and cytosolic fractions, and protein distribution was 
determined by SDS-PAGE and immunoblotting. Efficient palmitoylation of the mutant proteins 
was determined by the band-shift assay as discussed in Chapter 3.2.1. An immunoblot showing 
the profile of these mutant proteins in cytosol and membrane fractions prepared from PC 12 cells 
is shown in Figure 3.9A {Upper panel). The middle and lower panels compares the distribution 
of the transferrin receptor (TfR; Figure 3.9.4, Middle panel) and protein kinase B (PKB; Figure 
3.9/4, Lower panel). Interestingly, as shown in the upper panel of Figure 3.9A , mutation of 
lysine 137 to alanine (K137A) was found to significantly reduce membrane binding and 
palmitoylation of CSP (Figure 3.9A-C), implying that this residue is important for efficient 
membrane binding and/or palmitoylation of the cysteine string domain. In contrast, mutation of 
any other residue in the domain had no effect on either the level of membrane association or 
palmitoylation of EGFP-CSP (Figure 3.9A-C). Thus, lysine 137 has a critical role in both the 
membrane association and palmitoylation of full-length CSP, in agreement with the required 
role for this residue in the palmioylation of CSP truncation mutants (Figure 3.8).
To further investigate the role of lysine 137 in membrane binding and palmitoylation, 
alternative point mutations were constructed at this site. A conservative substitution of lysine - 
to-arginine (K137R), or the introduction of an oppositely charged glutamic acid residue 
(K137E), were assessed for effects on membrane binding and palmitoylation (Figure 3.10/4 
(upper panel), B-C). As before, the faithful partition of proteins into cytosolic and membrane 
fractions was confirmed by probing duplicate nitrocellulose membranes for the transferrin 
receptor (TfR; Figure 3.10/4, Middle panel) and protein kinase B (PKB; Figure 3.10/4, Lower 
panel). Interestingly, as determined by the band shift assay, both K137R and K137E mutations 
were tolerated far better than the K137A mutation, and displayed membrane binding and 
palmitoylation (asterisk) at similar to wild-type levels (Figure 3.10/4; compare with wild-type 
EGFP-CSP in Figure 3.9A). This is in contrast to the K137A mutant, which had significantly 
reduced membrane binding compared to wild-type EGFP-CSP (See above). Similarly, the 
percentage palmitoylation of the membrane-associated pool of both the K137E and the K137R 
mutants was not significantly different to that of wild-type EGFP-CSP. These results suggest 
that lysine 137 may be important in maintaining the correct membrane orientation of the 
cysteine string domain, rather than specifying interaction with a PAT. This region of the protein 
may require to be localised at the surface of the membrane to allow efficient palmitoylation of
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Figure 3.9 Requirement for a sp ecific  amino acid downstream  from the cysteine string 
domain for efficient membrane association  and palmitoylation of full-length CSP
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Figure 3.9 Requirement for a sp ecific  amino acid downstream  from the cystein e string 
dom ain for efficient m em brane a sso c ia tio n  and palm itoylation o f full-length CSP. A.
PC 12 cells transfected with wild-type EGFP-CSP or EGFP-CSP point mutants (K137A, P138A, 
K139A, A140L, P141A, E142A or G143A) for 48 h were fractionated into cytosolic (C) and 
membrane (M) fractions and analysed following SDS-PAGE and transfer to nitrocellulose 
membranes by immunoblotting using an anti-GFP monoclonal antibody (U p p e r  p a n e l) .  To 
confirm the faithful partition of proteins into cytosolic and membrane fractions, duplicate 
nitrocellulose membranes were probed to analyse the distribution of the transferrin receptor 
(TfR, membrane protein; M id d le  p a n e l)  and protein kinase B (PKB, cytosolic protein; L o w e r  
p a n e l) .  The position of molecular weight standards (in kDa) is shown on the left side of the 
panel; a s t e r i s k s  identify palmitoylated CSP and a r r o w h e a d s  indicate unpalmitoyiated CSP. 
Representative blots are shown. B . The percentage CSP palmitoylation +/- SEM w as 
determined by quantification of immunoblots by densitometry as a percentage of the total 
membrane-associated pool (n=3 from 3 separate experiments). Statistical significance w as 
determined by a Student’s f-test, whereby *** represents a p value of <0.0003 compared to wild- 
type EGFP-CSP. C. The percentage CSP membrane association +/- SEM was determined by 
quantification of immunoblots by densitometry (n=3 from 3 separate experiments). Statistical 
significance was determined by a Student’s f-test, whereby * represents a p value of <0.03 
compared to wild-type EGFP-CSP.
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Figure 3.10 Differential e ffec ts  of K137 su b stitu tion s on the m embrane binding and 
palm itoylation of CSP. A. PC12 cells transfected with EGFP-CSP(K137) point mutants 
(K137A, K137E or K137R) for 48 h were fractionated into cytosolic (C) and membrane (M) 
fractions and analysed following SDS-PAGE and transfer to nitrocellulose membranes by 
immunoblotting using an anti-GFP monoclonal antibody (Upper panel). To confirm the faithful 
partition of proteins into cytosolic and membrane fractions, duplicate nitrocellulose membranes 
were probed to analyse the distribution of the transferrin receptor (TfR, membrane protein; 
Middle panel)  and protein kinase B (PKB, cytosolic protein; Low er panel). The position of 
molecular weight standards (in kDa) is shown on the left side of the panel; aster isks  identify 
palmitoylated CSP and a r r o w h e a d s  indicate unpalmitoyiated CSP. The results shown are 
representative blots from the same experiment. B. The percentage CSP membrane association 
+/- SEM was determined by quantification of immunoblots by densitometry (n=3 from 2 separate 
experiments). C. The percentage CSP palmitoylation +/- SEM was determined by quantification 
of immunoblots by densitometry as a percentage of the total membrane-associated pool (n=3 
from 2 separate experiments).
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the cysteine string domain; this extra-membrane position would presumably be satisfied by the 
charged lysine, arginine or glutamic acid residues, whereas alanine may be more embedded in 
the lipid bilayer.
3 .7  C o n s e r v e d  a m in o  a c id s  u p s t r e a m  o f  t h e  c y s t e in e  s t r in g  d o m a in  a r e
IMPORTANT FOR C SP MEMBRANE BINDING
Finally, the primary sequence of the minimal membrane-binding domain of CSP (amino acids 
106-136) from various species was examined to identify conserved amino acids upstream from 
the cysteine string domain that may be important for CSP membrane binding. As illustrated in 
Figure 3.3E, there are several conserved amino acids immediately upstream of the cysteine 
string domain, within the minimal membrane-binding domain. Point and double mutations of 
the conserved lysine at position 107 and the conserved leucine at point 109 were constructed in 
full-length EGFP-CSP, and these mutants were transfected into PC 12 cells for 48 hours. 
Expressed proteins were separated into membrane and cytosolic fractions, and protein 
distribution was determined by SDS-PAGE and immunoblotting. Efficient palmitoylation of the 
mutant proteins was determined by the band-shift assay as detailed in Chapter 3.2.1. An 
immunoblot showing the profile of these mutant proteins in cytosol and membrane fractions 
prepared from PC12 cells is shown in Figure 3.1 IA. Figure 3.11A reveals that the proportion of 
the K107R, L109A and L109E mutants partitioning in the membrane fraction is similar to that 
of wild-type EGFP-CSP. The K107A and K107E point mutants, and the K107A/L109A and 
K107E/L109E double mutants, however, appear to have increased solubility compared to wild- 
type EGFP-CSP.
To confirm the reduction in membrane binding of the K107A and K107E point mutants, and the 
K107A/L109A and K107E/L109E double mutants statistically, immunoblots were quantified by 
densitometry and the percentage membrane binding is illustrated in Figure 3.11#. Indeed, 
compared to wild-type EGFP-CSP, the membrane binding of the K107A and K107E point 
mutants, and the K107A/L109A and K107E/L109E double mutants were significantly reduced. 
In contrast, the percentage membrane association of the K107R, L109A and L109E mutants was 
not statistically different to that of wild-type EGFP-CSP. Overall, this mutational analysis 
highlights an important role of the residues upstream of the cysteine string domain for 
membrane recognition and palmitoylation of full-length CSP, and supports the truncation 
analysis, which found a role for residues 106-136 in membrane binding.
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Figure 3.11 Amino acid s upstream from the cyste in e string domain are required for 
efficient membrane binding of full-length CSP A. PC12 cells transfected with wild-type 
EGFP-CSP, EGFP-CSP(K107) point mutants (K107A, K107E or K107R), EGFP-CSP(L109) 
point mutants (L109A or L109E) or EGFP-CSP(K107/L109) double mutants (K107A/L109A or 
K107E/L109E) for 48 h were fractionated into cytosolic (C) and membrane (M) fractions and 
analysed following SDS-PAGE and transfer to nitrocellulose membranes by immunoblotting 
using an anti-GFP monoclonal antibody. The position of molecular weight standards (in kDa) is 
shown on the left side of the panel; a s te r i s k s  identify palmitoylated CSP and a r r o w h e a d s  
indicate unpalmitoyiated CSP. Representative blots are shown. B. The percentage CSP 
membrane association +/- SEM was determined by quantification of immunoblots by 
densitometry (n=3 from 3 separate experiments). Statistical significance was determined by a 
Student’s f-test, whereby * represents a p value < 0.03 and ** represents a p value < 0.004 
compared to wild-type EGFP-CSP.
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3.8  D isc u ssio n
The mechanisms that control the initial membrane attachment of some soluble palmitoylated 
proteins are poorly understood. CSP is synthesized as a soluble protein and does not undergo 
any other known lipid modification prior to palmitoylation. Since palmitoyl transferases are 
integral membrane proteins, CSP must have a mechanism to associate with the membrane that 
houses the appropriate PAT for palmitate transfer to occur. The results in this chapter have 
demonstrated that the minimum membrane-binding domain of CSP maps to amino acids 1 Ob- 
136. This membrane targeting domain includes the cysteine string domain (amino acids 113- 
136) and a short stretch of amino acids immediately upstream in the linker domain. An 
interesting question is whether this domain associates directly with membranes or if another 
protein is required to present newly synthesized CSP to membranes. If this were the case, then 
the minimum membrane binding domain of CSP would presumably serve as the minimum 
binding site for these molecules. None of the known CSP binding partners interact specifically 
with residues 106-136, and thus if CSP is targeted to membranes by a “chaperone” then the 
identity of this molecule is unknown. The interaction of the minimal membrane binding domain 
of CSP with other molecules could be tested directly, for example by using purified 
recombinant protein encoding this domain as bait against cell lysates, followed by mass 
spectrometry analysis of putative interacting proteins.
Interestingly, the membrane binding of CSP truncation mutants (EGFP-CSP(I_136) and EGFP- 
CSP(106_i36)) occurs in the absence of CSP palmitoylation. This finding implies that membrane 
binding alone is not sufficient to initiate palmitoylation. The observation that truncated CSP 
mutants bind to membranes in the absence of palmitoylation also suggests that the minimum 
membrane binding domain is sufficiently hydrophobic to associate tightly with membranes. 
Indeed, these mutants remain associated with membranes after treatment with solutions of high 
ionic strength or high pH, and are only released from membranes following treatment with 
Triton® X-100. Therefore, the initial interaction of CSP with membranes is likely to involve 
direct hydrophobic interactions with membrane lipids. The interaction of the minimal 
membrane binding domain of CSP with lipids could be tested directly by examining the 
interaction of this domain with liposomes in vitro. Furthermore, by preparing liposomes with 
different lipid compositions, it would be possible to assess whether this domain of CSP has a 
specific lipid preference.
The finding that CSP truncation mutants are able to bind membranes tightly in the absence of 
palmitoylation raises the possibility that palmitoylation of CSP has functions independent of
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membrane anchoring. One possibility is that extensive palmitoylation is somehow required for 
the function of CSP. The known functions of palmitoylation, in addition to promoting stable 
membrane binding, include: mediating protein-protein interactions (Hayashi et al., 2005; 
Washbourne et al., 2001), regulating protein folding or promoting protein stability (Lam et al., 
2006; Valdez-Taubas and Pelham, 2005), targeting proteins to distinct subcellular membranes 
or membrane microdomains (El-Husseini et al., 2001; Roy et al., 2005), and regulating the 
trafficking of proteins between intracellular membranes (Goodwin et al., 2005; Kang et al., 
2004; Kinlough et al., 2006; Rocks et al., 2005).
Palmitoylation of CSP could perhaps regulate interactions with other proteins, such as the 
chaperone protein Hsc70, syntaxinlA, VAMP or synaptotagmin. Although the majority of 
binding studies used to identify CSP binding partners have utilised recombinant CSP, which is 
unpalmitoyiated, palmitoylation could exert a more subtle regulation on any of these 
interactions. It is possible that the extensive palmitoylation of CSP is more important in 
regulating CSP interactions in vivo than in vitro. For example, palmitoylation may ensure CSP 
has an optimal membrane topology to facilitate interactions with binding partners.
Another possibility could be that palmitoylation of CSP is directly involved in membrane fusion 
events. To examine this, correctly sorted but palmitoylation deficient CSP mutants could be 
employed to assess whether a reduced level of palmitoylation had any effects on exocytosis, 
assayed, for example, using carbon fibre amperometry (Graham and Burgoyne, 2000). Such 
functional studies would benefit from a procedure to inactivate endogenous CSP, such as RNA 
interference.
If palmitoylation were to regulate the correct folding or promote the stability of CSP, it is 
reasonable to assume that unpalmitoyiated CSP would form aggregates when expressed in cells, 
or would become degraded. Confocal microscopy of fluorescently labelled expressed proteins 
would allow any protein aggregation to be visualised, and pulse-chase labelling using 
radioisotopes would allow the half-life of the protein to be determined and compared to that of 
wild-type CSP: a decrease in half-life would suggest increased protein degradation.
Another possibility is that palmitoylation is required for the correct intracellular sorting of CSP, 
perhaps due to palmitate anchors preferentially partitioning into specific subcellular membranes 
or membrane microdomains. In this way, palmitoylation may act as a retention signal, by 
trapping CSP once it reaches a specific intracellular compartment. Alternatively, palmitoylation 
may serve to target CSP to the site of vesicle budding, thus facilitating the sorting of CSP onto
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vesicle membranes. In support of this idea was the observation that unpalmitoyiated CSP 
truncation mutants are localised almost exclusively to membranes of the ER, and not to the 
plasma membrane/vesicles where full-length CSP is resident. This suggests that the lack of 
extensive palmitoylation may interfere with the targeting of CSP to vesicle membranes. Indeed, 
once CSP truncation mutants become palmitoylated, following the addition of amino acids 
downstream of the cysteine string domain, they are no longer localised at the ER; instead, they 
are correctly sorted to post-ER membrane compartments. Thus, the results suggest, at present, 
that the palmitoylation of CSP functions to sort CSP to its correct intracellular compartment. It 
would be interesting to determine how many, and which, cysteines within the cysteine string 
domain are required for the correct intracellular sorting of CSP.
As unpalmitoyiated CSP mutants are associated with the ER, an obvious possibility is that CSP 
binding to ER membranes precedes palmitoylation, and that the enzyme(s) that palmitoylate 
CSP are ER-resident. However, since palmitoylating enzymes are localised to various 
intracellular membranes in addition to the ER, including the Golgi apparatus, the plasma 
membrane and endosomes, it will be important to identify CSP palmitoylating enzymes to more 
fully understand why unpalmitoyiated CSP mutants are localised to the ER. For example, it 
could be that unpalmitoyiated CSP accumulates at the ER if it cannot be trapped at other 
membranes by palmitoylation. Indeed, one possibility that needs to be considered is that the 
loss of the C-terminal domain may inadvertently force CSP truncation mutants to bind to 
inappropriate membranes (such as the ER) and become physically separated from their partner 
PAT.
The proposed role of palmitoylation in regulating CSP traffic out of the ER is similar to the 
previously reported palmitoylation-dependent sorting of Ras proteins from the ER/Golgi to the 
PM (Goodwin et al., 2005; Rocks et al., 2005). However, it is not clear how palmitoylation 
facilitates sorting to post-ER compartments. Palmitoylation has been proposed to increase the 
affinity of proteins for specific subdomains of the plasma membrane (Melkonian et al., 1999), 
and, by analogy, palmitoylation may therefore also promote the lateral segregation of proteins at 
the ER into domains that regulate vesicle budding. This could occur, for example, if 
palmitoylation increased the affinity of CSPs for a specific membrane geometry such as that 
occurring at ER exit sites. Alternatively, because palmitoylation has previously been suggested 
to regulate protein-protein interactions (Hayashi et al., 2005; W ashbourne et al., 2001), 
palmitoylation of CSP may enhance its binding to an ER-localised sorting chaperone. Another 
possibility is that palmitoylation of CSP increases its affinity for cholesterol-rich membrane
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domains, and the increasing gradient of cholesterol from the ER-Golgi-plasma membrane may 
thus regulate the sorting of palmitoylated CSP (Mitra et al., 2004).
Interestingly, the addition of amino acids downstream from the cysteine string domain of CSP 
truncation mutants, whilst restoring palmitoylation, also led to an increase in the soluble pool of 
these mutants. The reason for this is not clear, but it will be worthwhile investigating whether 
the relationship between the increase in palmitoylation and weaker membrane binding of CSP 
are connected or are simply coincidental. A stronger membrane affinity may inhibit 
palmitoylation by physically separating the substrate from the enzyme (for example, if the 
substrate tightly binds to the wrong membrane). Alternatively, tight membrane binding may 
cause cysteine residues to become deeply embedded in the bilayer thereby being inaccessible to 
the palmitoyl transferase. One possibility is that the tight membrane association following loss 
of the C-terminal domain in the truncation mutants is caused by the inadvertent creation of an 
artificial membrane spanning domain, whereby the cysteine string domain becomes embedded, 
or even traverses, the lipid bilayer. The mapping of the minimum membrane binding domain of 
CSP to amino acids 106-136 agrees well with in silico analysis, which predicts a membrane 
domain between residues 108-130 of CSP (Boal et al., 2007). The analysis revealed that this 
domain would be membrane embedded, but does not have a tendency to traverse the lipid 
bilayer. Thus, it is unlikely that removal of the C-terminal domain creates an artificial 
membrane spanning domain, though this possibility cannot be rejected.
The finding that palmitoylation and intracellular sorting of truncated CSP mutants was restored 
following the addition of residues downstream from the cysteine string domain prompted 
investigations into the requirement for specific amino acids within this region for palmitoylation 
of full-length  CSP. Alanine scanning mutagenesis was employed to determine if individual 
residues downstream of the cysteine string domain were important for palmitoylation and 
membrane binding of full-length CSP. Indeed, membrane binding and palmitoylation of full- 
length CSP is abolished when the conserved lysine (K137) immediately downstream from the 
cysteine string domain is mutated to an alanine residue. The specific requirement for this lysine 
in CSP palmitoylation might be to form part of a recognition site for a palmitoyl transferase. If 
this were the case, then in vitro binding between recombinant purified CSP and specific 
palmitoyl transferases would be predicted to be significantly reduced following mutation of the 
lysine 137 residue. Alternatively, lysine 137 may be more important in regulating the correct 
membrane orientation of CSP. Since lysine is a charged amino acid it is likely have an extra­
membrane position rather than be embedded in the bilayer; thus, it may help to orientate the 
cysteine string domain into a position at the membrane interface that facilitates palmitoylation.
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If this were the case, by substituting the lysine for any other charged amino acids would be 
predicted to restore palmitoylation. Indeed, when lysine 137 was substituted for other charged 
amino acids (for example, arginine or glutamic acid), membrane binding and palmitoylation of 
CSP were preserved, suggesting that the lysine 137 is not critical for palmitoylation per se, and 
that any charged amino acids downstream of the cysteine string domain could likely fulfil this 
role. If this hypothesis were true, then substituting the lysine 137 for other charged hydrophilic 
amino acids, for example histidine or aspartatic acid, would be tolerated, whereas uncharged 
hydrophobic amino acids (for example alanine, leucine or valine) would change the 
conformation of the cysteine string domain to an unfavourable position that does not permit 
palmitoylation of the cysteines. Interestingly, a charged residue at the N-terminus of the 
minimum membrane binding domain of CSP is also required for membrane binding of CSP: 
mutation of lysine 107 to alanine significantly reduces membrane binding, while mutation to 
arginine has no effect. It is tempting to speculate that K107 has a similar role as K137, to 
facilitate the orientation of the cysteine string domain to a position that is favourable for 
palmitoylation to proceed. On a similar note, there is also a conserved lysine towards the end of 
the cysteine string domain (at position 135), which may also regulate membrane orientation.
The alignment of the minimum membrane binding domain of CSP from different species 
reveals there are many conserved residues within this region (Figure 3.3E). One of these 
conserved residues is leucine at position 109. Though mutation of this leucine to an alanine or 
glutamic acid had no noticeable effect on membrane binding of CSP, when the L109E mutant 
was introduced into CSP(K107E), it dramatically potentiated the reduction in membrane 
association brought about by the K107E, almost abolishing total membrane binding. It would 
be interesting to assess the importance of other conserved residues in this region for membrane 
targeting of CSP. Of particular interest would be to look at the conserved phenylalanine at 
position 110; phenylalanine residues could play an important role in membrane interactions due 
to the hydrophobicity of their side chain. Amino acid substitutions introduced at position 110 
could therefore be used to assess the importance of this residue for membrane targeting.
C h a p t e r  Fo u r : C y s t e in e  h y d r o p h o b ic it y  g o v e r n s  C S P
MEMBRANE TARGETING
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4.1 In t r o d u c t io n
The defining characteristic of CSP is its cysteine string domain, which encodes a stretch of 
twenty-four amino acids containing a contiguous “string” of fourteen cysteines, the majority of 
which are thought to be palmitoylated in vivo (Gundersen et al., 1994). The results presented in 
chapter three reveal that, in PC 12 cells, the cysteine string domain alone is not sufficient for 
membrane binding or palmitoylation of CSP. Instead, the cysteine string domain acts in concert 
with amino acids present in the linker domain to promote CSP membrane association.
Interestingly, the results presented in Chapter Three reveal that palmitoylation of CSP 
truncation mutants is not essential for membrane binding. These results suggest that the 
intrinsic hydrophobicity of these mutants is sufficient to promote membrane association. In 
support of this hypothesis, several studies have previously documented that CSP remains 
membrane associated following chemical depalmitoylation with hydroxylamine (Chamberlain 
and Burgoyne, 1998; Mastrogiacomo et al., 1998; van de Goor and Kelly, 1996). Furthermore, 
chemically-depalmitoylated CSP can only be released from membranes by treating with 
detergent (M astrogiacom o et al., 1998), suggesting that CSP remains tightly bound to 
membranes following depalmitoylation. The membrane association of depalmitoylated CSP 
may be maintained by the ability of hydrophobic amino acids within the cysteine string domain 
to interact with the lipid bilayer: following deacylation, the cysteine residues within the cysteine 
string domain remain in a hydrophobic environment (Mastrogiacomo etal., 1998).
Interestingly, a CSP mutant in which the seven central cysteine amino acids were mutated to 
more hydrophilic serine residues (7CS), was not palmitoylated and was entirely cytosolic in 
both PC 12 and HeLa cells (Chamberlain and Burgoyne, 1998). This prompted the conclusion 
that although palmitoylation may not be required for stable membrane association of CSP 
(following depalmitoylation), it is required for initial membrane targeting (Chamberlain and 
Burgoyne, 1998a). However, since this study was published, palmitoyl transferases have been 
shown to be integral membrane proteins, and thus, initial membrane targeting of CSP must 
precede palmitoylation. The results presented in the previous chapter show that palmitoylation 
is not required for membrane binding of CSP truncation mutants, suggesting that there may be 
an alternative reason for the loss of membrane binding of the 7CS mutant. Although cysteine is 
often classified as a polar amino acid, the SH group in this amino acid is unreactive with water 
and thus it behaves essentially as a hydrophobic amino acid (Nagano et al., 1999). Replacement 
of the seven central cysteines with the more polar amino acid serine, which has a hydrophilic 
hydroxyl group, may lead to the loss of an intrinsically hydrophobic cysteine string domain,
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resulting in a more hydrophilic domain that is potentially unable to associate with membranes. 
Therefore, the 7CS mutant may be cytosolic and unpalmitoyiated simply because of a loss of 
hydrophobicity, rather than a loss of cysteines per se.
The requirement of individual cysteines within the cysteine string domain for initial membrane 
binding and palmitoylation of CSP is not clear. In this chapter, the importance of individual 
cysteine residues for CSP membrane binding and palmitoylation will be assessed, and at the 
same time, the hypothesis that the intrinsic hydrophobicity of the cysteine string domain 
mediates CSP membrane binding prior to palmitoylation will be tested.
4.2 A n  i n t a c t  c y s t e i n e  s t r i n g  d o m a in  is  r e q u i r e d  f o r  e f f i c i e n t  m e m b r a n e
ASSOCIATION OF CSP
Results presented in Figures 3.2-3 reveal that the cysteine string domain and the region 
immediately upstream mediate membrane association of CSP. However, it is not clear whether 
an intact cysteine string domain is required for membrane association. Previous studies have 
shown that a CSP mutant with a shortened cysteine string domain is membrane associated in 
Drosophila, suggesting that an intact cysteine string domain is not required for CSP membrane 
binding (Arnold et al., 2004). To investigate whether regions within the cysteine string domain 
are dispensable for the membrane binding of mammalian CSP, two C-terminal CSP truncation 
mutants lacking the C-terminal half (CSP,_124) or third (CSP,.,28) of the cysteine string domain 
were constructed. PC 12 cells were transfected with EGFP-CSP,_124, EGFP-CSP,.,?&, EGFP- 
CSP, _,36 for forty-eight hours, followed by the separation of cells into cytosolic and membrane 
fractions. Equal volumes of the isolated cytosolic and membrane fractions were subjected to 
SDS-PAGE, transfer to nitrocellulose and immunoblotting using a monoclonal antibody against 
GFP. Figure 4.1 shows that, in contrast to EGFP-CSP,_,36, C-terminal mutants having a 
truncated cysteine string domain display significantly reduced levels of membrane association. 
These results reveal that an intact cysteine string domain is required for the efficient membrane 
association of CSP (in the absence of palmitoylation).
4.3 R o l e  o f  s p e c i f i c  c y s t e i n e s  in  t h e  c y s t e i n e  s t r i n g  d o m a in  f o r  m e m b r a n e
ASSOCIATION AND PALMITOYLATION OF CSP
Results from the previous section revealed that the entire cysteine string domain is required for 
efficient membrane association of CSP. However, the role that specific cysteine residues within
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Figure 4.1 An intact cysteine sting domain is required for com plete membrane binding of 
CSP. A. PC12 cells transfected with EGFP-CSP cysteine string domain truncation mutants 
(EGFP-CSP(1.124), EGFP-CSP(i.128) or EGFP-CSP(1.136)) for 48 h were fractionated into cytosolic 
(C) and membrane (M) fractions and analysed following SDS-PAGE and transfer to 
nitrocellulose membranes by immunoblotting using an anti-GFP monoclonal antibody. The 
position of molecular weight standards (in kDa) is shown on the left side of the panel. 
Representative blots are shown. B. The percentage CSP membrane association +/- SEM was 
determined by quantification of immunoblots by densitometry (n = 7 from 5 separate 
experiments). Statistical significance was determined by a Student’s t-test, whereby * 
represents a p value of < 5 x 10'3 and ** represents a p value of < 5 x 10 7, compared to wild- 
type EGFP-CSP.
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the cysteine string domain play in CSP membrane binding is not clear. Although it is likely that 
most, if not all, of the cysteines in the cysteine string domain become palmitoylated (see Figure
3.1 A and Gundersen et al., 1994), the requirement for such an extensive palmitoylation of CSP 
is not understood. The results presented in chapter three have shown that palmitoylation 
appears to correlate with the correct intracellular sorting of CSP. However, it is not known if all 
cysteines within the cysteine string domain require to be palmitoylated for correct sorting to 
occur. To analyse the importance of individual cysteine residues, a mutational analysis of the 
cysteine string domain of CSP was performed. The cysteine string domain contains fourteen 
cysteine residues which have been designated 1-14 (see Figure 4.2A) and a set of four cysteine- 
to-serine mutants, each containing either three or four mutated cysteines, were constructed 
within full-length EGFP-CSP, and designated C1-3S, C4-7S, C8-10S and C11-14S (Figure 
4.2A). These constructs were transfected into PC 12 cells and the distribution of the mutant 
proteins in recovered cytosol and membrane fractions was examined by immunoblotting using 
an anti-GFP monoclonal antibody (Figure 4.2A; Upper panel). To confirm the faithful partition 
of proteins into cytosolic and membrane fractions, duplicate nitrocellulose membranes were 
probed to analyse the distribution of the transferrin receptor (TfR; Figure 4.2A, Middle panel) 
and protein kinase B (PKB; Figure 4.2A, Lower panel). Serine substitutions of cysteine 
residues located in the C-terminal half of the cysteine string domain (C8-10S and C11-14S) 
were well tolerated, retaining robust membrane binding and palmitoylation at levels that were 
not significantly different to wild-type EGFP-CSP (Figure 4.2B-D). In contrast, mutations 
introduced in the N-terminal half of the cysteine string domain (C1-3S and C4-7S) led to the 
mutant proteins being recovered largely in the cytosolic fraction (Figure 4.2B-D) .  To 
investigate the effects of these mutations on the level of palmitoylation, membranes were 
isolated from transfected cells and treated with 1 M hydroxylamine, pH 7.0, to depalmitoylate 
proteins (or 1 M Tris, pH 7.0 as a control) for 20 hours at room temperature. Following 
recovery of the treated membranes, the samples were subjected to SDS-PAGE, transfer to 
nitrocellulose membranes and immunoblotting using an anti-GFP monoclonal antibody. Figure 
4.2E reveals that, as demonstrated in Chapter 3, there is a marked molecular mass shift of ~8 
kDa between palmitoylated (Figure 4.2E\ asterisk) and unpalmitoylated (Figure 4.2E\ 
arrow head) forms of wild-type CSP. Similarly, and in agreement with the quantitative 
densitometry presented in Figure 4.2D, the C8-10S or C11-14S mutants exhibit a significant 
band-shift upon HA-induced depalmitoylation indicating that these mutants are modified by 
palmitoylation (Figure 4.2D). However, the HA-induced band-shift in the C8-10S and C11-14S 
mutants is smaller than for wild-type EGFP-CSP, suggesting that cysteines are likely to be 
palmitoylated (and hence to contribute to the mass shift) in wild-type CSP. The HA-induced
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Figure 4.2 Role of the cy ste in e  string dom ain in CSP m em brane binding and 
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Figure 4 .2  R ole o f the c y ste in e  string dom ain in CSP m em brane binding and  
palmitoylation: cysteine to serine substitutions. A. Amino acids sequence of the cysteine 
string domain; cysteine residues are numbered from 1-14. Blocks of 3-4 cysteines were 
mutated to serines within the cysteine string domain; the names given to these mutants and 
their position within the cysteine string domain are shown. B. PC12 cells transfected with 
EGFP-CSP cysteine string domain cysteine to serine substitutions (EGFP-CSP(C1-3S), EGFP- 
CSP(C4-7S), EGFP-CSP(C8-10S), EGFP-CSP(C11-14S)), for 48 h were fractionated into 
cytosolic (C) and membrane (M) fractions and analysed following SDS-PAGE and transfer to 
nitrocellulose membranes by immunoblotting using an anti-GFP monoclonal antibody ( U p p e r  
p a n e l ) .  To confirm the faithful partition of proteins into cytosolic and membrane fractions, 
duplicate nitrocellulose membranes were probed to analyse the distribution of the transferrin 
receptor (TfR, membrane protein; M id d le  p a n e l)  and protein kinase B (PKB, cytosolic protein; 
L o w e r  p a n e l) . The position of molecular weight standards (in kDa) is shown on the left side of 
the panel; on the right side of the panel, a s t e r i s k s  identify palmitoylated CSP and a r r o w h e a d s  
indicate unpalmitoylated CSP. Representative blots are shown. C. The percentage CSP 
membrane association +/- SEM w as determined by quantification of immunoblots by 
densitometry (n = 3 from 3 separate experiments). Statistical significance was determined by a 
Student’s  Mest, whereby * represents a p value of < 0.02 and ** represents a p value of < 
0.006, compared to wild-type EGFP-CSP. D. The percentage CSP palmitoylation +/- SEM was 
determined by quantification of immunoblots by densitometry of the total membrane-bound pool 
(n = 3 from 3 separate experiments). E. PC12 cells were transfected with EGFP-CSP cysteine 
to serine mutants for 48 h and isolated cell membranes were incubated in 1M Tris, pH 7.0 (T) or 
1M hydroxylamine, pH 7.0 (HA) for 20 hours at room temperature. The treated membranes 
were recovered by centrifugation at 196 000 x g  for 30 minutes and analysed following SDS- 
PAGE and transfer to nitrocellulose membranes by immunoblotting using an anti-GFP 
monoclonal antibody. The position of molecular weight standards (in kDa) is shown on the left; 
a s t e r i s k s  identify palmitoylated CSP and a r r o w h e a d s  indicate unpalmitoylated CSP. 
Representative blots are shown. F. PC 12 cells growing on glass coverslips and transfected 
with EGFP-CSP cysteine string domain cysteine to serine substitutions for 48 h were fixed and 
the localisation of the expressed proteins was determined by confocal microscopy. Images are 
representative of a single 0.13 fxm thick confocal section. Scale bar = 10 fxm.
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band-shift observed for the C8-10S and C11-14S mutants indicates that mutation of cysteine 
residues to serines within the C-terminal half of the cysteine string domain does not perturb 
palmitoylation of the remaining cysteines. To ascertain whether full palmitoylation of the 
cysteine string domain is required for the correct intracellular sorting of CSP, the subcellular 
localisation of the cysteine string domain mutants was assessed by confocal microscopy. Figure 
4.2F  illustrates that, in addition to being dispensable for membrane binding and palmitoylation 
of the remaining cysteines, cysteines within the C-terminal half of the cysteine string domain 
are not required for membrane sorting of CSP, as the C8-10S and C11-14S mutants showed a 
strong enrichment at the PM, similar to wild-type EGFP-CSP. In contrast, the C1-3S and C4-7S 
mutants were dispersed throughout the cytosol of PC 12 cells, consistent with their lack of 
membrane binding (Figure 4.2F). These results demonstrate that, despite CSP being extensively 
palmitoylated, cysteines in the C-terminal half of the cysteine string domain are dispensable for 
membrane binding, global palmitoylation and intracellular sorting of CSP. In contrast, 
cysteines in the N-terminal half of the cysteine string domain are important for membrane 
binding, palmitoylation and subcellular sorting of CSP.
4.4 R o l e  o f  t h e  f i r s t  t h r e e  c y s t e i n e s  in  t h e  c y s t e i n e  s t r i n g  d o m a in  f o r  C SP
MEMBRANE BINDING
The finding that mutation of cysteines in the N-terminal half of the cysteine string domain to 
serine residues inhibited membrane binding, palmitoylation and intracellular sorting, prompted 
an investigation into the role of individual cysteine residues in this region on CSP membrane 
association. Since the block replacement of these three cysteine residues with serines resulted 
in the greatest loss of membrane association of EGFP-CSP (Figure 4.2B and C; C1-3S), single 
and double serine substitutions were made to the cysteines in this region of EGFP-CSP (Figure 
4.3A). Following transfection of these constructs into PC 12 cells for 48 hours, expressed 
proteins were separated into cytosolic and membrane fractions, and subjected to SDS-PAGE, 
transfer to nitrocellulose membranes, and immunoblotting using an antibody against GFP. 
Immunoblots presented in the left panel of Figure 4.3B indicate that the replacement of any 
single cysteine residue with serine in the Cl-3 region (Cl 13S, C118S, or C119S) of EGFP-CSP 
is tolerated, with single cysteine mutants partitioning predominantly into the membrane fraction 
(Figure 4.3C). Furthermore, using the band-shift assay, the presence of a more slowly 
migrating band in the membrane fraction (asterisk ) compared to the cytosolic fraction 
(iarrowhead) suggests that these mutants are efficiently palmitoylated. However, introducing 
any combination of two cysteine-to-serine mutations in the C l-3  region (C l 13S/C118S, 
C113S/C119S or C118S/C119S) of EGFP-CSP promoted a significant reduction in levels
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Figure 4.3 Role o f the first three c y s te in e s  in the cy ste in e  string dom ain in CSP 
membrane binding: sing le  and double serine substitutions. A . The position of the mutated 
cysteines within the cysteine string domain. B. PC12 cells transfected with EGFP-CSP 
cysteine to serine single amino acid substitutions (L eft p a n e l)  or double amino acid substitutions 
(R ig h t p a n e l)  for 48 h were fractionated into cytosolic (C) and membrane (M) fractions and 
analysed following SDS-PAGE and transfer to nitrocellulose by immunoblotting using an anti- 
GFP monoclonal antibody. The position of molecular weight standards (in kDa) is shown on the 
left side of each panel; on the right side of each panel, a s te r is k s  identify palmitoylated CSP and 
a r r o w h e a d s  indicate unpalmitoylated CSP. Representative blots are shown. C. The percentage 
CSP membrane association +/- SEM was determined by quantification of immunoblots by 
densitometry (n = 3 from 3 separate experiments). Statistical significance was determined by a 
Student’s f-test, whereby * represents a p value of < 0.02, ** represents a p value of < 0.002 
and *** represents a p value of < 0.0009 compared to wild-type EGFP-CSP.
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of membrane association, with the mutants partitioning predominantly into the cytosolic 
fraction (Figure 4.3Z?; Right panel and C).
4.5 T h e  im p o r t a n c e  o f  a  h y d r o p h o b ic  c y s t e i n e  s t r i n g  d o m a in  f o r  CSP MEMBRANE
BINDING
The results presented in chapter three identified that two EGFP-CSP truncation mutants, EGFP- 
CSP]136 and CSPI06-i36> associate tightly with membranes in the absence of efficient 
palmitoylation (Figure 3.4A and B). The finding that CSP mutants are able to associate with 
membranes through mechanisms other than palmitoylation (most likely through hydrophobic 
interactions) suggests that the lack of membrane binding of CSP resulting from the replacement 
of cysteine residues within the N-terminal half of the cysteine string domain with serine 
residues, may not be caused solely by a loss of palmitoylation. Instead, it is possible that the 
hydrophobic nature of the cysteine residues provide CSP with an initial membrane affinity. To 
test this hypothesis, cysteines in the N-terminal half of the cysteine string domain were replaced 
with residues other than serine. In the first set of experiments, the first three cysteines in the 
cysteine string domain (C l-3) of EGFP-CSP were replaced with the amino acid alanine (Figure 
4.4A). Alanine was chosen as a substitute, since it has more hydrophobicity than serine (owing 
to an apolar methyl side group), but is less hydrophobic than cysteine. This mutant (C1-3A) or 
C1-3S was transfected into PC 12 cells, and forty-eight hours later the level of membrane 
association of the expressed proteins was assessed by cell fractionation, SDS-PAGE, transfer of 
proteins to nitrocellulose membranes and immunoblotting using an anti-GFP antibody. To 
confirm the faithful partition of proteins into cytosolic and membrane fractions, duplicate 
nitrocellulose membranes were probed to analyse the distribution of the transferrin receptor 
(TfR; Figure 4AB, Middle panel) and protein kinase B (PKB; Figure 4.4B, Lower panel). 
Interestingly, and in contrast to the C1-3S mutant, the C1-3A mutant associates with cell 
membranes and is robustly palmitoylated, as indicated by a band shift in the membrane- 
associated pool of this mutant (Figure 4.4B, Upper panel', asterisk). Although the level of 
membrane binding and palmitoylation of C l-3A is significantly reduced when compared to 
wild-type EGFP-CSP, there is a significant increase in both these parameters compared to C l- 
3S. These results support the hypothesis that palmitoylation of cysteines 1-3 is not essential for 
membrane association of CSP, and that polar residues introduced at these positions may directly 
inhibit membrane binding.
The remaining cysteine residues in the N-terminal half of the cysteine string domain (C4-7) 
have also been shown to be important for CSP membrane binding and palmitoylation (Figure
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Figure 4.4 Role of the first three c y s te in e s  in the cy ste in e  string dom ain in CSP 
membrane binding: com parison of serine and alanine substitutions.
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Figure 4 .4  Role o f the first three c y s te in e s  in the cy ste in e  string dom ain in CSP 
membrane binding: com parison o f serine and alanine substitutions. A . The position of 
the mutated cysteines within the cytsteine string domain. B. PC12 cells transfected with EGFP- 
CSP(C1-3S) or EGFP-CSP(C1-3A) for 48 h were fractionated into cytosolic (C) and membrane 
(M) fractions and analysed following SDS-PAGE and transfer to nitrocellulose by 
immunoblotting using an anti-GFP monoclonal antibody (U p p e r  p a n e l) . To confirm the faithful 
partition of proteins into cytosolic and membrane fractions, duplicate nitrocellulose membranes 
were probed to analyse the distribution of the transferrin receptor (TfR, membrane protein; 
M id d le  p a n e l)  and protein kinase B (PKB, cytosolic protein; L o w e r  p a n e l) .  The position of 
molecular weight standards (in kDa) is shown on the left side of each panel; on the right side of 
each panel, a s te r is k s  identify palmitoylated CSP and a r r o w h e a d s  indicate unpalmitoylated CSP. 
Representative blots are shown. C. The percentage CSP membrane association +/- SEM was 
determined by quantification of immunoblots by densitometry (n = 3 from 3 separate  
experiments). Statistical significance w as determined by a Student’s f-test, whereby * 
represents a p value of < 0.02 and ** represents a p value of < 3 x 10"4 compared to EGFP- 
CSP. D . The percentage CSP palmitoylation +/- SEM was determined by quantification of 
immunoblots by densitometry of the total membrane-bound pool (n = 3 from 3 separate 
experiments). Statistical significance was determined by a Student’s f-test, whereby * 
represents a p value of < 0.03 and ** represents a p value of < 0.02 compared to EGFP-CSP.
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4.2B-E). Thus, to extend this analysis, these cysteines were also substituted for alanine, or 
alternatively, for the more hydrophobic amino acid, leucine (Figure 4 .54). PC12 cells 
expressing these mutants for forty-eight hours were separated into cytosolic and membrane 
fractions and were analysed by SDS-PAGE, transfer to nitrocellulose membranes and 
immunoblotting using an anti-GFP monoclonal antibody (Figure 4.55; Upper panel). To 
confirm the faithful partition of proteins into cytosolic and membrane fractions, duplicate 
nitrocellulose membranes were probed to analyse the distribution of the transferrin receptor 
(TfR; Figure 4.55, Middle panel) and protein kinase B (PKB; Figure 4.55, Lower panel). In 
contrast to the increase in membrane partitioning and palmitoylation displayed by the C1-3A 
mutant compared to C1-3S (Figure 4.45-D ), a similar substitution of cysteines in the C4-7 
region (C4-7A) behaved essentially the same as C4-7S and was only weakly associated with 
membranes (Figure 4.55; Upper panel and C). However, replacing the four cysteines in this 
region with more hydrophobic leucine residues, led to a large pool of the protein associating 
with cell membranes (Figure 4.55, Upper panel). The membrane binding of all of the C4-7 
mutants was significantly reduced when compared to wild-type EGFP-CSP (Figure 4.5C), but 
the trend suggests a link between an increase in membrane binding and the hydrophobicity of 
the amino acids substituted for the cysteine residues (where leucine > alanine > serine). 
Surprisingly, and in contrast to other cysteine mutants, the membrane-bound pool of C4-7L has 
a similar molecular mass to the cytosolic pool (arrowhead), and only very small amounts of the 
protein migrates to the size expected for a palmitoylated pool {asterisk), suggesting that this 
mutant is unpalmitoylated. The replacement of C4-7 with serine, alanine or leucine residues 
significantly reduced palmitoylation when compared to wild-type EGFP-CSP (Figure 4.5D). 
However, the most severe reduction in palmitoylation was observed when the cysteines were 
replaced with leucine residues, which almost completely abolished the palmitoylation of the 
remaining cysteines in the cysteine string domain. This suggests that the C4-7L mutation, 
although preserving membrane binding of CSP, inhibits overall palmitoylation of the cysteine - 
string domain.
To confirm the observation that the C l-3A mutant was palmitoylated and that the C4-7L mutant 
was not, [3H] palmitate labelling experiments were performed on PC 12 cells expressing these 
mutant proteins. PC 12 cells were transfected in triplicate for 48 hours, and were metabolically 
labelled with [3H] palmitic acid for 4 hours, followed by immunoprecipitation of EGFP-CSP, 
SDS-PAGE and analysis by immunoblotting with an anti-GFP monoclonal antibody or 
fluorography. As shown in the left panel of Figure 4.64, the labelling pattern of C l -3A was 
similar to EGFP-CSP (compare to Figure 3.15), demonstrating that this protein is palmitoylated 
despite the absence of the first three cysteines in the string domain. The results for C1-3A are
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Figure 4.5 Role of cy ste in es 4-7 in the cysteine string domain in CSP membrane binding: 
com parison o f serine, alanine and leucine substitutions. A . The position of the mutated 
cysteines within the cytsteine string domain. B. PC12 cells transfected with EGFP-CSP(C4- 
7S), EGFP-CSP(C4-7A) or EGFP-CSP(C4-7L) for 48 h were fractionated into cytosolic (C) and 
membrane (M) fractions and analysed following SDS-PAGE and transfer to nitrocellulose 
membranes by immunoblotting using an anti-GFP monoclonal antibody ( U p p e r  p a n e l) . To 
confirm the faithful partition of proteins into cytosolic and membrane fractions, duplicate 
nitrocellulose membranes were probed to analyse the distribution of the transferrin receptor 
(TfR, membrane protein; M id d le  p a n e l) and protein kinase B (PKB, cytosolic protein; L o w e r  
p a n e l) .  The position of molecular weight standards (in kDa) is shown on the left side of each 
panel; on the right side of each panel, a s t e r i s k s  identify palmitoylated CSP and a r r o w h e a d s  
indicate unpalmitoylated CSP. Representative blots are shown. B . The percentage CSP 
membrane association +/- SEM w as determined by quantification of immunoblots by 
densitometry (n = 3 from 3 separate experiments). Statistical significance was determined by a 
Student’s f-test, whereby * represents a p value of < 0.02, ** represents a p value of < 0.003  
and *** represents a p value of < 7 x 10-4 compared to EGFP-CSP. C. The percentage CSP 
palmitoylation +/- SEM was determined by quantification of immunoblots by densitometry of the 
total membrane-bound pool (n = 3 from 3 separate experiments). Statistical significance was 
determined by a Student’s f-test, whereby * represents a p value of < 0.003 and ** represents a 
p value of < 6 x 10-4 compared to EGFP-CSP.
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Figure 4.6 Palmitoylation and membrane trafficking of cy ste in e  string domain mutants.
A. PC12 cells were transfected with EGFP-CSP(C1-3A) or EGFP-CSP(C4-7L) in triplicate for 48 
h followed by incubation in 3H palmitate for 4 hours. The EGFP tagged expressed proteins 
were immunoprecipitated from cell lysates and subjected to SDS-PAGE and transfer to 
nitrocellulose membranes, in duplicate. One membrane was analysed by probing with a 
monoclonal anti-GFP antibody (left side of each panel; “GFP”), the other was processed for 
fluorographic detection of incorporated radiolabel (right side of each panel; “3H-palm”). 
Representative blots are shown. B. PC12 cells growing on glass coverslips and transfected 
with EGFP-CSP(C1-3A) or EGFP-CSP(C4-7L) for 48 h were fixed in 4% (v/v) formaldehyde, 
permeabilised and probed with a polyclonal anti-calreticulin antibody to label the ER. 
Calreticulin labelling was detected by probing with a rhodamine-conjugated anti-rabbit IgG (red) 
and compared with the GFP signal (green). Localisation of the labelled proteins was 
determined by confocal microscopy and images are representative of a single 0.13 pm thick 
confocal section. Scale bar = 10 pm.
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similar to those seen for wild-type EGFP-CSP, with the higher molecular weight band 
incorporating [3H] label (asterisk), which is clearly distinct from the non-palmitoylated pool of 
this protein (arrowhead). Note that for both C l-3A and wild-type CSP, the lower molecular 
weight band incorporating the [3H] label is clearly distinct from the non-palmitoylated pool of 
this protein (arrowhead) and likely represents a degraded form of palmitoylated CSP that was 
visible after longer exposure of the immunoblot. In contrast to C l-3A, the major band detected 
for the C4-7L mutant (arrowhead) does not incorporate [3H] label, although a very minor (~ 
5%) higher molecular weight pool of the protein is clearly modified with [3H] palmitate (Figure 
4.6A, right panel; asterisk). In several experiments, the [3H] signal detected for the C4-7L 
mutant always overlaid exactly with the minor higher molecular weight band denoted by an 
arrowhead. Thus, the major pool of membrane-bound C4-7L mutant is unpalmitoylated.
Having shown that mutation of cysteines at position 8-10 and 11-14 could be tolerated without 
affecting intracellular sorting of CSP (Figure 4.2F), the intracellular distribution of the C1-3A 
and C4-7L mutants (i.e. the mutants in the N-terminal half of the cysteine string domain that 
were membrane-bound) were also examined. PC12 cells were transfected with EGFP-CSP(C1- 
3A) or C4-7L for forty-eight hours, and the cells were fixed, permeabilised and probed with a 
polyclonal anti-calreticulin antibody to label the ER. Detection of calreticulin was determined 
by probing cells with a rhodamine-conjugated anti-rabbit IgG antibody prior to visualization by 
confocal microscopy. Similar to the C8-10S and C11-14S mutants, the C1-3A mutant was 
efficiently sorted, showing a strong enrichment at the plasma membrane and little overlap with 
the marker for the ER, calreticulin (Figure 4.65; Upper panel). In contrast, the C4-7L mutant 
was completely excluded from the plasma membrane and, similar to the unpalmitoylated EGFP- 
CSP(]06-i36) and EGFP-CSP(i_,36) mutants, exhibited substantial overlap with the ER marker, 
calreticulin (Figure 4.65; Lower panel). Note that cells expressing EGFP-CSP(C4-7L) were 
permeabilised with digitonin prior to fixation to remove the cytosolic pool of protein (see 
Chapter 2.6 and (Chamberlain et al., 1996).
4.6 M e m b r a n e  a s s o c ia t io n  o f  EGFP-CSP(C4-7L)
Finally, the membrane interactions of EGFP-CSP(C4-7L) were further examined to determine if 
the mechanism of membrane binding was the same as that for wild-type EGFP-CSP. This was 
investigated exactly as for EGFP-CSP(1_i36) in Chapter 3.2.4. Figure 4.7 illustrates that, as in 
Figure 3.6, the peripheral membrane proteins m uncl8-l and aSNA P are released to different 
extents from membranes treated with sodium chloride or sodium carbonate. In contrast, EGFP- 
CSP(C4-7L) is tightly associated with membranes and can only be released into the supernatant
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Figure 4.7 A nalysis of m em brane binding of EGFP-CSP(C4-7L). PC12 cells were 
transfected with EGFP-CSP(C4-7L) for 48 h and isolated cell membranes were incubated in 
HES Buffer, 1M NaCI, 0.1 M Na2C 0 3, pH 11.5, or HES Buffer supplemented with 1% (v/v) 
Triton X-100 for 30 minutes at 4 °C. Supernatant (S) and pelleted membrane (P) fractions were 
recovered by centrifugation at 196 000 x g  for 30 minutes and analysed following SDS-PAGE 
and transfer to nitrocellulose membranes by immunoblotting using an anti-GFP monoclonal 
antibody (Upper panel). To examine the partition of peripheral membrane proteins into 
supernatant and pelleted membrane fractions, nitrocellulose membranes were probed using 
mouse monoclonal antibodies against Munc 18 (Middle pane l) and cx-SNAP (Low er  panel).  
Representative blots are shown.
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following treatment with Triton® X-100. This result is comparable to that found for both wild- 
type EGFP-CSP and EGFP-CSP(]136), and supports the idea that the membrane association of 
the unpalmitoylated EGFP-CSP(C4-7L) mutant is mediated by hydrophobic interactions 
between the cysteine string domain and the membrane.
4.7 D is c u s s io n
The results presented in Chapter 3 revealed that palmitoylation of CSP truncation mutants is not 
required for their membrane association, and suggested that the membrane association of CSP 
prior to palmitoylation may be mediated by hydrophobic interactions between the cysteine 
string domain and the lipid bilayer. Here, detailed mutagenesis of the cysteine string domain of 
full length CSP has been used to test this hypothesis, and to examine the role of individual 
cysteines in membrane binding and palmitoylation.
The results presented in this chapter have shown that cysteine residues in the C-terminal half of 
the cysteine string domain are dispensable for global palmitoylation and trafficking of CSP. 
The finding that specific cysteine residues can be mutated without effect on membrane sorting 
suggests that the extensive palmitoylation of CSP is not a fundamental prerequisite for either 
membrane binding or intracellular sorting. Although extensive palmitoylation of CSP may be 
important to maintain the appropriate membrane orientation of the protein, it is also possible 
that such multiple palmitoylation of CSP is important for some other aspect of CSP function. In 
support of this, a CSP mutant in which several cysteines in the cysteine string domain had been 
deleted was correctly targeted to membranes but was unable to rescue the null mutant 
phenotype when expressed in Drosophila (Arnold et al., 2004). The identification of correctly 
sorted CSP mutants that have reduced levels of palmitoylation (i.e. the C8-10S, C11-14S and 
C1-3A CSP mutants identified in this chapter) will be a valuable tool for future studies 
investigating the role of palmitoylation in CSP function. Perhaps the proposed function of CSP 
in exocytosis is dependent on an extensively palmitoylated cysteine string domain, either 
directly, or through protein-protein interactions. Palmitoylation-deficient CSP mutants that are 
correctly sorted could be expressed in cells that have a CSP null background (for example, 
following short interference RNA (siRNA) knockdown); any change in secretion or protein 
interactions could be measured and attributed to the reduction in palmitoylation.
The finding that membrane binding is preserved following the substitution of cysteines located 
in the N-terminal half of the cysteine string domain with other hydrophobic amino acids 
(alanine or leucine), and abolished following substitution with hydrophilic residues (serine)
-127-
I  11AI I I ,K K M  K
suggests that the overall hydrophobicity of the cysteine string domain may be important for 
initial membrane interactions. The hydrophobicity of this domain may therefore act as a 
membrane targeting motif, that allows CSP to target its partner PAT; alternatively, a 
hydrophobic motif may form part of a recognition site that allows the PAT to identify its 
substrate protein. Interestingly, Gundersen’s group (Mastrogiacomo et al., 1998) provided 
evidence that the cysteine string domain is embedded in the bilayer after chemically induced 
depalmitoylation; however, it was suggested that it was hydroxylamine treatment that promoted 
a nonphysiological membrane interaction of the cysteine string region. Although the work 
presented here supports the results of Mastrogiacomo et al., it clearly implies that membrane 
insertion of the cysteine string domain of CSP may be physiological and may precede 
palmitoylation. Interestingly, intermediate immunoreactive bands corresponding to partially 
palmitoylated CSP are never detected by SDS-PAGE (Chapter 3 (Gundersen et al., 1994). 
Similarly, membrane-associated, unpalmitoylated protein has not consistently been detected for 
wild-type CSP. These points imply that the full palmitoylation of CSP is a rapid event, is likely 
enzyme mediated and occurs in the same compartment to which CSP initially binds. It is 
interesting to note however that Drosophila CSP does not associate with membranes and is not 
palmitoylated when expressed in PC 12 cells (Van de Goor and Kelly, 1996). This finding may 
suggest that membrane integration of the cysteine string domain prior to palmitoylation requires 
a specific chaperone factor that is not conserved between Drosophila and mammalian CSPs.
A mutant has been identified of full-length CSP (C4-7L), which has a robust membrane binding 
occurring in the absence of palmitoylation. This mutant behaves in a similar way to the C- 
terminal truncation mutants (introduced in Chapter 3) and indeed, has a similar ER localisation. 
The discovery that a full length CSP mutant shares the same ER localisation in the absence of 
palmitoylation as the C-terminal truncation mutants argues against the notion that the loss of the 
C-terminal domain creates an artificial membrane-spanning domain that forces these mutants to 
associate with membranes inappropriately.
The results presented in Figure 4.5 suggest that the hydrophobicity of the cysteine string domain 
also appears to be critical in determining whether CSP becomes palmitoylated: palmitoylation is 
inhibited if the hydrophobicity of the cysteine string domain is either too high (C4-7L) or too 
weak (C4-7S). This supports the finding that a weakened membrane binding correlated with the 
palmitoylation of CSP truncation mutants (Chapter 3). Thus, two different sets of experiments 
have suggested a link between the strength of membrane binding and the incidence of 
palmitoylation. One possibility for this link may be explained if the mutants that have an 
increased level of membrane affinity get “trapped” on the wrong membrane, and so become
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physically separated from their partner palmitoyl transferase. Conversely, mutants with 
membrane affinities that are too weak may simply never encounter membranes, and by 
association, palmitoyl transferases. Alternatively, the strength of membrane binding may be 
important for enzyme-substrate recognition, or possibly palmitate transfer onto substrate 
proteins. Indeed, the strength of initial membrane interaction of substrate proteins may be one 
way a palmitoyl transferase exhibits a level of substrate specificity.
The membrane interaction of hydrophobic cysteine-rich domains may play a general role in 
initial membrane binding of palmitoylated proteins. Of interest, El-Husseini et al. (2000) 
identified a hydrophobic sequence, 3Cys-Leu-5Cys-Ile-Val, required for palmitoylation and 
correct targeting of PSD-95; the cysteines at position 3 and 5 of this sequence are both sites for 
palmitoylation. Mutation of either cysteine at position 3 or 5 of this sequence to serine almost 
abolished total palmitoylation of PSD-95; however, single leucine mutations (particularly at 
position 5) allowed robust incorporation of palmitate (El-Husseini et al., 2000; Topinka and 
Bredt, 1998). Furthermore, the overall hydrophobic character of the sequence Met-Leu-Cys- 
Cys-Met was essential for the palmitoylation of GAP-43 (El-Husseini et al., 2000). These 
results were interpreted to suggest that the PSD-95 and GAP-43 PATs may specifically 
recognize these hydrophobic sequences. However, based on the results in this chapter, it is 
possible that this sequence also plays an important role in membrane binding (independently of 
PAT) before palmitoylation. Thus, hydrophobic cysteine rich domains may represent a 
common motif that directly associates with membranes before palmitoylation. It would be 
interesting to determine whether hydrophobic cysteine rich domains present in other proteins, 
such as SNAP25, also serve this same function. A caveat is that inhibition of PSD-95 
palmitoylation increases the soluble pool of this protein (El-Husseini et al., 2000), suggesting 
that the membrane interaction of this protein in the absence of palmitoylation is weaker than 
observed for CSP mutants.
The three separate membrane-associated mutants generated so far (EGFP-CSP(]06_136), EGFP- 
CSP(1136) and EGFP-CSP(C4-7L)), which each display defective palmitoylation, co-localise 
with ER markers. This finding raises the possibility that CSP may associate initially with the 
ER, and that subsequent palmitoylation is required for ER exit and correct intracellular sorting 
of CSP.
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C h a p t e r  F iv e : S pe c ific  DHHC p r o t e in s  p a l m it o y l a t e  CSP
AND PROMOTE ITS STABLE MEMBRANE ASSOCIATION
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5.1 I n t r o d u c t io n
Palmitoylation regulates the membrane interactions of many proteins. In addition to functioning 
as a simple membrane anchor, palmitoylation can also regulate protein sorting and the micro­
localisation of proteins within membranes (El-Husseini et al., 2001; Goodwin et al., 2005; Kang 
et al., 2004; Rocks et al., 2005; Roy et al., 2005). Despite several attempts to identify palmitoyl 
transferases over many years, it was only relatively recently that palmitoylating enzymes 
containing a conserved DHHC cysteine rich domain (CRD) were first identified in yeast (Lobo 
et al., 2002; Roth et al., 2002), where they mediate the majority of palmitoylation reactions 
(Roth et al., 2006). Subsequent analyses in mammalian cells identified a family of twenty-three 
proteins containing a conserved DHHC-CRD, and several of these proteins have since been 
shown to have palmitoyl transferase activity (Fernandez-Hernando et al., 2006; Fukata et al., 
2004; Huang et al., 2004; Keller et al., 2004; Swarthout et al., 2005).
Sequence analyses of DHHC proteins predicts that they are polytopic membrane proteins, with 
the DHHC region present on the cytosolic face of the membrane (Politis et al., 2005). Two 
lines of evidence have suggested that the DHHC domain of these proteins may form part of the 
enzyme active site. First, mutations introduced into the DHHC domain of these enzymes 
renders them inactive (Ducker et al., 2004; Fernandez-Hernando et al., 2006; Fukata et al., 
2004; Hayashi et al., 2005; Huang et al., 2004; Lam et al., 2006; Lobo et al., 2002; Roth et al., 
2002; Smotrys et al., 2005; Swarthout et al., 2005; Valdez-Taubas and Pelham, 2005). Second, 
reports have demonstrated that these enzymes become palmitoylated on the conserved cysteine 
residue within the DHHC domain, suggesting that they may form an acyl-enzyme intermediate 
(Ducker et al., 2004; Fukata et al., 2004; Hayashi et al., 2005; Keller et al., 2004; Lobo et al., 
2002; Roth et al., 2002; Smotrys et al., 2005; Swarthout et al., 2005).
The localisation of DHHC proteins (or palmitoyl transferase activity) have been identified at the 
Golgi apparatus, ER, plasma membrane, on endosomes/vesicular compartments and the yeast 
vacuole (Dunphy et al., 1996; Fukata et al., 2004; Huang et al., 2004; Keller et al., 2004; Roth 
et al., 2002; Schroeder et al., 1996; Singaraja et al., 2002; Swarthout et al., 2005; Uemura et al., 
2002; Valdez-Taubas and Pelham, 2005; Veit et al., 2001). The subcellular localisation of only 
a subset of the DHHC proteins has been determined so far, however, gaining a complete profile 
of the localisation of each of the DHHC proteins may help to understand how palmitoylation is 
spatially regulated.
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Cysteine string protein is palmitoylated on up to fourteen cysteine residues present within its 
cysteine string domain (Gundersen et al., 1994). Although the enzymes that palmitoylate CSP 
have not been identified, two recent studies have reported a loss of CSP palmitoylation in the 
nervous system of DHHC 17 mutant D rosophila, which results in defective presynaptic 
neurotransmission (Ohyama et al., 2007; Stowers and Isacoff, 2007). However, it is not known 
whether DHHC 17 palmitoylates mammalian CSP in vivo, and it is also formally possible that 
the effects of the DHHC17 mutation in Drosophila  on CSP palmitoylation are indirect. In 
addition, CSP has a widespread tissue distribution outside the nervous system of both mammals 
and Drosophila (Chamberlain and Burgoyne, 1996; Coppola and Gundersen, 1996; Eberle et 
al., 1998), and it is not clear whether the same DHHC protein(s) palmitoylate CSP in every cell 
type. Furthermore, it is possible that more than one DHHC protein may be active against CSP; 
indeed, eNOS, SNAP25, G^, GAP43 and Lck have each been shown to be substrates for 
multiple palmitoyl transferases (Fernandez-Hernando et al., 2006; Fukata et al., 2004; Huang et 
a l,  2004).
Determining the palmitoyl transferases that are active towards CSP, and the intracellular 
localisations of these enzymes, will provide important information about the intracellular 
location of CSP palmitoylation.
5.2 L o c a l isa t io n  o f  DHHC p r o t e in s  in  PC12 c e l l s .
To identify the localisation of all of the twenty-three murine DHHC proteins, PC12 cells 
growing on duplicate glass coverslips were transfected with HA-tagged versions of each of the 
twenty-three DHHC proteins for forty-eight hours prior to the cells being fixed and 
permabilised. To detect expressed DHHC proteins, the cells were probed with a FITC- 
conjugated anti-HA antibody. The DHHC proteins studied to date have been shown to be 
predominantly localised to the ER and Golgi apparatus in mammalian cells (Huang et al., 2004; 
Keller et al., 2004; Singaraja et al., 2002; Swarthout et a l ,  2005; Uemura et al., 2002). 
Therefore, cells on one coverslip were probed for a marker of the ER by incubating in a 
polyclonal anti-calreticulin antibody ; on another coverslip, cells were probed for a marker of the 
Golgi apparatus by incubating with a GRASP55 (Golgi reassembly stacking protein of 55 kDa; 
Shorter et al., 1999) antibody. Calreticulin and GRASP55 labelling was detected by probing 
with rhodamine-conjugated anti-rabbit and anti-sheep IgGs, respectively, and the fluorescence 
was visualised by confocal microscopy. Screening of coverslips by confocal microscopy 
revealed that overexpressed DHHC proteins in PC 12 cells can be broadly classed into three
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subcellular localisations: predominantly Golgi-localised, ER-localised, or having a plasma 
membrane/endosomal localisation (Figure 5.1A). The majority of DHHC proteins are localised 
at the Golgi apparatus, and this is the case for DHHC3, -7, -8, -9, -11, -12, -15, -16, -17, -21, 
and -22. Seven DHHC proteins displayed coincidence with the ER marker calreticulin: 
DHHC1, -4, -6, -13, -18, -19, and -23. The remaining DHHC proteins, DHHC2, -5, -10, -14 
and -20, displayed partial localisation at both the plasma membrane and an intracellular 
location, a distribution that may represent endosomal compartments. Representative images 
illustrating examples of Golgi-, ER- and plasma membrane/endosomal-localised DHHC 
proteins against endogenous calreticulin and GRASP55 staining in PC12 cells are presented in 
Figure 5.1 B-D.
5.3  CSP MEMBRANE BINDING AND PALMITOYLATION IS INEFFICIENT IN HEK293 CELLS 
AND IS ENHANCED BY CO-EXPRESSION OF SPECIFIC GOLGI-LOCALISED DHHC PROTEINS
The identification of the unpalmitoylated CSP mutants, CSP].136 and C4-7L (in Chapters Three 
and Four), which are localised to ER membranes led to the hypothesis that CSP first associates 
with ER membranes prior to palmitoylation, and that CSP palmitoylating enzymes (and hence 
the site of CSP palmitoylation) are also localised to this compartment. This hypothesis would 
imply that the CSP,.136 and C4-7L mutants are somehow “unpalmitoylatable”, perhaps due to an 
altered membrane topology or altered protein folding. However, it is also possible that CSP 
becomes palmitoylated at a distinct membrane compartment to the ER, and that the CSP,_136 and 
C4-7L mutants associate inappropriately with ER membranes, and thereby remain 
unpalmitoylated because they are physically separated from their partner palmitoyl transferases. 
By identifting the palmitoyl transferases that modify CSP, it will be possible to determine the 
subcellular localisation of CSP palmitoylation, which will illuminate the pathway involved in 
CSP membrane trafficking. As a first step, a range of cell types were screened in order to 
identify cells that inefficiently palmitoylate CSP. Chinese hamster ovary (CHO), COS1, HeLa, 
Human Embryonic Kidney (HEK) 293 and PC 12 cells (as a control) were transfected with 
EGFP-CSP for forty-eight hours, and cells were separated into cytosolic (C) and membrane 
fractions (M) and analysed following SDS-PAGE and immunoblotting using a polyclonal anti- 
CSP antibody (Figure 5.2). Of all the cells types examined, endogenous CSP immunoreactivity 
was only detected in PC 12 cells, consistent with CSP being predominantly found in neuronal 
and neuroendocrine cell types. The transfection efficiency and palmitoylation of CSP 
(identified by an asterisk) varied greatly between cell types, with PC 12 and HEK293 cells 
showing the greatest levels of CSP expression. The presence of immunoreactive bands in the 
membrane fractions that migrate at different sizes by SDS-PAGE suggests that the efficiency of
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Figure 5.1 Localisation of DHHC clones in PC12 cells
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Figure 5.1 Localisation of DHHC clo n es in PC12 cells. A . The localisation of the 23 DHHC 
clones in PC 12 cells was determined by confocal microscopy and can be categorised into the 
following localisations: ER, Golgi, or PM/endosomal compartment. PC 12 cells growing on glass 
coverslips were transfected with empty vector or each of the 23 DHHC clones for 48 h, in 
duplicate. Cells were fixed in 4% (v/v) formaldehyde, permeabilised and probed with a FITC- 
conjugated anti-HA antibody to label overexpressed DHHC. Transfected cells were co-stained 
with a marker for the ER by probing with a polyclonal anti-calreticulin antibody. Calreticulin 
labelling was detected by probing with a rhodamine-conjugated anti-rabbit IgG. Alternatively, 
transfected cells were co-stained with a marker for the Golgi apparatus by probing with a 
polyclonal anti-GRASP55 antibody. GRASP55 labelling was detected by probing with a 
rhodamine-conjugated anti-sheep IgG. B. Representative images showing examples of DHHC 
clones that have a Golgi-localisation, DHHC3 and DHHC7 (green). Golgi-localisation was 
determined by the coincidence of green fluorescence with that of GRASP-55 (red). C. 
Representative images showing exam ples of DHHC clones that have an ER localisation, 
DHHC4 and DHHC6 (green). ER-localisation was determined by the coincidence of green 
fluorescence with that of calreticulin (red). D. Representative images showing exam ples of 
DHHC clones that have a PM/endosomal localisation, DHHC5 and DHHC20 (green). DHHC5 
fluorescence was compared to that of Golgi-localised GRASP55 (red; U p p e r  p a n e l) ]  DHHC20 
fluorescence was compared to that of ER-localised calreticulin (red; L o w e r  p a n e l) . Images are 
representative of a single 0.13 urn thick confocal section. Scale bar = 1 0  fim.
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Figure 5.2 Membrane binding and palmitoylation of EGFP-CSP in various cell types.
PC12, CHO, COS1 , HeLa and HEK293 cells were transfected with EGFP-CSP. Forty-eight 
hours post-transfection, the cells were fractionated into cytosolic (C) and membrane (M) 
fractions and analysed following SDS-PAGE and transfer to nitrocellulose membranes by 
immunoblotting using an anti-CSP polyclonal antibody. Note the presence of endogenous CSP 
(at approximately 28 kDa; indicated by an arrow) is only detected in PC 12 cells. The positions of 
molecular weight standards (in kDa) are shown on the left side of the panel; aster isks  identify 
palmitoylated CSP and a rro w h e a d s  indicate unpalmitoylated CSP. A representative blot is 
shown.
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CSP palmitoylation varies significantly between cell types. Whereas the upper palmitoylated 
band is the major form of EGFP-CSP in transfected PC12 cells, only a small pool of the protein 
is palmitoylated when expressed in HEK293 cells (Figure 5.2). This suggests that only a limited 
amount of palmitoyl transferases active against CSP are expressed in HEK293 cells, and thus, 
this cell type was employed to characterise CSP palmitoylating enzymes in mammalian cells. 
To determine whether any of the DHHC proteins are able to palmitoylate CSP in HEK293 cells, 
cells were cotransfected with EGFP-CSP and HA-tagged versions of each of the twenty-three 
DHHC proteins. Twenty-four hours post-transfection, the cells were separated into cystosolic 
and membrane fractions, followed by analysis by SDS-PAGE and immunoblotting using an 
anti-GFP monoclonal antibody (Figure 5.3A and B). CSP membrane binding was specifically 
and significantly enhanced by DHHC3, -7 ,-15 and -17, which was due to the palmitoylation of 
CSP as determined by the band-shift on SDS-PAGE gels (Figure 5.3/4; asterisk). Thus, 
expression of these specific DHHC proteins is sufficient to catalyse the extensive palmitoylation 
of CSP and to promote its stable membrane attachment. Interestingly, co-expression of EGFP- 
CSP with DHHC 11 consistently and significantly reduced the basal level of CSP membrane 
interaction in HEK293 cells (Figure 5.3 A and B).
To determine the expression levels of the individual DHHC clones, lysates of HEK293 cells 
expressing each of the twenty-three HA-tagged DHHC proteins were subjected to SDS-PAGE 
and immunoblotting using a monoclonal anti-HA antibody (Figure 5.4). The DHHC proteins 
were expressed at different levels, and the blot shown in Figure 5.4 is highly exposed (and 
clearly saturated for certain DHHCs) to allow expression of poorly expressed DHHCs to be 
visualised. Poor expression levels of some of the DHHC proteins is also apparent in other 
studies (Femandez-Hemando et al., 2006; Ohno et a l ,  2006). That some of the DHHC proteins 
were poorly expressed in HEK293 cells (Figure 5.4) may indicate that the identification of only 
four enzymes that palmitoylate CSP may be an underestimate; however, repeated attempts to 
either “normalise” the expression levels of the DHHCs or significantly increase the expression 
levels of the poorly expressed DHHCs have proved unsuccessful. However, note that several 
“inactive” DHHC proteins were expressed at greater or similar levels than “active” DHHC 
proteins, confirming the specificity of the results. The identification of DHHC 17 as an enzyme 
that palmitoylates mammalian CSP agrees well with recent analyses of Drosophila  mutants 
(Ohyama et al., 2007; Stowers and Isacoff, 2007).
The finding that the enzymes that are able to palmitoylate CSP in HEK293 cells are Golgi- 
localised in PC12 cells (Figure 5.1 A and B) was interesting since results presented in the 
previous chapters have suggested that CSP becomes palmitoylated at the ER in PC 12 cells. 
This proposal was based on the ER localisation of non-palmitoylated CSP mutants. To
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Figure 5.3 Specific DHHC proteins regulate EGFP-CSP membrane binding
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Figure 5.3 Specific DHHC proteins regulate EGFP-CSP membrane binding. A . HEK293 
cells were transfected with 0.8 jig of EGFP-CSP in the absence (-) or presence of 1.6 ng of 
each of the 23 HA-tagged DHHC consructs (1-23). Forty-eight hours post-transfection, the cells 
were fractionated into cytosolic (C) and membrane (M) fractions and analysed following SDS- 
PAGE and transfer to nitrocellulose membranes by immunoblotting using a monoclonal anti- 
GFP antibody. The positions of molecular weight standards (in kDa) are shown on the left side 
of the panel; a s t e r i s k s  identify palmitoylated CSP and a r r o w h e a d s  indicate unpalmitoylated 
CSP. Representative blots are shown. B. The percentage CSP membrane association +/- 
SEM was determined by quantification of immunoblots by densitometry (n=5 from 5 separate 
experiments). * represents a p value of < 0.03 and ** represents a p value of < 0.004 compared 
to EGFP-CSP in the absence of DHHC expression.
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Figure 5.4 Expression of DHHC c lo n es in HEK293 ce lls. HEK293 cells were transfected 
with equal amounts of empty vector (-) or each of the 23 murine DHHC clones (DHHC1-23). 
Forty-eight hours post-transfection, the cells were lysed and analysed following SDS-PAGE and 
transfer to nitrocellulose membranes by immunoblotting using an anti-HA monoclonal antibody. 
The positions of molecular weight standards (in kDa) are shown on the left side of the panel A 
representative blot is shown.
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investigate whether the CSP palmitoylating enzymes are localised to the same compartment 
when overexpressed in HEK293 cells, cells growing on glass coverslips were transfected with 
HA-tagged versions of each of DHHC3, -7, -15, and -17 for forty-eight hours. The cells were 
fixed, permeabilised, and overexpressed DHHC proteins were labelled by probing the cells with 
a FITC-conjugated anti-HA antibody. Cells were probed with an anti-GRASP55 antibody to 
label the Golgi apparatus, and GRASP55 staining was detected by probing with a rhodamine- 
conjugated anti-sheep IgG prior to visualisation by confocal microscopy. Figure 5.5A reveals 
that, as in PC12 cells, DHHC3, -7, -15, and -17 all overlap with the marker for the Golgi 
apparatus. To confirm that different DHHC proteins are localised to specific compartments in 
HEK293 cells, cells were also transfected with DHHC4 and -6 and were probed with anti- 
calreticulin antibody to label the ER. To detect ER staining, cells were probed with a 
rhodamine-conjugated anti-rabbit antibody followed by confocal microscopy analysis. As 
shown in Figure 5.5B DHHC4 and -6 are both localised to the ER when expressed in HEK293 
cells and have the same localisation when expressed in PC12 cells. Since several other DHHC 
proteins are also localised to the Golgi in HEK293 cells (Ohno et al., 2006), there is clearly 
specificity for CSP within this Golgi subset of DHHC proteins. It will be interesting to 
determine the factors that regulate this substrate specificity.
To ensure that the changes in membrane binding/palmitoylation of CSP induced by co­
transfection of DHHC3, -7, -15 and -17 were mediated by direct palmitoylation of CSP by the 
transfected enzymes, the effect of catalytically-inactive DHHC mutants on CSP membrane 
binding and palmitoylation were examined in HEK293 cells. A loss of DHHC protein 
palmitoylating activity has been reported whenever cysteine mutations have been introduced 
into the DHHC domain of several DHHC proteins (Ducker et al., 2004; Femandez-Hemando et 
al., 2006; Fukata et al., 2004; Hayashi et al., 2005; Huang et al., 2004; Lam et al., 2006; Lobo 
et al., 2002; Roth et al., 2002; Smotrys et al., 2005; Swarthout et al., 2005; Valdez-Taubas and 
Pelham, 2005). Cyseine-to-serine substitutions were constructed in the DHHC domains of 
DHHC3, -7, -15, and -17 (DHHC3(C157S), DHHC7(C160S), DHHC15(C159S) and 
DHHC17(C457S)), and wild-type or mutant DHHC proteins were transfected along with EGFP- 
CSP into HEK293 cells. Twenty-four hours later, the transfected cells were separated into 
cytosolic and membrane fractions to measure the extent of membrane association of the 
transfected proteins. Equal volumes of the isolated cytosolic and membrane fractions were 
subjected to SDS-PAGE, transfer to nitrocellulose and immunoblotting using a monoclonal 
antibody against GFP to detect EGFP-CSP, or HA to detect DHHC expression. EGFP-CSP, 
when transfected into HEK293 cells alone, partitions predominantly in the cystosolic fraction, 
with only a minimal pool of the protein palmitoylated and membrane-associated (Figure 5.6A;
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Figure 5.5 CSP palmitoylating enzym es are localised  to the Golgi in HEK293 ce lls. A.
HEK-293 cells growing on glass coverslips and transfected with HA-DHHC3, HA-DHHC7, HA- 
DHHC15 or HA-DHHC17 for forty-eight hours were fixed in 4% (v/v) formaldehyde, 
permeabilised and probed with a FITC-conjugated monoclonal anti-HA antibody. Golgi 
localisation was determined by probing with an anti-GRASP55 polyclonal antibody. GRASP-55 
labelling was detected by probing with an Alexa Fluor® 568 donkey anti-sheep (red) and 
compared with the FITC signal (green). B. HEK-293 cells growing on glass coverslips 
transfected with HA-DHHC4 or HA-DHHC6 for 48 h were fixed in 4% (v/v) formaldehyde, 
permeabilised and probed with a FITC-conjugated monoclonal anti-HA antibody. Calreticulin 
labelling was detected by probing with an Alexa Fluor® 594 goat anti-rabbit antibody (red) and 
compared with the GFP signal (green). Images are representative of a single 0.13 |im thick 
confocal section through HEK-293 cells. Scale bar = 10 urn.
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Figure 5.6 Increased m em brane binding and palm itoylation of EGFP-CSP by DHHC 
proteins is prevented by mutations in the DHHC domain.
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Figure 5.6 Increased m em brane binding and palm itoylation o f EGFP-CSP by DHHC 
proteins is prevented by m utations in the DHHC Domain. HEK-293 cells were transfected 
with 0.8 i^g of EGFP-CSP or co-transfected with 0.8 ^g of EGFP-CSP and 1.6 ng of wild-type 
DHHC3, -7, -15 or -17, or 1.6 ng of the inactive DHHC mutants, DHHC3(C157S), 
DHHC7(C160S), DHHC15(C159S) or DHHC17(C457S). Forty-eight hours post-transfection, 
expressed proteins were separated into cytosolic and membrane fractions and analysed  
following SDS-PAGE and transfer to nitrocellulose membranes by immunoblotting using an anti- 
GFP monoclonal antibody (U p p e r  p a n e l) . The co-expression of DHHC proteins was confirmed 
by probing duplicate nitrocellulose membranes using an anti-HA monoclonal antibody (L o w e r  
p a n e l) -  The positions of molecular weight standards (in kDa) are shown on the left side of each  
panel; a s t e r i s k s  identify palmitoylated CSP and a r r o w h e a d s  indicate unpalmitoylated CSP. 
Representative blots are shown. A . The membrane profile of EGFP-CSP in HEK-293 cells ( le f t  
p a n e l )  and EGFP-CSP following co-transfection with DHHC3 and DHHC3(C157S) ( c e n t r e  
p a n e l) .  R ig h t p a n e l  The percentage CSP membrane association +/- SEM was determined by 
quantification of immunoblots by densitometry (n=6 from 4 separate experiments). * represents 
a p value of < 0.03, ** represents a p value of < 0.003, and *** represents a p value of < 2 x 10' 
4 B . The membrane profile of EGFP-CSP in HEK-293 cells following co-transfection with 
DHHC7 and DHHC7(C160S)(/efif p a n e l) . R ig h t  p a n e l  The percentage CSP membrane 
association +/- SEM was determined by quantification of immunoblots by densitometry (n=6 
from 4 separate experiments). * represents a p value of < 6 x 10"4 and ** represents a p value 
of < 2 x 10'5. C. The membrane profile of EGFP-CSP in HEK-293 cells following co-transfection 
with DHHC15 and DHHC15(C159S)( le ft p a n e l) . R ig h t p a n e l  The percentage CSP membrane 
association +/- SEM was determined by quantification of immunoblots by densitometry (n=8 
from 5 separate experiments). * represents a p value of < 0.004. D. The membrane profile of 
EGFP-CSP in HEK-293 cells following co-transfection with DHHC17 and DHHC17(C457S)(/eft 
p a n e l) .  R ig h t p a n e l  The percentage CSP membrane association +/- SEM was determined by 
quantification of immunoblots by densitometry (n=5 from 3 separate experiments). * represents 
a p value of < 0.04, ** represents a p value of < 0.002, and *** represents a p value of < 2 x 10'
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Left panel). In contrast to the wild-type DHHC proteins, and despite being expressed at similar 
levels, all of the inactive mutants had no stimulatory effect on CSP palmitoylation or membrane 
binding in HEK293 cells (Figure 5.6A-D). Furthermore, all of the mutant DHHC proteins 
inhibited CSP palmitoylation, and this was significant for both DHHC3 and -17 (Figure 5.6A 
and D\ Right panel). Thus, the ability of DHHC3, -7, -15 and -17 to increase membrane binding 
and palmitoylation of CSP is dependent upon the palmitoyl transferase activity of the enzymes.
5.4 L ik e  CSP, SNAP25 m e m b r a n e  b in d in g  is  e n h a n c e d  b y  c o -e x p r e s s io n  o f  s p e c if ic  
GOLGI-LOCALISED DHHC PROTEINS IN HEK293 CELLS
The SNARE protein SNAP25 is similar to CSP in that it is multiply palmitoylated and lacks 
transmembrane domains or prenylation/myristoylation sites. In addition, the cysteines in 
SNAP25 are also present in an overall hydrophobic domain. Thus, it was of interest to examine 
whether DHHC proteins could also enhance membrane binding of SNAP25. SNAP25 is 
membrane-associated due to palmitoylation on up to four cysteine residues present within its 
cysteine-rich linker domain (Gonelle-Gispert et al., 2000; Lane and Liu, 1997; Veit et al., 
1996). Overexpression of DHHC-3, -7 and -17 have been shown to increase incorporation of 
radiolabelled palmitate into SNAP25 in HEK293 cells (Fukata et al., 2004). The majority of 
EGFP-SNAP25 is found in the cytosolic fraction of transfected HEK293 cells, suggesting that 
palmitoylation is inefficient in these cells (Figure 5.1 A\ Left panel). To determine whether the 
co-expression of DHHC proteins is able to increase the membrane affinity of SNAP25, 
HEK293 cells transfected with EGFP-SNAP25 and DHHC3, -7, or -17 for forty-eight hours 
were separated into cytosolic and membrane fractions and the distribution of proteins in these 
fractions was examined by SDS-PAGE and immunoblotting (Figure 5.1 A-C). Co-expression of 
DHHC3, -7, and -17 proteins promoted a significant increase in EGFP-SNAP25 membrane 
association: this effect was specific as it was abolished by mutations within the DHHC domain, 
and indeed mutant DHHC7 and -15 significantly decreased the level of EGFP-SNAP25 
membrane binding (Figure 5.1 A-C). These results demonstrate that specific DHHC proteins are 
also able to promote the stable membrane binding of SNAP25 in HEK293 cells, suggesting that 
the mechanisms of palmitoylation and membrane binding of CSP and SNAP25 are similar.
5.5 CSP CO-LOCALISES AT THE GOLGI WITH CO-EXPRESSED DHHC PROTEINS
To extend the observation that co-expression of DHHC3, -7, -15, and -17 promote membrane 
association of CSP, confocal imaging analysis was used to compare the subcellular localisations 
of EGFP-CSP and HA-tagged DHHC proteins following their co-transfection into HEK293
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Figure 5.7 Membrane binding of EGFP-SNAP25 is increased by co-expression  of DHHC 
proteins.
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Figure 5.7 Membrane binding o f EGFP-SNAP25 is increased by co-exp ression  of DHHC 
proteins. HEK-293 cells were transfected with 0.8 jig of EGFP-SNAP25 or co-transfected with 
0.8 fig of EGFP-SNAP25 and 1.6 pig of wild-type DHHC3, -7, or -17, or 1.6 pig of the inactive 
DHHC mutants, DHHC3(C157S), DHHC7(C160S), or DHHC17(C457S). Forty-eight hours 
post-transfection, expressed proteins were separated into cytosolic and membrane fractions 
and analysed following SDS-PAGE and transfer to nitrocellulose membranes by immunoblotting 
using an anti-GFP monoclonal antibody (U p p e r  p a n e l) . The co-expression of DHHC proteins 
was confirmed by probing duplicate nitrocellulose membranes using an anti-HA monoclonal 
antibody (L o w e r  p a n e l) . The positions of molecular weight standards (in kDa) are shown on the 
left side of each panel. Representative blots are shown. A. The membrane profile of EGFP- 
SNAP25 in HEK-293 cells (le ft p a n e l)  and EGFP-SNAP25 following co-transfection with DHHC3 
and DHHC3(C157S)(cer7fre p a n e l) .  R ig h t  p a n e l  The percentage SNAP25 membrane 
association +/- SEM was determined by quantification of immunoblots by densitometry (n=4 
from 2 separate experiments). * represents a p value of < 0.002 and ** represents a p value of 
< 4 x 10'5. B . The membrane profile of EGFP-SNAP25 in HEK-293 cells following co­
transfection with DHHC7 and DHHC7(C160S)(/e/if p a n e l) . R ig h t p a n e l  The percentage SNAP25 
membrane association +/- SEM w as determined by quantification of immunoblots by 
densitometry (n=4 from 2 separate experiments). * represents a p value of < 0.05, ** represents 
a p value of < 0.004, and *** represents a p value of < 0.002. C. The membrane profile of 
EGFP-CSP in HEK-293 cells following co-transfection with DHHC17 and DHHC17(C457S)(/e/if 
p a n e l) .  R ig h t p a n e l  The percentage CSP membrane association +/- SEM was determined by 
quantification of immunoblots by densitometry (n=4 from 2 separate experiments). * represents 
a p value of < 0.03 and ** represents a p value of < 9 x 10-4.
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cells. When EGFP-CSP was co-transfected into HEK293 cells with empty pEFBOS-HA vector, 
expressed CSP displayed a dispersed localisation throughout the cytosol, consistent with the 
results of subcellular fractionation (Figure 5.8A; Upper panel). In contrast, co-expression of 
EGFP-CSP with DHHC3, -7, -15 or -17 lead to the redistribution of EGFP-CSP from the 
cytosol to a perinuclear compartment that coincides with the localisation of the DHHC protein 
(Figure 5.8,4). Thus, CSP co-localises at the Golgi with DHHC3, -7, -15 and -17. Mutations in 
the DHHC domain of DHHC3, -7, -15 and -17 inhibits the palmitoylating activity of these 
enzymes towards CSP (Figure 5.6). To investigate the localisation of inactive DHHC proteins 
in HEK293 cells, and determine whether the co-expression of the mutants has any effect on 
CSP localisation, HEK293 cells were co-transfected with EGFP-CSP and HA-tagged 
DHHC3(C157S) or DHHC7(C160S) and the localisation of the proteins was determined by 
confocal microscopy (Figure 5.8B). Although the DHHC-to-DHHS mutations in DHHC3 or -7 
did not appear to change the intracellular distribution (i.e. Golgi localisation) of these enzymes 
compared to wild-type, there was no obvious co-localisation of EGFP-CSP with mutant DHHC 
protein, and indeed, the localisation of EGFP-CSP was similar to that observed in HEK293 cells 
co-expressing EGFP-CSP and the empty pEFBOS-FLA vector (Figure 5.8A; Upper panel, and 
Figure 5.SB). Together, these results demonstrate that the co-expression of CSP palmitoylating 
enzymes promotes the interaction of CSP with Golgi membranes, and that this interaction is 
dependent on the catalytic activity of the palmitoyl transferase.
5.6 O v e r e x p r e s s io n  o f  c a t a l y t ic a l l y  in a c t iv e  DHHC p r o t e in s  d o e s  n o t  p r e v e n t
CSP MEMBRANE BINDING, PALMITOYLATION OR TRAFFICKING IN PC12 CELLS
DHHC-to-DHHS mutation leads to a loss of CSP palmitoylating activity of DHHC proteins in 
HEK293 cells, and indeed, these mutants appear to have a dominant-negative activity in this 
cell type by suppressing the basal level of CSP palmitoylation and membrane binding. Thus, it 
was examined whether the inactive DHHC mutants could act as dominant negative mutants of 
CSP palmitoylation in a cell type where CSP is endogenously expressed and efficiently 
palmitoylated. In PC 12 cells, the majority of overexpressed EGFP-CSP is predominantly found 
in the membrane fraction and, as highlighted by the change in migration following SDS-PAGE, 
is fully palmitoylated (Figure 3. IB and C; Figure 5.9A: Left panel). EGFP-CSP and the inactive 
DHHC mutants DHHC3(C157S), DHHC7(C160S), DHHC15(C159S) or DHHC17(C457S) 
were co-transected into PC 12 cells and, forty-eight hours later, cystoslic and membrane 
fractions were isolated and examined by SDS-PAGE and immunblotting using an anti-GFP 
monoclonal antibody (Figure 5.9A; Right panel). No detectable change in either the level of 
EGFP-CSP membrane association or palmitoylation could be observed following co-expression
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Figure 5.8 Localisation of EGFP-CSP in HEK-293 ce lls  following co-expression  of DHHC 
proteins.
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Figure 5.8 Localisation of EGFP-CSP in HEK-293 ce lls  following co-expression  of DHHC 
proteins. HEK-293 cells growing on glass coverslips were co-transfected with EGFP-CSP and 
empty vector (pEF-BOS-HA), HA-DHHC3, HA-DHHC7, HA-DHHC15 or HA-DHHC17 (A) or the 
inactive mutants HA-DHHC3(C157S) or HA-DHHC7(C160S)(B). Forty-eight hours later, the 
cells were fixed in 4% (v/v) formaldehyde, permeabilised and probed with a rhodamine- 
conjugated mouse monoclonal anti-HA antibody to label expressed DHHC proteins (red) and 
compared with the GFP signal (green). Localisations of the labelled proteins were determined 
by confocal microscopy and images are representative of a single 0.13 pm thick confocal 
section through HEK-293 cells. Scale bar = 1 0  pm.
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Figure 5.9 Inactive DHHC m utants do not a ffect CSP m em brane a sso c ia tio n ,  
palmitoylation or localisation in PC12 cells. A . PC12 cells were transfected with 0.8 |ng of 
EGFP-CSP or co-transfected with 0.8 p,g of EGFP-CSP and 1.6 p,g of the inactive DHHC 
mutants DHHC3(C157S), DHHC7(C160S), DHHC15(C159S) or DHHC17(C457S), or 1.6 \ig  of 
DHHC11. Forty-eight hours post-transfection, expressed proteins were separated into cytosolic 
and membrane fractions and analysed following SDS-PAGE and transfer to nitrocellulose 
membranes by immunoblotting using an anti-GFP monoclonal antibody. The positions of 
molecular weight standards (in kDa) are shown on the left side of each panel; a s te r i s k s  identify 
palmitoylated CSP and a r r o w h e a d s  indicate unpalmitoylated CSP. Representative blots are 
shown. B. PC 12 cells growing on glass coverslips were transfected with empty vector (pEF- 
BOS-HA) or the inactive DHHC mutants, DHHC3(C157S), DHHC7(C160S), DHHC15(C159S) 
or DHHC17(C457S). Forty-eight hours later, the cells were fixed in 4% (v/v) formaldehyde, 
permeabilised and probed with a rhodamine-conjugated mouse monoclonal anti-HA antibody to 
label expressed DHHC proteins (red). To label endogenous CSP, the cells were probed with a 
polyclonal anti-CSP antibody. CSP labelling was detected by probing with an Alexa Fluor® 488 
goat anti-rabbit IgG (green) and compared with the DHHC signal. C. PC12 cells growing on 
glass coverslips were transfected with HA-DHHC7. Forty-eight hours later, the cells were fixed 
and permeabilised. DHHC7 was detected by probing cells with a FITC-conjugated anti-HA 
mouse monoclonal antibody (green). Endogenous CSP was labelled by probing cells with a 
polyclonal anti-CSP antibody. CSP labelling was detected by probing with an Alexa Fluor® 494 
goat anti-rabbit IgG (red) and compared with the DHHC signal. Localisation of the labelled 
proteins were determined by confocal microscopy and images are representative of a single 
0.13 pirn thick confocal section through PC12 cells. Scale bar = 10 urn.
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of the inactive DHHC mutants in PC12 cells. Since DHHC11 consistently and statistically 
reduced the basal level of EGFP-CSP membrane binding following co-transfection in HEK293 
cells (Figure 5.3), this protein was also co-expressed with EGFP-CSP in PC12 cells to 
investigate whether DHHC 11 could prevent CSP membrane binding or palmitoylation. As 
shown in Figure 5.9A (Right panel) the co-expression of DHHC 11 also had no effect on EGFP- 
CSP membrane binding or palmitoylation. To determine whether the expression of the inactive 
DHHC mutants had any effect on the distribution of endogenous CSP, PC 12 cells were 
transfected with the HA-tagged DHHC C-S mutants (or empty pEFBOS-HA vector as a 
control), and the localisation of endogenous CSP in DHHC transfected cells was determined by 
immunofluorescence and confocal microscopy (Figure 5.9B). There was no detectable change 
in the localisation or trafficking of CSP in PC 12 cells transfected with the C-S DHHC mutant 
proteins compared to empty pEFBOS-HA vector (Figure 5.9B), consistent with the previous 
finding that the inactive DHHC mutants have no effect on CSP membrane binding or 
palm itoylation (Figure 5.9A). Interestingly, and in contrast to the effects of DHHC 
overexpression on CSP localisation in HEK293 cells (Figure 5.8A), no change in subcellular 
localisation was observed for endogenous CSP following the overexpresion of DHHC7 in PC 12 
cellls (Figure 5.9C).
There are a number of possibilities to explain why DHHC C-to-S mutants have no effect on 
CSP membrane binding and palmitoylation in PC 12 cells. One aspect that may be particularly 
relevant is whether the mutants have strong or weak dominant-negative activity. For example, 
expression of the mutants in HEK293 cells may be sufficient to out-compete the limiting 
amount of DHHC proteins active against CSP in these cells, but may be inefficient at blocking 
palmitoylation in PC 12 cells if these cells contain excess DHHC protein. To determine the 
efficiency with which the individual inactive DHHC-DHHS mutants are able to suppress the 
catalytic activity of wild-type DHHC protein, HEK293 cells were transfected with EGFP-CSP 
alone, co-transfected with EGFP-CSP and DHHC3, or co-transfected with EGFP-CSP, DHHC3 
and DHHC3(C157S), DHHC7(C160S), DHHC15(C159S) or DHHC17(C457S). Cells were 
separated into cytosolic and membrane fractions, and the partitioning of EGFP-CSP into these 
fractions was determined by subjecting equal volumes of each fraction to SDS-PAGE, transfer 
to nitrocellulose and immunoblotting using a monoclonal anti-GFP antibody. Figure 5.10 (Left 
p a n e l) demonstrates that, as previously shown, EGFP-CSP membrane binding and 
palmitoylation is inefficient in HEK293 cells, but is promoted following co-expression with 
DHHC3. Interestingly, the efficient membrane binding and palmitoylation of EGFP-CSP 
following co-expression of DHHC3 is not perturbed by the co-expression of the inactive 
DHHC-DHHS mutants (Figure 5.10). This result clearly shows that these mutants are not able
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Figure 5.10 Inactive DHHC mutants do not act as dom inant negative against wild-type 
protein. HEK 293 cells were transfected with 0.8 of EGFP-CSP or co-transfected with 0.8 
pg of EGFP-CSP and 1.6 pg of DHHC3 (Left pane l ) or co-transfected with 0.8 pg of EGFP- 
CSP, 1.6 pg  of DHHC3 and 1.6 ng  of either DHHC3(C157S), DHHC7(C160S), 
DHHC15(C159S) or DHHC17(C457S) (Right panel).  Forty-eight hours post-transfection, 
expressed proteins were separated into cytosolic and membrane fractions and analysed 
following SDS-PAGE and transfer to nitrocellulose membranes by immunoblotting using an anti- 
GFP monoclonal antibody. The positions of molecular weight standards (in kDa) are shown on 
the left side of each panel; a s te r is k s  identify palmitoylated CSP and arrow heads  indicate 
unpalmitoylated CSP. Representative blots are shown.
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to act as strong dominant negative inhibitors of DHHC enzymic activity, and provides an 
explanation as to why these mutants do not affect CSP palmitoylation in PC 12 cells.
5.7 D isc u ssio n
The twenty-three murine DHHC clones have been expressed in PC 12 cells and their 
localisation, as determined by confocal microscopy, can been broadly categorised into three 
groups: ER, Golgi apparatus, and plasma membrane/endosomal (Figure 5.1). The localisation 
of the DHHC proteins to these subcellular organelles fits well with published data in which the 
localisation of a subset of the DHHC proteins and/or palmitoyl transferase activity has been 
identified (Dunphy et al., 1996; Fukata et al., 2004; Huang et al., 2004; Keller et al., 2004; Roth 
et al., 2002; Schroeder et al., 1996; Singaraja et al., 2002; Swarthout et al., 2005; Uemura et al., 
2002; Valdez-Taubas and Pelham, 2005; Veit et al., 2001). Recently, the intracellular 
localisation of the twenty-two human DHHC proteins in HEK293 cells has been published 
(Ohno et al., 2006). While the subcellular localisation of the murine DHHC clones determined 
in this study agrees well with published data for the human DHHCs, a few discrepancies have 
arisen. The notable differences include the different localisations of DHHC4, -11 and -12; 
however, this may reflect the different localisation of DHHC proteins between species. 
However, Sw fl, the yeast homologue of DHHC4, is ER-localised (Valdez-Taubas and Pelham, 
2005), supporting the observations of an ER localisation of murine DHHC4 in mammalian cells 
(Figure 5.1C; Upper panel’, Figure 5.5B\ Upper panel). In contrast, Ohno et al reports human 
DHHC4 at the Golgi (Ohno et al., 2006). The lack of readily available antibodies specific for 
the DHHC proteins has hindered the characterisation of endogenous DHHC proteins in various 
cell types or tissues, and the generation of such antibodies will be an important development. In 
addition, techniques such as quantitative PCR could be employed to detect DHHC mRNA in 
individual cell types and tissues.
The results presented in Chapter Four suggest that the hydrophobic cysteine-rich domain of CSP 
facilitates membrane anchoring prior to palmitoylation. However, it was not clear whether this 
interaction is stable or weak/transient. The inefficient palmitoylation of EGFP-CSP in HEK293 
cells allowed this question to be addressed. Indeed, despite the large fraction of unpalmitoylated 
EGFP-CSP in HEK293 cells, no significant quantity of this unpalmitoylated protein can be 
detected in the membrane fraction (Figure 5.2). This suggests that the cysteine-rich domain is 
not able to mediate stable membrane binding of full-length CSP in the absence of 
palmitoylation. Confocal imaging also revealed a dispersed, mainly cytosolic localisation of 
EGFP-CSP in HEK293 cells (Figure 5.8/1; Upper panel).
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Results in this chapter have identified four palmitoyl transferases, DHHC3, -7, -15 and -17, that 
are able to palmitoylate CSP and lead to its stable membrane binding (Figure 5.3). These CSP 
palmitoylating enzymes are localised to the Golgi apparatus, based on their coincidence with the 
medial Golgi protein GRASP55 as observed by confocal microscopy in both HEK293 and 
PC 12 cells (Figures 5.1 and 5.5A), and this implies that CSP palmitoylation also occurs in the 
Golgi. This finding was surprising, as the unpalmitoylated CSP mutants identified in Chapters 
Three and Four were localised to the ER, prompting the suggestion that CSP is targeted to the 
ER for palmitoylation to occur. However, the identification of the Golgi apparatus as the site of 
CSP palmitoylation suggests that the CSP mutants may instead be mislocalised at the ER, and 
perhaps be unpalmitoylated because they are physically separated from their partner palmitoyl 
transferases. Now that the intracellular site of CSP palmitoylation has been highlighted, it is 
important to establish the mechanisms that enable CSP to target its cognate palmitoyl 
transferase on Golgi membranes.
The identification of four DHHC proteins that palmitoylate CSP may be an underestimate, since 
many of the DHHC proteins were only poorly expressed in HEK293 cells (Figure 5.4). 
However, many non-active DHHC proteins were expressed at similar or higher levels than 
DHHC3, -7, -15 and -17. For example, DHHC2 and -4 were expressed at higher levels than 
DHHC3 and -7, and DHHC 11 was expressed at similar levels, yet these proteins had no 
stimulatory effect on CSP palmitoylation. Similarly, DHHC 12, -14, -16 and -22 were all 
expressed at similar levels to DHHC 17 (and DHHC 13 was more highly expressed), yet these 
enzymes also failed to palmitoylate CSP. This demonstrates that the ability of DHHC3, -7, -15 
and -17 to modify CSP are not simply related to expression levels, and confirms the specificity 
of the results. As four enzymes were able to palmitoylate CSP in HEK293 cells, there may be 
some redundancy in palmitoylation of DHHC substrates. Indeed, several other proteins have 
also been found to be substrates for multiple DHHC proteins, and thus the finding that four 
palmitoyl transferases are active towards CSP is not surprising in the context of a cellular 
screening assay. However, it is worth noting that genetic studies carried out in yeast have 
demonstrated that specific enzyme-substrate pairing, whereby the substrate protein is only able 
to be palmitoylated by a single enzyme, does occasionally occur (Kihara et al., 2005; Lobo et 
al., 2002; Roth et al., 2002; Smotrys et al., 2005; Valdez-Taubas and Pelham, 2005). Perhaps 
enzyme-substrate specificity is regulated in mammalian cells partly through different expression 
profiles of DHHC isoforms, in distinct cell types and tissues. For example, perhaps one of the 
DHHC proteins active against CSP is expressed at significantly higher levels than the others in 
PC 12 cells. It is important to note that all the enzymes identified as CSP palmitoyl transferases 
do display some degree of substrate specificity. For example, DHHC 17 did not palmitoylate
-156-
L l I A P r H R  r l Y H
PSD-95, GAP-43, Ga or the y2 subunit of GABAa (Fang et al., 2006; Fukata et al., 2004). 
Similarly, DHHC15 was inactive against Lck, H-ras and Ga, and was only marginally active 
against the y2 subunit of GABAa (Fang et al., 2006; Fukata et al., 2004). DHHC7 did not 
enhance palmitoylation of Lck or H-ras, whereas DHHC3 was not active against Lck (Fukata et 
al., 2004). Furthermore, many of the DHHC proteins that tested negative against CSP have 
previously been shown to palmitoylate specific substrates (Fernandez-Hemando et al., 2006; 
Fukata et al., 2004; Swarthout et al., 2005). Thus, there appears to be a good degree of 
specificity exhibited by the DHHC proteins that palmitoylate CSP. At present it is not known 
how CSP/DHHC specificity is regulated, but possibilities may include specific structural 
features within the DHHC region and/or other domains of DHHC3, -7,-15 and -17 that regulate 
the interaction with CSP. Alternatively, these DHHC proteins may associate with specific sub- 
domains of the Golgi, which facilitates the interaction with CSP. That other DHHC proteins are 
also localised to the Golgi yet are inactive towards CSP further strengthens the specificity of the 
reaction between CSP and DHHC3, -7, -15 and -17.
The expression of CSP palmitoylating enzymes in HEK293 cells leads to co-localisation of CSP 
with the DHHC proteins at the Golgi apparatus (Figure 5.8/1). The localisation of CSP at the 
Golgi may occur due to an absence of important factors in HEK293 cells that are required for 
the forward transport of CSP out of the Golgi. However, it is important to note that several 
studies have found that when DHHC proteins are co-expressed with their substrate proteins, the 
substrate protein becomes trapped with the partner palmitoyl transferase at the intracellular 
compartment where the palmitoyl transferase normally resides (Fernandez-Hernando et al., 
2006; Fukata et al., 2004; Hayashi et al., 2005; Huang et al., 2004; Keller et al., 2004; Uemura 
et al., 2002). Why substrate proteins become trapped in this way is not known, however one 
possibility could be due to the lack of DHHC auxiliary proteins, which could serve to control 
the cycle of enzyme-substrate binding and release. Indeed, the DHHC proteins that 
palmitoylate yeast and mammalian Ras, Erf2p and DHHC9, require accessory proteins for their 
activity (Lobo et al., 2002; Swarthout et al., 2005). Trapping may not reflect direct CSP-DHHC 
binding as attempts to isolate CSP-DHHC interaction by co-immunoprecipitations were 
unsuccessful.
The overexpression of inactive CSP palmitoylating enzymes in PC 12 cells had no effect on CSP 
membrane binding, palmitoylation or trafficking (Figure 5.9), suggesting that they are not able 
to act as dominant negative proteins. Another possibility is that PC 12 cells express more than 
one enzyme that is active against CSP, and that this may be able to compensate following the 
over-expression of an inactive mutant. However, as the overexpression of inactive DHHC
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mutants in HEK293 cells was not able to suppress the palmitoylating activity of DHHC3 over­
expression towards CSP (Figure 5.10), it is likely that inactive DHHC proteins are only weakly 
dominant negative. An alternative method to study the DHHC proteins that palmitoylate CSP 
in PC12 cells is RNAi, and efforts are currently ongoing to optimise protocols for siRNA- 
induced knockdown of proteins in this cell line. Once these protocols are established, siRNA 
molecules could be designed against DHHC3, -7, -15 and -17, and their effects on CSP 
palmitoylation can be investigated.
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6.1  I n t r o d u c t io n
Previous attempts to identify the enzymes responsible for protein palmitoylation were hindered 
due to difficulties in preserving enzymic activity following purification and the appearance of 
false positives (Liu et al., 1996), and so the discovery of the DHHC-family of palmitoyl 
transferases was only made relatively recently (Fukata et al., 2004; Lobo et al., 2002; Roth et 
al., 2002). Sequence analysis of members of the DHHC family predict that they are polytopic 
membrane proteins, with the DHHC domain present on the cytosolic face of the membrane 
(Politis et al., 2005). The discovery that palmitoylating enzymes are membrane-associated was 
interesting, as previously palmitoylation was regarded as being a prerequisite for the membrane 
targeting of palmitoylated proteins (Chamberlain and Burgoyne, 1998). As DHHC proteins are 
integral membrane proteins, substrates must therefore contain additional membrane targeting 
signals to mediate membrane association prior to palmitoylation. This sets palmitoylation apart 
from isoprenylation and myristoylation, which occur in the cytosol, and indeed these 
modifications often facilitate membrane association of proteins prior to palmitoylation (for 
example, H- and N-Ras (Goodwin et al., 2005; Rocks et al., 2005). The primary membrane 
targeting information contained within many palmitoylated proteins is easily identifiable (for 
example, myristoyl and isoprenyl attachment sites, or transmembrane domains). However, the 
mechanisms employed by other palmitoylated proteins for initial membrane targeting are less 
well understood.
Two unpalmitoylated CSP mutants were identified in Chapters Three and Four and were found 
to be localised predominantly to the ER in PC 12 cells; these mutants either contain a truncation 
of the C-terminus immediately after the cysteine-rich domain (CSPM36) or have four cysteines 
in the cysteine string domain replaced with leucine residues (CSP(C4-7L)). The identification 
of two unpalmitoylated CSP mutants that are both localised to ER membranes led to the 
hypothesis that CSP might interact initially with ER membranes through its hydrophobic 
cysteine string domain, with palmitoylation being required to allow ER exit and subsequent 
sorting. The results presented in Chapter Five, however, have identified four CSP- 
palmitoylating DHHC proteins, DHHC3, -7, -15 and -17, which are all localised to Golgi 
membranes. The finding that CSP is palmitoylated at the Golgi was surprising; however, the 
lack of palmitoylation of CSP,.136 and CSPC4-7L might be explained if the initial membrane 
interaction of these mutants is altered, resulting in these mutants accum ulating on 
‘inappropriate’ intracellular membranes. In this way, the mutant proteins would be physically 
separated from their partner palmitoyl transferase, and would remain unpalmitoylated.
-160-
Results presented in Chapter Three identified a correlation between the strength of membrane 
association of CSP C-terminal truncation mutants and the probability of palmitoylation (Figure 
3.8D). Mutants displaying increased levels of membrane binding were associated with an 
inhibition of palmitoylation (for example, in the CSP,.,36 mutant), whereas mutants that had 
weaker membrane binding were found to promote palmitoylation (for example, CSPM46). Thus, 
it appears that for CSP truncation mutants (at least), the strength of membrane binding inversely 
correlates with palmitoylation. Furthermore, the coincidence of palmitoylation of C-terminal 
truncation mutants is associated with the onward sorting of CSP (Figure 3.8E)\ however, it is 
not known what factors, other than palmitoylation, regulate CSP trafficking.
6.2 C o r r e l a t io n  b e t w e e n  CSP m e m b r a n e  a f f in it y  a n d  p a l m it o y l a t io n
As CSP paimitoylating enzymes are localised to the Golgi, it was reasoned that perhaps the ER 
localisation of the CSPi_136 and CSP(C4-7L) mutants reflects a perturbation of initial membrane 
interactions. It is not easy to determine if CSP,_,36 and CSP(C4-7L) have an altered membrane 
affinity relative to wild-type CSP in PC 12 cells due to efficient palmitoylation of the wild-type 
protein in this cell type. Thus, the membrane binding of CSP,_,36 and CSP(C4-7L) were 
analysed in HEK293 cells, which express only limited amounts of the DHHC proteins that are 
active against CSP (Figure 5.2). EGFP-CSP, EGFP-CSP,_,36 and EGFP-CSP(C4-7L) were 
transfected into HEK293 cells for twenty-four hours, and the distribution of these proteins in 
recovered cytosol and membrane fractions was examined by immunoblotting using an anti-GFP 
monoclonal antibody (Figure 6.1A). This analysis clearly revealed that both EGFP-CSP,_,36 and 
CSP(C4-7L) significantly associated more tightly with membranes than wild-type CSP (Figure 
6.1 A and B). Note that the membrane-associated fraction of wild-type CSP that was quantified 
in Figure 6. IA corresponds to the small amount of protein that is palmitoylated in HEK293 
cells. Thus, the membrane affinity of CSP,_,36 and CSP(C4-7L) compared to unpalmitoylated 
wild-type CSP will be substantially greater than suggested by the quantification. Co-expression 
of EGFP-CSP and active DHHC proteins in HEK293 cells redistributes CSP from the cytosol to 
a perinuclear localisation, which coincides with the localisation of the co-expressed DHHC 
protein (Figure 5.8A). EGFP-CSP,.136 and EGFP-CSP(C4-7L) are both localised to the ER in 
PC 12 cells (Figures 3.5 and 4.6B), and the intracellular localisations of the two mutants with 
HA-DHHC3 were compared in HEK293 cells using confocal microscopy by Dr. Luke 
Chamberlain. This analysis revealed a clear physical separation of both CSP mutants from the 
Golgi-localised DHHC protein (Figure 6.1C; Upper and middle panels). Furthermore, both 
CSP mutants exhibit an ER-like distribution, which is similar to the localisation observed 
following their overexpression in PC 12 cells (Figures 3.5 and 4.6B), and was confirmed by
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Figure 6.1 Membrane binding of CSP m utants in HEK293 ce lls . A HEK293 cells 
transfected with EGFP-CSP, EGFP-CSPM36 and EGFP-CSP(C4-7L) mutants for 24 h were 
fractionated into cytosolic (C) and membrane (M) fractions and analysed following SDS-PAGE 
and transfer to nitrocellulose membranes by immunoblotting using an anti-GFP monoclonal 
antibody. The position of molecular weight standards (in kDa) is shown on the left side of the 
panel. Representative blots are shown. B. The percentage CSP membrane association +/- 
SEM was determined by quantification of immunoblots by densitometry (n = 6 from 3 separate 
experiments). Statistical significance was determined by a Student’s f-test, whereby * 
represents a p value of < 5 x 10“5 and ** represents a p value of < 3 x 106, compared to wild- 
type EGFP-CSP. C. HEK293 cells were transfected with EGFP-CSP^se and HA-DHHC3 
(Upper panel), EGFP-CSP(C4-7L) and HA-DHHC3 (Centre panel), or with EGFP-CSP-m36 
alone (Lower panel). Cells were fixed, permeabilised, and incubated with rhodamine-conjugated 
anti-HA (Upper and  Centre panels)  or with anti-calreticulin antibody followed by Alexa Fluor 
543-conjugated rabbit secondary antibody (Lower panel). Images are representative of a single 
0.13 thick confocal section. Scale bar = 1 0  [xm. Panel C was kindly provided by Dr. Luke 
Chamberlain.
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immunofluorecence of HEK293 cells that were expressing EGFP-CSP,.136 and were probed for 
the ER resident protein calreticulin (Figure 6AC,  Lower panel). Thus, CSP mutants that 
enhance membrane affinity promote association with ‘inappropriate’ cell membranes, offering 
an explanation for the finding that these mutants are not efficiently palmitoylated in PC 12 cells 
(See Figures 3.4B and 4.6A; Right panel).
The addition of amino acids downstream from the cysteine string domain of EGFP-CSP,.,36 
weakened CSP membrane interactions, which simultaneously promoted its palmitoylation in 
PC 12 cells (Figure 3.8A-D). To determine whether the addition of residues downstream from 
the cysteine string domain similarly weakens the membrane binding of CSP in HEK293 cells, 
CSP C-terminal truncation mutants were expressed in HEK293 cells for twenty-four hours, and 
the level of membrane affinity was assessed by separating the cells into cytosolic and membrane 
fractions and immunoblotting using a monoclonal anti-GFP antibody (Figure 6.2A). 
Interestingly, the level of membrane affinity of CSP truncation mutants expressed in HEK293 
cells decreased as amino acids were added to the C-terminus of the cysteine string domain, and 
the presence of K137-P138-K139 in the CSP,.,39 mutant weakened membrane binding 
significantly (Figure 6.2). Strikingly, this loss of membrane binding correlated near perfectly 
with the appearance of a palmitoylated fraction of EGFP-CSP, which became apparent 
following a longer exposure of the blot (Figure 6.2A; Lower panel’, asterisk). These findings in 
HEK293 cells further highlight the inverse correlation between membrane affinity of CSP 
mutants and palmitoylation.
These analyses in HEK293 cells clearly show that the level of membrane binding of CSP 
mutants decreases as successive amino acids are added to the end of the cysteine string domain. 
However, these experiments do not provide direct data on initial membrane binding of CSP, 
which directly follows protein synthesis. Thus, to extend this analysis, [35S] cysteine/methionine 
pulse-chase studies were employed to study the membrane binding and palmitoylation of newly 
synthesised wild-type and mutant CSP in PC12 cells. To determine the time-course of 
membrane binding and palmitoylation of full-length CSP, PC 12 cells transfected with EGFP- 
CSP (or EGFP as a control) for forty-eight hours were incubated with radiolabelled 
cysteine/methionine mix for 15 minutes. Radiolabel was then removed by washing the cells in 
fresh media, and the cells were separated into cystosolic and membrane fractions following a 
chase period of 15-60 minutes. GFP-tagged proteins were recovered from isolated cytosol and 
membrane fractions by im m unoprecipitation using anti-GFP magnetic beads. The 
immunoprecipitated samples were analysed by SDS-PAGE, transfer to duplicate nitrocellulose 
membranes, and immunoblotting using a monoclonal anti-GFP antibody or by autoradiography
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Figure 6.2 Membrane binding of CSP C-terminal truncation mutants in HEK293 cells. A.
HEK293 cells were transfected with w ild-type EGFP-CSP and the indicated C-terminal 
truncation mutants. Cells were then fractionated into cytosol (C) and membrane (M) fractions, 
which were examined by immunoblotting with an anti-GFP monoclonal antibody. Shown is a 
short and long exposure of the same blot. The position of molecular weight standards (in kDa) is 
shown on the left side of the panel; a r r o w h e a d s  indicate unpalmitoylated CSP, whereas 
asterisks  highlight palmitoylated CSP. Representative blots are shown. B. The percentage CSP 
membrane association +/- SEM was determ ined by quantification of immunoblots by 
densitometry (n = 5 from 3 separate experiments). Statistical significance was determined by a 
Student’s f-test, whereby * represents a p value of < 0.02, ** represents a p value of < 2 x 10'3, 
and *** represents a p value of < 8 x 10'6 compared to EGFP-CSP^^e-
-164-
l . H . M ’ l h l \  A l . \
(Figure 6.3A). Two significant observations can be made from results presented in the Upper 
panel of Figure 6.3A. First, there was a time-dependent appearance of palmitoylated CSP on 
membranes {asterisk). Second, although unpalmitoylated CSP {arrowhead) was clearly 
associated with membranes, the level of membrane association of unpalmitoylated CSP was 
relatively constant over time. This would be expected if a protein with a weak membrane 
affinity were transiently associating to cell membranes. Note that in the Upper panel of Figure 
6.3A, the faint band present in the control cytosol lane (pEGFP) is a non-specific band that was 
occasionally detected in control samples; this band migrates more slowly than the CSP cytosolic 
band. The initial membrane interaction of CSP C-terminal truncation mutants in PC 12 cells was 
determined using [35S] cysteine/methionine pulse-chase studies, as before and with a 60 minute 
chase period. C-terminal truncation of CSP causes a marked increase in the level of initial 
membrane binding of CSP,_,36 (Figure 6.3B  and C). Consistent with the HEK293 experiments, 
the addition of three extra residues (K137-P138-K139) downstream of the cysteine string 
domain significantly reduced the initial membrane binding of CSP (Figure 6.3B and C), 
highlighting a clear inverse correlation between the strength of initial membrane tethering and 
palmitoylation. Note that although a palmitoylated band is present for the CSP,_i39 and CSP,.,40 
mutants in the immunoblots presented in Figure 6.3B, a corresponding band is not readily 
detectable for these proteins in the 35S-labelled samples. The difficulty detecting a palmitoylated 
35S-labelled band for these mutants most likely reflects their decreased efficiency of 
palmitoylation compared with wild-type CSP (Figure 3.8A and B).
6.3 M e m b r a n e  b in d in g  a n d  p a l m it o y l a t io n  o f  CSP a r e  in s e n s it iv e  t o  B r e f e l d in
A TREATMENT
The results presented thus far are consistent with the notion that wild-type CSP likely has a 
weak membrane affinity (mediated by the cysteine string domain), which is enhanced either by 
C-terminal truncation (CSP,_136) or by the introduction of more hydrophobic amino acids (C4- 
7L). CSP palmitoylation occurs at the Golgi apparatus, but the mechanism by which CSP 
targets Golgi membranes for palmitylation to occur is not known. To determine whether wild- 
type CSP has a specific affinity for Golgi membranes, or whether it has a more general 
membrane affinity, the effects of Brefeldin A (BFA) on CSP membrane binding and 
palmitoylation were examined. BFA inhibits the function of ARF1 (ADP-ribosylation factor 1; 
(D onaldson et al., 1991; Lippincott-Schwartz et al., 1989), a protein essential for vesicle 
budding from the ER. BFA treatment thus blocks ER-to-Golgi transport and promotes a loss of 
Golgi integrity and the fusion of Golgi membranes with the ER. HEK293 cells were transfected 
with EGFP-CSP alone, or co-transfected with EGFP-CSP and DHHC3 or DHHC7, for four
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Figure 6.3 Membrane binding of newly syn th esised  CSP in PC12 cells.
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Figure 6.3 Membrane binding of newly sy n th esised  CSP in PC12 ce lls . A. PC12 cells 
transfected with wild-type EGFP-CSP or empty vector (pEGFP) for 48 h were incubated with 
[35S]-labelled cysteine/methionine for 15 min, washed and chased for various times as  
indicated, ranging from 0-60 min. The labelled cells were fractionated into cytosol (C) and 
m em brane (M) fractions, from which G FP-tagged proteins w ere recovered by 
immunoprecipitation and subsequently analysed by immunoblotting using an anti-GFP 
monoclonal antibody ( U p p e r  p a n e l ;  G F P ) .  Duplicate g e ls  were developed  using  
autoradiography (L o w e r  p a n e l ;  f  S ]) .  Note that the 5S-labelled band detected in the EGFP 
cytosol fraction is a non-specific band that migrates more slowly than cytosolic EGFP-CSP. B. 
PC12 cells transfected with the indicated EGFP-CSP C-terminal truncation mutants or empty 
vector (pEGFP) for 48 h were incubated with [35S]-labelled cysteine/methionine for 15 min, 
washed and chased for 60 min. The labelled cells were fractionated into cytosol (C) and 
membrane (M) fractions. GFP-tagged proteins were recovered by immunoprecipitation and 
subsequently analysed by immunoblotting using an anti-GFP monoclonal antibody ( U p p e r  
p a n e l;  G FP). Duplicate gels were developed using autoradiography (L o w e r  p a n e l ;  / ST). The 
positions of molecular weight standards (in kDa) are shown on the left side of each panel; on 
the right side of each panel, a s t e r i s k s  identify palmitoylated CSP and a r r o w h e a d s  indicate 
unpalmitoylated CSP. Representative blots are shown. C. The percentage membrane 
association of newly-synthesised CSP +/- SEM w as determined by quantification of 
autoradiographs by densitometry (n = 5 from 3 separate experiments). Statistical significance 
was determined by a Student’s f-test, whereby * represents a p value of < 0.02 and ** 
represents a p value of < 2 x 10'3 compared to EGFP-CSPM3 6 .
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hours and the cells were then incubated in the presence or absence of 30 pg/ml BFA for a 
further four hours. In this experimental set-up, BFA will prevent the trafficking of co­
transfected DHHC3 and DHHC7 from the ER. Cells were separated into cytosolic and 
membrane fractions, and the partitioning of EGFP-CSP was analysed by immunoblotting using 
a monoclonal anti-GFP antibody (Figure 6.4A). Figures 6.4A and C show that BFA treatment 
did not significantly inhibit membrane binding or palmitoylation of EGFP-CSP either in the 
absence or presence of DHHC co-transfection. A parallel experiment in which HEK293 cells 
were transfected with EGFP-SNAP25 demonstrated an almost complete inhibition of membrane 
binding following BFA treatment (Figure 6.4B) in agreement with previous work (Gonzalo and 
Linder, 1998), and confirms the action of BFA under similar experimental conditions. The 
results presented in Figure 6.4A and C imply that CSP palmitoylation does not require a specific 
intracellular localisation of partner DHHC proteins, but only sufficient cellular expression levels 
of the enzymes. These results are thus consistent with the notion that CSP has a general 
membrane affinity rather than recognising specific features inherent to intact Golgi membranes.
To extend these observations and to determine whether CSP membrane association and 
palmitoylation is also BFA-resistant in a cell type that expresses endogenous CSP, membrane 
binding and palmitoylation of EGFP-CSP was examined in PC 12 cells. Due to lower 
transfection efficiencies in PC 12 cells compared to HEK293 cells, protein expression could not 
be detected by immunoblotting following an eight-hour transfection period. Thus, [35S] 
cysteine/methionine pulse-chase experiments were employed to follow membrane binding and 
palmitoylation specifically of newly synthesised EGFP-CSP. PC 12 cells were transfected with 
pEGFP, EGFP-SNAP25 or EGFP-CSP for forty-eight hours, and were incubated in the presence 
or absence of 30 p.g/ml BFA for 15 minutes. The cells were then incubated in radiolabel in the 
presence or absence of BFA for 15 min, and, having established that CSP palmitoylation was 
readily detectable following a 60 minute ‘chase’ period (Figure 6.3A), the cells were washed 
and incubated for a further 60 minutes in the presence or absence of BFA. In this assay, CSP 
palmitoylation is dependent upon endogenous DHHC proteins; BFA treatment will promote 
redistribution of Golgi DHHC proteins to a fused ER-Golgi compartment. Following 35S- 
labelling, GFP-tagged proteins were then recovered from isolated cytosol and membrane 
fractions by immunoprecipitation using anti-GFP magnetic beads. The immunoprecipitated 
samples were resolved by SDS-PAGE, transferred to duplicate nitrocellulose membranes, and 
immunoblotted using a monoclonal anti-GFP antibody, or were developed by autoradiography. 
As shown in Figure 6.5A and B, the initial membrane binding of EGFP-SNAP25 was 
significantly reduced in the presence of BFA, consistent with previous results (Gonzalo and 
Linder, 1998) and the results presented in Figure 6.4Z? for HEK293 cells. In contrast, BFA had
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Figure 6.4 Effect of Brefeldin A on EGFP-CSP palmitoylation and membrane association  
in HEK293 cells. A. HEK293 cells were transfected with EGFP-CSP in the presence/absence 
of DHHC3 or DHHC7. Four hours after transfection, fresh media was added either with or 
without 30 ^ig/ml BFA and, after an additional four hours, the cells were fractionated into cytosol 
(C) and membrane (M) fractions. Equal volumes of the fractions were probed using a 
monoclonal antibody against GFP. B. HEK293 cells transfected with EGFP-SNAP25B were 
processed as in A. The positions of molecular weight standards (in kDa) are shown on the left 
side of each panel; on the right side of each panel, a s te r isk s  identify palmitoylated CSP and 
arrow heads indicate unpalmitoylated CSP. Representative blots are shown. C. The percentage 
membrane association of EGFP-CSP +/- SEM in the absence or presence of DHHC3 and -7 co­
expression +/- BFA treatment was determined by quantification of immunoblots by densitometry 
(n = 3 from 2 separate experiments). Statistical significance was determined by a Student’s t- 
test, whereby * represents a p value of < 0.05.
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Figure 6.5 Membrane associa tion  of new ly-synthesised  CSP is resistant to Brefeldin A 
treatment in PC12 cells.
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Figure 6.5 Membrane associa tion  of new ly-synthesised  CSP is resistant to Brefeldin A 
treatment in PC12 cells. PC12 cells were transfected with EGFP-SNAP25B (A) or EGFP-CSP 
(C) or empty vector (pEGFP; A  and C) for forty-eight hours. Transfected cells were incubated 
with [35S]-labelled cysteine/methionine for 15 min, washed and chased for a further 60 min. The 
labelled cells were fractionated into cytosol (C) and membrane (M) fractions, from which GFP- 
tagged proteins were recovered by immunoprecipitation, subjected to SDS-PAGE and 
developed using autoradiography ( U p p e r  p a n e l  o f A  an d  C; [ 5S] ) .  Duplicate gels were 
analysed by immunoblotting using an anti-GFP monoclonal antibody (L o w e r  p a n e l  o f  A  and C; 
GFP). The positions of molecular weight standards (in kDa) are shown on the left side of 
panels A  and C; on the right side of panel C, a s t e r i s k s  identify palmitoylated CSP and 
a r r o w h e a d s  indicate unpalmitoylated CSP. Representative blots are shown. B.  The 
percentage membrane association of newly-synthesised SNAP25B in the presence or absence  
of BFA +/- SEM was determined by quantification of autoradiographs by densitometry (n = 3 
from 2 separate experiments). Statistical significance was determined by a Student’s f-test, 
whereby * represents a p value of < 0.04 between BFA-treated and untreated cells. D. The 
percentage palmitoylation of membrane-associated newly-synthesised CSP in the presence or 
absence of BFA +/- SEM was determined by quantification of autoradiographs by densitometry 
(n = 3 from 2 separate experiments). E. The percentage membrane association (sum of 
unpalmitoylated and palmitoylated membrane bands) of newly-synthesised CSP in the 
presence or absence of BFA +/- SEM was determined by quantification of autoradiographs by 
densitometry (n = 3 from 2 separate experiments).
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no significant effect on either palmitoylation or membrane association of radiolabelled EGFP- 
CSP (Figure 6.5C-E). Thus, in both HEK293 cells and PC 12 cells, membrane binding and 
palmitoylation of EGFP-CSP is independent of Golgi integrity or intracellular distribution of 
DHHC proteins. These results support the notion that CSP has a general (and weak) membrane 
affinity and that stable membrane attachment requires only sufficient cellular expression of 
appropriate DHHC proteins.
6.4 B r e f e l d in  A t r e a t m e n t  p r o m o t e s  t h e  p a l m it o y l a t io n  o f  CSP(C4-7L) b u t  n o t  
CSPUM
As CSP-palmitoylating DHHC proteins retain activity following BFA treatment, it is possible 
that the BFA-mediated redistribution of Golgi-localised DHHC proteins to the ER could 
facilitate the palmitoylation of the ER-localised CSP mutants. Thus, the effects of BFA 
treatment on palmitoylation of CSP,_,36 and CSP(C4-7L) were examined in PC 12 cells. These 
experiments are important as they will determine whether CSP(C4-7L) and CSP,.]36 are 
unpalmitoylated because they are physically separated from their partner DHHC proteins, or 
because structural changes in the mutant proteins prevent their palmitoylation. PC 12 cells, 
transfected with EGFP-CSP,.136 and EGFP-CSP(C4-7L) for forty-eight hours, were incubated 
with or without 30 ng/ml BFA in the presence of 10 pig/ml cycloheximide. The use of 
cycloheximide to block protein synthesis ensures that the effects of BFA are attributable to 
redistribution of Golgi enzymes to the ER rather than the ‘trapping’ of newly synthesised 
DHHC proteins at the ER. As an additional control, transfected cells were also incubated in 10 
^ig/ml nocodazole. This drug prevents the assembly of microtubules, which are required for 
retrograde transport of Golgi-derived vesicles to the ER, and BFA treatment in the presence of 
nocodazole results in Golgi dispersal but no fusion at the Golgi and ER (Lippincott-Schwartz et 
al., 1990). The cells were separated into cytosolic and membrane fractions, and protein 
distribution was determined following SDS-PAGE and immunoblotting using a monoclonal 
anti-GFP antibody. Interestingly, BFA treatment promoted the robust palmitoylation of EGFP- 
CSP(C4-7L) and significantly enhanced its level of membrane association (Figure 6.6A-C). 
This observation suggests that BFA-induced mixing of ER and Golgi membranes allows access 
of Golgi DHHC proteins to EGFP-CSP(C4-7L), facilitating the palmitoylation of this mutant. 
Furthermore, the presence of nocodazole significantly reduced the level of BFA-induced 
palmitoylation of EGFP-CSP(C4-7L) (Figure 6.6A; p<0.03; n = 4), implying that ER-Golgi 
fusion is essential for the effects observed. In contrast to EGFP-CSP(C4-7L), BFA treatment 
had no effect on the palmitoylation status of EGFP-CSP,.136. Overall, these results in PC 12 cells
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Figure 6.6 Effect of Brefeldin A on CSP mutant proteins in PC12 cells. A. PC12 cells 
were transfected with EGFP-CSP(C4-7L) or EGFP-CSPM36. Forty-eight hours following 
transfection, cells were incubated for four hours with or without 30 pg/ml BFA in the presence or 
absence of 10 (ig/ml nocodazole. When cells were incubated in both BFA and nocodazole, the 
nocodazole was added two hours prior to BFA treatment, and maintained throughout the BFA 
treatment. Cycloheximide (10 ^ig/ml) was present in all samples. Cells were fractionated into 
cytosolic (C) and membrane (M) fractions and analysed following SDS-PAGE and transfer to 
nitrocellulose by immunoblotting using an anti-GFP monoclonal antibody. The positions of 
molecular weight standards (in kDa) are shown on the left side of the panel; on the right side of 
each panel, asterisks  identify palmitoylated CSP and arrow heads  indicate unpalmitoylated CSP 
Representative blots are shown. B. The percentage C4-7L membrane association in the 
presence or absence of BFA +/- SEM was determined by quantification of immunoblots by 
densitometry (n = 4). Statistical significance was determined by a Student’s f-test, whereby * 
represents a p value of < 7 x 1CT4 C. The percentage C4-7L palmitoylation in the presence or 
absence of BFA +/- SEM was determined by quantification of immunoblots by densitometry of 
the total membrane-bound pool (n = 4). Statistical significance was determined by a Student’s t- 
test, whereby * represents a p value of < 2 x 10'3.
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are particularly relevant as they strongly support the conclusion that DHHC proteins active 
against CSP are localised predominantly to the Golgi. Furthermore, they support the notion that 
lack of EGFP-CSP(C4-7L) palmitoylation results from a physical separation of this mutant from 
its partner Golgi-localised DHHC proteins. These experiments were performed forty-eight 
hours post-transfection and therefore following the extensive intracellular accumulation of 
unpalmitoylated EGFP-CSP(C4-7L), yet the majority of expressed EGFP-CSP(C4-7L) is 
palmitoylated following BFA treatment for four hours (Figure 6.6.4). In comparison, only 
around 20 % of wild-type CSP produced during a 15 minute labelling period was palmitoylated 
after an hour (Figure 6.5C). These findings suggest that the BFA-induced palmitoylation of 
CSP(C4-7L) is more efficient than palmitoylation of wild-type CSP. The most likely 
explanation for these findings is that whereas palmitoylation of CSP is limited by its weak 
membrane affinity, the tighter membrane binding of CSP(C4-7L) ensures a faster rate of 
palmitoylation when Golgi enzymes are re-localised to the ER.
As approximately 20% of EGFP-CSP is found palmitoylated and in the membrane fraction 
when expressed in HEK293 cells (Figure 5.3B), a limited amount of DHHC proteins active 
against CSP must be present in HEK293 cells, albeit at low expression levels. If the extent of 
CSP palmitoylation is regulated by a combination of the membrane affinity of unpalmitoylated 
CSP and the cellular expression levels of DHHC proteins, then the enhanced membrane affinity 
of CSP(C4-7L) would be predicted to facilitate a more efficient palmitoylation of this mutant in 
BFA-treated HEK293 cells than observed for wild-type CSP. To test this idea, BFA 
experiments were performed on HEK293 cells expressing EGFP-CSPM36 and EGFP-CSP(C4- 
7L). HEK293 cells were cells transfected with EGFP-CSP,_136 or EGFP-CSP(C4-7L) alone, or 
co-transfected with these plasmids and DHHC3 or DHHC7. Four hours post-transfection, the 
cells were incubated in the presence or absence of 30 pg/ml BFA for a further four hours to 
promote the mixing of Golgi and ER membranes. Cells were separated into cytosolic and 
membrane fractions, and the partitioning of EGFP-CSP1136 and EGFP-CSP(C4-7L) was 
analysed by immunoblotting using a monoclonal anti-GFP antibody (Figure 6 .74). As 
predicted, BFA treatment of HEK293 cells promoted an ~ 7-fold increase in the extent of 
EGFP-CSP(C4-7L) palmitoylation in the absence of DHHC co-expression, with around 70% of 
the protein palmitoylated following BFA treatment (Figure 6.1B). This is in contrast to the 
almost complete lack of EGFP-CSP(C4-7L) palmitoylation when transfected either in the 
absence or presence of DHHC3 or -7, but without BFA-induced mixing of ER and Golgi 
membranes (Figure 6.74; Upper panel). These findings support the notion that, when localised 
to the same intracellular compartment as partner DHHC proteins, the enhanced membrane 
affinity of EGFP-CSP(C4-7L) facilitates a faster rate of palmitoylation.
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Figure 6.7 Effect of Brefeldin A on palmitoylation of CSP mutant proteins in HEK293 
cells. A. HEK293 cells were transfected with EGFP-CSP(C4-7L) or EGFP-CSPi.136 in the 
presence or absence of HA-DHHC3 or -7. Four hours post-transfection, the cells were 
incubated in the absence or presence of 30 ng/ml BFA for a further 4 hours. The cells were then 
fractionated into cytosol (C) and membrane (M) fractions, equal volumes of which were resolved 
by SDS-PAGE and probed by immunoblotting using a monoclonal anti-GFP antibody. The 
positions of molecular weight standards (in kDa) are shown on the left side of each panel; on 
the right side of each panel, a s te r is k s  identify palmitoylated CSP and a rro w h e a d s  indicate 
unpalmitoylated CSP. Representative blots are shown. B. The percentage palmitoylation +/- 
SEM of membrane associated EGFP-CSP(C4-7L) (without co-expression of DHHCs) in the 
absence or presence of BFA treatment (n=7 from 3 separate experiments). Statistical 
significance was determined by a Student’s f-test, whereby * denotes a p value of < 3 x 10'7.
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As in PC 12 cells, EGFP-CSP,_|36 was not detectably palmitoylated following BFA-treatment of 
HEK293 cells, either in the presence or absence of DHHC co-expression (Figure 6.7A; Lower 
panel). The inability of BFA treatment to promote palmitoylation of EGFP-CSPM36 may be 
because residues in the C-terminus (such as K137-P138-K139) are important for palmitoylation. 
Indeed, results presented in Chapter Three demonstrated that palmitoylation of full-length CSP 
was inhibited following mutation of the conserved lysine (K137) immediately downstream from 
the cysteine string domain to alanine in PC I2 cells (Figure 3.9,4 and B ). The CSP1]36 mutant 
might also adopt a membrane orientation that indirectly prevents palmitoylation. For example, it 
is possible that the lack of a significant amount of charged residues at the C-terminal end of 
CSP1136 results in the protein ‘slipping’ into the membrane interior, thus preventing interaction 
with DHHC proteins.
6.5 CSP(C4-7L) DOES NOT NOTICEABLY REDISTRIBUTE FOLLOWING BREFELDIN A 
WASHOUT
Palmitoylation plays an important role in the trafficking of many proteins (El-Husseini et al., 
2001; Goodwin et al., 2005; Kang et al., 2004; Kinlough et al., 2006; Rocks et al., 2005; Roy et 
al., 2005). Indeed, results presented in Chapter Three demonstrated that palmitoylation of CSP 
C-terminal truncation mutants is coupled to efficient intracellular sorting (Figure 3.8E). To 
determine if CSP palmitoylation is always coupled to forward transport in the secretory 
pathway, BFA washout experiments were performed by Dr Luke Chamberlain, in order to 
analyse whether palmitoylated CSP(C4-7L) protein is able to traffic from the ER. PC 12 cells 
growing on glass coverslips were transfected with EGFP-CSP(C4-7L) or EGFP-tagged DHHC- 
17 as a control for a Golgi protein. Forty-eight hours post-transfection, the cells were treated 
with 30 pg/ml BFA for 2 hours in the presence of 10 pg/ml cycloheximide. The cells were then 
either fixed in 4% (v/v) formaldehyde, or were washed five times in fresh media containing 
cycloheximide but without BFA, and allowed to recover for 4 hours prior to fixing. The 
distributions of EGFP-tagged proteins were then examined by confocal imaging. As shown in 
the lower panel of Figure 6.8A, DHHC 17 showed the expected distributions: Golgi in control 
cells, dispersed after BFA treatment and Golgi following BFA washout. To quantify these 
changes, EGFP-DHHC17 distribution was examined by scoring cells for either Golgi 
localisation or dispersed (ER) distribution (Figure 6.8B). Interestingly, and in contrast to 
EGFP-DHHC 17, no changes in the distribution of EGFP-CSP(C4-7L) following BFA washout 
could be detected (Figure 6.8A; Upper panel). This finding suggests that palmitoylation is not 
sufficient to direct the exit of EGFP-CSP(C4-7L) from the ER. The amino acid
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Figure 6.8 Intracellular localisation of EGFP-CSP(C4-7L) follow ing BFA treatment and 
w ash out. A. PC12 cells transfected with EGFP-CSP(C4-7L) or EGFP-DHHC17 were either 
untreated (control), incubated in 30 (ig/ml BFA and 10|.tg/ml cycloheximide for 2 hours (‘+BFA’), 
or BFA/cycloheximide treated and then washed and incubated in the presence of cycloheximide 
for 4 hours (‘BFA washout’). Cells were examined using a Zeiss LSM510 axiovert laser 
scanning confocal microscope. For clarity, a rough outline of the cell membrane (solid line) and 
nuclei (dashed line, n) is shown for DHFIC17-EGFP-expressing cells that were untreated or 
subjected to BFA washout. Scale bars represent 10 ^m. B. DHFIC17-EGFP-expressing cells 
under all treatments were scored for a Golgi localisation or an ER (dispersed) localisation. The 
total number of cells counted was 61 for the control condition, 50 for BFA treatment and 74 for 
BFA washout. This figure was kindly provided by Dr. Luke Chamberlain.
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sequence/structure of palmitoylated CSP may thus facilitate the movement into budding vesicle 
at the Golgi but not at the ER. Thus, the specific intracellular compartment at which CSP is 
palmitoylated, and hence stably anchored to, is likely to play a major role in determining 
targeting specificity.
6.6 D isc u ssio n
The finding that unpalmitoylated CSP mutants are localised to the ER (Chapter Four), but that 
CSP palmitoylating enzymes are localised to the Golgi apparatus (Chapter Five) was somewhat 
of a paradox. The apparent inverse correlation between the strength of membrane binding of 
CSP mutants and the incidence of palmitoylation suggested that the in itia l membranes 
interactions of CSP might somehow regulate palmitoylation, and that the ER localisations of 
CSP,.,* and CSP(C4-7L) might reflect perturbations of membrane binding prior to 
palmitoylation.
It is difficult to assess the membrane affinity of wild-type and mutant CSP in PC 12 cells, since 
CSP is so efficiently palmitoylated in this cell type. Therefore, HEK293 cells, which express 
only limited amounts of the DHHC proteins that are active against CSP (Figure 5.2), were used 
to examine the relative affinities of wild-type and mutant CSP for membranes in the absence of 
palmitoylation. In HEK293 cells, unpalmitoylated CSP is largely cytosolic (Figure 6.1/4), and 
membrane binding can be enhanced following the removal of the C-terminal domain (CSP,.136) 
or through mutations within the cysteine string domain (CSP(C4-7L)). As in PC 12 cells, these 
CSP mutants are localised to the ER, where they are physically separated from the Golgi- 
localised CSP palmitoylating enzymes (Figure 6.1C). The physical separation of CSP mutants 
from their partner DHHC proteins offers an explanation why these mutants are unable to be 
palmitoylated in PC 12 cells, and points to perturbations in initial membrane interactions being 
responsible for a loss of palmitoylation. Further experiments to compare membrane affinities 
could compare binding of CSP, CSP1136 and CSP(C4-7F) to liposomes, either employing 
ultracentrifugation or sucrose plasmon resonance measurements.
Pulse-chase labelling was used to analyse the membrane interactions of newly-synthesised wild- 
type CSP in PC 12 cells. CSP has an underlying weak membrane affinity in PC 12 cells, based 
on the finding that there is little change in the amount of unpalmitoylated CSP found in the 
membrane fraction over time (Figure 6.3A). In contrast, there was an increase in the 
palmitoylated pool of CSP in the membrane fraction (Figure 6.3A). This phenotype would be 
expected of a protein that has an underlying weak membrane affinity, and that only becomes
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stably membrane associated following palmitoylation. The addition of residues downstream 
from the cysteine string domain was found to weaken the membrane affinity of CSP C-terminal 
truncation mutants in PC12 cells (Figure 3.8/4 and C). To investigate whether the decrease in 
membrane binding of these mutants was due to a decrease in initial membrane interactions, the 
membrane binding of these mutants was assessed in HEK293 cells (Figure 6.2), and pulse-chase 
studies were employed in PC 12 cells (Figure 6.3B and C). Both sets of experiments showed 
that the addition of specific amino acids downstream from the cysteine string domain, in 
particular K137A-P138A-K139A, weakened CSP membrane affinity and prom oted 
palmitoylation in both cell types.
That CSP has such a weak membrane affinity implies that CSP may cycle on and off 
membranes until it becomes “trapped” by palmitoylation by a Golgi-localised DHHC protein. 
To determine whether CSP recognises a specific factor associated with the Golgi, the fungal 
metabolite Brefeldin A was utilised. BFA inhibits vesicle budding from the ER (Donaldson et 
al., 1991; Lippincott-Schwartz et al., 1989), blocking ER-to-Golgi transport and inducing the 
fusion of Golgi membranes with the ER, thereby promoting the loss of Golgi integrity. 
Treatment of both PC 12 and HEK293 cells with BFA had no effect on CSP palmitoylation, 
suggesting that an intact Golgi apparatus is not essential for CSP to locate its partner DHHC 
protein and that CSP does not recognise a specific factor associated with the Golgi. 
Furthermore, these findings highlight the fact that the subcellular localisation of CSP 
palmitoylating enzymes is not important for CSP palmitoylation. It is not known why CSP 
palmitolating enzymes are only localised to the Golgi; however, it is possible that factors 
associated with the Golgi are important for the sorting of CSP to secretory vesicles. In support 
of this notion, is the finding that following BFA treatment, the unpalmitoylated and ER- 
Iocalised mutant, CSP(C4-7L) was palmitoylated in both PC 12 and HEK293 cells, however, 
palmitoylation of CSP(C4-7L) did not allow its exit from the ER (Figure 6.8).
Palmitoylation is clearly essential for the sorting of CSP, but it is not clear whether 
palmitoylation plays an active role in this process (for example, by driving association of CSP 
with budding vesicles) or an indirect role (by promoting stable membrane attachment and thus 
allowing other domains of CSP to facilitate sorting). Whatever the mechanism, the experiments 
examining CSP(C4-7L) localisation following BFA washout (Figure 6.8) suggest that 
palmitoylation of CSP can be uncoupled from forward transport in the secretory pathway. It is 
possible that loss of specific palmitoylated cysteines in the CSP(C4-7L) mutant directly inhibits 
traffic from the ER (that is, that CSP needs to be fully palmitoylated to traffic). However, this is 
unlikely as other CSP mutants, which lack 3-4 cysteines residues, and hence palmitoylation
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sites, were identified in Chapter Four, and these traffic similarly to wild-type protein (Figure 
4.2F  and Figure 4.66; Upper panel). Thus, the view that forward traffic of palmitoylated CSP is 
linked to palmitoylation at a specific cell location (the Golgi) and that factors required for CSP 
sorting are not present at the ER following BFA washout is favoured.
CSP(C4-7L) is palmitoylated in HEK293 cells following BFA treatment in the absence of 
DHHC co-expression (Figure 6.7), suggesting that the limited level of endogenous DHHC 
protein present in HEK293 cells is sufficient to palmitoylate CSP(C4-7L) but not wild-type 
CSP. CSP(C4-7L) has a stronger membrane affinity than wild-type CSP (Figure 6.1), and thus 
it is possible that palmitoylation of CSP(C4-7L) is more efficient compared to wild-type CSP 
following BFA treatment due to a longer-lived membrane association increasing the probability 
of encountering a DHHC protein. Future work to test this notion might include experiments 
that allow the rate of CSP palmitoylation to be measured against the rate of CSP(C4-7L) 
palmitoylation following BFA treatment of HEK293 cells. In this experimental set-up, cells 
expressing CSP or CSP(C4-7L) would be treated with BFA (in the presence of cycloheximide) 
for different time-points prior to fractionation. This analysis may also be performed in the 
PC 12 cells transfected with CSP and CSP(C4-7L) in the presence of a palmitoylation inhibitor 
(such as 2-bromopalmitate). Palmitoylation of CSP and the CSP(C4-7L) mutant could then be 
compared at different time-points following the removal of the palmitoylation block and 
addition of BFA.
Further work will be needed to determine the factors that specify the sorting of palmitoylated 
proteins, such as CSP, into Golgi-derived secretory vesicles. It is possible that the specific lipid 
composition of the Golgi is well suited to accommodate lipid anchors such as palmitate groups. 
One hypothesis would be that palmitoylation increases the affinity of CSP for cholesterol-rich 
membrane domains, and that the increasing gradient of cholesterol from the ER-Golgi-plasma 
membrane may facilitate the onward trafficking of palmitoylated CSP onto vesicle membranes 
(Mitra et al., 2004).
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7.1 S u m m a r y
The study of protein palmitoylation has been fuelled in recent years by the identification of the 
DHHC family of palmitoyl transferases (Fukata et al., 2004; Linder and Deschenes, 2007). 
These enzymes are predicted to be polytopic membrane proteins encoding 4-6 transmembrane 
domains, which contain a conserved DHHC cysteine rich domain located cytoplasmically, 
which likely forms the enzyme’s active site (B artels et al., 1999; Ducker et al., 2004; 
Fernandez-Hemando et al., 2006; Fukata et al., 2004; Hayashi et al., 2005; Huang et al., 2004; 
Keller et al., 2004; Lam et al., 2006; Lobo et al., 2002; Politis et al., 2005; Roth et al., 2002; 
Smotrys et al., 2005; Swarthout et al., 2005; Valdez-Taubas and Pelham, 2005). Since their 
identification, DHHC proteins have been shown to be localised to many intracellular 
compartments, including the ER, Golgi apparatus, plasma membrane, endosomal compartments 
and the yeast vacuole (Dunphy et al., 1996; Fukata et al., 2004; Huang et al., 2004; Keller et al., 
2004; Roth et al., 2002; Schroeder et al., 1996; Singaraja et al., 2002; Swarthout et al., 2005; 
Uemura et al., 2002; Valdez-Taubas and Pelham, 2005; Veit et al., 2001).
Since DHHC proteins are membrane-associated, all substrate proteins must contain additional 
membrane targeting signals to mediate membrane association prior to palmitoylation. There are 
several mechanisms that substrate proteins use to reach the membrane that houses their partner 
DHHC protein. A majority of palmitoylated proteins are associated with membranes prior to 
palmitoylation because they are transmembrane proteins (R o th  et al., 2006), and their 
membrane-spanning domains are inserted into the ER membrane co-translationally, allowing 
them to traffic through the secretory pathway until they reach their partner DHHC protein. 
Other palmitoylated proteins first become modified by another lipid moiety, such as isoprenyl 
or myristoyl groups, which confers sufficient hydrophobicity to allow the protein to interact 
transiently with membranes.
However, a subset of palmitoylated proteins are synthesised on free ribosomes and do not 
undergo any known type of lipid modification other than palmitoylation. Examples of such 
proteins include the enzyme GAD-65, the SNARE protein SNAP-25, the scaffolding protein 
PSD-95 and the exocytotic chaperone protein CSP. The mechanisms employed by this class of 
palmitoylated proteins for initial membrane targeting are not well understood.
The aim of this study was to identify the mechanisms that govern the initial membrane binding, 
palmitoylation and subsequent trafficking of CSP. It was hoped that these analyses, as well as 
providing essential information on CSP, would also serve as a paradigm to understand the
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pathway of palmitoylation utilised by other palmitoylated proteins. In this study, the intrinsic 
elements that target CSP to the membranes where palmitoyl transferases are localised has been 
determined and the enzymes that palmitoylate CSP identified.
The results of this study present evidence that:
1. The minimum membrane-binding domain of CSP is composed of residues 106-136, 
which include the cysteine string domain (113-136) and a short stretch of amino acids 
immediately upstream in the linker domain.
2. Mutations that enhance CSP membrane affinity promote mislocalisation and inhibit 
palmitoylation.
3. Membrane association prior to palmitoylation relies on the intrinsic hydrophobicity of 
cysteine residues present in the cysteine string domain; mutation of the cysteines to 
more hydrophilic amino acids (for example, serine residues) abolishes membrane 
binding of full-length CSP.
4. Palmitoylation of CSP is dependent upon amino acids downstream of the cysteine string 
domain, which are important to weaken membrane affinity of the unpalmitoylated 
protein.
5. The affinity of CSP for membranes regulates palmitoylation, and these two factors are 
inversely correlated.
6. The Golgi-localised enzymes DHHC3, -7, -15 and -17 palmitoylate CSP.
7. Palmitoylation of CSP specifically on Golgi membranes may be important for the 
subsequent sorting of CSP.
7.2 A MODEL OF CSP MEMBRANE INTERACTIONS, PALMITOYLATION AND TRAFFICKING
Based upon these results, a model for CSP membrane binding and palmitoylation is proposed. 
In this model, CSP utilises a weak membrane affinity to bind transiently to cell membranes and 
‘sample’ them for DHHC content. This weak membrane affinity requires interplay between the 
hydrophobic cysteine-rich domain and downstream residues. Upon association with Golgi 
membranes, CSP is recognised by DHHC3, -7, -15, or -17, which catalyse the palmitoylation 
and stable membrane anchoring of CSP, facilitating forward transport (Figure 7.1/4). CSP 
mutants that have an enhanced membrane affinity rapidly and irreversibly bind to the most 
abundant cellular membranes, such as the ER, where they become physically separated from 
their palmitoylating enzymes (Figure 7.16). BFA treatment induces the fusion of ER and Golgi 
membranes and puts CSP(C4-7L) and DHHC proteins on the same membrane compartment.
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Figure 7.1 Membrane binding and palm itoylation o f CSP. A . CSP utilises a weak 
membrane affinity to sample intracellular membranes (1). Upon binding to Golgi membranes, 
CSP is recognised and palmitoylated by its partner DHHC proteins (2). Palmitoylation leads to 
stable membrane binding of CSP, and may facilitate forward transport. 8. The enhanced 
membrane affinity of CSPi.136 and CSP(C4-7L) leads to tight binding to the most abundant 
cellular membranes, such as the ER, and physical separation from Golgi-localised DHHC 
proteins. C. Brefeldin A (BFA) treatment induces the fusion of ER and Golgi membranes and 
puts CSP(C4-7L) and DHHC proteins on the same membrane compartment. This membrane 
mixing allows palmitoylation of CSP(C4-7L) but is not sufficient to allow transport out of the ER.
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This membrane mixing allows palmitoylation of CSP(C4-7L) but is not sufficient to allow 
transport out of the ER, suggesting that the membrane integrity of the Golgi apparatus is 
required for the subsequent sorting and transport of CSP onto secretory vesicles (Figure 7.1C).
At the heart of this model is the proposed transient membrane association of CSP. Although 
direct data to show reversible association of CSP with membranes has not been demonstrated, 
the following points support this idea:
1. Specific mutations around or within the cysteine string domain lead to stable membrane 
binding, consistent with the wild-type protein having an underlying membrane affinity.
2. In silico analysis identified a region in CSP including the cysteine string domain having 
a propensity to move to the membrane interface but not traverse the bilayer, and 
experiments in vitro showed an association of recombinant CSP with isolated cellular 
membranes (Boal et al., 2007).
3. Pulse-chase experiments in PC 12 cells reveal a tim e-dependent increase in 
palm itoylated CSP on membranes but very little change in the extent of 
unpalmitoylated CSP in the membrane fraction (Figure 6.3A). These observations 
would be predicted if CSP was rapidly associating/dissociating from membranes and 
required palmitoylation for stable membrane binding.
Future work might employ the use of FRAP (fluorescence recovery after photobleaching) 
techniques to directly demonstrate the association/dissociation of CSP with intracellular 
membranes (Goodwin et al., 2005; Rocks et al., 2005). Another approach would be to use 
surface plasmon resonance to measure CSP binding to immobilised lipids (Besenicar et al., 
2006).
The model for CSP membrane binding and palmitoylation presented in this study is reminiscent 
of the kinetic trapping model proposed by Shahinian and Silvius (Shahinian and Silvius, 1995) 
for prenylated or myristoylated proteins, as exemplified by recent work studying palmitoylation 
and trafficking of H- and N-Ras (Goodwin et al., 2005; Rocks et al., 2005). Famesylation of 
these proteins provides a weak membrane affinity (Magee et al., 1987; Shahinian and Silvius, 
1995), which is presumed to allow Ras to cycle on and off membranes, where it can “sample” 
the different intracellular membranes, until it eventually encounters a membrane housing its 
partner PAT. Because the Ras palmitoyl transferase, DHHC9, is localised to ER/Golgi 
membranes (Swarthout et al., 2005), palmitoylation only occurs on these membranes. 
Palmitoylation confers a stronger membrane affinity to a protein than does prenylation or
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myristoylation (Peitzsch and McLaughlin, 1993; Shahinian and Silvius, 1995; Silvius and 
l'Heureux, 1994), and may ensure that a protein does not dissociate from membranes during 
vesicle budding and trafficking. Palmitoylation of Ras at the ER/Golgi probably allows Ras to 
access the secretory pathway, thus facilitating its forward transport to the plasma membrane 
(Goodwin et al., 2005; Rocks et al., 2005). The results presented in this thesis suggest that 
membrane ‘sampling’ through transient membrane interactions is not restricted to lipidated 
(prenylated or myristoylated) proteins, but may also occur through specialised protein domains, 
such as the cysteine string domain of CSP.
7.3 C o n c l u d in g  r e m a r k s
It is clear that palmitoylation can be a more intricate signal than simply providing a hydrophobic 
membrane anchor. The multiple functions of palmitoylation are diverse and wide: 
palmitoylation targets both soluble and transmembrane proteins to distinct membrane 
compartments and membrane microdomains (El-Husseini et al., 2001; Roy et al., 2005; Salaiin 
et al., 2005); it is responsible for the trafficking of proteins between various intracellular 
organelles (Goodwin et al., 2005; Kang et al., 2004; Kinlough et al., 2006; Rocks et al., 2005); 
it promotes protein stability (Lam et al., 2006; Linder and Deschenes, 2007; Valdez-Taubas and 
Pelham, 2005); and regulates protein-protein interaction (Hayashi et al., 2005). In addition, 
palmitoylation is unique in that it is a reversible modification; indeed, many of the varied 
functions of palmitoylation rely on this fact (Rocks et al., 2005). Furthermore, the reversibility 
of palmitoylation means that it can be viewed as a process that must be under regulation. The 
identification of twenty-three mammalian DHHC proteins has been critical towards 
understanding the diverse functions of palmitoylation. Importantly, the discovery that DHHC 
proteins and/or palmitoyl transferase activity is localised to multiple subcellular membranes 
raises an important question: what regulates the specificity of palmitoylation reactions? For 
example, is specificity encoded by the DHHC proteins, the subcellular localisation of the 
DHHC proteins, or a combination of these factors? This question could be addressed by 
studying palmitoylation of CSP in vitro using purified enzymes. Under these conditions, is CSP 
still only palmitoylated by DHHC3, -7, -15 and -17, or does the removal of cell constraints now 
allow other DHHC enzymes to palmitoylate CSP?
A CSP mutant protein that associates with ER membranes can effectively be palmitoylated once 
the Golgi-localised palmitoyl transferases are redistributed following BFA treatment of cells. 
Thus it is likely that one form of regulation is brought about by the specific subcellular 
localisation of the different DHHC proteins. Determining the factors that target the individual
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DHHC proteins to their resident membrane compartment would help in understanding how 
DHHC protein localisation is spatially regulated. Interestingly, the length of a protein’s 
membrane-spanning domain has been found to be an important factor in determining the 
subcellular localisation of membrane proteins (Bretscher and Munro, 1993). Site-directed 
mutagenesis could be used to artificially change the length of membrane-spanning domains in 
DHHC proteins. Mutating the hydrophobic amino acids that are positioned at the border of the 
membrane-spanning domain to hydrophilic amino acids would artificially shorten the length of 
the membrane-spanning domain; in contrast, the residues that flank membrane-spanning 
domains could be mutated to hydrophobic amino acids to artificially lengthen membrane- 
spanning domains. Such studies may reveal factors that govern the various subcellular 
localisations of different DHHC proteins. However, comparison of predicted membrane- 
spanning length in DHHC proteins present at distinct intracellular locations does not reveal any 
obvious differences. Another intriguing possibility is that palmitoylation regulates the sorting 
of specific DHHC proteins. It is well established that DHHC proteins are palmitoylated in their 
DHHC domain (Fukata et al., 2004); interestingly, removal of the DHHC domain of DHHC 17 
led to a loss of Golgi targeting (Huang et al., 2004).
The mechanism by which DHHC proteins transfer palmitoyl groups onto substrate proteins is 
also unknown. Several studies, including this one, have shown that mutating the conserved 
cysteine within the DHHC motif renders DHHC proteins catalytically inactive (Ducker et al., 
2004; Fernandez-Hemando et al., 2006; Fukata et al., 2004; Hayashi et al., 2005; Huang et al., 
2004; Lam et al., 2006; Lobo et al., 2002; Roth et al., 2002; Smotrys et al., 2005; Swarthout et 
al., 2005; Valdez-Taubas and Pelham, 2005). In addition, many studies have reported that the 
conserved cysteine residue within the DHHC motif become palmitoylated itself, with the 
suggestion that DHHC proteins form acyl-enzyme intermediates (Ducker et al., 2004; Fukata et 
al., 2004; Hayashi et al., 2005; Keller et al., 2004; Lobo et al., 2002; Roth et al., 2002; Smotrys 
et al., 2005; Swarthout et al., 2005). Understanding how DHHC proteins are able to 
palmitoylate substrate proteins is key to determining how palmitoylation reactions are regulated.
Another useful method to analyse how DHHC substrate specificity is regulated would be the 
creation of chimeric DHHC proteins. For example, the DHHC-CRD of a Golgi-localised 
enzyme inactive against CSP (for example, DHHC11) could be replaced with the cysteine-rich 
domain of DHHC3, -7, -15 or -17, and this chimeric DHHC protein could be assessed for its 
ability to palmitoylate CSP. This type of experiment would determine whether the DHHC-CRD 
of a PAT is responsible for substrate recognition. Furthermore, creating a chimeric ER- 
localised DHHC protein that has the DHHC-CRD of a CSP-palmitoylating PAT could extend
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this type of experiment. If such chimeras were active towards CSP, then it would be possible to 
conclude that the subcellular localisation of the PAT is not a factor determining either substrate 
specificity or enzymic acitivity.
In addition to the questions detailed above, many other important aspects about DHHC proteins 
and CSP palmitoylation should be addressed, including: (i) What DHHC proteins are expressed 
in PC 12 cells? The generation of antibodies against specific DHHC proteins would be a 
valuable tool to investigate this; additionally, quantitative PCR would be a useful approach to 
determine the relative levels of DHHC mRNA in vivo; (ii) What effect does RNAi knockdown 
of DHHC expression have on CSP palmitoylation?; (iii) How does palmitoylation of CSP at the 
Golgi facilitate sorting into budding vesicles? The specific lipid composition of the Golgi may 
be one factor, and this could be analysed for example following cholesterol depletion of cells or 
by disrupting the synthesis of specific phospholipids; (iv) As CSP mutants with reduced 
palmitoylation are efficiently sorted, what function does multiple palmitoylation of CSP play? 
In this regard it would be interesting to deplete cells of endogenous CSP using siRNA and 
compare the abilities of transfected (siRNA-resistant) CSP palmitoylation mutants to support 
exocytosis. These experiments should strengthen our understanding of the mechanisms 
involved in CSP membrane binding, palmitoylation and trafficking, and the role that 
palmitoylation plays in CSP function.
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A p p e n d ix  O n e : O l ig o n u c l e o t id e  p r im e r s  u s e d  t o  g e n e r a t e  CSP N -t e r m in a l
TRUNCATION MUTANTS
CSPg3_]3g
Fwd 5 ’ -GCTCAAGCTTCTTGCTCTACGTGGCCGAGCAG-3 ’
C S P ^ 136
Fwd 5 ’ -GCTC A AGCTTGTACGTGGCCGAGCAGTTC-3 ’
CSP87_136
Fwd 5 ’ -GCTCAAGCTTGGCCGAGCAGTTCGGGGAG-3 ’
CSP89.136
Fwd 5 ’ -GCTCAAGCTTGCAGTTCGGGGAGGAGAAC-3 ’
CSP91.136
Fwd 5 ’ -GCTCAAGCTTGGGGGAGGAGAACGTGAAC-3 ’
CSP92.136
Fwd 5 ’ -GCTCAAGCTTGGAGGAGAACGTGAACACC-3 ’
CSP*.,*
Fwd 5 ’ -GCTCAAGCTTGGAGAACGTGAACACCTAC-3 ’
CSPc(4.i36
Fwd 5 ’ -GCTCAAGCTTGAA CGTGAACA CCTA CTTTG-3 ’
CSP95_136
Fwd 5 ’ -GCTCAAGCTTGGTGAACACCTACTTTGTG-3 ’
CSP*.,3* 
Fwd 5 ’ -GCTCAAGCTTGACCTACTTTGTGCTCTCC-3 ’
CSP 100-136
Fwd 5’ -CACAAGCTTGGTGCTCTCCAGCTGGTGG-3’
CSP103.i36
Fwd 5’ -TGTAAGCTTGAGCTGGTGGGCCAAGGCC-3 ’
CSP 106-136 
Fwd 5 ’ -GG A AGCTTGGCCG AAGGCCCTGTTCATCTTC-3 ’
CSP 107-136 
Fwd 5 ’ -GGAAGCTTGAAGGCCCTGTTCATCTTCTGTG-3 ’
CSP 109-136 
Fwd 5’ -GGAAGCTTGCTGTTCATCTTCTGTGGG-3’
CSPj jo-136 
Fwd 5 ’ -GGAAGCTTGTTCATCTTCTGTGGGCTG-3 ’
CSP] ii.i36 
Fwd 5 ’ -GG A AGCTTG AT CTT CT GT GGGCT CCTC-3 ’
CSP] 12.136
Fwd 5’ -GGAAGCTTGTTCTGTGGGCTCCTCACC-3 ’
CSPj i3.,36 
Fwd 5 ’ -GGAAGCTTGTGTGGGCTCCTCACCTGCTGC-3 ’
CSPX-i36
Rev 5 ’ -CGCGG ATCCTTAGCACTTGCCACAGCAGCA-3 ’
CSPX.,98
Rev 5 ’ -GG ATCCTT AGTTGAACCCGTCGGTGTG-3 ’
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A p p e n d ix  T w o :  O l i g o n u c l e o t i d e  p r im e r s  u s e d  t o  g e n e r a t e  CSP C - t e r m i n a l
TRUNCATION MUTANTS
CSP 1.1]2
Fwd 5 ’ -CAAGGCCCTGTTCATCTTCTAATGTGGGCTCCTCACCTGCTG-3 ’
Rev 5 ’ -CAGCAGGTGAGG AGCCCACATTAGAAG ATGAACAGGGCCTTG-3 ’
CSP]137
Fwd
Rev
5 ’ -CTGCTGTGGCAAGTGCA AGTAACCCAAGGCGCCTGAGGGG-3 ’ 
5’-CCCCTCAGGCGCCTTGGGTTACTTGCACTTGCCACAGCAG-3’
CSP 1.]38
Fwd
Rev
5 ’ -GTGGCAAGTGCAAGCCCTAAAAGGCGCCTG AGGGGGAGG AG-3 ’ 
5’-CTCCTCCCCCTCAGGCGCCTTTTAGGGCTTGCACTTGCCAC-3’
CSP]_139
Fwd
Rev
5 ’ -GGCAAGTGCA AGCCCAAGT A AGCGCCTGAGGGGGAGGAG-3 ’ 
5 ’-CTCCTCCCCCTCAGGCGCTTACTTGGGCTTGCACTTGCC-3 ’
CSP |.140
Fwd
Rev
5 ’ - CA AGTGCAAGCCCAAGGCGTA ACCTG AGGGGGAGGAGACG-3 ’ 
5 ’- CGTCTCCTCCCCCTCAGGTTACGCCTTGGGCTTGCACTTG-3’
CSP !-14]
Fwd
Rev
5 ’ - GTGCAAGCCCAAGGCGCCTTAAGAGGGGGAGGAGACGGAG-3 ’ 
5 ’- CTCCGTCTCCTCCCCCTCTTAAGGCGCCTTGGGCTTGCAC-3’
CSP | - 1 4 2
Fwd
Rev
5 ’ - CA AGCCC AAGGCGCCTG AGTA AGGGG AGG AG ACGG AGTTC-3 ’ 
5 ’ - GAACTCCGTCTCCTCCCCTTACTCAGGCGCCTTGGGCTTG-3 ’
CSP ] _ i 4 3
Fwd
Rev
5 ’ - GCCCAAGGCGCCTGAGGGGTAAGAGGAGACGGAGTTCTATG-3 ’ 
5’- CATAGAACTCCGTCTCCTCTTACCCCTCAGGCGCCTTGGGC-3’
CSP i  - 1 4 4
Fwd
Rev
5 ’ -CCC AAGGCGCCTGAGGGGG AGT A AG AG ACGG AGTTCTATGTGTC-3 ’ 
5 ’- GACACATAGAACTCCGTCTCTTACTCCCCCTCAGGCGCCTTGGG-3’
CSP i_)45
Fwd
Rev
5 ’ - GGCGCCTG AGGGGG AGG AGT A AACGG AGTTCT ATGTGTCCC-3 ’ 
5 ’ - GGGACACATAGAACTCCGTTTACTCCTCCCCCTCAGGCGCC-3 ’
CSP ] . 1 4 6
Fwd
Rev
5’- GCGCCTGAGGGGGAGGAGACGTAAGAGTTCTATGTGTCCCCCG-3’ 
5 ’ - CGGGGG ACACATAG A ACTCTT ACGTCTCCTCCCCCTCAGGCGC-3 ’
CSP j.156
Fwd
Rev
5 ’ - GTCCCCCGAGGACCTGGAGTAAGCGCAGCTGCAGTCCGATG-3 ’ 
5 ’ - CATCGGACTGCAGCTGCGCTTACTCCAGGTCCTCGGGGGAC-3 ’
CSP,.,*
Fwd 5 ’ - GTCCGATGAGAGGGAGGCCTAAGCAGACACGCCGATCGTC-3 ’
Rev 5 ’ - GACGATCGGCGTGTCTGCTTAGGCCTCCCTCTCATCGGAC-3 ’
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A p p e n d ix  T h r e e : O l ig o n u c l e o t id e  p r im e r s  u s e d  t o  g e n e r a t e  C SP s it e -d ir e c t e d
MUTANTS
K107A
Fwd 5 ’-CTCTCCAGCTGGTGGGCCGCGGCCCTGTTCATCTTCTG-3 ’
Rev 5 ’ -CAGAAG ATGAACAGGGCCG£GGCCC ACCAGCTGGAGAG-3 ’
K107E
Fwd S’-GCTCTCCAGCTGGTGGGCCGAGGCCCTGTTCATCTTCTG-S’
Rev 5 ’ -CAGAAGATGAACAGGGCCTCGGCCCACCAGCTGGAGAGC-3 ’
K107R
Fwd 5 ’ -CTCTCCAGCTGGTGGGCCCGGGCCCTGTTCATCTTCTG-3 ’
Rev 5 ’ -C AGAAG ATGAACAGGGCCCGGGCCCACCAGCTGGAGAG-3 ’
LI 09 A
Fwd 5 ’ -CAGCTGGTGGGCCAAGGCCGCGTTCATCTTCTGTGGGCTC-3 ’
Rev 5 ’-GAGCCCACAGAAGATGAACGCGGCCTTGGCCCACCAGCTG-3’
L109E
Fwd 5 ’ -GCTGGTGGGCCAAGGCCGAGTTCATCTTCTGTGGGCTC-3 ’
Rev 5’-GAGCCCACAGAAGATGAAClCGGCCTTGGCCCACCAGC-3’
K107A/L109A
Fwd 5’-CTCCAGCTGGTGGGCCGCGGCCGCGTTCATCTTCTGTGGG-3’
Rev 5 ’ -CCCACAG A AGATGAACGCGGCCGCGGCCCACCAGCTGG AG-3 ’
K107E/L109E
Fwd 5 ’-CTCCAGCTGGTGGGCCGAGGCCGAGTTCATCTTCTGTGGG-3’
Rev 5 ’ -CCCACAG AAG ATG AACTCGGCCT£GGCCCACC AGCTGG AG-3 ’
K137A
Fwd 5 ’-GCTGCTGTGGCAAGTGCGCGCCCAAGGCGCCTGAGG-3’
Rev 5 ’ -CCTC AGGCGCCTTGGGCGCGCACTTGCC ACAGCAGC-3 ’
K137E
Fwd 5 ’ - GCTGCTGTGGCAAGTGCGAGCCCAAGGCGCCTGAGG-3 ’
Rev 5 ’ - CCTCAGGCGCCTTGGGCTCGCACTTGCCACAGCAGC-3 ’
K137R
Fwd 5 ’- GCTGCTGTGGCAAGTGCCGGCCCAAGGCGCCTGAGG-3’
Rev 5 ’ - CCTCAGGCGCCTTGGGCCGGCACTTGCCACAGCAGC-3 ’
P138A
Fwd 5 ’ -GCTGTGGCAAGTGCAAGfiCCA AGGCGCCTGAGGGGG-3 ’
Rev 5 ’ -CCCCCTCAGGCGCCTTGGCCTTGC ACTTGCC AC AGC-3 ’
K139A
Fwd 5 ’ -GTGGCAAGTGCA AGCCCGCGGCGCCTGAGGGGGAGG-3 ’
Rev 5’-CCTCCCCCTCAGGCGCCGCGGGCTTGCACTTGCCAC-3’
A140L
Fwd 5 ’ -GGCAAGTGCAAGCCCAAGCTGCCTGAGGGGG AGGAGAC-3 ’
Rev 5 ’ -GTCTCCTCCCCCTCAGGC AGCTTGGGCTTGCACTTGCC-3 ’
P141A
Fwd 5 ’ -CA AGTGC A AGCCCAAGGCGGCTGAGGGGGAGGAG ACGG AG-3 ’
Rev 5 ’ -CTCCGTCTCCTCCCCCTC AGCCGCCTTGGGCTTGCACTTG-3 ’
El 42 A
Fwd 5’-GTGCAAGCCCAAGGCGCCTGCGGGGGAGGAGACGGAGTTC-3’
Rev 5 ’ -GAACTCCGTCTCCTCCCCCGCAGGCGCCTTGGGCTTGCAC-3 ’
G143A
Fwd 5’-GCCCAAGGCGCCTGAGGCGGAGGAGACGGAGTTCTATGTG-3’
Rev 5 ’-CACATAGAACTCCGTCTCCTCCGCCTCAGGCGCCTTGGGC-3’
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C l-3 A
Fwd 5 ’ -GTTCATCTTC£CTGGGCTCCTCACC£CC£CCTACTGTTGC-3 ’
Rev______ 5 ’-GCAACAGTAGGCGG£GGTGAGGAGCCCAGCGAAGATGAAC-3’
C4-7A
Fwd 5 ’ -CACCTGCTGCTACGCTGCCGCCGCCCTCTGCTGCTGCTTC-3 ’
Rev______ 5 ’ -GA AGCAGCAGCAGAGGGCGGCGGCAGCGTAGCAGCAGGTG-3 ’
C4-7L
Fwd 5’-
GCCTCCT C ACCT GCT GCTACCTT CTCCTTCTCTT AT GCT GTT GCTT 
TAACTG-3’
Rev 5’-
CAGTTAAAGCAACAGCATAAGAGAAGGAGAAGGTAGCAGCAGGT 
GAGGAGGC -3’
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A p p e n d ix  Fo u r : O l ig o n u c l e o t id e  p r im e r s  u se d  t o  g e n e r a t e  in a c t iv e  DHHC 15 
DHHC15(C159S)
Fwd 5’-GTTTTAAAAATGGACCATCATT£CCCATGGGTTAATAACTGCATTG-3’ 
Rev 5’-CAATGCAGTTATTAACCCATGGGGAATGATGGTCCATTTTTAAAAC-3’
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